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Abstract 
αβ T cell Receptors (TCR) recognise peptide antigen (p) presented on Major 
Histocompatability Complexes (MHC) via Complementarity Determining Regions (CDRs).  
TCRs are required to respond to a vast plethora of differing antigens and the CDR regions are 
suitably diverse, encoded by an array of gene-segments, which recombine during T cell 
development to generate diverse repertoires of TCRs.  CDR1 and 2, which predominantly 
interact with the MHC, are encoded within gene-segments, and are subject to evolutionary 
pressure. However, CDR3 loops are non-germline and created through junctional diversity. 
TCRs are ‘MHC restricted’ and only respond to antigen in the context of MHC. An influential 
theory proposes that CDR1 and 2 have co-evolved with MHC and as such are inherently 
predisposed towards MHC recognition. This thesis used preliminary data derived from whole 
genome analysis of TCR CDR1 and 2 diversity relative to those of related immunoglobulins 
(which are not MHC restricted) to determine if there is any relationship between germline 
CDR diversity and MHC restriction. Conventional mutagenesis involving substituting CDR1 
and 2 with artificial peptide linkers and replacement of βCDR1 and 2 with those of the related 
yet MHC unrestricted γTCR chain was carried out in concert with a novel system that 
embedded recombination cassettes into the CDR1 or 2 allowing in vivo generation and 
selection of a library of non-germline CDR1 or 2 mutants. Collectively, these data strongly 
infer a lack of requirement of germline CDR sequences in mediating MHC recognition in 
both pMHC-mediated T cell development and function. However, alteration of the germline 
sequence did affect the efficiency of T cell development, preference of MHC class type and 
the diversity of the subsequent T cell repertoire. Thus, germline CDR structures may facilitate 
a more diverse array of MHC docking modes to maximise the resultant TCR repertoire, 
contributing to an increased capacity for cross-reactivity, rather than imposing MHC 
restriction.  
 
 
 
 
 
 
 
  6 
Acknowledgements 
I would like to first and foremost acknowledge Julian for all his help, supervision and 
encouragement for the past three and a half years. I greatly appreciate your enthusiasm for my 
project and that from my very first week as a Masters student that you were open and 
interested in my ideas and opinions. Thank you also for the support you gave me when 
undertaking things not directly related to my project including my internship and 
presentations at the Houses of Parliament. (Also, thanks for the Bob Dylan tickets!). 
In terms of technical assistance, I would like to thank Julian, Chai and Cristina for carrying 
out mouse work while I was being trained. I sincerely thank David for carrying out the skin 
grafting operations used for this work and teaching me how to score the experiments. This lab 
is truly the most altruistic I have come across and I am very much indebted to all your help 
over the last 3 and half years. I thank the previous students who contributed to making some 
of the original TCR constructs during their Masters projects, namely Matt, Eleni and Ed. I am 
indebted to our collaborators, Immanuel Luescher and Raphael Genolet for running my 
cDNA samples through their TCRβ V-segment qRT-PCR analysis. Ashkenaz Richard, an 
MSc student under my supervision, generated the βCDR1γ2γ3Δ constructs based on my design 
and tested the constructs in vitro. Immunohistochemistry was kindly carried out by Fang-Ping 
and autoantibody ELISAs with Marta Szajna. Most of all I would like to thank Istvan, who 
designed and optimised the retrogenic approach for modified TCRs used in our lab and who 
literally taught me almost every technical aspect that was required to carry out this work 
during my own Masters rotation and at the beginning of my PhD. 
Finally, I would like to acknowledge the fellow PhD students from the Wellcome Trust 
course for the fantastic sense of camaraderie and co-workers from the 10th floor immunology 
department for making the day to day working in the lab as enjoyable as it was. In particular I 
would like to acknowledge Eoin, Nick and Sonja for experiencing London and beyond with 
me over the past 4 years and I look forward to the inevitable crossing of paths in the future. 
Thanks to Chris and Graeme for indulging in my request to play some final gigs in 2010 and 
2011 back up home, it was by the far the most enjoyable time I think we had and is no doubt 
not over yet. 
 
 
  7 
List of papers submitted and published as a result of the work carried out during this 
thesis 
• Bartok, I., S. J. Holland, H. W. Kessels, J. D. Silk, M. Alkhinji & J. Dyson, (2010) T 
cell receptor CDR3 loops influence alphabeta pairing. Mol Immunol 47: 1613-1618. 
• Furmanski, A. L., I. Bartok, J. G. Chai, Y. Singh, C. Ferreira, D. Scott, S. J. Holland, 
C. Bourdeaux, T. Crompton & J. Dyson, Peptide-specific, TCR-alpha-driven, 
coreceptor-independent negative selection in TCR alpha-chain transgenic mice. J 
Immunol 184: 650-657. 
• Holland, S.J., I. Bartok, M. Attaf, R. Genolet, I.F. Luescher, E. Kotsiou, A. Richard, 
E. Wang, M. White, D. Coe, J-G. Chai, C. Ferreira and J. Dyson. The αβTCR uses an 
antibody-like strategy to engage MHC ligands, Submitted. 
 
 
 
                
  8 
Table of Contents 
ABSTRACT........................................................................................................................................................ 5 
ACKNOWLEDGEMENTS................................................................................................................................ 6 
LIST OF PAPERS SUBMITTED AND PUBLISHED AS A RESULT OF THE WORK CARRIED OUT 
DURING THIS THESIS.................................................................................................................................... 7 
TABLE OF FIGURES......................................................................................................................................11 
LIST OF TABLES............................................................................................................................................13 
ABBREVIATIONS ..........................................................................................................................................14 
CHAPTER 1: INTRODUCTION...................................................................................................................18 1.1 OVERVIEW OF ADAPTIVE IMMUNITY RECEPTOR EVOLUTION, THE T CELL RECEPTOR AND MHC RESTRICTION.....................................................................................................................................................................18 
1.1.1 Evolution of adaptive immunity receptor diversity...........................................................................18 
1.1.2 T cells and the αβTCR .....................................................................................................................................21 
1.1.3 Discovery and characterisation of MHC restriction ..........................................................................25 1.2 T CELL DEVELOPMENT AND THYMIC SELECTION.................................................................................................26 
1.2.1 Overview of the thymus and homing of stem cells for T cell development ..............................26 
1.2.2 Early development and commitment to the αβ lineage ..................................................................28 
1.2.3 T cell selection, CD4/8 lineage choice and post­thymic development.......................................31 
1.2.4 Development and selection of nTregs and other T cell sub­types................................................34 1.3 GENERATION OF THE TCR REPERTOIRE ..............................................................................................................37 
1.3.1 Genetic structure of the αβ TCR loci in mice and humans..............................................................37 
1.3.2 V(D)J recombination .......................................................................................................................................39 
1.3.3 Maximising and maintaining TCR repertoire diversity ...................................................................41 1.4 TCR‐PMHC INTERACTIONS ...................................................................................................................................44 
1.4.1 The MHC – an overview..................................................................................................................................44 
1.4.2 TCR binding to pMHC complexes ...............................................................................................................48 
1.4.3 CD4 and CD8: Structure, ligand binding and function .....................................................................53 
1.4.4 TCR binding and triggering mechanisms...............................................................................................56 
1.4.5 TCR­pMHC in disease: Alloreactivity and autoreactivity ................................................................61 1.5 THE MECHANISM OF TCR RESTRICTION TO MHC..............................................................................................66 
1.5.1 Germline encoded restriction of TCR CDR1 and 2 to MHC .............................................................66 
1.5.2 Evidence against germline restriction of TCR to MHC and alternative theories ..................74 1.6 AIM OF PROJECT ........................................................................................................................................................82 
CHAPTER 2: GERMLINE TCR CDR ANALYSIS AND OVERVIEW OF EXPERIMENTAL 
APPROACH.....................................................................................................................................................83 2.1 COMPARISON OF TCR AND IG GERMLINE CDR1 AND 2 REPERTOIRES ..........................................................83 
2.1.1 Overview ...............................................................................................................................................................83 
2.1.2 Comparison of CDR1 and 2 lengths in TCR and Ig molecules........................................................84 
2.1.3 Analysis of germline CDR1 and 2 diversity in TCR and Ig molecules .........................................86 
2.1.4 Conservation of CDR position is not directly related to MHC recognition...............................94 2.2 DESIGN AND OVERVIEW OF RETROGENIC APPROACH USED TO STUDY TCR CDR1 AND 2 .........................95 
2.2.1 Overview ...............................................................................................................................................................95 
2.2.2 Overview of retrogenic system....................................................................................................................95 
2.2.3 Generation of modified TCRα and β chains...........................................................................................99 
2.2.4 General comments on using a retrogenic approach ......................................................................102 2.3 CHAPTER SUMMARY.............................................................................................................................................. 104 
CHAPTER 3: DESIGN AND USE OF A NOVEL IN VIVO MEDIATED RECOMBINATION SYSTEM 
TO MUTATE TCR CDR1 AND 2 .............................................................................................................. 106 3.1 REDIRECTION OF V(D)J RECOMBINATION TO WT TCRβ CDR1 AND 2 GENERATES FUNCTIONAL TCRS IN VIVO THAT CAN MEDIATE MHC RECOGNITION................................................................................................... 106 
3.1.1 Overview of constructs ................................................................................................................................106 
  9 
3.1.2 Adoptive transfer of transduced HSC and detection of T cell selection..................................107 3.2 MATURE T CELLS GENERATED FROM RECOMBINATION CASSETTES INSERTED INTO WT TCRβ CDR1 AND 2 HAVE A DIVERSE NON‐GERMLINE REPERTOIRE ........................................................................................... 109 
3.2.1 Sorting of peripheral T cells and detection of recombined TCRβ chains ..............................109 
3.2.2 Analysis of in vivo generated non­germline CDR1 and 2 repertoires .....................................110 
3.2.3 Increase in net positive charge detected in modified CDR1 and CDR2 ..................................117 3.3 REDIRECTION OF V(D)J RECOMBINATION TO THE CDR1 OF A TCRβ CHAIN LACKING BOTH GERMLINE CDRS PRODUCES A NON‐GERMLINE REPERTOIRE INDEPENDENT OF WT SEQUENCE...................................... 120 
3.3.1 Overview of construct ..................................................................................................................................120 
3.3.2 Adoptive transfer of transduced HSC and detection of T cell selection..................................121 3.4 MATURE T CELLS GENERATED FROM RECOMBINATION CASSETTES INSERTED INTO A TCRβ CDR1 GENERATE DIVERSE CDR1 REGIONS INDEPENDENT OF ANY GERMLINE STRUCTURE ...................................... 123 
3.4.1 Sorting of peripheral T cells and detection of recombined TCRβ chains ..............................123 
3.4.2 Analysis of in vivo generated WT CDR independent CDR1 repertoire....................................124 3.5 CHAPTER SUMMARY.............................................................................................................................................. 129 
CHAPTER 4: FUNCTIONAL ANALYSIS OF TCRα  AND TCRβ  CDR1 AND 2 ................................ 132 4.1 DESIGN, GENERATION AND TESTING OF TCR MUTANTS ................................................................................ 132 
4.1.1 Design of TCRα and TCRβ CDR1 and 2 mutants ..............................................................................132 
4.1.2 Generation of TCRα and TCRβ CDR1 and 2 mutants .....................................................................135 
4.1.3 TCRs with modified CDR1 and 2 can form surface expressed TCRs with an endogenous 
partner chain repertoire........................................................................................................................................136 4.2 ANALYSIS OF THYMIC DEVELOPMENT OF T CELLS IN MICE LACKING TCRα AND TCRβ CDR1 AND 2 . 138 
4.2.1 Mice expressing exogenous TCRα chains have delayed T cell development and lower 
numbers of peripheral T cells than mice expressing exogenous TCRβ chains ...............................138 
4.2.2 Analysis of thymi from mice expressing TCRβ chains lacking WT CDR1 and 2 have 
reduced selection efficiency and MHC class bias.........................................................................................143 
4.2.3 Competition between GFP+ and GFP­ cells results in poor T cell selection in retrogenic 
TCRα mice ....................................................................................................................................................................147 
4.2.4 Removal of TCRβ but not TCRα CDR1 and 2 may inhibit Treg development......................151 
4.2.5 Removal of TCRα or TCRβ CDR1 and 2 results in a decrease in endogenous partner chain 
CDR3, but not V­segment, diversity...................................................................................................................155 
4.2.6 Section summary............................................................................................................................................166 4.3 EXPRESSION OF TCRβ CHAINS GRAFTED WITH TCRγ CDR1 AND 2 RESTORES WT PHENOTYPE......... 166 
4.3.1 Overview ............................................................................................................................................................166 
4.3.2 Design, generation and testing of the βCDR1γCDR2γCDR3Δ mutant ....................................................168 
4.3.3 Mice expressing TCRβ with TCRγ CDR1 and 2 display thymic selection comparable to 
mice with WT TCRβ CDR1 and 2........................................................................................................................170 4.4 FUNCTIONAL ANALYSIS OF T CELLS LACKING TCRα AND TCRβ CDR1 AND 2......................................... 172 
4.4.1 Overview ............................................................................................................................................................172 
4.4.2 T cells lacking TCRα or TCRβ CDR1 and 2 can still mediate Th2 responses........................173 
4.4.3 Loss of TCRα or TCRβ CDR1 and 2 does not prevent allo­responses.......................................174 4.5 ISOLATED CASE OF LUPUS LIKE AUTOIMMUNITY IN MICE LACKING TCRβ CDR1 AND 2 ......................... 180 
4.5.1 Mice repopulated with βCDR1Δ2Δ3Δ expressing T cells displayed significant weight loss and 
skin pathogenesis......................................................................................................................................................180 
4.5.2 Autoimmune phenotype was not induced by loss of Tregs but may have been related to 
increased anti­dsDNA antibody titres..............................................................................................................182 
CHAPTER 5: DISCUSSION........................................................................................................................ 184 5.1 OVERVIEW............................................................................................................................................................... 184 5.2 LIMITATIONS OF THE RETROGENIC APPROACH ................................................................................................ 184 5.3 ANALYSIS OF GERMLINE AND CASSETTE GENERATED CDR1 AND 2 SUPPORT A REQUIREMENT FOR DIVERSITY OF MHC ENGAGEMENT ............................................................................................................................ 185 5.4 FURTHER USES OF THE RECOMBINATION CASSETTES IN MHC RESTRICTION AND IMMUNOTHERAPY .. 188 5.5 GERMLINE TCR CDRS HAVE AN OPTIMISING BUT NON‐ESSENTIAL ROLE IN MHC ENGAGEMENT........ 189 
  10 
5.6 IMPLICATIONS FOR ALLOREACTIVITY AND TOLERANCE TO SELF‐MHC....................................................... 192 5.7 TCR DOCKING ANGLE AND TCR BINDING AND TRIGGERING ......................................................................... 193 5.8 GENERAL FEATURES OF CDR BIOLOGY MAY BE IMPORTANT IN OPTIMAL MHC ENGAGEMENT ............. 194 5.9 COMMENT ON THE ISOLATED CASE OF AUTOIMMUNITY IN βCDR1Δ2Δ3Δ MICE AND MHC CLASS BIAS...... 196 5.11 SUMMARY ............................................................................................................................................................. 200 
CHAPTER 6: METHODS AND MATERIALS ......................................................................................... 203 6.1 TCR NOMENCLATURE ........................................................................................................................................... 203 6.2 TCR RESIDUE NUMBERING................................................................................................................................... 203 6.3 C6 TCR.................................................................................................................................................................... 203 6.4 CELL COUNTS.......................................................................................................................................................... 203 6.5 MICE......................................................................................................................................................................... 203 6.6 ANALYSIS OF GERMLINE TCR AND IG REPERTOIRE......................................................................................... 204 6.7 MOLECULAR BIOLOGY........................................................................................................................................... 204 
6.7.1 RNA extraction and generation of cDNA.............................................................................................204 
6.7.2 TCR repertoire analysis...............................................................................................................................205 
6.7.3 Mutant TCR generation by overlap PCR mutagenesis...................................................................206 
6.7.4 Recombination cassette design and synthesis...................................................................................207 
6.7.5 Cloning of modified TCRs into pMigR1 vector...................................................................................207 
6.7.6 DNA sequencing..............................................................................................................................................208 6.8 TRANSFECTION OF PHOENIX ECOTROPIC CELL LINE....................................................................................... 208 6.9 TRANSDUCTION OF PRIMARY CELLS WITH VIRAL SUPERNATANT................................................................. 209 
6.9.1 HSC .......................................................................................................................................................................209 
6.9.2 ConA blasts .......................................................................................................................................................209 6.10 CELL PURIFICATION ............................................................................................................................................ 210 6.11 GENERATION OF BMDC .................................................................................................................................... 210 6.12 IN VITRO PROLIFERATION ASSAY...................................................................................................................... 210 6.13 FLOW CYTOMETRY .............................................................................................................................................. 211 
6.13.1 Antibodies and hardware used .............................................................................................................211 
6.13.2 Preparation of tissues ...............................................................................................................................211 
6.13.3 Surface staining ...........................................................................................................................................211 
6.13.4 Internal staining..........................................................................................................................................212 
6.13.5 Secondary staining after serum incubation ....................................................................................212 
6.13.6 Fluorescence activated cell sorting (FACS) .....................................................................................212 6.14 HISTOLOGY ........................................................................................................................................................... 213 6.15 ENZYME‐LINKED IMMUNOSORBENT ASSAY (ELISA)................................................................................... 213 
6.15.1 Class switching ELISA................................................................................................................................213 
6.15.2 Autoimmune ELISA ....................................................................................................................................213 6.16 SKIN GRAFTING.................................................................................................................................................... 214 6.17 STATISTICAL ANALYSIS...................................................................................................................................... 214 
6.17.1 Shannon’s entropy analysis ....................................................................................................................214 
6.17.2 Unpaired student’s t­test and One­way ANOVA.............................................................................215 
REFERENCES............................................................................................................................................... 216 
APPENDICES ............................................................................................................................................... 237  
 
 
 
 
  11 
 
Table of figures 
Figure 1. 1: Overview of TCR structure. ............................................................................................................................................24 
Figure 1. 2: Summary of T cell development in the thymus. .......................................................................................................28 
Figure 1. 3: Only TCRs that bind pMHC within a narrow range of affinities are positively selected.......................34 
Figure 1. 4: Chromosomal organisation of the murine TCRα/δ and TCRβ loci................................................................38 
Figure 1. 5: Overview of V(D)J recombination. ..............................................................................................................................40 
Figure 1. 6: The structures of MHC class I and II. ........................................................................................................................46 
Figure 1. 7: The TCR binds pMHC with varying docking angles. ...........................................................................................53 
Figure 1. 8: Structure of the CD4 and CD8 co-receptors. ..........................................................................................................56 
Figure 1. 9: The TCR signals as part of the immunological synapse. ....................................................................................60 
Figure 1. 10: Autoreactive TCRs can bind pMHC with abnormal topologies. ...................................................................65 
Figure 1. 11: Conserved germline CDR interactions form interaction codons. .................................................................69 
Figure 1. 12: Sequestering of signalling molecules by co-receptors may enforce TCR restriction to MHC. .........79  
Figure 2. 1: Analysis of TCR and Ig germline CDR1 and 2 from mice and humans. .......................................................86 
Figure 2. 2: Amino acid use within germline CDRs of mouse and human TCR and Ig variable gene segments. .89 
Figure 2. 3: Summary of average number of amino acids used per CDR position in TCR and Ig molecules. .......90 
Figure 2. 4: Summary of average amino acid diversity per CDR position in TCR and Ig molecules........................93 
Figure 2. 5: Schematic of pMigR1 retroviral vector used for cloning of WT and modified TCRα  and β  chains. 97 
Figure 2. 6: Overview of the retrogenic system used to analysis TCR CDR function in vivo. ......................................98 
Figure 2. 7: Summary of transfection efficiency into a packaging cell line of TCRα  or β  chain genes cloned into 
the pMigR1 retroviral vector...................................................................................................................................................................99 
Figure 2. 8: Schematic overview of overlap PCR used to modify TCR CDR regions. .................................................. 100 
Figure 2. 9: Schematic overview of novel recombination cassette TCR CDR modification system. ....................... 102 
Figure 2. 10: The inherent variation in the retrogenic system results in adoptive transfer of varying numbers of 
GFP+ HSC. .................................................................................................................................................................................................. 104 
 
Figure 3. 1: Insertion of recombination cassettes into the WT CDR1 and 2 of βCDR3Δ. ...................................... 107 
Figure 3. 2: Generation of GFP+ T cells from βCDR1WT-Rec and βCDR2WT-Rec mice. ............................................... 108 
Figure 3. 3: Detection of splenic GFP+Vβ11+ T cells in TCRβδ-/- mice using βCDR1WT-Rec and βCDR2WT-Rec 
constructs. ............................................................................................................................................................ 109 
Figure 3. 4: Analysis of cDNA from mice using βCDR1WT-Rec and βCDR2WT-Rec constructs confirms cassette 
recombination....................................................................................................................................................... 110 
Figure 3. 5: Overall diversity of non-germline CDR1 and CDR2 mutants generated in vivo from βCDR1WT-Rec and 
βCDR2WT-Rec mice. ................................................................................................................................................... 115 
Figure 3. 6: Redirected V(D)J recombination to germline CDRs generates a restricted CDR1 but not CDR2 loop 
length. ................................................................................................................................................................... 116 
Figure 3. 7:  Amino acid and nucleotide modifications generated from WT TCRβ  CDR1 and 2. ...................... 117 
Figure 3. 8: In vivo generation of random non-germline CDR1 and 2 mutations result in an increase in net 
positive charge. .................................................................................................................................................... 119 
Figure 3. 9: Insertion of recombination cassettes into the CDR1 of a TCR βCDR3Δ lacking germline CDR1 and 2
.............................................................................................................................................................................. 121 
Figure 3. 10: Generation of GFP+ T cells from βCDR1Δ-Rec mice.......................................................................... 122 
Figure 3. 11: Detection of splenic GFP+Vβ11+ T cells in TCRβ -/- mice using βCDR1Δ-Rec construct. .................. 122 
Figure 3. 12: Analysis of cDNA from mice using the βCDR1Δ-Rec construct confirms cassette recombination. .... 123 
Figure 3. 13: Overall diversity of non-germline CDR1 mutants generated in vivo from βCDR1Δ-Rec mice........... 126 
Figure 3. 14: Redirected V(D)J recombination to non-germline CDR1 generates a restricted CDR1 length.... 127 
Figure 3. 15:  Amino acid and nucleotide modifications generated from non-germline TCRβ  CDR1. .............. 127 
Figure 3. 16: In vivo generation of random non-germline CDR1 mutations in the absence of any WT CDR 
sequence also results in an increase in net positive charge................................................................................. 129 
  12 
 
Figure 4. 1: Overview of CDR modification design to the C6 TCRα  and β  chain templates. ............................ 133 
Figure 4. 2: Generation of TCRα  and TCRβ  CDR mutants and sub-cloning to the pMigR1 vector. ................. 136 
Figure 4. 3: TCRα  and β  germline CDR mutants can form surface expressed TCR with an endogenous partner 
chain repertoire.................................................................................................................................................... 137 
Figure 4. 4: Generation of mice expressing WT and CDR modified TCRα  and TCRβ  chains........................... 139 
Figure 4. 5: Retrogenic mice expressing exogenous WT or mutant TCRα  chains develop few GFP+ T cells.... 141 
Figure 4. 6: Loss of TCRβ  CDR1 and 2 results in increased homeostatic expansion of CD4 and CD8 T cells. 142 
Figure 4. 7: Replacement of germline CDR1 and 2 structures with glycine-alanine linkers results in decreased 
selection efficency................................................................................................................................................. 144 
Figure 4. 8: Removal of germline βCDR1 and 2 results in a CD4 bias selected in the thymus.......................... 146 
Figure 4. 9: The thymically selected CD4 bias in βCDR1Δ2Δ3Δ mice is maintained in peripheral lymphoid organs.
.............................................................................................................................................................................. 147 
Figure 4. 10: T cell selection in WT and mutant TCRα  retrogenic mice is poor, regardless of the selecting 
haplotype. ............................................................................................................................................................. 148 
Figure 4. 11: GFP- cells from TCRα  retrogenic mice progress through T cell development and populate the DP 
compartment......................................................................................................................................................... 149 
Figure 4. 12: Removal of TCRα  germline CDR1 and 2 results in a slight CD8 bias in peripheral lymphoid 
organs................................................................................................................................................................... 150 
Figure 4. 13: Replacement of germline CDR1 and 2 flattens the interaction surface of TCR. ........................... 151 
Figure 4. 14: Removal of germline TCRβ  CDR1 and 2 does not prevent thymic generation of nTregs. ............ 152 
Figure 4. 15: TCRα  and TCRβ  retrogenic mice contain both induced and natural Tregs based on FoxP3 and 
helios expression. ................................................................................................................................................. 154 
Figure 4. 16: Removal of TCRα  CDR1 and 2 does not alter endogenous TCRβ  V-segment diversity............... 156 
Figure 4. 17: Removal of TCRβ  CDR1 and 2 does not alter endogenous TCRα  V-segment diversity............... 157 
Figure 4. 18: Schematic depicting the definition of TCRα  and TCRβ  CDR3 boundaries as used in this study. 158 
Figure 4. 19: Removal of germline TCRα  or TCRβ  CDR1 and 2 results in a decrease in endogenous J-segment 
usage..................................................................................................................................................................... 164 
Figure 4. 20: Removal of germline TCRα  or TCRβ  CDR1 and 2 results in a decrease in endogenous CDR3 
diversity. ............................................................................................................................................................... 165 
Figure 4. 21: Design and creation of the βCDR1γ2γ3Δ construct. ........................................................................... 169 
Figure 4. 22: T cells using the βCDR1γ2γ3Δ chain can be selected in vivo. ............................................................ 170 
Figure 4. 23: Replacement of germline TCRβ  CDR1 and 2 with TCRγ  CDR1 and 2 maintains WT selection 
efficiency............................................................................................................................................................... 171 
Figure 4. 24: Replacement of germline βCDR1 and 2 with non-germline, structured CDR1 and 2 regions retains 
a WT like T cell development phenotype. ............................................................................................................. 172 
Figure 4. 25: TCRs lacking germline α  or βCDR1 and 2 can still adapt to induce Th2 responses. .................. 174 
Figure 4. 26: TCRs lacking germline α  or βCDR1 and 2 maintain the ability to distinguish self and non-self 
MHC in vitro. ....................................................................................................................................................... 175 
Figure 4. 27: TCRβ  chains lacking germline CDR1 and 2 maintain the ability to reject allogeneic skin in vivo.
.............................................................................................................................................................................. 177 
Figure 4. 28: Less efficient allo-recognition in βCDR1Δ2Δ3Δ is related to sub-optimal repopulation of the grafted 
mice. ..................................................................................................................................................................... 179 
Figure 4. 29: Indication of autoimmunity in mice adoptively transferred with βCDR1Δ2Δ3Δ T cells...................... 181 
Figure 4. 30: βCDR1Δ2Δ3Δ mice displaying autoimmune phenotype had increased titres of autoantibodies. ........ 183 
 
Figure 5. 1: Replacement of C6 TCRα  and TCRβ  CDR1 and 2 with glycine-alanine linkers polarises the net 
charge of each chain. .............................................................................................................................................................................. 200 
 
 
  13 
List of Tables 
 
Table 1. 1: T cell lineages.........................................................................................................................................................................36 
Table 1. 2: Number of TCR gene segments encoded in the mouse and human genome...............................................39 
Table 1. 3: Forms of TCR cross­reactivity .........................................................................................................................................43 
Table 1. 4: Summary of common polymorphic MHC alleles .....................................................................................................44 
Table 1. 5: Summary of known common HLA allele numbers .................................................................................................47 
Table 1. 6: Overview of proposed mechanisms for TCR signal triggering..........................................................................59 
Table 1. 7: Summary of autoimmune TCRs......................................................................................................................................65 
Table 1. 8: Vβ8.2 TCRs with unique TCRα or βD­J­CDR3 usage maintain germline contacts...................................69 
Table 1. 9: Summary of key germline TCR CDR positions and corresponding MHC interactions highlighted by 
Marrack et al, 2008....................................................................................................................................................................................70 
Table 1. 10: Summary of further evidence supporting a form of germline­encoded restriction of TCR to MHC
.............................................................................................................................................................................................................................73 
Table 1. 11: Summary of proposed non­MHC αβTCR ligands .................................................................................................81 
 
Table 2. 1: Calculated diversity of most common length CDR in Ig and TCR chains in mice and humans ..........92 
Table 2. 2: Brief overview of TCR genes cloned into pMigR1 vector.....................................................................................96 
 
Table 3. 1: Full repertoire of sequences generated from βCDR1WT­Rec mice........................................................................ 111 
Table 3. 2: Full repertoire of sequences generated from βCDR2WT­Rec mice........................................................................ 113 
Table 3. 3: Sample sequences from the whole thymus of a βCDR2WT­Rec mouse ............................................................... 120 
Table 3. 4: Full repertoire of sequences generated from βCDR1Δ­Rec mice .......................................................................... 125 
 
Table 4. 1: Summary of common mouse strain haplotype and MHC allele use ............................................................ 135 
Table 4. 2: Summary of unique CDR3 sequences associated with Vα9 in TCRβ retrogenic mice ......................... 161 
Table 4. 3: Summary of unique CDR3 sequences associated with Vβ7 in TCRα retrogenic mice ......................... 163 
 
Table 6. 1: Forward (F) and reverse (R) primers used to analyse TCR repertoires via sequencing .................... 205 
Table 6. 2: Forward (F) and reverse (R) primer sequences for overlap mutagenesis................................................ 207 
Table 6. 3: List of sequencing primers............................................................................................................................................. 208 
 
 
  14 
Abbreviations 
 
Abbreviation Definition 
°C Degrees Celsius 
5-FU 5-Fluorouracil 
Å Angstroms 
Ag Antigen 
AID Activation-induced Cytidine Deaminase 
AIRE Autoimmune Regulatory Protein 
APC Antigen Presenting Cell 
Be Beryllium 
BM Bone Marrow 
BMDC Bone Marrow derived Dendritic Cell 
bp Base Pairs 
BSA Bovine Serum Albumin 
c-Kit Tyrosine Protein-kinase Kit 
CBD Chronic Beryllium Disease 
CCR Chemokine Receptor 
CD Cluster of Differentiation Gene 
cDNA Complementary DNA 
CDR Complementarity Determining Region 
Ci Curie Sievert 
cm2 Centimetres Squared 
CNS Central Nervous System 
CO2 Carbon Dioxide 
ConA Concanavalin A 
cSMAC Central SMAC 
cTEC Cortical Thymic Epithelial Cell 
CTL Cytotoxic Lymphocyte 
CXCL C-X-C Motif Ligand 
CXCR C-X-C Motif Receptor 
D Diversity 
DC Dendritic Cell 
ddH20 Double Distilled Water 
DN Double Negative 
DNA Deoxyribonucleic Acid 
DP Double Positive 
ds Double Stranded 
dSMAC Distal SMAC 
E Enhancer 
EBV Epstein Barr Virus 
EDTA Ethylenediaminetetraacetic Acid 
ELISA Enzyme Linked Immunosorbent Assay 
ETP Early Thymocyte Progenitor 
FACS Fluorescence Activated Cell Sorting 
FasL Fas Ligand 
FCS Foetal Calf Serum 
FLT3 Fms-related Tyrosine Kinase 3 
FTOC Foetal Thymic Organ Culture 
GFP Green Fluorescent Protein 
  15 
GM-CSF Granulocyte Macrophage-Colony Stimulating Factor 
GPCR G-protein Coupled Receptor 
H SA Heat Stable Antigen 
HEL Hen Egg Lysozyme 
HLA Human Leukocyte Antigen 
HMGB High Mobility Group Protein B 
HPRT Hypoxanthine-guanine Phosphoribosyltransferase  
HTLV-1 Human T cell Lymphotrophic Virus 1 
HV Hypervariable Region 
i.p. Intraperitoneal 
i.v. Intraveneous 
ICAM-1 Intracellular Adhesion Molecule 1 
IEL Intra-epithelial Lymphocyte 
IFN Interferon 
Ig Immunoglobulin 
IgSF Immunoglobulin Super Family 
IL Interleukin 
IMDM Iscove’s Modified Dubeccos Medium  
IRES Internal Ribosomal Entry Site 
IS Immunological Synapse 
iSP Immature Single Positive 
ITAM Immunoreceptor Tyrosine-based Activation Motif 
ITC Isothermal Titration Calorimetry 
iTregs Inducible Regulatory T cells 
J Joining 
kg Kilogram 
KO Knockout 
Lck Lymphocyte-Specific Protein Tyrosine Kinase 
LCMV Lymphocytic Choriomeningitis Virus 
LFA-1 Lymphocyte Function-associated Antigen 1 
LN Lymph Node 
LPS Lipopolysaccharide 
LTR Long Terminal Repeats 
MBP Myelin Basic Protein 
mg Milligram 
MHC Major Histocompatibility Complex 
ml Millilitre 
MLP Myeloid Lymphoid Progenitors 
MLR Mixed Lymphocyte Response 
mM Millimolar 
MP Matrix Protein 
MS Multiple Sclerosis 
MSEP Mean Surface Electrostatic Potential 
MST Median Survival Time 
mTEC Medullary Thymic Epithelial Cell 
mϕ Macrophage 
nM Nanomolar 
nm Nanometres  
nTregs Natural Regulatory T cells 
OH Hydroxyl Group 
PBS Phosphate Buffer Solution 
PCR Polymerase Chain Reaction 
PEco Phoenix Ecotropic 
pMHC Peptide-MHC complex 
PSGL-1 P-selectin Ligand 1 
pSMAC Peripheral SMAC 
  16 
pTα Pre-TCRα Chain 
RAG Recombinase Activating Genes 
RNA Ribonucleic Acid 
RPM Revolutions Per minute 
RPMI Roswell Park Memorial Institute 
RSS Recombination Signal Sequence 
RT Room Temperature 
RTE Recent Thymic Emigrants 
s.c. Subcutaneous 
S.E.M Standard Error of the Mean 
SCF Stem Cell Factor 
SCZ Sub-capsular Zone 
SD Standard Deviation 
SLE Systemic Lupus Erythematosus 
SMAC Supramolecular Activation Complex 
SN Supernatant 
SPF Specific Pathogen Free 
SPR Surface Plasmon Resonance 
TAP Transporter Associated with Antigen Processing 
TCR T cell receptor 
TdT Terminal Deoxynucleotidyl Transferase 
TEA T Early Alpha 
Th T Helper Cell 
TM Transmembrane 
TREC TCR Excision Circles 
Tregs Regulatory T cells 
UTR Untranslated Region 
V Variable 
ZAP70 Zeta Chain-association Protein Kinase 70 
β2m β2-Microglobulin 
µg Microgram 
µl Microlitre 
µM Micromolar 
  17 
 
 
 
 
 
 
 
 
 
  18 
Chapter 1: Introduction 
 
1.1 Overview of adaptive immunity receptor evolution, the T cell receptor and MHC 
restriction 
1.1.1 Evolution of adaptive immunity receptor diversity The  immune  system  is  the  second  most  complex  studied  after  the  central  nervous system  (CNS).  The  multifarious  nature  of  the  immune  system  is  underpinned  by  its ability to rid the body of pathogens both through effective innate and exquisitely specific adaptive means, with these branches often cooperating across almost every tissue and organ  in  the  body.  The  fundamental  property  of  an  adaptive  immune  system  is  the generation  of  diversity  in  lymphocytic  cell  receptors:  facilitating  potent  but  targeted responses to clear specific infections. Coupled to this effector role is the requirement to self‐regulate, both against over‐reaction to  infection and unintentional reaction to self.  In all jawed vertebrates, the adaptive immune response is mediated through cellular and humoral  arms,  which  are  controlled  by  T  cell  and  B  cell  lymphocytes  respectively.  Diversity  is  created  via  the  generation  of  clonal  repertoires  through  recombination  of loci  that  contain  multiple  related,  but  distinct  gene‐segments  that  are  recombined  in unique combinations in each lymphocyte. An adjunct to this generation of combinatorial diversity is that of junctional diversity, whereby the addition and subtraction of random nucleotides upon segment joining creates hypervariable, non‐germline junctions. While evolution and speciation inevitably results in adaption and specialisation of organs and systems,  the  adaptive  immune  system has  remained  incredibly  conserved  in  terms  of basic  features  and  machinery,  with  evolution  instead  working  within  a  common framework (Pancer and Cooper, 2006).  In  jawed vertebrates  the adaptive machinery  is  formed from three distinct but related heterodimeric molecules from the immunoglobulin superfamily (IgSF) which all contain structurally  similar  immunoglobulin  (Ig)  domains  (see  the  next  section).  The  IgSF domains  are  the  most  common  used  in  immune  defence  molecules  (Barclay,  2003). These molecules  include  the  Immunoglobulins  (Ig)  and  the  two T  cell  receptor  (TCR) isotypes, αβ and γδTCRs, expressed on B cells and T cells respectively. All three receptor types  and  their  associated  immune  responses  are  conserved  from  the  earliest cartilaginous  fish  (Rumfelt et  al 2001 and Criscitiello et  al,  2010)  and  share  the  same 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form of recombination process (See Section 1.3.2). Further, the presence of both primary (lymphocyte  developing)  and  secondary  (lymphocyte  responding)  organs  in  jawed vertebrates is also maintained. Very few modifications of these basic constituents have been  selected  for  during  evolution.  Perhaps  the  most  extreme  adjustment  is  the organisation of  the  lymphoid organs  themselves, which can vary anatomically  (Boehm and Bleul, 2007). Indeed, a functional second thymus (where TCR recombination occurs during  T  cell  development)  was  discovered  in  mice  (Terszowski  et  al,  2006).  Also,  a mammalian  specific novel TCR  locus  termed TCRµ  has been discovered  in  the ancient monotreme,  the  duck‐billed  platypus,  that  is  absent  from  all  marsupial  and  placental mammals studied and other jawed vertebrates (Wang et al, 2011).  Such is the overall evolutionary “success”, however, of the adaptive immune system that a remarkable occurrence of convergent evolution has been recently defined  in  jawless chordates,  which  include  lampreys  and  hagfish.  Jawless  fish  while  containing  IgSF molecules,  do  not  appear  to  express  diverse  Ig  or  TCR  related  molecules,  yet  could conduct  immune  responses  that  infer  the  presence  of  diverse  and  specific  repertoire (Finstad  and  Good,  1964).  RNA  extracted  from  lamprey  larvae  immunised  with  a heterogeneic bacterial mixture was discovered to contain a diverse repertoire of leucine rich  repeat  (LRR)  containing  receptors,  now  termed  variable  lymphocyte  receptors (VLRs; Pancer et al, 2004). These unique but similarly diverse proteins have now been shown to contain distinct but comparable recombination loci structures, recombination processes  (Rogozin et al,  2007) and have even been shown  to demonstrate analogous humoral  and  cellular  B  and  T‐like  lineages  and  show  evidence  of  primary  lymphoid thymus‐like structures (Alder et al, 2005; Kim et al, 2007 and Bajoghili et al, 2011).  Igs consist of a heavy (H) and a light (κ or λ) chain, each of which are encoded through the  rearrangement  of  distinct  loci.  Similarly,  the  α,  β,  γ  and  δ  TCR  chains  are  also encoded by distinct loci. However, evidence suggests cross‐loci recombination may have been prevalent in ancestral systems (Criscitiello et al, 2010). Based on the processes of recombination to create the variable domain of these proteins, the IgH, TCRα and TCRγ can be considered comparable chains, as can the partner Igκ, Igλ, TCRβ and TCRδ. The former  group’s  variable  domains  are  generated  from  variable  (V)  and  joining  (J) segments  and  the  latter  V,  J  and  diversity  (D)  segments  in  a  process  called  V(D)J recombination. These  are  then  spliced  to  the  constant  (C) domain  (see Section 1.3  for 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details).  Phylogenetic  analysis  comparing  the  constant  domains  of  each  chain  has proposed that the γδTCR loci pre‐empted the evolution of the Ig and αβTCR (Richards and Nelson, 2000). Another model based on comparison of mouse and human genomes predicted  a  primordial  heterodimer  consisting  of  one  V‐J‐C  and  one  V‐D‐J‐C  chain underwent a duplication to generate Ig and TCRαβ loci and a second duplication of the 
αβTCR loci resulted in the γδ loci (Glusman et al, 2001). Regardless of  the original source of  the variable  IgSF based receptor,  three key events underlie the subsequent evolution of repertoire generation: the “space” and pressure to generate a variety of gene‐segments, a mechanism with which to facilitate combinatorial diversity via  recombination and a  system to  introduce  the hypervariable  sequences at the  non‐homologous  segment  joins.  As  with  any  genome  diversification,  gene duplication  is  required  to  loosen  the  constraints  on  maintaining  the  original  genes’ sequence. However  it  is  the duplication of  the whole chordate genome,  termed the 2R hypothesis  that  is  proposed  to  have  heeded  the  emergence  and  subsequent diversification of adaptive  immune genes (Kasahara, 2007).    In order to generate gene segments,  one  assumes  a  proto‐immune  receptor  would  need  to  be  split.  The  basic process of recombination is centred on the function of two DNA repair enzymes called recombination activating genes  (RAG) 1  and 2, which have been  characterised  for  the majority  of  vertebrates.  These  enzymes  catalyse  the  breaking  of  DNA  between  gene‐segments through recognition of recombination signal sequence (RSS; Section 1.3.2). It is believed  these  genes  were  acquired  through  horizontal  transfer  from  commensal  or pathogenic  bacteria  and  are most  related,  in  terms  of  sequence,  gene  orientation  and RSS to a transposon called transib (Kapitonov and Jurka, 2005 and Fugmann et al, 2006). It  is  likely  that  the  horizontal  transfer  process  resulted  in  insertion  into  an  ancestral antigen receptor gene that consisted of exons encoding for proto‐V and C like domains. Transposon  insertion  to  the proto‐V  exon would  result  in  splitting  into  a proto‐V  and proto‐J  segment  for  example  (Lewis  and  Wu,  1997;  Schatz,  2004  and  Mazza  and Malissen, 2007). As will  be discussed,  the generation of hypervariaibilty  through non‐homologous end  joining during  recombination  is  arguably  the most  important  feature facilitating  antigen  (Ag)  recognition  in  the  adaptive  immune  response.  This  process during  Ig  and  TCR  loci  recombination  is  mediated  by  terminal  deoxynucleotidyl transferase (TdT; Section 1.3.2). As with the RAG1/2 complex, TdT is an early progenitor that  is  highly  conserved  throughout  jawed  chordates  that  was  discovered  upon sequencing  of  the  purple  sea  urchin  genome,  which  also  contained  other  factors 
  21 
required  for  V(D)J  recombination    including  xrrC4,  Ku70,  Ku80  and  DNA  ligase  IV (Hibino  et  al,  2006;  Section  1.3.2).  Overall,  the  nature  of  adaptive  immunity  has  been favoured from a very basic evolutionary point  in chordata evolution, thus emphasising the  benefits  of  diverse  immune  receptors.  Despite  the  wasteful  nature  of  loci recombination,  the  changing  and  evolving  nature  of  host‐pathogen  interactions  no doubt  underpin  the  retention  of  such  a  diverse  system.  As  discussed  in  the  next  two sections however, despite common evolutionary starting points, related structures and identical  recombination processes,  the αβTCR has evolved a very unique and complex form of Ag recognition relative to Ig and most likely γδ T cells also. 
1.1.2 T cells and the αβTCR In mice and humans, αβ T cells form approximately 90‐95% of the total T cell population (Davis et al, 1998) with the remaining 5‐10% made up by the γδ lineage. αβ T cells fall under  two major  functional  lineages,  the  decision  of  which  is  imparted  during  T  cell selection in the thymus (Section 1.2). These lineages are defined by the expression of a CD4  or  CD8  co‐receptor,  which  aid  the  TCRs  in  antigen  recognition  and  downstream signalling (see Section 1.4.3). CD8 T cells, also known as cytotoxic T lymphocytes (CTLs), kill cells infected with intracellular pathogens, such as viruses. Upon engagement of the TCR with  its  ligand, a class I major histocompatibility complex presenting an antigenic peptide  (pMHC;  see  next  section),  CD8  T  cell  responses  include  production  of  the cytokine interleukin (IL)‐2 resulting in proliferation of the activated cells. Infected cells up‐regulate  cell  surface  expression  of  Fas  ligand  (FasL),  which  is  recognised  by  its receptor, Fas, on activated CD8 T cells ultimately inducing apoptosis (Nagata, 1994). IL‐2  also  induces  expression  of  perforin  which  inserts  into  the  target  cell’s  membrane (Podack  and  Konigsberg,  1984)  facilitating  the  entry  of  effector  molecules  such  as granzyme  B,  a  serine  protease  that  activates  caspase  enzymes,  which  subsequently cleave cathepsin substrates leading to DNA degradation and thus apoptosis (Jenne and Tschopp, 1988).  CD4 T cells were for a long time divided into two helper subsets, Th1 and Th2 that could be  induced  upon  TCR  engagement  with  class  II  pMHC.  The  classic  Th1  response  is mediated through TCR engagement coupled to interferon‐γ (IFNγ) and IL‐12 production from  the MHC  expressing  antigen  presenting  cells  (APC)  such  as  dendritic  cells  (DC). Th1 lineage commitment is defined by expression of the transcription factor Tbet (Szabo 
et  al,  2000)  that  regulates  Th1  effector  functions,  such  as  IFNγ  and  IL‐2  production, 
  22 
controlling macrophage  (mΦ) activation and T cell proliferation respectively. The Th2 response  is  also  defined  by  expression  of  a  dominant  transcription  factor,  GATA‐3 (Yamashita et al, 2004). The classic Th2 response is characterised by autocrine IL‐2 and IL‐4  loops.  Production  of  IL‐4  and  IL‐5  results  in  induction  of  the  humoral  immune response  through  activation  of  B  cells  and  subsequent  production  of  Igs.  In  the  past decade or so,  several additional T cell  lineages have been defined  including  those  that are induced in the periphery and those that develop in the thymus and possess effector and regulatory functions (Section 1.2.3). The majority of T cell responses, both effector and regulatory, are mediated through the 
αβTCR and its recognition of class I or class II pMHC complexes in conjunction with the CD4 or CD8 co‐receptor. The αβ TCR chains were  first  isolated and  identified as being variable  by  Kappler  et  al  (Kappler  et  al,  1983)  through  tryptic  peptide  fingerprint analyses of isolated protein from T cell hybridomas. Here, fingerprints from the same T cell clone contained identical readouts that differed from other clones. Analysis of T cell specific  cDNA  sequences  and  comparison  to  known  Ig  sequences  in  three  parallel landmark  studies  published  in  Nature,  for  the  first  time  defined  chains  of  the  T  cell antigen receptor (Hedrick et al, 1984; Hedrick et al, 1984b and Yanagi et al, 1984). The studies also predicted these receptors would be structurally comparable to the antigen recognition portion of  Ig molecules,  the  so‐called  Fab portion, which  incorporates  the IgC and IgV domains of the light chain and the IgV and terminal IgC domains of the heavy chain.  Mutagenesis of a TCR specific for pigeon cytochrome‐c presented on H2‐Ek MHC molecule (see Section 1.4.1 for MHC nomenclature) found that alteration of a residue in the  proposed  βCDR1  region  prevented  recognition  of  the  cognate  ligand,  further supporting the Fab basis for TCR structure and Ag recognition (White et al, 1993). The  first  isolated TCR chains were  crystallised  in 1995  from  the 14.3.d  (Bentley et al, 1995) and 1934.4 (Fields et al, 1995) TCRs. The first structures of αβ TCR heterodimers containing  the Vα  and Vβ  domains were  solved a year  later  (Garboczi et al,  1996 and Garcia et al, 1996). The αβTCR is a heterodimer of the TCRα and β chains, which contain two  Ig domains  each,  termed  the  constant  and variable domains. The  IgSF  family  fold consists  of  two  anti‐parallel  β‐sheets  that  are  sandwiched  together  by  internal hydrophobic interactions and disulphide links. Two members of the IgSF make up TCRα and β chains. IgC1 domains, which generally contain 7 relatively shorter strands in their sheets, form the constant domains of both chains. The variable domains are made from 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IgV domains, which consist of 9 strands in the β sheets and are generally longer. The β‐sheet strands are labelled A, B, C, C’, C”, D, E, F and G (Figure 1.1A).  The loops protruding from  the  surface of  the Vα  and Vβ  domains  are  termed  complementarity determining regions  (CDR).  These  are  the  regions  where  diversity  is  focused  as  a  result  of  the aforementioned  combinatorial  and  junctional  variation.  Both  chains  contain  two germline CDRs (CDR1 and 2) that are encoded entirely within the variable V‐segments and constitute the peptide  loops  linking strands B‐C and C’‐C” respectively. Strand F  is also encoded within the germline V‐segments and links to strand G. Strand G is encoded entirely by (D)J segments and the resultant loop that forms between them during V(D)J recombination  encodes  for  the  hypervariable  CDR3.  Jα  and  Jβ  segments  contain  a  di‐glycine motif  (GXG) that serves to bulge the peptide loop ensuring proper orientation of the CDR3 and pairing of the Vα and Vβ domains  in the heterodimer (Figure 1.1B). The TCRβ chain also contains a fourth region of hypervariability, often termed hypervariable (HV) 4 or CDR4. This region was determined by  Jores et al  (Jores et al, 1990) through application  of  the Wu‐Kabat  variability  coefficient  on  collated  sequences  of  119 TCRβ chains and proposed to exist between strands D‐E. CDR switching and structural studies have demonstrated that CDR4 is rarely implemented in any form of Ag recognition with the  exception  of  some  superantigens  –  pathogen  or  genome  encoded  proteins  that interact with pMHC and TCR ectopically, relative to normal Ag recognition (Irwin et al, 1993; White et al, 1993; Asmuss et al, 1996 and Papageorgiou et al, 2009). As discussed in Section  1.4, αβ  TCRs  can undergo  conformational  changes upon  ligand  engagement and the majority of this is restricted to the CDR3 loops. In the unbound form, germline CDR1 and 2 loops from both TCR chains are proposed to exist in defined canonical states that is determined predominantly by CDR length and amino acid composition that result in differences  in  the ϕ  and Ψ peptide bond angles  generating  three possible  states  in each of the germline CDRs (Al‐Lazikani et al, 2000). The overall elbow angle of the TCRα and  TCRβ  chains,  the  angle  formed  between  V  and  C  domains,  ranges  from  between 140°‐210°, which  is  less  than  for comparable  Ig measurements, most  likely due  to  the requirements of downstream molecular interactions (Rudolph et al, 2006). The most conserved region of the TCRα and TCRβ chains are the transmembrane (TM) stalks  that  anchor  the  chains  to  the  membrane  and  facilitate  interaction  with  the downstream  signalling  complex,  CD3.  These  were  named  conserved  antigen  receptor transmembrane  (CART)  motifs.  Comparison  of  Ig,  TCRα,  TCRβ,  TCRγ  and  TCRδ  TM 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sequences revealed a relatively conserved sequence that when modelled,  formed a TM 
α‐helix, placing the conserved residues in key positions to interact with the lipid bilayer or  other  amino  acids  within  the  membrane  (Campbell  et  al,  1994).  Despite  the evolutionary and conserved tertiary structural relationship between the αβTCR and Ig molecules,  the  αβTCR  has  evolved  a  remarkable  and  hitherto  unique  relationship  in regard to ligand recognition. While both receptors respond to Ag in the form of peptide fragments,  Ig  CDRs  recognise  intact,  pathogen  derived  Ag,  whereas  αβ  TCRs  only respond to Ag in the context MHC class I or II, the phenomenon termed MHC restriction.  
 
Figure 1. 1: Overview of TCR structure. 
(A) Schematic of αβTCR variable (V), constant (C) and transmembrane (TM) domains (left). The picture on the 
right represents a birds-eye view of the TCR variable domain. Squares represent the tops of the β-strands that 
make up the domains and are labelled as described in the text. The red lines represent the three αCDRs (α1-3) 
and four βCDRs (β1-4) and black lines represent other non-CDR links between the β-sheets. The relative 
carboxyl (C) and amino (N) termini are labelled for each chain. Diagram is adapted from Al-Lazikani et al, 
2000. (B) Crystal structure (right) depicting the general structure of the 2C TCR (PDB: 1TCR). The TCRα (red) 
and β (green) chain domains are labelled as for part A. The portion magnified on the left shows the three CDR 
loops of the TCRα chain (grey) to demonstrate their relative position.  
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1.1.3 Discovery and characterisation of MHC restriction In 1936, studies “transplanting” sera from donor mice to recipients of a different strain followed by measuring agglutination reactions with  isolated erythrocytes was  the  first proof  of  the  body’s  ability  to  distinguish  self  from  non‐self  (Gorer,  1936).  This relationship was  further  defined  genetically  by George  Snell who  summarised  several studies  that  included  the  transplant  of  tumours  to  inbred mice  of  different  pure  and crossed  strains  and  measuring  tumour  rejection,  showing  a  clearly  delineated relationship between genetic background and  tumour rejection  (Gorer et al, 1948 and Snell,  1948).  He  subsequently  first  coined  the  phrase  “histocompatibility”  gene  and suggested that such genetic differences would apply to any transplanted tissues.  In 1975, Zinkernagel and Doherty’s Nobel Prize winning experiments demonstrated that in order to respond to Ag from lymphocytic choriomeningitis virus (LCMV) the infected cells had to express the correct class I MHC gene as well as the viral Ag (Zinkernagel and Doherty, 1975). Fused T cell hybridomas with different MHC and Ag specificities were found to retain both individual reactivity to the original hybridomas, but did not acquire the  capability  to  respond  to  the MHC of  one  hybridoma with  the Ag  specificity  of  the other, inferring a physical link between TCR‐Ag‐MHC (Kappler et al, 1981). Two models were proposed to explain this result; one involving a physical relationship between the Ag and MHC,  jointly  recognised by  the T  cells  and a  second whereby  the MHC and Ag interact  allosterically  and  are  jointly  recognised  by  distinct  regions  of  the  same  TCR (Schwarz, 1985). Experiments by Haber‐Katz et al (Haber‐Katz et al, 1983) showed the ability of a single T cell clone to recognise a moth cytochrome c derived Ag in the context of two different MHC molecules, whereas the related pigeon cytochrome derived Ag was only recognised in the context of one of the MHC molecules. Through mutagenesis, this was demonstrated to be related to residue differences between the Ag that must affect MHC binding and not TCR stimulation, thus proving a direct Ag‐MHC relationship.  Final evidence highlighting the relationship between peptide Ag and MHC came through experiments  demonstrating  that  Ag  from  influenza  virus  was  required  to  facilitate assembly of a surface expressed class I MHC (Townsend et al, 1989). Experiments from both class  I and class  II MHC eventually confirmed direct binding of peptide Ag  to  the MHC (Babbitt et al, 1985 and Boyd et al, 1992). Similarly, TCR‐pMHC interactions have been  characterised  in  in‐depth  structural  and  functional detail  for  their  roles  in T  cell development  in  the  thymus, T  cell  homeostasis,  and allogeneic  recognition of non‐self 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MHC  as  well  as  in  immune  responses.  However,  as  is  the  main  crux  of  the  study presented herein, the molecular underpinning of why TCRs are MHC restricted has yet to be elucidated or demonstrated  irrefutably. The  following sections  summarise T cell development in the thymus and the generation and optimisation of the TCR repertoire, before discussing  the  current molecular understanding of TCR‐pMHC  interactions  and recent theories surrounding the molecular basis of TCR restriction to MHC. 
1.2 T cell development and thymic selection 
1.2.1 Overview of the thymus and homing of stem cells for T cell development The  thymus  is  a  lobed  structure  found directly  in  front of  the heart  in humans. While originally  thought  of  as  lymphocyte  cemetery,  due  to  the  high  level  of  cell  death, thymectomised mice were  shown  to  lack  a  specific  type  of  lymphocyte,  subsequently named T cells (Miller, 1961). The high level of cell death is in fact related to the stringent developmental  rules  applied  for  successful T  cell development  (see Section 1.2.3). The process  of  αβ T  cell  development  includes  two  defined  phases,  split  into  distinct developmental checkpoints. First  is TCR independent development, which includes the homing of  stem cells  to  the  thymus and  commitment  to T  cell  development  ending  in induction of TCRβ, γ  and δ  loci  rearrangement. For αβ T  cell development,  the second phase  is TCR dependent  and  requires  rearrangement of  the TCRα  locus  (see previous section  and  Section  1.2.3),  the  audition  of  TCR  genes  for  surface  expression  and signalling, followed by selection steps that assess the ability of the TCR to recognise Ag in the context of MHC. The affinity of the TCR for MHC and preference for class I or class II  determine  thymocyte  survival  and  co‐receptor  expression.  T  cell  development  from entrance  to  the  thymus  to  emigration  as  a  mature  T  cell  takes  approximately  three weeks in adult mice. T cell production peaks after adolescence in all higher vertebrates due to the generation of a suitably diverse repertoire. Subsequently, progressive thymus involution and declining T cell output occurs with increasing age. The  overall  process  is  highly  complex  and  stringently  regulated  both  genetically,  and spatially  due  to  the  importance  of  producing  a  diverse  but  tolerant  TCR  repertoire. 
Figure 1.2  summarises  the progression of T  cell  development  in  the mouse  thymus  in terms  of  developmental  stages,  cell  surface  markers,  stages  of  proliferation  in  the context of the time and spatial occurrence of development. 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Haematopoietic  stem cells  (HSC)  that populate  the bone marrow (BM) ultimately give rise  to  early  T  cell  progenitors  (ETP)  directly,  or  indirectly  through  a  second  lineage negative  intermediate  called  non‐renewing  myeloid‐lymphoid  progenitors  (MLP; Morisson  et  al,  1995  and  Adolfson  et  al,  2005).  For  an  extensive  review  of  HSC mobilisation  and  homing  to  the  thymus  see  Schwarz  and  Bahndoola  (Schwartz  and Bahndoola, 2006). Briefly, HSC are  retained within  specialised BM niches by adhesion molecules  including  N‐cadherin  and  the  integrin  VLA‐4  (Williams  et  al,  1991; Papayannopoulou  et  al,  1995  and  Zhang  et  al,  2005)  and  chemokines  including chemokine  C‐X‐C  motif  ligand  (CXCL)  12  and  its  receptor  chemokine  C‐X‐C  motif receptor (CXCR) 4 (reviewed by Lapidot and Petit, 2002). It is unclear whether release from the BM  is a  stochastic,  cyclical or a  continuous process, however proliferation of HSC  is  related  to  subsequent  release  from  the  BM,  via  the  effects  of  factors  such  as CD135,  IL‐3,  IL‐6  and  granulocyte  stem  cell  factor  (G‐SCF)  which  mediate  HSC proliferation  and  induce  BM  release  (Lapidot  and  Petit,  2002).  Circulating  HSCs  are likely to migrate selectively into the thymus. Again the CXCR4 interaction is vital to HSC adhesion  to  thymic  stromal  tissue  at  the  cortico‐medullary  junction  (Scimone  et  al, 2006). Entry and survival in the thymus marks the loss of pluripotency and the first step towards  T  cell  commitment.  However  some  studies  suggest  differences  exist  before entry to the thymus, which can distinguish ETPs from other HSC lineages (Schlenner et 
al, 2010). 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Figure 1. 2: Summary of T cell development in the thymus. 
Diagram represents the progression of T cell development from left to right, highlighting the key cell types 
(HSC = Haematopoietic stem cell; DN = Double negative; iSP = Immature single positive; DP = Double 
positive; SP = Single positive; nTreg = Natural regulatory T cell; NK = Natural killer cells; DC = Dendritic 
cells), key developmental events, the relative time to progress through each stage of development, key cell 
markers, the relative proliferation and the estimated number of cells generated from each HSC that enters the 
thymus. CM = Cortico-medullary junction; SCZ = Sub-capsular zone and X refers to cell apoptosis which 
contributes to the decrease in relative proliferation at the DN3 and selection phases of development. 
 
1.2.2 Early development and commitment to the αβ lineage After entry to the thymus, T cell progenitors are named according to characteristic cell surface markers –with major subsets divided based on expression of the CD4 and CD8 co‐receptors,  named double  negative  (DN;  CD4‐CD8‐),  double  positive  (DP;  CD4+CD8+) and  single  positive  (SP;  CD4+  or  CD8+).  DN  thymocytes  migrate  outwardly  from  the cortico‐medullary  boundary  through  the  cortex  via  signals  from  cortical  thymic epithelial cells (cTECs) expressing P‐selectin  ligand‐1 (PSGL‐1) that binds to P‐selectin expressed  on  DN  thymocytes  (Rossi  et  al,  2005).  DN  cells  progress  towards  the  sub‐capsular zone (SCZ) at  the periphery of  the cortex through changing cTEC chemokines and  adhesion  molecules  including  the  aforementioned  CXCR4  and  C‐C  chemokine receptor 7 (CCR7; Misslitz et al, 2004). The first two of four DN stages (DN1 and DN2) 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occur en route  to  the SCZ  in  the cortex. DN phases are distinguished via expression of CD44  and  CD25  cell  surface markers.  The  DN1  phase  of  development  constitutes  the point where  thymocytes  can  differentiate  into  T  cells  or  other  lymphoid  cells  such  as natural  killer  (NK)  cells  or  dendritic  cells  (DC).  DN1  thymocytes  (CD44+CD25‐)  are further divided to five subsets (DN1a‐e) delineated via relative expression of CD24 (heat stable antigen; HSA) and CD117 (tyrosine‐protein kinase Kit; c‐Kit). Only DN1a and 1b progress  to  the  DN2  phase  of  T  cell  development,  which  is  defined  through  a proliferative  burst  not  present  in  other DN1  subtypes  that  give  rise  to  other myeloid lineages (Porritt et al, 2004). DN2 thymocytes (CD25+CD44+) are marked via a burst of proliferation prior  to  lineage commitment stages where a high proportion of cells will fail to meet the criteria and subsequently apoptose.  DN3 (CD25+CD44‐) thymocytes represent the first stage where absolute commitment to T  cell  development  is  observed.    CCR9  functions  in  a non‐redundant manner  to  guide DN2‐DN3  thymocytes  through  the  SCZ  where  the  first  step  of  lineage  commitment between αβ  T  cells  and  γδ  T  cells  occurs  (Benz  et  al,  2004).  Interestingly  however  a CCR9 KO mouse still develops normal T cells, with  the SCZ microenvironment “spread out”  towards  the  cortex  (Benz et al,  2004). Lineage differentiation between αβ T  cells and γδ T cells is a contentious topic as reviewed recently by Ciofani and Zuniga‐Pflucker (Ciofani  and  Zuniga‐Pflucker,  2011).  Several  mechanisms  have  been  proposed  to account for αβ T cell and γδ T cell lineage decision. Most simply, DN3 thymocytes could be pre‐determined or dependent purely on whether the TCRβ or TCRδ and γ rearranges and signal first. However, functionally rearranged TCRβ genes are present in mature γδ T  cells  (Bosco  et  al,  2008).  Other  relevant  mechanisms  include  differential  signalling requirements,  for  example  the  requirement  of  IL‐7  signalling  via  STAT  5  in  γδ  loci rearrangement (Moore et al, 1996; Schlissel et al, 2000; Ye et al, 1999; Kang et al, 1999; Durum et al, 1998). Similarly, αβ T cell development requires Notch signalling to inhibit the  protein  E2A, which  facilitates  proliferation,  whereas  γδ  signalling  is  sufficient  for E2A inhibition (Berndt et al, 2000). However, dependence on signalling strength (Hayes and Love, 2005 and Hacks et al,  2005)  and  trans‐conditioning mechanisms where  the rearrangement of the TCRβ may actually support γδ lineage commitment may also play a role (Burtrum et al, 1996 and Wilson and MacDonald, 1998). DN3 cells that progress towards the αβ T cell lineage next undergo TCRβ‐selection. Here the TCRβ  locus  rearranges  (see next  section  for a description of V(D)J  recombination) 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with  successfully  rearranged TCRβ  chains  expressed  at  the  cell  surface where  it  pairs with the non‐rearranging IgSF protein, pre‐TCRα (pTα) which structurally resembles a full  TCRα  chain  lacking  the  V‐domain  and  is  restricted  in  expression  to  thymocytes (Raulet et al, 1985). The exact mechanism of interaction between TCRβ chains and the p‐Tα  is not  fully understood, with recent reports suggesting  the pTα exists  in  top to  tail dimeric  form which  interacts with  the V and C‐domains of  the TCRβ  chain  to  stabilise the complex (Pang et al, 2010). However, pTα lacking the external domain can function with  TCRβ  chain  and  retains  signalling  capacity  (Irving  et  al,  1998).  Upon  successful pairing  of  the  TCRβ  and  pTα  to  form  the  pre‐TCR,  ligand‐independent  signalling  is induced  which  provides  survival  signals  and  also  instigates  allelic  exclusion  through chromatin remodelling around the second TCRβ  loci, increasing the distance between J and D segments and restricting access  to  the V‐segments, ensuring the clonality of  the surface TCRβ chain (Jackson et al, 2005; Yamasaki et al, 2006 and Kondillis‐Mangum et 
al, 2011). Dependence on signalling  for survival ensures only structurally sound TCRβ chains  with  signalling  capability  progress  to  the  DN4  (CD25‐CD44‐)  stage  of development.  DN4 thymocytes undergo a second round of proliferation transiently passing through an immature SP (iSP) phase characterised by CD8 expression ultimately leading to the DP stage  while  progressing  from  the  SCZ  to  the  middle  of  the  cortex.  During  this  time, chromatin  remodelling  and  re‐expression  of  the  recombination  machinery  facilitates rearrangement of the TCRα locus (see Section 1.3) and loss of pTα expression. Unlike the case  for  TCRβ  rearrangement,  TCRα  rearrangement  allows  successive  rounds  of  V‐J recombination  facilitated  by  spatially  ordered  recombination  within  the  TCRα  locus (Krangel et al, 2004) and lack of allelic exclusion. It  is not uncommon for developing T cells  to  express  two  functional  TCRα  chains,  however  successful  pairing  of  one ultimately leads to the switching off of one locus (Lacorazza and Nikolich‐Zuglich, 2004, Davodeau  et  al,  2001  and  Malissen  et  al,  1992).  DP  thymocytes  make  up  the  largest proportion  (~80%)  of  all  thymocytes  due  to  the  proliferative  burst  induced  through TCRβ‐pTα signalling. This vast population is required due to the stringent nature of the subsequent  selection  of  αβTCRs  that  results  in  less  than  5%  of  DP  being  positively selected to develop into naïve SP T cells (Miller, 1961) despite the fact more than four times  that  number  can  audition  with  pMHC  (Merkenschlager  et  al,  1997).  DP 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thymocytes  that  fail  to make  a  viable TCRα  chain,  die  through neglect, whereas  those that form successful heterodimers are subjected to T cell selection.  
1.2.3 T cell selection, CD4/8 lineage choice and post-thymic development TCRβ‐selection  and  successful  pairing  of  an αβTCR  heterodimer  ensures  structurally sound TCR heterodimers but does not assess Ag‐reactivity or potential usefulness as a component  of  the  mature  TCR  repertoire  (Section  1.3).  Two  distinct  but  overlapping processes,  positive  and  negative  selection,  function  to  produce  a  narrower  TCR repertoire  that  is both useful  (MHC  responsive) but not  autoreactive  (reactive  to  self‐pMHC). DP thymocytes have around three days to audition for thymic selection, if they have not  found a  suitable αβTCR pair, or have  too  low an affinity  to bind with pMHC, they die through neglect. Positive  selection  of DP  thymocytes  occurs  in  the  thymic  cortex where  cTECs  express MHC class I and class II molecules presenting self‐peptides. Thymic DCs are also present in the cortex and may bring in extra‐thymic self‐Ag to broaden the scope of positive and negative  selection  (see  review  by  Klein  et  al,  2009).  The  stringent  requirements surrounding positive selection are exemplified by the presence of the thymoproteasome, a cTEC specific proteasome containing a unique β5 subunit generating peptides that are efficient  at  positively  selecting  CD8  T  cells  (Nitta  et  al,  2010).  Further,  it  was  shown through  work  with  MHC  dimers  expressing  different  peptides  that  positive  selection requires a much narrower range of peptides than negative selection (Juang et al, 2010). DP  thymocytes  are  very  sensitive  to  pMHC  complexes,  due  to  lower  levels  of glycosylation  on  cell  surface  proteins  leading  to  closer  cell‐cell  contact,  which  lowers signalling  thresholds  (Starr  et  al,  2003).  Further  CD5,  a  negative  regulator  of  TCR signalling,  is  expressed  at  lower  levels  on  DP  cells  prior  to  positive  selection,  with increased expression a marker of efficient T cell selection  (Tarakhovsky et al, 1995 and Azzam et al, 2001).  It  is now fully accepted that DP thymocytes are positively selected based  on  their  affinity  and  avidity  for  self‐pMHC  molecules.  Studies  of  TCR  affinity associated  with  positively  and  negatively  selecting  pMHC  complexes  revealed  a remarkable  difference  in  affinity,  with  higher  affinity  complexes  inducing  negative selection (Alam et al, 1996). Similarly, mice expressing three distinct pMHC transgenic molecules  demonstrated  different  affinities  of  DP  interactions,  revealing  a  constant upper  level  of  affinity  for  positive  selection  (Naher  et  al,  2007).  Optimal  affinity 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interactions  also  relate  to  increased  avidity,  which  ultimately  facilitates  positive selection  (Scott  et  al,  1989  and  Ashton‐Rickardt  et  al,  1994).  Stronger  signals  induce apoptotic  pathways,  whereas  optimal  affinities  induce  survival  signals  and  cells  with poor affinity  that die of neglect do so via a mechanism distinct  from  induced negative selection (Scott et al, 1989; Hogquist et al, 1994 and Sebzda et al, 1994). As discussed in 
Section 1.2.4,  an  important  subset  of  regulatory T  cells  termed natural Tregs  (nTregs) also develop thymically during positive selection. nTregs have been shown to require a slightly  higher  affinity  than  conventional  effector  T  cells  and  have  a  largely  non‐overlapping  repertoire  (Apostolou  et  al,  2002;  Jordan  et  al,  2001  and  Walker  et  al, 2003). Upon positive selection, maturation to CD4 or CD8 SP thymocytes results  in up regulation of molecules associated with mature T cell function including the TCR itself, the  aforementioned  CD5  and  CD69,  which  are  involved  in  lymphocyte  signalling (Yamashita, 1993).  DP cells express both CD4 and CD8 and  thus all DP have  the potential  to develop  into class I or class II specific T cells (see Section 1.4.1 for details). While the respective MHC classes  ultimately  select  the DP  cells  into  their  lineage  (Sebzda  et  al,  1999),  some DP thymocytes  will  interact  with  both  classes  of  MHC  and  the  mechanism  for  lineage selection  is  not  yet  fully  understood.  There  is  evidence  from  some  structural  and functional studies that specific Vα or Vβ segments contain an inherent preference for a specific  class  of MHC  (DerSimonian  et  al,  1991  and  Jameson  et  al,  1990), while  other work has demonstrated  the ability of all V‐segments  to be used across both classes of MHC (Valkenburg et al, 2010 and Jorgensen et al, 1992). Conversely, other evidence has suggested  that  class  preference  is  entirely  independent  of  the  TCR  and  is  controlled through the actions of cytokines such as IL‐7 (Park et al, 2010). A review by Singer et al summarised three potential mechanisms for lineage determination (Singer et al, 2011). First, a basic stochastic mechanism whereby T cells randomly turn off CD4 or CD8 co‐receptor genes and are only positively selected if they interact with the MHC class with the  correspondingly  correct  co‐receptor  interaction  (Davis et  al,  1993  and Chan  et  al, 1993).  Second,  based  on  the  strength  of  the  signal  linked  with  observation  that signalling  is  stronger  in  the  CD4  lineage  compared with  the  CD8  lineage  (Itano  et  al, 1996 and Seong et al, 1992). However a third model is becoming increasingly accepted and is related to signal duration. While experiments concluding signal strength was the key determinant mainly altered the activity of downstream signalling kinases, mutation of  the  TCR  immunoreceptor  tyrosine‐based  activation  motifs  (ITAM),  which  more 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directly decreased signalling intensity, demonstrated an overall reduced output of SP T cells,  but  with  no  change  in  CD4/8  proportions  (Erman  et  al,  2006).  It  has  been demonstrated  now  that  initial  positively  selecting  signals  induce  down‐regulation  of CD8 (Brugnera et al, 2000 and Lundberg et al, 1995) creating a CD4+CD8Lo intermediate. Signalling  will  be  maintained  only  if  MHC  class  II  is  being  engaged  leading  to commitment  to  the  CD4  SP  lineage,  permanently  shutting  off  CD8  expression. Conversely, if MHC class I is being engaged, signalling in CD4+CD8Lo thymocytes will be curtailed resulting in silencing of the CD4 gene and re‐expression of CD8, generating the CD8 SP population. This model incorporates the role for IL‐7, which is also expressed as part  of  the  curtailed  signalling  event  on  class  I  MHC  resulting  in  ultimate  class  I preference.  This  selection  mechanism was  demonstrated  conclusively  in  experiments that switched the control elements for the CD4 and CD8 genes, demonstrating a reversal in the kinetic requirements for lineage commitments (Sarafova et al, 2005). SP thymocytes bare all the hallmarks of naïve T cells, however a CCR7 mediated process guides SP cells to interact with medullary thymic epithelial cells (mTECs). Loss of CCR7 expression does not prevent SP cells from exiting the thymus, but resulted in increased self‐reactivity  and  systemic  autoimmunity  (Kurobe  et  al,  2006).  This  is  due  to  the requirement of a  final stage of negative selection that occurs only with mTECs. mTECs and associated DCs are highly  specialised  in Ag presentation and have been  shown  to express non‐thymic tissue specific genes allowing deletion of TCRs specific for a range of ‘peripheral’ self‐proteins. This process is mediated by the autoimmune regulator (AIRE) gene, which  encodes  for  a  transcription  factor  that  initiates  the  ectopic  expression  of many  tissue‐specific  proteins,  such  as  insulin,  that  allow  negative  selection  of  self‐peptide reactive T cells through induction of apoptosis (Anderson et al, 2002).  After this final  selection  process,  exit  from  the  thymus  is  mediated  by  the  G‐protein  coupled receptor (GPCR), for sphingosine1‐phosphate (Rosen and Goetzel, 2005). Recent thymic emigrants (RTEs), have been defined as a unique subset relative to other naïve T cells (reviewed  by  Fink  and  Hendricks,  2011).  RTEs  are  functionally  immature  with  poor proliferation and cytokine secretion upon stimulation and poor capacity  to polarise  to other T cell subtypes (see next section).   It has been proposed that immaturity may be required as the peripheral repertoire of RTEs is further shaped through receptor editing and  further  deletion  of  SP  T  cells  in  an MHC  independent manner  through  extended negative  selection  outside  of  the  thymus  (Hale  et  al,  2010).  Maturation  of  RTEs  to mature naïve T cells has been proposed not to be related purely to survival, but to also 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require interactions in the peripheral lymphoid organs (Boursalllin et al, 2004; Houston and Fink, 2008 and Fink and Hendricks, 2011).   
 
Figure 1. 3: Only TCRs that bind pMHC within a narrow range of affinities are positively selected.  
Only TCRs that bind pMHC within a narrow range of affinities are positively selected. Schematic chart 
depicting the relative affinities at which DP>SP T cells will be positively or negatively selected. Affinity is 
represented on the x-axis. Cells that bind with negligible affinities will receive no survival signals and die by 
neglect. However cells that bind too strongly will receive apoptotic signals and become negatively selected. 
Cells that bind with low-medium affinities will receive survival signals and mature as conventional (Con) T 
cells. nTreg (Reg) T cells appear to select at slightly higher affinities than conventional T cells.   
1.2.4 Development and selection of nTregs and other T cell sub-types The exquisite, complex and stringent process of T cell selection, functions to ensure that few self‐reactive TCRs enter the periphery. Central tolerance is not, however perfect and as discussed in Section 1.4.4, autoreactive TCRs may cause significant disease to the host. Thus  a  form  of  peripheral  tolerance  is  required  to  balance  the  failings  of  central tolerance.  Immunosuppressive  CD4+CD25+  T  cells,  now  termed  Tregs,  are  defined through expression of  forkhead box P3 (FoxP3), which is a master transcription factor for  Treg  function  (Sakaguchi,  2005  and  Kim  and  Rudensky,  2006).  Consequently, absence  of  FoxP3  results  in  severe  autoimmunity  (see  review  by  van  der  Vilet  and Nieuwenhuis,  2007).  Exogenous  expression  of  FoxP3  in  conventional  CD4  T  cells  can convert an effector phenotype into a regulatory one.  While some Tregs are induced in the periphery (see Table 1.1), CD4+CD25+FoxP3+ cells were observed in the CD4 SP thymic compartment using expression of green fluorescent 
Neglect
Positive Selection
Con Reg Negative Selection
TCR-pMHC Affinity
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protein  (GFP)  under  control  of  the  FoxP3  promoter  (Fontenot  et  al,  2005).  There  is ongoing debate whether  the generation of nTregs  is a TCR  instructive or  independent process  (reviewed  by  Josefowicz  and  Rudensky,  2009).  TCR  instructive  processes  are supported  by  the  discoveries  that  nTregs  and  conventional  T  cells  have  largely  non‐overlapping  TCR  repertoires  and  that  nTregs  select  in  the  thymus  on  higher  affinity pMHC  interactions  –  which may  be  advantageous  as  such  receptors  would  be  highly reactive  to  self‐Ag  but  with  an  immunosuppressive  functional  response  (Figure  1.3). However  there  is  evidence  that  nTreg  lineage  commitment  occurs  earlier  in  T  cell development – for example interruption of the DN3 phase through pTα KO, resulted in an  increased  proportion  of  nTregs  (Bosco  et  al,  2006  and  Pennington  et  al,  2006). Finally, as well as nTregs, other T cell subtypes and lineages can develop in the thymus or be polarised in the periphery. Many new subtypes have been identified recently and there  are  current  controversies  on  the  plasticity  and  stability  of  such  lineages.  These major T cell subtypes are summarised in Table 1.1. 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Table 1. 1: T cell lineages 
 
 
 
 
Main Identifier Name Function References
Naïve CD8 T cell
Unactivated CD8 T cells that become CTL or CD8 memory 
T cells upon activation via class I pMHC.
Zhou et al, 2009
Cytotoxic T Lymphocyte (CTL)
Activated CD8 T cell that kill infected cells directly via 
perforin and and granzyme B release.
Zhou et al, 2009
CD8!! T cell
Intraepithelial T cells that express the CD8!! homodimer 
and reside in the gut. They can express "# or !$ TCRs 
enriched for self-specificity and function in a regulatory or 
effector mechanism. Also known as intraepithelial 
lymphocytes (IEL).
Cheroutre et al, 2011
Exhausted
CTL that have been chronically activated resulting in 
exhaustion that are characterised by an inability to 
respond to stimulation and expression of inhibitory 
molecules.
Wherry, 2011
Naïve CD4 T cell
Unactivated CD4 T cells that become activated by APC 
bearing class II MHC. Differentiate into other CD4 helper 
or regulatory lineages.
Zhou et al, 2009
T helper (Th)1
Function to kill intracellular pathogens via secretion of IFN-
" and activation of m% via class II pMHC activation.
Zhou et al, 2009
Th2
Instigate humoral immune responses through IL-2 and IL-
4 which activate B cells resulting in Ig secretion.
Zhou et al, 2009
Th9
Have a role in immune responses against extracellular 
pathogens such as nematode worms. Often contribute to 
inflammatory and allergic diseases. Characterised by 
expression of IL-9
Zhou et al, 2009
Th17
Thought to be important in immunity against extracellular 
bacteria and fungi at mucosal surfaces through the actions 
of IL-17A, IL-17F and IL-21. Often implicated in 
autoimmune diseases. Generated in the presence of TGF-$ 
and IL-6. 
Weaver et al, 2007
Th22
Yet to be confirmed as a genuine subset of T cells. 
Identified in inflammatory skin diseases. Characterised by 
IL-22 expression.
Eyerich et al, 2009
Follicular Helper T cells (TFH)
Cells that are specialised in instigating immune responses 
in the germinal centres of lymph nodes such as Ig class 
switching in B cells.
Vinuesa et al, 2005
T Regulatory (TR) 1
Peripherally induced Tregs that produce the 
immunosuppressive cytokine IL-10 but unlike other Tregs 
does not require the FoxP3 transcription factor. Also known 
as Th3 T cells
Carrier et al, 2007
nTreg
Immunosuppressive T cells that are generated in the 
thymus during normal T cell development. Express the key 
transcription factor FoxP3 with self-specific TCR.
Horwitz et al, 2008
iTreg
Produce immunosuppressive cytokines such as IL-10 and 
TGF-$ akin to nTregs, but are induced in the periphery 
from conventional CD4 T cells apparently in a TGF-$ and IL-
2 dependent manner.
Horwitz et al, 2008
Natural Killer T cells (NKT)
Express semi-invariant TCR! chains that are restricted to 
MHC class I-like CD1d molecules presenting lipid Ag and 
have broad ranging immune functions.
Godfrey et al, 2004
"# T cell
Differentiate from the !$ T cell lineage at the DN3 stage of 
thymic development and express "# TCRs. Exact ligands 
are not yet characterised. They are often enriched for at 
epithelial surfaces and function in pro- and anti-
inflammatory mechanisms.
Born et al, 2006
Memory T cells
Ag specific CD4 or CD8 T cell subset that persist after an 
infection has been neutralised. They function to allow a 
quick response upon re-exposure to the original pathogen 
for a second time. Exist as central or effector sub-
populations based on differential expression of CCR7 and L-
selectin.
Sallusto et al, 2000
Recent Thymic Emigrant (RTE)
The most recent exudant of newly selected T cells from the 
thymus. They are proposed to be distinct from other naïve 
T cells through changes in surface expression of the TCR 
and CD24 as well as other cell markers. Unlike fully 
mature naïve T cells, RTEs do not respond well to Ag 
stimulation.
Fink and Hencricks, 2011
Table 1.1: T cell lineages
CD8
CD4
Other
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1.3 Generation of the TCR repertoire 
1.3.1 Genetic structure of the αβ TCR loci in mice and humans TCR loci in all vertebrates are organised in a translocon configuration, with similar gene segments  forming  groups  within  the  locus,  as  opposed  to  a  cluster  formation  where different gene‐segments exist in pre‐arranged orders required to make a single receptor (Figure 1.4). Such an organisation is beneficial two‐fold: first, separation of similar gene segments  into  distinct  clusters  facilitates  combinatorial  diversity, which would not  be possible  in  a  cluster  format.  This  could  encourage  gene‐segment  duplication  and  thus select  for greater diversity of TCR genes. Second, a  translocon structure would ensure only a  single  receptor generated per cell  (assuming allelic exclusion;  see next  section) thus  creating  a  balance  between  maximal  diversity  while  avoiding  self‐reactivity (Boehm, 2011).  The  TCRα  locus  in  mice  and  humans  exists  as  the  TCRα/δ  locus,  with  the  δ  gene segments situated between the Vα and Jα segments (not discussed in detail here; Chien 
et al, 1987) on chromosome 14 in both genomes, spanning approximately 1.1Mb.   The TCRα gene segments are arranged Vα‐Jα‐Cα  in a 5’‐3’ orientation, with all segments in the  same  transcriptional  orientation.  The  promoter  region  is  encoded  5’  to  the  Vα segments.  A  single  Cα  gene  segment  consists  of  four  exons  that  encode  for  the extracellular  domain,  a  sixteen  amino  acid  stretch  that  encodes  for  the  key  cystine required  for  the  inter‐chain  link,  the TM region and  intra‐cytoplasmic  region with  the final  exon  encoding  a  3’  untranslated  (UTR)  region.  Vα  and  Jα  segment  numbers  are summarised  in Table  1.2.  The  locus  also  contains  an  enhancer  element  (Eα)  to  aid  in transcription and V(D)J recombination (Abarrategui and Krangel, 2006). The delta locus contains  a  distinct  enhancer  element  (Eδ)  which  ensures  correct  temporal rearrangement of  the α  and δ  loci  at  the DP and DN3  stages  respectively  (see Section 
1.2.2; Hernandez‐Munain et al, 1999). The TCRα locus also encodes for an element called T early alpha (TEA) which exists upstream of the Jα segment 5’ boundary. It recombines to a pseudo Jα found 3’ of the Cδ region thus removing a stretch of DNA that brings the Vα and Jα segments closer together which is thought to facilitate a broader array of V‐J pairings which would otherwise be  limited due  to  the  separation  caused by  the TCRδ loci (Villey et al, 1996). 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The  TCRβ  locus  spans  approximately  700  Kb  on  chromosome  6  and  620  Kb  on chromosome 7 in mice and humans respectively (Lefranc et al, 2003), containing V, D, J and  C  segments  (Figure  1.4).  The  two  unique  features  of  the  TCRβ  loci,  conserved throughout all higher vertebrates so far analysed,  is the existence of two distinct D‐J‐C clusters positioned in tandem and the presence of a single Vβ segment present at the 3’ terminal  in  the  opposing  transcriptional  direction  (thus  requiring  a  reversion  to  be utilised  functionally;  Figure  1.4).  The  locus  therefore  contains  two  unique,  but functionally  redundant,  constant  regions,  similarly  made  up  with  four  exons  as described  for  the  Cα  gene  segment.  A  transcriptional  enhancer  element  (Eβ)  is  also encoded within  the  locus  at  the  3’  end  (McDougall  et  al,  1988  and Krimpenfort  et  al, 1988).  The  TCRβ  locus  contains  an  internal  promoter  found  5’  of  the  Dβ1  segment termed PDβ1, and is vital in the initiation of V(D)J recombination (see next section).  
 
Figure 1. 4: Chromosomal organisation of the murine TCRα/δ and TCRβ loci. 
Schematic representation of the TCRα/δ (top) and TCRβ (bottom) loci. Numbers of gene-segments are 
representative of the proportions present in the genome. Gene segments are shown in red (variable; V), yellow 
(diversity; D), purple (joining; J) and green (constant; C) segments. Loci are organised 5’-3’ direction. Blue 
diamonds represent promoters that control TCR gene expression after locus rearrangement. The arrows depict 
the orientation of the reading-frame. TEA = Early T α element which ensures the TCRα gene-segments 
rearrange instead of the TCRδ segments when required. Eα and Eβ (grey boxes) represent the positions of 
enhancer elements that attract the recombination machinery to the locus. The double slanted-line breaks 
represent larger distances that exist between the adjacent sections of the locus. Diagram adapted from Schatz and 
Ji, 2011).  
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Table 1. 2: Number of TCR gene segments encoded in the mouse and human genome 
 
1.3.2 V(D)J recombination V(D)J  recombination  as  described  in  Section  1.2,  occurs  at  defined  stages  of  T  cell development and  is  critical  for  successful  generation of  the TCR and T  cell  repertoire.  Gene segments are flanked by recombination signal sequences (RSS) that exist 5’ and/or 3’ depending on the segment and consist of one of two forms. Conserved heptamer and nonamer  sequences  can  be  separated  by  either  a  non‐conserved  stretch  of  12  or  23 nucleotides. V and J gene segments are flanked by one RSS, with the conserved heptamer sequence proximal to the gene segment (Figure 1.5). V‐segments contain 3’‐7/23/9 RSS and  J‐segments  a  5’‐9/12/7 RSS.  The Dβ  segments  however  contain  both  a  3’‐7/23/9 RSS  and  a  5’–9/12/7  RSS.  Recombination  of  gene  segments  is  dependent  on  the  so‐called 12/23 rule, where only segments with opposing linker sequence lengths based on opposite sides of the segments can efficiently recombine together (van Gent et al, 1996 and  Eastman  et  al,  1996).  Importantly,  this mechanism  ensures  the  Dβ  segment with two RSS is only recombined to the 5’ of the Jβ segment and 3’ of the Vβ (Sleckman et al, 2000). As mentioned  in  Section  1.2.1,  recombination  is  mediated  by  two  complexes  that  are restricted in their expression to lymphocytes: RAG1/2 and TdT. These molecules, along with  more  general,  household  DNA  repair  enzymes  mediate  the  process  of recombination. While RAG1/2 catalyses  the  recombination  reaction  through  induction of double stranded (ds) DNA breaks, distinct TdT isoforms function to  insert or delete nucleotides generating junctional diversity that encodes for the hypervariable CDR3 of the TCR (Thai et al, 2002). The process of V(D)J recombination is summarised in Figure 
1.5 (for a detailed review of the process, please see Schatz and Ji, 2011). Importantly, the process  of  “choosing”  which  segments  join  together  is  not  random  and  seems  to  be 
Genome TCR Chain V-segments D-segments J-segments Constant
TCR! 54 - 61 1
TCR" 64 2 14 2
TCR! 73 - 38 1
TCR" 35 2 11 2
Data taken from IMGT Database (see Materials and Methods for details). Numbers are 
estimates and do not include pseudogenes or orphan genes.
Table 1.2 Number of TCR gene segments encoded in the mouse and human genome
Human
Mouse
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constrained  by  relative  locus  position  (Pasqual  et  al,  2002).  As  the  TCRα  locus  can audition  several  receptors  and  has  no  mechanism  for  allelic  exclusion  (see  previous section), it has developed a distinct two phase mechanism of recombination, with more 3’  Vα  segments  recombining  first,  followed  by  the  more  5’  segments  (Krangel  et  al, 2004). TCR CDR3 generated  through V(D)J  recombination are generally more uniform than their Ig and γδTCR counterparts (Rock et al, 1994), most likely due to the structural constraints  of  recognising  Ag  in  the  context  of  MHC.  Despite  the  vast  array  of combinatorial  and  junctional  diversity  generated  in  the  TCR  repertoire,  the  potential number of receptors is still grossly outnumbered by the number of potential Ag one can encounter. Thus,  several molecular  and  cellular mechanisms  function  to maximise  the use of the limited TCR repertoire. 
 
Figure 1. 5: Overview of V(D)J recombination.  
The diagram represents a simplified overview of the recombination of two segments from the TCRα/δ locus. 
Chromosome remodelling loops the loci to bring gene-segments to closer proximity (top left; 5’-3’). The 
RAG1/2 complex (light blue rectangle) is stabilised by binding to the nonamer of the RSS, most likely the 7/12/9 
RSS (red triangle). The functionally redundant high-mobility group protein B1 or 2 (HMGB), which functions to 
further bend the gene-segments into closer proximity binds in concert with the RAG1/2 complex and allows it to 
bind to the second RSS forming a synaptic complex (top right). Adapted from Schatz and Ji, 2011. A single 
stand nick occurs at each RSS leaving a 3’ hydroxyl (OH) group resulting in nucleophilic attack on the second 
strand generating two hairpins and separates the RSS within the RAG1/2 complex (middle right).  The TdT 
isoforms and other members of the non-homologous end-joining (NHEJ) complex that includes the molecules 
discussed in Section 1.1.1 (orange box; middle left) are then recruited to the synapse. TdT functions to open the 
hairpins and insert and remove nucleotides, generating junctional diversity before the NHEJ complex repairs the 
DNA breaks, joining the two segments and two RSS together forming a partially recombined TCR locus (bottom 
left) and TCR excision circle (TREC). Adapted from Schatz and Ji, 2011.  
TCR!/"
C!
J!
V!
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1.3.3 Maximising and maintaining TCR repertoire diversity Based on pure combinatorial diversity, Ig molecules are significantly more diverse than TCRs, with hundreds  instead of  tens of V‐segments. However TCRs have  the ability  to generate  a  much  greater  array  of  junctional  diversity  based  on  significantly  larger numbers of J‐segments. Sequencing studies revealed approximately 1x106 unique TCRβ chains in circulating T cells, paired to on average 25 TCRα chains, giving a total unique TCR  repertoire  of  around  1x108  (Arstila  et  al,  1999).  This  is  much  lower  than  the potential  2,500  variable  region  and  ~1x1015  junctional  combinations,  as  a  result  of positive and negative selection during T cell development.   MHC  class  I  molecules  can  present  Ag  peptides  from  around  8  to  13  amino  acids  in length, whereas class II MHC have no real restrictions, but generally bind peptides with a minimum of 13 residues (see next section). The maximum number of different peptide 13mers  that  can  be  created  from  the  pool  of  twenty  amino  acids  is  also  calculated  at >1x1015,  i.e. more than the whole potential unique TCR repertoire (Mason, 1998). And while  not  all  peptides  can  be  appropriately  processed  or  loaded  onto  MHC,  the  final number presented  still  dwarves  the naïve T  cell  repertoire by orders  of magnitude. T cells  therefore  must  function  to  recognise  as  broad  a  repertoire  of  Ag  as  possible  in order to avoid exploitation by pathogens of “blind spots” in the TCR diversity. While the size of an animal generally dictates the final number of T cells that can exist (~x1012 and ~x108 in humans and mice respectively for example), which facilitates broader scope for clonal diversity in larger animals, the number of cells required for one TCR for every Ag would be  too  great  for  even  the biggest  animal.  To  compensate  it was  calculated  that every  TCR  would  have  to  recognise  >1x106  peptides  (Mason,  1998).  This  ability  is achieved  through  the  molecular  mechanism  of  cross‐reactivity,  with  homeostatic processes ensuring diversity is maintained in the naïve T cell pool. Cross‐reactivity is a broad term used to describe a TCR’s ability to respond to more than one pMHC complex and can be broken down to three terms: degeneracy, poly‐specificity and molecular mimicry. These  terms are defined  in  this study as summarised  in Table 
1.3 with specific examples described  throughout Section 1.4. The  terms are often used interchangeably  or  with  differing  definitions  in  the  literature  (Wucherpfennig  et  al, 2007). All of these mechanisms function to allow the TCR to respond to various pMHC, thus  facilitating required cross‐reactivity. These cross‐reactive responses often rely on conformational  changes  in  the  CDRs  of  the  TCR,  however  deeper  structural  changes 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resulting in different TCR “conformers” or inter‐domain angles can also facilitate greater diversity of ligand recognition. For example, two similar TCRs bound to a similar pMHC demonstrated  a  different  binding  footprint  due  to  changes  in  the  inter‐domain Vα‐Vβ angle (McBeth et al, 2008). A TCR recently found to bind to both class I and class II MHC molecules  showed  a  change  in  the  interactions  between  strands  F  and G  in  the TCRα chain (linked by the CDR3) when bound to class I relative to class II, resulting in an open conformation of the αCDR1. It was proposed these open and closed conformers further diversify the TCR’s ability to bind with different ligands (Yin et al, 2011b). Finally, when the same TCR chain is paired with distinct partners, the partner chain can influence how the common chain  interacts with the pMHC,  furthering the scope for diversifying TCR‐pMHC interactions and cross‐reactivity (Stadinski et al, 2011). The structural details of these studies are discussed in Sections 1.4 and 1.5 in more detail where relevant. Recent  high  throughput  studies  using  peptide  libraries  (Wooldridge  et  al,  2008  and 2011)  have  revealed  that  cross‐reactivity  does  generate  a  TCR  repertoire  capable  of recognising the number of Ag estimated by Mason (Mason, 1998).  In the latter study, for the IE6 T cell clone, the cognate Ag is a ten amino acid long peptide derived from pre‐proinsulin, presented on a class I MHC (HLA‐A2; see next section for nomenclature). The clone  was  shown  to  respond  to  >1.3x106  peptides  altered  from  the  original,  with strengths  at  physiological  levels.  While  such  a  high  level  of  cross‐reactivity  seems  at odds with  concept of TCR  specificity,  especially  in  the  context of  self‐tolerance,  as  the authors noted, with more than 1x1013 potential decamer peptides possible from a pool of 20 amino acids, cross‐reactivity to around 1x106 still only represents a recognition of 1/10,000,000 decamer peptides. While  containing  a  peripheral  repertoire  that  can  deal with  a  broad  array  of  Ag,  only small  numbers  of  clones  will  be  required  for  specific  infections.  Thus  the  naïve repertoire  of  T  cells  must  be  homeostatically  maintained  in  such  a  way  as  to  retain clonal diversity. The two most defined regulators of T cell homeostasis are  interaction with self‐pMHC and IL‐7 (reviewed by Takada et al, 2009). TCR:self‐pMHC interactions in  the periphery  are not  fully understood,  but  the  general  belief  is  that  an  interaction results in a weak signal that promotes survival, but is not strong enough to elicit a full immune  response.  Such an  interaction  is  akin  to positive  selection  in  the  thymus  (see 
Section  1.2.2).  Indeed,  self‐pMHC  complexes  that  positively  select  specific  TCRs  in  the thymus have been shown to provide homeostatic cues in the periphery to the same TCR 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(Lo  et  al,  2009).  However  non‐selecting  self‐pMHC  complexes  can  also  mediate  this function  in  the  periphery  (Leitao  et  al,  2009).  How  clonal  diversity  is maintained  via homeostasis  is  not  fully  understood,  however  it  could  be  explained  by  several mechanisms (Takada et al, 2009). First, if different clones are specific for different self‐pMHC,  it would  ensure  competition would be  intraclonal, maintaining  representatives from  a  broad  array  of  specificities.  An  adjunct  to  this  mechanism,  where  T  cells  are competing for access to different self‐pMHC molecules on the same APC, competition for extrinsic  survival  factors  may  be  important  in  determining  repertoire  competition  (Moses et al, 2003; Troy et al, 2003 and Agenes et al, 2008). Where the same self‐pMHC is recognised by more than one clone, interclonal competition could also ensure that no one clone becomes overly dominant in the repertoire (Hao et al, 2006).  Thus, while  TCR  repertoire  diversity  is  potentially  vast,  the  near  limitless  plethora  of potential Ag  requires T  cells  to  be  able  to  respond  to potentially millions  of  peptides. This  cross‐reactivity  is  also  vital  for  unique  pMHC  interactions,  including  thymic selection, homeostatic maintenance and immune response. Such diversity in the TCR, Ag and MHC has made deciphering the molecular nature of TCR‐pMHC binding difficult. The following  section  describes  the  variability  in  TCR‐pMHC  binding  that  contributes  to cross‐reactivity enabling immunity to the vast number of peptide epitopes and is vital in understanding the molecular nature of TCR restriction to MHC.  
 
Table 1. 3: Forms of TCR cross­reactivity 
 
 
 
Term Definition
Molecular mimicry
The ability of a different MHC allele or presented peptide to 
appear structurally similar to the cognate MHC or peptide, 
resulting in tolerance or activation respectively
Poly-specificity
The ability of a TCR to recognise entirely different Ag to it's 
cognate peptide with the same level of response despite using 
different contacts or modes of interaction.
Peptide degeneracy
The ability of a TCR to respond to pMHC presenting different 
peptides, but with less specificity/strength of response as to 
the cognate ligand through altered interactions.
Table 1.3 Forms of TCR cross-reactivity
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1.4 TCR-pMHC interactions 
1.4.1 The MHC – an overview  The MHC region of  the genome encapsulates  three classes of genes with both  immune and  non‐immune  functions.  These  loci  are  located  on  chromosome  6  and  17  in  the human and mouse genomes respectively. Class I region genes encode for Ag presenting molecules  as  well  as  proteins  that  aid  in  class  I  MHC  peptide  loading  and  assembly, including transporter associated with antigen processing (TAP) and tapasin. As well as peptide presenting proteins, the class II locus also encodes for genes that aid in class II peptide loading (DM, DQ, DP and DR). The class III MHC region doesn’t encode peptide presenting MHC molecules,  but  does  express  immune  related molecules. Murine MHC presenting  molecules  are  defined  by  the  prefix  H2  (named  during  the  early histocompatability  experiments,  see  Section  1.1.3)  whereas  human  MHC  are  termed human  leukocyte  antigen  (HLA)  after  human  cells  on which  the molecules were  first detected. For notes on MHC nomenclature in mice and humans please refer to Ellis et al, 2006. For reference, when discussing TCR‐pMHC interactions the constituent molecules are written as TCR‐MHC allele‐peptide.  
 
Table 1. 4: Summary of common polymorphic MHC alleles The  MHC  class  I  HLA‐A2  allele  was  the  first  Ag  presenting  MHC  molecule  to  be crystallised, albeit with an “unknown” Ag (Bjorkman et al, 1987). The first class II MHC crystal  was  the  HLA‐DR2  presenting  an  Ag  derived  from  the  influenza  virus haemagglutinin  (HA)  protein  (Stern  et  al,  1994).  Class  I  MHC  molecules  are heterodimers  consisting  of  a  heavy  α  chain  with  3  α  domains  (α1‐3)  with  a  non‐
Genome Class
! "
Mouse I K -
D -
L -
II A! A"
E! E"
Human I A -
B -
C -
II DP! DP"
DQ! DQ"
DR! DR"
Table 1.4 Summary of common polymorphic MHC alleles
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covalently bound single domain β2‐microglobulin (β2m; Figure 1.6). The β2m forms the membrane proximal fragment of the protein along with the α3 domain, which contains a protruding hydrophobic TM stalk with an  intracellular  carboxyl‐terminus. The α1 and 
α2 domains form the peptide‐binding groove and sit on top of the β2m and α3 domains respectively.  MHC  class  II  molecules  are  also  heterodimers  but  consist  of  more equivalent α  and β  chains which  both  contain membrane  proximal  domains with  TM stalks (α2 and β2 domains) with both chains contributing to the peptide binding domain via  their α1 and β1 domains  (Figure  1.6).  The membrane proximal domains of  class  I and II MHC consist of IgSF folds, which contain two characteristic anti‐parallel β‐sheets. The peptide‐binding groove  is  formed  from two alpha helices  flanking a 7‐stranded β‐sheet and is not part of the Ig superfamily. Class I MHC typically bind extended peptides ranging  from  8‐10  amino  acids.  The  majority  of  polymorphism  is  focussed  in  the peptide‐binding  groove  (Bjorkman  et  al,  1987b;  Falk  et  al,  1991  and  van  Bleek  et  al, 1991),  thus  maximising  the  diversity  of  peptides  bound  throughout  the  population. Peptides that bind to the same class I allele will all contain comparable anchor residues that mediate  binding  specificity  (Fremont  et  al,  1992  and Madden  et  al,  1993).  These anchor  residues  can differ  in  chemical nature and position depending on  class  I  allele polymorphisms.  Interestingly,  occasional  longer  peptides  can  bind  to  class  I  MHC, resulting  in  a  bulging  of  the  peptide,  which  has  implications  for  the  nature  of  TCR recognition of MHC (see next section; Speir et al, 2001 and Tynan et al, 2005). Class II MHC molecules have no restriction on bound peptide length due to the final residues of the  class  I  α1  helix  being  replaced  by  β  strand  structure  in  the  class  II  α1  domain (Rudolph et al, 2006). Class II peptides are generally no less than 13 residues in length and form a polyproline type II helix conformation, resulting in peptides sitting deeper in the binding‐groove. 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Figure 1. 6: The structures of MHC class I and II.  
Crystal structures of MHC class I and II presenting peptides. The crystal structures show human class I HLA-
B27 presenting a model 9 amino acid peptide (PDB: 1HSA) and class II HLA-DR1 presenting the influenza 
virus derived HA1 peptide (PDB: 1FYT). The β2m (class I) and α-chain (class II) are shown in blue and the α-
chain (class I) and β-chain (class II) in green as cartoon diagrams. The presented peptides are shown as red 
space-fill structures. The top panels show the pMHC from straight on and the bottom panels, top-down facing 
the peptide binding grooves. 
 Sequence analysis of primitive vertebrates, including lancelets and sea squirts revealed equivalent versions of MHC genes found in single copy form. Loci in higher vertebrates have diversified over evolutionary time in an unparalleled manner (Danchin et al, 2004) and the key classical polymorphic class I and II MHC genes are summarised in Table 1.5. These class I and class II genes, as well as being highly polymorphic and polygenic, are expressed co‐dominantly, thus maximising MHC diversity at a population and individual level. Every human  is capable of expressing up  to 6 unique class  I and up  to 8 unique class II classical MHC molecules, with identical genotypes being vanishingly rare, except 
Class I Class II 
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for  identical  twins. Such population wide diversity most  likely  reflects  the  individual’s inability  to  cope  with  the  vast  and  constantly  evolving  plethora  of  pathogenic  Ag. Maintaining diversity across the population could thus ensure the majority of potential Ag can be presented, protecting the population at large as is exemplified by a pathogen’s ability to modify its genome rapidly in the context of different HLA alleles (Moore et al, 2002).  Indeed,  as  described  earlier,  the  majority  of  polymorphism  is  thus  focussed around  the  peptide  binding  grooves.  Mutational  analysis  of  peptides  from  hen  egg lysozyme (HEL) able to bind H2‐Ak demonstrated the ability of the same class II MHC to bind the same peptide in different “reading frames”, increasing the diversity of peptide binding  further  (Gugasyan  et  al,  2000).  The  diversity  of  peptide  MHC  interactions  is further highlighted from the estimation that each cell using a single complement of MHC molecules can present 2000‐10,000 peptides (Mason, 1998).   
 
Table 1. 5: Summary of known common HLA allele numbers  Thus, the overall diversity of the TCR (Table 1.2) and MHC (Table 1.5) has been selected for  maximal  levels  of  recognition  while  maintaining  manageable  allele  levels  and avoiding  self‐reactivity  from  a  repertoire  that  must  recognise  self‐MHC  in  order  to respond  to  non‐self  Ag.  Despite  an  increasing  number  of  TCR‐pMHC  co‐crystal structures  in  the  last 15 years, a clear molecular basis  for  the observed modes of TCR mediated recognition, binding or triggering mechanism has not emerged.   
Class Chain Alleles Proteins
I A 1,729 1,264
B 2,329 1,786
C 1,291 938
II DP!1 33 16
DQ!1 46 29
DR! 7 2
DP"1 150 130
DQ"1 160 111
DR"1 1,051 792
Table 1.5: Summary of known common HLA allele No.
IMGT HLA database: Accessed 21/11/11
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1.4.2 TCR binding to pMHC complexes The  first αβTCR‐pMHC  co‐crystal,  solved  in  1996 was  that  of  the  2C  TCR  bound  to  a murine MHC class I presenting the dEV8 peptide (Garcia et al, 1996). Since then, many co‐crystal  TCR‐pMHC  structures  have  been  solved,  including  immunogenic  (pathogen specific), alloreactive (transplant specific), autoreactive (self specific) and xenoreactive (cross‐species  specific)  TCRs  as well  as  TCRs  in  an  unbound  form  and  in  conjunction with  varying  altered  peptide  ligands  (APL) which  can  both  enhance  and  inhibit  TCR‐pMHC  interactions  (Rudolph  et  al,  2006).  Based  on  sequence  alignments  it  was proposed  the  TCR  would  form  a  Fab  like  structure,  and  that  the  non‐somatic  CDR3 would most  likely be positioned over  the presented Ag  (Claverie et  al,  1989).  Further models predicted the α and βCDR3 would contact the presented Ag and CDR3 switching enabled  the  transfer  of  Ag  specificity  from  one  TCR  clone  to  another  (Davis  and Bjorkman, 1988 and Katayama et al, 1995). Work that utilised 59 H2‐Kb specific CD8 T cell  cones demonstrated  they shared a common binding motif  to  the class  I molecules and extensive mutagenesis of  the carboxyl‐terminal but not  the amino‐terminal of  the MHC peptide groove α‐helices abrogated  the majority of  the clones’  recognition of  the class  I  molecules,  predicting  a  TCR  binding  footprint  that  was  “parallel  to  the  beta‐pleated strands and diagonal to the alpha helices” (Sun et al, 1995). Generally,  the TCR adopts a diagonal orientation relative  to  the pMHC as predicted by Sun et al. The TCRα chain is positioned over the α2 domain or the β1 domain of the class I and II MHC respectively and the TCRβ the corresponding α1 domains for class I and II. This docking mode places the germline encoded α and βCDR2 loops in contact with the 
α‐helices of the MHC peptide‐binding groove. The germline βCDR1 can contact the MHC and peptide (see below) whereas the hypervariable CDR3 is focussed on the presented peptide. Thus, the TCRα and TCRβ chains are focused towards the amino‐ and carboxyl‐terminal  residues  of  the  presented Ag  respectively.   While  an  approximately  diagonal docking mode can be considered standard, such  is  the variation of TCR‐pMHC docking angles that this generalisation over simplifies the complexity and variability of the TCR‐MHC  relationship.  Indeed,  there  are  no  globally  conserved  interactions  that  exist between all reported structures. Based on the summary from Rudolph et al (Rudolph et 
al, 2006), TCR docking angles  from class  I  restricted TCRs vary  from 21°‐70° and 53°‐80°  in  class  II  restricted TCRs.  As  discussed  later,  some  autoimmune TCR‐pMHC with abnormal  binding  topologies  show  a  docking  angle  of  only  40°  on  a  class  II molecule (Sethi et al, 2011). This analysis  from a general perspective also suggests there are no 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inherent  differences  between  the  ways  class  I  restricted  and  class  II  restricted  TCRs interact with their  ligands. Indeed, the YAe62 TCR was originally shown to bind to the class II H2‐Ab‐3K pMHC (Dai et al, 2008) but has recently been shown to also specifically recognise the class I H2‐Kb‐pWM (Yin et al, 2011b).  While  such  general  rules  of  TCR‐pMHC  engagement  are  appealing,  many  solved structures  contradict  any perceived defined  roles  for  the CDRs at  the pMHC  interface. While  it  is  not  uncommon  for  the  germline α  and  βCDR1  to  contact  the  amino‐  and carboxyl termini of the presented Ag respectively (Rudolph et al, 2006), there are also examples of  the germline CDR2 regions making extensive  contacts with presented Ag.  The Vα10.2‐Vβ17  JM22 TCR  contains  a  public  TCRβ  chain  (a  dominant  TCR  chain  for recognition  of  a  particular  Ag  that  is  found  in multiple  individuals)  that mediates  the majority of CD8 T cell responses against the matrix protein (MP) from influenza virus in people  containing  the  HLA‐A2  allele  (Stewart‐Jones  et  al,  2003).  While  these  TCRs contain  conserved  CDR3 motifs  across  the  population,  the  extreme  69°  binding  angle also places the germline βCDR2 over the centre of the peptide, making two contacts via a conserved  glutamine,  with  the  βCDR1  also  making  one  peptide  contact  through  an aspartic  acid  (Stewart‐Jones  et  al,  2003).  Similarly,  the  majority  of  CD8  T  cells  that respond in HLA‐A*201+ subjects presenting the melanoma epitope MART, use the Vα2.1 segment  (Trautmann  et  al,  2002).  The  Vα2.1‐Vβ20.1 MEL5 TCR when  bound  to HLA‐A2*201 presenting the common MART peptide (ELAGIGILTV) demonstrated the public TCRα chain dominated peptide recognition, with a glutamine at P31 in the CDR1α chain making 6 distinct interactions with P1, 2, 4 and 5 with the presented peptide (Cole et al, 2009). Conversely, in other public TCRs, the non‐germline CDR3 has been implemented in  recognition  of  the MHC molecule  (Kjer‐Nielson  et  al,  2003).  LC13,  is  a  public  TCR found  in HLA‐B8  containing  individuals  and  specific  for  the EBV peptide FLRGRAYGL. Crystallisation  of  this  structure  revealed  a  docking  angle  of  60°  with  6  and  3  CDR3 residues  contacting  the MHC  from  the TCRα  and β  chains  respectively. CDR3 has  also been found to bind the MHC in autoreactive TCR structures, which can show an altered binding topology (see Section 1.4.4; Hahn et al, 2005). Finally, structural and biophysical studies on the AHIII TCR bound to  three HLA‐A2 with different point mutations  found that  they  interfered  with  the  TCR  response  to  the  pMHC.  Subsequently,  co‐crystals revealed  that  the MHC mutant with  the  greatest  affect  on AHIII  affinity  and  reactivity was related to conformational adaptations in the CDR3 regions (without changes to the presented peptide structure; Miller et al, 2007; Figure 1.7). 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Such are  the variety of TCR‐pMHC  interactions,  specific  roles  for TCR CDRs have been contradictory.  Independent  alanine‐scanning  studies  opposingly  concluded  that  the CDR3 (Borg et al, 2005) and CDR1 and 2 (Manning et al, 1998) were more important in defining  the  energetic  landscape  of  TCR  MHC‐peptide  interactions.  Interestingly  the different  results may be due  to  the nature of  the CDR3  loops of  the TCR used  in  each study  (Kranz, 2005). Borg et al  used  the LC13 TCR with more  complex CDR3  regions, resulting  in  the  CDR3  loops  providing  the  majority  of  the  main  interaction  energies, whereas Manning et al used the 2C TCR with relatively simpler CDR3 regions and found the CDR1 and 2 contributed most of the MHC‐peptide binding energy. As described in Section 1.3.3, cross‐reactivity is vital in maximising the ability of TCRs to successfully  respond  to  the  excess  of  potential  Ag  the  body  encounters.  The  ability  of CDR  loops  to  alter  their  conformation  upon  ligand  engagement  no  doubt  functions  to broaden  the  reactivity  of  TCRs,  with  comparison  of  all  bound  versus  unbound  TCR structures having at least one CDR altering its position by 2Å, with the majority having one CDR that changes by 5Å (Armstrong et al, 2008). A review of the available TCR and TCR‐pMHC structures led Armstrong et al (Armstrong et al, 2008) to conclude that CDR conformational changes occur as en bloc and not mass rearrangements and  that  three distinct  motions  are  possible:  Complete  loop  remodelling  through  multiple  ψ  and ϕ peptide bond angles; hinge‐bending motions that occur near the beginning or end of the loops;  rigid  body  shifts  where  the  loop  itself  does  not  alter  its  conformation  but  its position  is  altered  from  movements  deep  in  the  framework.  Generally  speaking,  the germline CDR1 and 2 are  subjected  to minimal en bloc movements as evidenced  from structural data.  As  with  the  overall  characteristic  of  TCR‐pMHC  interactions,  the  nature  of conformational  changes  upon  pMHC  binding  is  variable.  Structural  analysis of the 2C 
TCR in free and bound to H2-Kb with agonist and super-agonist APLs (Rudolph et al, 2006; 
Garcia et al, 1996; Garcia et al, 1998 and Degano et al, 2000) revealed that upon pMHC 
binding, major conformational changes are restricted to the CDR3 regions of the TCRα and β 
chains.  Opposingly, the A6 TCR recognises the human T cell lymphotropic virus 1 (HTLV-
1) peptide, Tax, presented on class I HLA-A2. Functional and crystallographic analysis upon 
modification of the Tax peptide revealed striking differences in T cell responses between the 
different APLs, but an overall lack of significant conformational changes throughout all of the 
CDR regions (Ding et al, 1999). However, there are also clear examples of major 
conformational changes upon pMHC binding. The KB5-20 TCR was first crystallised with 
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the TCRV domain associated with the C domains of a Fab fragment (Housset et al, 1997) and 
demonstrated a tightly packed, elongated βCDR3 in a novel conformation butted up against 
the αCDR3. Upon binding the H2-Kb-pKB1, the KB5-20 βCDR3 moved an unprecedented 
15Å to facilitate binding to the pMHC surface (Reiser et al, 2002). These generally limited 
conformational changes (with the exception of the KB5-20) were crystallised mostly in 
conjunction with class I MHC presenting extended, fixed length peptide which may account 
for the minimal conformation changes (Mazza and Malissen, 2007). As mentioned in Section 
1.4.1, occasionally class I MHC molecules will present peptides of a length longer than the 
canonical 8-10 amino acids. In such instances the presented Ag will bulge out of the peptide-
binding domain. One would perhaps expect that TCR recognition of such pMHC complexes 
would require major conformational modifications to the TCR CDR3 to facilitate specific 
binding. Indeed, the EBV-derived 13-mer Ag, LPEP, was crystallised bound to HLA-B*3508 
with the SB27 TCR. The steric obstacle posed by the bulging peptide resulted in CDR3 
conformational adaptations, leading to minimal interactions with the MHC itself (Tynan et al, 
2005). Interestingly however, a structure of a second EBV-derived 13-mer peptide (termed 
EPLP) presented on the related HLA-B*3501 that was recognised by the ELS4 TCR 
demonstrated a remarkable conservation of TCR CDR conformation, but a corresponding 
“flattening” of the peptide relative to its unbound form (Tyanan et al, 2007), making the most 
striking example of pMHC conformational change upon TCR engagement. Indeed, previously 
only the aforementioned A6-HLA-A2-Tax structures revealed any real change in peptide 
conformation (Ding et al, 1999). Overall, these data reflect the lack of consistency of CDR3 
conformational change requirement upon ligand recognition. There are also examples of 
CDR1 and 2 conformational changes upon pMHC binding in the LC13-HLA-B8-
FLRGRAYGL system described above (Kjer-Nielson et al, 2003). The immense variability in TCR‐pMHC binding and the nature of conformational change upon binding, no doubt contributes to the vital, if sometimes pathogenic consequence of cross‐reactivity. While  some  instances  of  cross‐reactivity  have  been  verified  as  being genuine  cases  of  molecular mimicry,  for  example  the  structures  of  the  TCR  from  the Hy.2E11 T cell clone, isolated from a multiple sclerosis (MS) patient, was shown to bind HLA‐DRB*0101  presenting  an  EBV  derived  Ag  and  HLA‐DRB*1501  presenting  an autoreactive  myelin  basic  protein  (MBP)  derived  Ag  using  a  near  identical  topology (Lang et al, 2002). Further, recent structural analyses revealed an instance of molecular mimicry  instigated by both an allo‐MHC and  its bound allo‐peptides  (MacDonald et al, 2009;  See  Section  1.4.4  for  more  details).  In  2003,  Resier  et  al  (Reiser  et  al,  2003) 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demonstrated  that  two peptides  that bore no primary sequence homology  (pBM1 and VSV8)  could both be  recognised by  the BM3.3 TCR  in  the  context  of H2‐Kb.  Structural analysis  revealed maintenance  of  general  topology  between  the  TCR  and  class  I MHC molecule  was  achieved  through  alteration  of  CDR3  conformation  to  accommodate recognition of the peptide, demonstrating peptide cross‐reactivity (Mazza and Malissen, 2007).    Recent  examples  have  also  demonstrated  a  similar  CDR3  conformational adaption  to different peptides while maintaining a conserved TCR‐MHC docking mode (Newell et al, 2011). Although, some other structural studies have suggested an overall similar binding topology coupled to minor adaptations to peptide recognition are in fact “imperfect” molecular mimics, such as the A6 TCR, whose cognate ligand is HLA‐A2‐Tax, was  found  to bind  in an overall  similar manner  to a cross reactive HLA‐A2 presenting the neuronal peptide HuD, but required a minimal readjustment of CDR3 conformations (Borbulevych et al, 2011).  In  conclusion,  the  final  docking  modes,  conformational  binding  upon  cognate  ligand interactions and  the molecular basis of  cross‐reactivity,  all  show significant variability with  examples  of  both  stringent molecular mimicry  and  gross  conformational  change from unbound to bound forms and the binding to cross‐reactive ligands. While specific recognition of pMHC by the TCR is the key event in the T cell  immune response, many other  interactions,  in  the  form  of  co‐receptors  (see  below  and  Section  1.4.3)  facilitate successful recognition of pMHC. The most immediate and important of these receptors are the co‐receptors CD4 and CD8, which confer MHC class specificity and also bind to MHC in conjunction with the TCR. 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Figure 1. 7: The TCR binds pMHC with varying docking angles. 
Crystal structures demonstrating the variability of TCR docking on pMHC. (A) A representative diagonal 
docking mode of a TCR (top) binding a pMHC ligand (bottom). The structure shows the HA1.7 TCR bound to 
the class II HLA-DR1 MHC (cartoon diagram) presenting the HA1 peptide (space-fill diagram). Protein chains 
and the peptide Ag are as labelled in the diagram (PDB: 1HSA). (B) A summary of 13 class I specific TCRs 
modelled over a single class I MHC demonstrating the variability of docking modes present in TCR-pMHC 
binding. The balls represent the centre of mass of the TCRα and TCRβ variable domains and the linking bars the 
binding angle relative to the pMHC. Diagram adapted from Collins and Riddle, 2008. 
 
1.4.3 CD4 and CD8: Structure, ligand binding and function While  co‐receptor  is a generic  term, both CD4 and CD8 co‐receptors are  involved  in a number of distinct roles contributing  to TCR recognition of and stabilisation  to pMHC. Early studies transfecting cells with cDNA encoding for CD4 demonstrated the ability of these cells  to adhere  to MHC class  II positive, but not negative, B cell  lines (Doyle and Strominger, 1987). Similar cell‐cell adhesion assays using B cell expressing class I MHC demonstrated reciprocal results for CD8 (Norment et al, 1998). The crystal structures of secreted  forms of CD4 and CD8 co‐receptors provided  the  first view of  their structure (Leahy et al, 1992 and Wu et al, 1997). As discussed in Section 1.4.3, CD8 exists in two isoforms  (α  and  β)  with αα  homodimers  characterising  the  distinct  subset  of  T  cells responsible for IELs, whereas the αβ heterodimer is expressed by the majority of class I restricted CD8 T cells. The α and β CD8 monomers consist of a single  IgSF  fold,  in  the form of an IgV domain (see Section 1.1.2) connected to a long stalk that traverses the cell 
antigen. The genetic origins for both TCR and MHC can be traced back (approximately) to
the same phylogenetic branchpoint, thus it may be stated that the two gene families co-
evolved. However, the specific question addressed in this review is whether or not
members of one gene family directly exerted selective pressure on members of the other.
TCR binds to MHC in a diagonal to orthogonal orientation
Numerous structural studies of TCRs in complex with their pMHC targets have revealed
many details of the elements of T cell antigen recognition [1–6]. Although dissimilar in
their specific binding interactions on a case by case basis, when these structures are
superimposed with respect to the MHC, all of the TCRs assume a strikingly similar
docking orientation that is roughly diagonal with respect to the path of the antigenic
peptide (Fig. 1). In this depiction, the TCR axis is defined by the centers of mass of the
Fig. 1 T cell receptor docks on
class I MHC in a diagonal to
orthogonal orientation. (a) The
currently available T cell
receptor/MHCI co-crystal
structures were superimposed on
the peptide-binding groove of
HLA-A2. The centers of mass of
the variable gene segments are
shown as pairs of connected
spheres and overlayed on top of
the molecular surface of p1049/
A2 [7]. The definition of the
docking angle is with respect to
the path of the antigenic peptide
(colored magenta in the surface
representation). (b) The same
surface is rotated 90! to show the
rotation of the TCR docking atop
the peptide that depends on the
TCR and pMHC. Both figures
were generated in PyMol
(http://pymol.sourceforge.net/)
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membrane. The dimers are formed by a disulphide link at the outer membrane proximal portion of  the stalk regions. The CD4 molecule contains  four IgSF domains,  termed D1 (membrane proximal) to D4, with D1 and D3 resembling IgV folds and D2 and D4,  IgC folds  (see  Section  1.1.2).  CD4  contains  a  hinge  region  between  D2  and  D3  that  may facilitate appropriate binding to class II MHC.  Structural studies analysing the interaction between CD4 and CD8 and their respective MHC ligands remain incomplete. No bona fide CD8aβ‐MHC class I crystal structures have been solved, although CD8αα bound to human HLA‐A2 and murine H2‐Kb exist (Gao et 
al,  1997  and  Fern  et  al,  1998).  Both  show  overall  similar,  but  species‐specific, interactions with  a  single  loop of  the α3 domain of  their  respective  class  I molecules. These binding  interfaces are  fixed, with no conformational changes  to  the pMHC upon binding and both CD8 IgSF domains partake in bi‐dentate recognition of the MHC. CD8α and CD8β  are of  similar  size and electrostatic potential,  the main difference being  the latter  containing a  slightly  longer TM stalk  region. Biochemical  analysis demonstrated that  the  CD8β  chain  could  compensate  for  inactive  CD8α  mutants  and  vice‐versa, indicating  a  functional  redundancy  (Chang  et  al,  2006)  suggesting  the  CD8αβ heterodimer  interacts  in  a  similar  way  to  CD8αα.  Similarly,  a  crystal  structure  of  a CD8αβ heterodimer complexed with a Fab antibody revealed a similar mode of binding as  the  CD8αα  to  MHC  class  I.  Blocking  assays  using  monoclonal  antibodies  (mAb) against  CD8α  or  CD8β  confirmed  this  CD8β  epitope  was  likely  to  be  important  for activation via class I engagement (Shore et al, 2008). Until recently, only a 4.3Å resolution structure existed for a human CD4 binding to H2‐Ak (Wang et al, 2001). Despite the low resolution, the structure demonstrated that the key interacting portions of  the D1  IgV  like domain  (see Section 1.1.2) were contributed by the C” strand and D‐E helix. This year, Wang et al (Wang et al, 2011b) obtained a set of human CD4 mutants  that bound with higher affinity  to HLA‐DR  through yeast  surface display,  focussing on key  interacting regions gleaned from the previous structure. CD4 mutants  were  found  to  interact  with  HLA‐DR1  across  the  α2  and  β2  class  II  MHC domains  (Section  1.4.1)  using  the  D1  domain  exclusively.  Interestingly,  the  CD4 contacting residues on HLA‐DR1 were completely conserved across selected HLA‐DP, ‐DQ  and  –DR  alleles  inferring  a  highly  conserved  binding  mode  despite  MHC  class  II polymorphism (Figure 1.8). 
  55 
The  observation  that  two  CD8  domains  (Sun  et  al,  1995b)  but  only  one  CD4  domain interact  with  their  respective  MHC  classes  suggests  the  functional  role  of  each  co‐receptor  may  not  be  identical.  Membrane proximal cystine motifs in the intracellular 
domains of both co-receptors bind to the membrane associated Lck kinase, which also 
contains a fatty-acid tail that facilitates insertion to the cell membrane prior to co-receptor 
localisation (Marth et al, 1986; Barber et al, 1989; Turner et al, 1990 and Paige et al, 1993). 
However CD4  binds  to  class  II  MHC  with  lower  affinity  (≥200µM)  relative  to  CD8 (~10µM)  resulting  in  the  former  having  no  effect  on  TCR‐pMHC  binding  affinity  or kinetics  using  soluble  CD4  ectodomain  binding  to  H2‐Ak‐Conalbumin  in  conjunction with its cognate D10 TCR (Xiong et al, 2001). However CD8 molecules have been shown to  influence  TCR‐pMHC  stability  and  strength  of  response  (Luescher  et  al,  1995; Woolridge et al, 2005 and Stone et al, 2011). Further, palmitoylation of CD8β has been shown  to  enrich  CD8αβ  into  lipid  rafts  along  with  the  TCR  (Arcaro  et  al,  2000  and Arcaro et al,  2001). These apparently  contrasting effects, may be due  to  the proposed role of CD4 dimerisation and the hypothesis that TCR via class II pMHC signalling may be  reliant on  cross‐linking of CD4  to  a different pMHC  than  that of  its  associated TCR (see  Section  1.4.4).  The  entirely  conserved  nature  of  co‐receptor  binding  to  MHC, coupled  to  its  requirement  for  downstream  signalling  has  also  been  proposed  to contribute to the phenomenon of TCR restriction to MHC (see Section 1.5.2). 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Figure 1. 8: Structure of the CD4 and CD8 co-receptors.  
Schematic overview of the CD4 (left) and CD8αβ (right) co-receptors bound to the cell membrane. For CD4, the 
four domains (D1-4) are shown in relative size to each other including the TM domain. The CD8αβ heterodimer 
is joined by a disulphide link (horizontal bar) with both chains having a single extracellular domain and a TM 
domain. Both co-receptors are associated with the Lck kinase (pink circle), which is tethered to the lipid bilayer 
via palmitoylation (black line).   
1.4.4 TCR binding and triggering mechanisms Despite  the  increased  knowledge  gained  from  structural,  functional  and  biophysical studies, three major areas of TCR‐pMHC biology remain unresolved. First, the molecular mechanism that underpins MHC restriction of TCRs – i.e. what imposes the requirement of TCRs to respond to Ag in the context of MHC. Second,  is the process by which TCRs scan  and  discriminate  between  potential  pMHC  ligands  and  the  third  is  how,  upon successful  recognition  of  pMHC,  the  appropriate  signal  is  effectively  and  sensitively triggered.  These  areas  are  inextricably  linked  but  all  still  court  significant  debate  and discussion. As  this study aims to address  the question of MHC restriction,  the  theories surrounding  TCR  binding  and  triggering  are  only  briefly  described  here, with  a  fuller description of MHC restriction presented in Section 1.5. As presented by Stone et al (Stone et al, 2009), the basic characterisation of a TCR‐pMHC interaction can be defined by the following kinetic equation, which is used to calculate key parameters in understanding TCR‐pMHC kinetics: 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Here,  kon  is  the  association  rate  and  koff  is  the  dissociation  rate,  which  facilitates calculation  of  the  half‐life  (t1/2  =  ln  2/koff).  The  affinity  of  the  interaction  can  be calculated as the ratio between the association and dissociation rates or through other methods.  TCR affinities for pMHC are comparatively low, due to relatively poor overall shape complementarity, with KD values ranging from 1‐100µM (Rudolph et al, 2006), a fact related to the variability of TCRs and MHC molecules coupled to thymically selected lower affinities which avoid self‐reactivity. The first step of the equation, the association rate, has been calculated to be moderately slow to slow (1,000‐10,000M‐1s‐1), which has been  linked  to  the  structurally observed conformational  changes  that occur upon TCR binding of pMHC (see Section 1.4.2). An induced fit mechanism was initially proposed by Boniface et  al  (Boniface et  al,  1999), who demonstrated  that binding of TCR  to pMHC required  energy  barriers  to  be  overcome  inferring  a  two‐step  model  of  recognition followed  by  binding. Wu  et  al  (Wu  et  al,  2002)  provided  functional  evidence  for  this, showing  that mutations  of  key MHC  residues  on  the α‐helices  of  the  peptide  binding groove could decrease association rates of TCR binding, ultimately proposing a two‐step process whereby germline CDR1 and 2 bind the MHC, allowing hypervariable CDR3 to scan  the  presented Ag.  Further  thermodynamic  and  kinetic  studies  using  the  TCRCMV‐HLA‐A*201‐pp65  system  clearly  defined  the  two  proposed  steps,  supporting  the mechanism  (Gakamsky  et  al,  2007).  Such  a  process  however  requires  the  ability  of germline CDR1 and 2 to uniquely and naturally recognise MHC (see Section 1.5) and is not  supported  by  the  reported  variation  that  exists  between  TCR‐pMHC  binding,  for example  cases  of  bulging  peptide  presentation,  germline  CDRs  contacting  the  Ag  and CDR3 interacting with MHC (See Section 1.4.2).  Work inferring that contributions from both  the  MHC  and  Ag  are  required  to  stabilise  the  interaction  with  the  TCR  (Davis‐Harrison et al, 2007) also go against such a defined two‐step model. An alternative could be conformational selection, whereby a pre‐existing equilibrium of CDR conformations exists  and  one  is  selected  upon  binding,  as  is  the  case  for  Ig  molecules  (Foot  and Milstein, 1994) and was also suggested for TCRs (Willcox et al, 1999). However, recent work  demonstrating  the  relative  rigidity  of  TCR CDRs  and  rare  instances  of  complete CDR remodelling (Armstrong and Baker, 2007 and Armstrong et al, 2008) suggest such variable unbound states are unlikely. The exquisite sensitivity of TCR response to ligand engagement has been demonstrated through the ability of single amino acid changes in APLs to entirely alter the outcome of response  from  agonistic  to  antagonistic.  Similarly,  the  TCR  often  needs  different 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strengths  of  response  in  different  scenarios  –  for  example  during  thymic  selection, homeostatic maintenance or  immune response, which can  take place  in  the context of different peptides and different MHC alleles. Two key elements have been proposed to define  the sensitivity of TCR  triggering: affinity of  the  interaction and  t1/2  (see above). The  evidence  describing  the  role  of  these  parameters  have  been  described  in  detail elsewhere  (Stone et  al,  2009  and Bridgeman et  al,  2011). Other  key  factors  have  also been  implemented,  including  the  potential  to  trigger  signalling  through  the  multiple rebinding of the TCR to the same pMHC, creating a dichotomy of optimal “dwell time” of TCR‐pMHC  association.  This  allows  suitable  time  bound  to  the  pMHC  to  instigate  an effect,  coupled  to  the  ability  to  rebind  quickly  through  fast  kon  rates  creating  an aggregate t1/2 that is greater than a single, longer binding event (Aleksic et al, 2010 and Govern et al, 2010). Further, TCR‐pMHC engagement initiates and occurs in the context of the immunological synapse (IS; Figure 1.9) and receptor clustering has been shown to play  a  role  in  signalling  events  (Dustin  and Depoli,  2011)  and  has  been  implicated  in aiding  the  efficiency  of  T  cell  memory  responses  (Kumar  et  al,  2011).  Newer  in  situ techniques that take the role of co‐receptors and clustering into consideration (Huppa et 
al, 2010) coupled to traditional approaches for measuring TCR‐pMHC binding (surface plasmon  resonance  –  SPR  and  isothermal  titration  calorimetry  –  ITC)  will  further advance  the  thermodynamic  and  kinetic  requirements  for  sensitive  TCR  triggering. Several  models  reliant  on  kinetic,  physical  and  clustering  mechanisms  have  been proposed to describe the overall process of TCR triggering, most recently reviewed by van der Merwe and Dushek (van der Merwe and Dushek, 2011) and are summarised in 
Table 1.6. 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Table 1. 6: Overview of proposed mechanisms for TCR signal triggering           
Mechanism Model Overview References
Kinetic Kinetic Proofreading
Successful recognition by TCR of pMHC (through single or 
multiple interactions) generates a half-life that facilitates 
the organisation of down-stream signalling molecules and 
events.
McKeithan, 2005
Induced Fit
A scanning process by the TCR that results in successful 
binding to a pMHC ligand inducing a conformational change 
in the TCR CDRs that can be transmitted through the TCR 
inducing a physical change that facilites signalling.
Boniface et al, 1999
Conformational change 
induced aggregation
Conformational changes induced through ligand binding 
transduced to the constant region resulting in aggregation 
of TCR complexes that facilitates signalling via amplification
Kuhns et al, 2010
Piston movements
Binding of TCR to pMHC with suitable kinetics facilitates 
membrane pulling forces that induces conformational 
changes in the TCR-CD3 signalling complex that facilitates 
downstream signalling.
Sun et al, 2001
Permissive Geometry
A specific model whereby only through multimeric TCR-
pMHC interactions occuring at the correct binding angle will 
induce a scissor-like rotation of the TCR chains relative to 
each other which is passed on to CD3 chains and allows 
phosphorylation.
Minguet and Schammel, 2008
Heterodimerisation
Binding of the TCR and the co-receptor to the same pMHC 
assembles machinary and kinases required for subsequent 
downstream signalling porcesses.
Trautmann and 
Randriamampita, 2003
Pseudo-dimerisation
Where a TCR specific for the pMHC is assoicated with a co-
receptor that binds to a neighbouring pMHC, lowering the 
activation threshold for non-specific TCRs, in the context of 
a specific initial interaction.
Juang et al, 2010; Krogsgaard 
et al, 2005
Kinetic segregation
Upon IS formation after TCR-pMHC interaction, proteins 
with smaller ectodomains cluster together, forcing out 
molecules with larger ectodomains that include inhibitory 
phosphatases such as CD45 and CD148.
Davis and van der Merwe, 
2006
Lipid raft segregation
Binding of TCR to pMHC enriches pro-signalling molecules to 
lipid rafts thus reducing the presence of inhibitory 
phosphatases from the cluster.
van der Merwe and Dushek, 
2011
Integrated Mechanisms
Use elments of all of the above. At a resting state, 
dephosphorylation outbalances constant phosphorylation 
(due constitutively activated Lck) maintaining inactivity. 
Engagement of TCR-pMHC induces receptor clustering and 
segregation of phosphatases from the synapse. The 
resulting cluster will contain agonist and non-agonist pMHC, 
with the former working to lower the activation threshold of 
the latter through cross linking. Kinetic proof reading will 
ensure if the process will proceed long enough to induce a 
full signalling response.
van der Merwe and Dushek, 
2011
Table 1.6 Overview of proposed mechanisms for TCR signal triggering
Conformational Change
Aggregation
Segregation
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Figure 1. 9: The TCR signals as part of the immunological synapse. 
Schematic overview of the immunological synapse (IS). Key molecules from both APC and T cells form a semi-
stable IS that consists of three distinct supramolecular activation clusters (SMAC); the distal (dSMAC), 
peripheral (pSMAC) and central (cSMAC). The cSMAC contains the TCR-pMHC complex as well as the co-
receptor (in this case CD4). CD4 is associated with Lck and the TCR is associated with the CD3 complex. The 
CD3 complex and the TCR associate via opposing charges that exist in the TM regions. Successful binding of 
TCR-pMHC with the co-receptor forms the IS and allows Lck to phosphorylate ITAM motifs present on the 
CD3 chains. Such phosphorylation attracts the downstream signalling kinase zeta-chain associated protein kinase 
70 (ZAP70), which leads to downstream signalling events. Successful signalling and IS formation is dependent 
on interaction between adhesion molecules that are expressed on both the APC and T cell including CD2/CD48, 
CD28/CD80 and lymphocyte function-associated antigen 1 (LFA-1) and intercellular adhesion molecule 
(ICAM) 1. The formation of these interactions in the cSMAC and pSMAC respectively results in a curvature of 
the cell membranes that functions to exclude larger inhibitory molecules such as the CD45 phosphatase to the 
dSMAC that would otherwise de-phosphorylate CD3. 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1.4.5 TCR-pMHC in disease: Alloreactivity and autoreactivity While  the  intended purpose of  the TCR‐pMHC system  is  to distinguish and respond to pathogen‐derived  Ag,  TCR‐pMHC  interactions  are  also  associated  with  disease.  These pathogenic  interactions  are  derived  from  the  advent  of  whole  organ  transplants, resulting in alloreactive responses to non‐self MHC, the autoreactive recognition of self‐pMHC  as  foreign  due  to  imperfect  tolerance  and  the  co‐evolved  subversion  by pathogenic  agents  such  as  bacteria  and  viruses  in  the  form  of  superantigens.  For understanding MHC restriction,  the  first  two processes are most relevant and thus the latter  is  omitted  from  this  discussion.  Understanding  the  structural  interactions  of alloreactive and autoreactive TCRs with pMHC can also be useful  in defining  the more general basis of TCR specificity for pMHC. Scientifically,  the  process  of  alloreactivity  aided  characterisation  of  the  wider phenomenon of MHC restriction (see Section 1.1.3) whereas medically it  is relevant for successful organ transplantation. Between 0.5‐10% of all T cells are alloreactive, orders of  magnitude  higher  than  peptide  Ag  specific  T  cells  (Lindahl  and Wilson,  1977  and Suchin et al 2001). The underpinning of such broad specificity was originally proposed through two distinct mechanisms: the altered self and high determinant density models. Both  models  were  based  on  diversity  of  MHC  alleles  in  an  outbred  population,  but anticipated  different  roles.  The  altered  self  model  (Matzinger  and  Bevan,  1977) predicted  that self‐MHC presenting self‐peptides would not elicit an  immune response due to tolerance imparted during thymic selection. However allo‐MHC molecules, due to allelic  differences  would  present  the  same  self‐peptides  in  an  altered  fashion,  which would induce T cell responses. Bevan however (Bevan, 1984) subsequently inferred that the  allelic  differences  in  allo‐MHC  would  be  directly  recognised  as  the  antigenic determinant by T cells.  Comparison  of  the HA1.7  TCR  bound  to  its  cognate  HLA‐DR4  and  allo‐HLA‐DR1  both presenting  the  same  haemagglutinin  (HA)  Ag  revealed  that  the  overall  TCR  binding mode  to  the  different MHC were  very  similar,  with  the  root mean  squared  deviation (RMSD)  of  the  Cα  atoms  =  0.34Å  (Hennecke  et  al,  2002).  However  polymorphic differences resulted in alterations to the width of the peptide‐binding groove and to the presentation  of  P5  and  P6,  inferring  peptide‐centric,  altered  self  alloreactivity. Interestingly, structural analysis of the LC13 TCR which is alloreactive with HLA‐B*4402 and HLAB*4405 presenting different peptides revealed that  the overall engagement of 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both  complexes  was  near  identical  to  the  cognate  HLA‐B*0801‐FLRGRAYGL  complex, despite  polymorphism  between  both  the MHC  and  peptides  (MacDonald  et  al,  2009). Here  it  was  suggested  that  molecular mimicry  between  the  syngeneic  and  allogeneic MHC  prevented  MHC‐centric  alloreactivity  and  that  molecular  mimicry  from  both unique  allo‐peptides  would  therefore  drive  TCR  reactivity.  Such  peptide‐centric interactions would  infer TCRs could display polyspecificity as opposed  to MHC‐centric peptide‐degeneracy. Indeed in vitro experiments showed that T cell hybridomas specific for the same MHC allotype, were highly specific for different peptides presented on the same  allo‐MHC  (Felix  et  al,  2007).  Further  evidence  for  MHC  molecular  mimicry focussing allorecognition on peptide specific responses  is garnered from evidence that MHC alleles  that differ by only a single amino acid, such as  the HLA‐B*4402 and HLA‐B*4403, also evoke an alloreactivity. However,  the  strength  of  alloreactivity  is  directly  proportional  to  the  disparity  of  the MHC alleles involved, inferring that MHC can play a crucial role. Crystallisation of the 2C TCR with  the allogeneic H2‐Ld‐QL9 when compared  to  the  cognate H2‐Kb‐dEV8  ligand revealed  the  overall  binding  geometry  shifted  by  more  than  20°,  with  very  few conserved  contacts  between  the  two  structures  (Colf  et  al,  2007).  In  this  instance however, the interaction with peptide was not affected and mutation of the CDR3α did not  affect  allo‐MHC  recognition.  Interestingly  however,  the  same  receptor  with  the alternative  allo‐H2‐Kbm3‐dEV8  ligand  revealed  that  differences  in  the  peptide  binding groove that affected peptide presentation was the driving factor that resulted in extreme alteration  of  TCR‐MHC  contacts  (Luz  et  al,  2002).  It  has  also  been  suggested  that mutation of the αCDR3 in the 2C‐H2‐Ld‐QL9 structure does not fully rule out a role for the  presented  peptide  (Wolfson  et  al,  2011).    Molecular  evidence  therefore  shows  a potential role for both peptide and MHC in allo‐recognition, which may be dependent on the nature and severity of the allelic MHC differences (Felix et al, 2007b and Wolfson et 
al, 2011) and further serves to highlight the diversity with which TCR can interact with pMHC  complexes.  This  adaptability  of  TCR  in  pMHC  recognition  is  perhaps  most elegantly represented by the work of Gras et al  (Gras et al, 2009). As described above, the  LC13 TCR’s  cognate  ligand  is  restricted  to HLA‐B8  and  is  alloreactive  to HLA‐B44 alleles. Yet individuals heterozygous for both alleles still produce TCRs that respond to the original LC13 ligand, while maintaining tolerance to the HLA‐B44 MHC. A structure of  such  a  TCR,  CF34,  bound  HLA‐B8‐FLRGRAYGL  when  compared  to  original  LC13 structure  revealed  both  bound within  normal  angles  and  affinities with  related  TCRβ 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chains,  yet  the  CF34  shifted  recognition  towards  the  N‐terminal  of  the  peptide, confirmed by mutational studies. Thus thymic development can produce T cells specific for  the  same  ligands  in  unique  binding  modes  in  the  context  of  different  MHC haplotypes,  demonstrating  the  role  of  TCR  adaptability  in  maintaining  tolerance  and avoiding autoreactivity.  Autoreactivity  is  induced  when  the  immune  system  responds  to  self‐Ag  as  foreign, inducing an immune response against specific organs or systems in which the self‐Ag is derived. The role of TCR‐pMHC in autoimmunity is clear due to the genetic segregation of  specific MHC  alleles  and  autoimmune phenotypes.  Seven  structures  of  autoreactive TCR bound  to  self‐pMHC  ligands have been solved,  from humans and mice  (Table 1.7; Reinhertz et al, 1999; Hahn et al, 2005; Li et al, 2005, Maynard et al, 2005, Feng et al, 2007; Sethi et al,  2011; Yin et al,  2011 and Wucherpfennig et al,  2009). All  structures demonstrate  atypical  TCR  binding  parameters,  but  without  an  overall  consistent mechanism of altered recognition. Interestingly, all but the most recent human examples have severely altered binding topologies not seen in the murine structures (Figure 1.10). The  one  consistent  feature  of  these  autoreactive  TCRs  is  their  generally  low  affinity, related  to  weak  TCR‐pMHC  interactions  or  weakened  peptide‐MHC  interactions (Wucherpfennig  et  al,  2009).  Such  weakened  affinities  are  proposed  to  facilitate avoidance of negative selection  in the thymus. The high density of Ag  in the periphery could  then  compensate  for  weak  affinity  thus  resulting  in  TCR  triggering,  despite variable  binding  topologies.  Regardless  of  biological  implications,  these  autoreactive TCRs  further  demonstrate  the  flexibility  of  TCR  recognition  of  pMHC.  In  the  most extreme example, the Hy.1B11 TCR from a multiple sclerosis (MS) patient recognises a MBP  derived  peptide  presented  on  HLA‐DQ.  A  binding  angle  of  40°  is  the  lowest recorded  for  any  class  II  MHC  structure  reported  and  as  a  result,  the  αCDR1  and  2 regions made no contacts at all with  the pMHC with  the αCDR3 contacting  the Ag and MHC, with the βCDR2 making minimal contacts (Sethi et al, 2011). This variability is also further emphasised by evidence suggesting molecular mimics exist for auto‐TCR ligands. For example  the Ob.1A12 TCR, which  is autoreactive  for  the HLA‐DR2b‐MBP complex, was shown to bind the same MHC presenting a peptide derived from the engA peptide encoded by E. coli using the same altered binding mode, resulting in multiple sclerosis like symptoms in a humanised mouse model (Harkiolaki et al, 2009), linking the role of infectious agents and autoimmunity. Finally, other atypical TCR‐pMHC interactions have also  been  shown  to  display  altered  binding  topologies. While  the majority  of  disease 
  64 
causing  agents produce proteinacious or  lipid Ag,  for  some pathologies,  such  as  those caused  by  over  exposure  to  metals  can  be  linked  to  the  immune  system.  Chronic beryllium  disease  (CBD)  is  characterised  by  a  population  of  CD4  T  cells  specific  for beryllium (Be), which are restricted to HLA‐DP (Fontenot et al 2000 and 2002). A recent mutagenesis analysis of a Vβ5.1 containing TCR reactive to HLA‐DP‐peptide‐Be inferred an  altered  binding  topology  very  similar  to  the  aforementioned Hy.1B11  autoreactive TCR, with residue alterations suggesting germline αCDR1 and 2 make no contacts with the ligand (Dai et al, 2010 and Bowerman et al, 2011). Overall therefore, despite original predictions and hypotheses, alloreactive TCRs appear to  engage  to  their  ligands  in  the  same manner  attributed  to  self‐restricted TCR‐pMHC interactions  and  thus  further  the  scope  of  TCR‐pMHC  adaptability.  Only  autoreactive TCRs have demonstrated truly atypical binding and thus represent the extreme end of the  spectrum of  variability  present  in  the TCR‐pMHC  relationship.  Thus,  as  presented here,  there  is  immense variability  in TCR‐pMHC relationship  that  is dependent on  the nature of  the TCR, MHC and Ag. Due to  the extreme diversity of all  these components, the identification of a clear underlying molecular mechanism for TCR restriction to MHC has  not  been  established.  Nevertheless,  several  lines  of  work  now  propose  that  a germline  code  that  creates  an  intrinsic  preference  for MHC  recognition  by  TCR  exists and has resulted from co‐evolution between receptor and ligand. The following section summarises the evidence for and against such a code, including alternative theories that propose the nature of MHC restriction is functionally conferred by the CD4 and CD8 co‐receptors. 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Figure 1. 10: Autoreactive TCRs can bind pMHC with abnormal topologies. 
Comparison of an immunogenic TCR with normal binding topology and an autoreactive TCR with altered 
topology. The immunogenic HA.1 TCR binds to the HLA-DR1 class II MHC presenting the HA1 peptide with a 
canonical binding mode: CDR2 interacting with the MHC helices, CDR1 with the MHC helices and the peptide 
ends and the CDR3 interacting predominantly with the presented peptide (left). The autoreactive Ob.1A12 TCR 
bound to the HLA-DR2b class II MHC presenting a peptide derived from MBP shows altered binding however. 
Here the germline αCDR1 and 2 and βCDR2 are positioned away from the MHC due to the altered binding 
angle shifting the whole interaction towards the terminus of the peptide. This also allows the CDR3α to interact 
with the MHC β chain α-helix. The peptides are shown in orange, TCRβ CDRs in yellow and TCRα CDRs in 
purple. Adapted from Wucherpfennig et al, 2009. 
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Unlike other TCRs, which contact the MHC a-helices
mainly through the germline-encoded CDR1 and CDR2
loops of Va and Vb, most contacts to MHC made by
Ob.1A12 are mediated by the more structurally variable
CDR3 loops. Thus, CDR3b straddles the peptide-bind-
ing groove and contacts both a-helices of HLA-DR2b
(Figure 1b). Another feature that distinguishes the
Ob.1A12–MBP–DR2b complex from complexes invol-
ving antiforeign TCRs is a large, dome-shaped pocket,
composed of the two CDR3 loops, that accommodates the
P2 side chain of MBP, in addition to a side chain from
HLA-DR2b (His81b) (Figure 2b). By contrast, this
pocket accommodates only a single peptide residue
(P5) in MHC class II-restricted antiforeign TCRs
(Figure 2a) [8,11,12!!].
The distinctive offset position of the Ob.1A12 footprint
on the MBP–DR2b self-ligand (Figure 1b) is maintained
in a complex between Ob.1A12 and a crossreactive pep-
tide from Escherichia coli bound to HLA-DR2b [13!!].
This naturally processed microbial peptide, which is
derived from the guanosine triphosphate-binding protein
engA, shares limited sequence identity with MBP 85–99
[14]. Nevertheless, the engA peptide induced MS-like
disease in humanized Ob.1A12–DR2b transgenic mice by
crossreacting with the TCR [13!!]. Comparison of the
Structures of autoimmune TCRs Wucherpfennig et al. 591
Table 1a
Structural defects of self-reactive TCRs
Ob.1A12
human MS
3A6
human MS
E8 human
melanoma
172.10
mouse EAE
1934.4
mouse EAE
cl19
mouse EAE
Altered binding topology H H H
Partial occupancy
of peptide-binding
groove
H H H
Recognition of peptide
by CDR3 loops alone
H H H H
Paucity of side chain
specific hydrogen
bonds between
peptide and TCR
H H H H
Low affinity binding Ha Ha Ha Hb Hb Hb
a Caused by weak interaction between TCR and peptide–MHC.
b Caused by weak interaction between peptide and MHC.
Figure 1
Structural comparison of TCR–peptide–MHC class II complexes. (a) Upper panel: top view of the human antimicrobial HA1.7–HA–DR1 complex (PDB
accession code 1FYT). MHC a-chain is dark blue and b-chain is light blue; TCR a-chain is magenta and b-chain is yellow; peptide is an orange line.
The peptide residue occupying the P5 position of the peptide-binding grove is shown as an orange sphere. Bottom panel: positions of the Va and Vb
CDR loops (numbered 1–3) on the pep ide–MHC surf ce. (b) The human autoimmune Ob.1A12–MBP–DR2b complex (1YMM). (c) The human
autoimmune 3A6–MBP–DR2a complex (1ZGL). (d) The human antitumor E8–mutTPI–DR1 complex (2IAM). (e) The mouse autoimmune 172.10–MBP–I-
Au complex (1U3H). The comparison shows the shift of human self-reactive TCRs Ob.1A12, 3A6, and E8 toward the peptide N-terminus and the MHC
class II b chain helix (light blue).
www.sciencedirect.com Current Opinion in Immunology 2009, 21:590–595
HA1.7-HLA-DR1-HA Ob.1A12-HLA-DR2b-MBP 
TCR pMHC System Reference
Ob.1A12 HLA-DR2b-MBP Human Hahn et al, 2005
3A6 HLA-DR2a-MBP Human Li et al, 2005
Hy.1B11 HLA-DQ1-MBP Human Sethi et al, 2011
172.10 H2-A
u
-Ac1-11 Mouse Maynard et al, 2005
1934.4 H2-A
u
-Ac1-11 Mouse Feng et al, 2007
cl19 H2-A
u
-Ac1-11 Mouse Feng et al, 2007
Table 1.7: Summary of autoimmune TCRs
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1.5 The mechanism of TCR restriction to MHC 
1.5.1 Germline encoded restriction of TCR CDR1 and 2 to MHC In  1973,  before  the  full  characterisation  of  the  TCR  or  the  role  of  MHC  in  immune response  (see Section 1.1.3),  Jerne proposed  two subsets of  “antibody” producing cells that have evolved to either encode  for proteins  that react against  their own haplotype (and  are  thus  removed  during  cell  development)  and  cells  that  encode  proteins  that recognise  allotypes  that  are  not  their  own  (Jerne,  1971).  Effectively  this  anticipated  a germline  encoded  affinity  for  restriction  elements  where  self  reactivity  is  removed during development of  the cells  in primary  lymphoid organs,  leaving allo‐specific cells that also respond to foreign Ag due to somatic mutations. In 1986, around the time when the  TCR,  MHC  and  their  relationship  were  beginning  to  be  characterised  in  detail, Blackman  et  al  (Blackman  et  al,  1986),  described  experiments  where  hybridomas encoding for a single TCRα chain when fused with cells expressing different TCRβ chains could recognise a class I or class II MHC ligand, further inferring an intrinsic capability of the same TCR (α chain) to recognise distinct classes of MHC ligand. As the CDR1 and 2 of the  αβTCRs  were  germline  encoded,  compared  to  the  non‐germline  CDR3,  it  was presumed  these  regions would  be  the  source  of  germline‐encoded  restriction.  Indeed the earlier described mutational experiments by Sun et al  (see Section 1.4.2) predicted the CDR1 and 2 would predominantly  interact with the presenting MHC molecule. The key studies surrounding the dominant hypothesis are described in detail below. Direct  evidence  came  first  from  studies  that  attempted  to  analyse  the  pre‐selection repertoire  of  T  cells,  i.e.  before  TCRs  “see”  MHC  for  the  first  time.  Ignatowicz  et  al (Ignatowicz et al, 1996) used MHC class II knockout (KO) mice expressing a transgene encoding  for  a  class  II H2‐Ab β‐chain,  covalently  linked  to  a  peptide  named Ep. When crossed to mice that express the partner H2‐Ab α‐chain, T cells could only be selected on the  single  pMHC  class  II  complex.  Removal  of  peptide  diversity  was  predicted  to facilitate selection of those T cells that would otherwise be negatively selected on other self‐peptides  presented  in  the  thymus,  as  demonstrated  by  the  high  reactivity  to  self‐peptide‐H2‐Ab  complexes  in  the  study. These CD4 T  cells were  also  found  to  be more cross‐reactive  with  responders  from  different  allotypes,  with  frequency  of  response indirectly proportional to the relatedness of the allotype with H2b, concluding that these pre‐selected  T  cells  have  an  inherent  bias  to  recognise  MHC,  which  is  diminished 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through the process of T cell selection. Similarly, using MHC KO mice that would trap T cells at the DP stage of selection before MHC mediated selection, Zerrahn et al (Zerrahn 
et al, 1997) cultured the DP population ex vivo in foetal organ thymic cultures (FTOC) to SP T cells and tested this MHC naïve fraction for reactivity, again discovering that MHC reactivity was equal, or more than that of  those SP T cells selected canonically  in vivo, again  inferring  a  natural  affinity  for  MHC  in  pre‐selected  T  cells.    Further  indirect evidence, was presented by Vidovic et al and Sim et al (Sim et al, 1996 and Vidovic et al, 1997). Vidovic et al, showed T cells selected on MHC class II H2‐Ab ββ‐homodimers were still  alloreactive  to  normal  αβ  class  II  heterodimers,  concluding  MHC  reactivity  was germline and not ontogeny‐related. Sim and colleagues showed that mutating key CDR residues on Vα3.1 was sufficient to switch MHC class preference from class II to class I, indicating  an  inherent  MHC,  and  perhaps  MHC  class  bias  in  the  germline  repertoire. Recent work  comparing  peptide‐recognising CDR3  sequences  in  alloreactive  and non‐alloreactive TCRs has further suggested that the ability to react to allo‐MHC molecules is limited only through induction of tolerance by the endogenous selecting peptides in the thymus  and  not  the  TCR  itself,  explaining  why  such  a  high  level  pre‐selection alloreactivity inferred from studies such as Ignatowicz et al is only present in up to 10% of mature cells (Morris et al, 2011).  The first molecular model for such a germline‐encoded restriction came from a tour de 
force  study  from  Huseby  et  al  (Huseby  et  al,  2005).  Mice  in  which  the  pre‐selection repertoire was selected on a single class II pMHC complex (H2‐Ab‐SP; Ignatowicz et al; see above) were immunised with dendritic cells (DC) expressing H2‐Ab covalently linked to the 3K peptide, with C57BL/6 immunised as a control. T cell clones from both sets of mice specific for the H2‐Ab‐3K complex were converted into hybridomas and subjected to  a  barrage  of  tests.  Hybridomas  from  the  negative  selection  impaired  mice demonstrated comparable affinity and avidity as the WT counterparts but were far less susceptible  to  peptide  mutations,  suggesting  a  peptide  degenerate  and  more  MHC focussed  repertoire.  A  comprehensive  panel  of  H2‐Ab‐3K  MHC  and  peptide  mutants tested  with  a  range  of  hybridomas  from  both  sets  of  mice  further  highlighted  the flexibility  of  the  H2‐Ab‐SP  clones,  with  hybridomas  from  these  mice  also  exhibiting greater  alloreactivity  and  some  clones  that  could  respond  to  class  I  and  II  MHC.  The authors  concluded  that  the  pre‐selection  TCR  repertoire  has  co‐evolved  to  recognise conserved,  backbone  features  of  the MHC molecules, with negative  selection  acting  to remove those that respond too strongly to self‐MHC, whereas positive selection occurs 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on those TCRs where the non‐germline CDR3 loops have refocused the CDR1 and 2 away from overly reactive MHC interactions – also explaining why there is little conservation in TCR footprints bound to pMHC. This model also provides an explanation for the high level  of  alloreactive  cells  as  the  remodelling  of  CDR1  and  2  contacts  during  positive selection will only impart tolerance to self‐MHC thus leaving many TCRs who still retain a strong preference to the general features of allogeneic MHC. Rubtsova and colleagues further  supported  this  notion  by  making  a  panel  of  CDR3  mutants  in  the  H2‐Ab‐3K specific  YAe62  βCDR3  showing  that  these  changes  did  not  alter,  and  some  instances increased, TCR cross‐reactivity whereas similar mutations to the βCDR1 and 2 regions severely limited cross‐reactive capabilities (Rubtstova et al, 2007). Feng  et  al  (Feng  et  al,  2007)  analysed  two  new  TCR‐pMHC  structures  (derived  from single  chain  soluble  TCR  V‐domains)  and  compared  them  to  related  TCRs  bound  to similar ligands for which the structures were already known (Reinhertz et al, 1999 and Maynard et al, 2005). These TCRs (Table 1.8) all contained Vβ8.2 in conjunction with a Jβ2 sub‐family member segment. Three of these receptors recognised the H2‐Au‐MBP1‐11 complex, with the D10 TCR recognising the highly similar H2‐Ak‐conalbumin. Despite unique identifiers, such as distinct CDR3 sequences and different partner TCRα chains, all four TCRβ showed remarkable superimposition relative to each other. In particular, despite heterogeneous partner TCRα interactions, the Vβ8.2 contains chains maintained highly  conserved  interactions.  The  authors  concluded  that  analysis  of  similar  TCRs finally highlighted a germline code in the form of the βCDR2 residues Y48, Y50 and E56 (based  on  Kabbat  database  numbering)  that  contacted  similarly  conserved  MHC residues, despite variable partner chain interactions (Figure 1.11). This data was further supported by Dai et al  (Dai et al, 2007) who solved  three structures  from clones with variable  specificity  for H2‐Ab‐3K  complex  used by Huseby et  al  as  described  above  to observe  pre‐selection  TCR  specificities.    The  three  TCR  included  one  clone  from  a control C57BL/6 mouse  (B3K506 – highly  specific) and  two clones  from  the H2‐Ab‐SP background  with  inhibited  negative  selection,  one  that  showed  mild  cross‐reactivity (2W20)  and  one  that was  highly  cross‐reactive  (YAe62).  As with  Feng  et  al,  all  three used Vβ8 family members in their TCRβ chains. Moving from the highly specific B3K506, to  the  most  cross‐reactive  YAe62,  the  authors  reported  a  focussing  of  the  germline repertoire  highlighting  the  exact  same  βCDR2  residues  as  Feng  et  al,  thus  showing conserved Vβ8 CDR2  contact with  pMHC  from H2‐Ab, H2‐Ak  and H2‐Au.  Dai  et  al  also 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highlighted Vα  Y29  as  a  conserved TCRα  residue  between  the  structures. βCDR2 Y48 was specifically highlighted as forming a very specific “knob‐in‐hole” complementarity, slotting  into  a  conserved depression on  the H2‐A α1 helix  across  all  three haplotypes (Garcia et al,  2009). The pre‐selection YAe62 T cell  clone, as well being susceptible  to changes in its cognate H2‐Ab‐3K complex, was also reactive with allogeneic class 1 pMHC complexes  (Huseby  et  al,  2005).  Recent  studies  also  discovered  syngeneic  class  I molecules recognised by the YAe62 and solved the structure of the YAe62‐H2‐Kb‐pWM complex  (Yin et al,  2011b). Remarkably,  the TCR maintained key germline  contacts  in the βCDR2 as highlighted by Feng et al and Dai et al in recognising class I as it had done class II through switching of structural conformers. 
 
Table 1. 8: Vβ8.2 TCRs with unique TCRα  or βD­J­CDR3 usage maintain germline contacts  
 
Figure 1. 11: Conserved germline CDR interactions form interaction codons.  
Overlay of the four Vβ8.2 containing TCRs described in Table 1.8 interacting with the H2-A MHC with 
conserved contacts. The panel on the left shows the βCDR1 and βCDR2 loops of the four TCRs and show those 
germline interactions with MHC that are conserved despite the differences in TCRα or pMHC ligands. The 
interactions are summarised on the right and are colour co-ordinated with the crystal structures, showing the 
interactions with H2-A (I-A on the diagram) sequence. The conserved βCDR2 tyrosines (Y) and glutamic acid 
(E) were proposed to make up an evolutionarily maintained interaction codon. Figure adapted from Feng et al, 
2007. 
 
V! J! !CDR3 V" D" J" "CDR3
1943.4 4.1 31 ALSENYGNEKI 8.2 2.1 2.3 ASGDASGAETL H2-A
U
-MBP1-11
CI19 4.1 31 ALSENYGNEKI 8.2 2.1 2.4 ASGDASGGNTL H2-A
U
-MBP1-11
172.10 2.3 39 AASANSGTYQ 8.2 2.1 2.7 ASGDAGGYEQ H2-A
U
-MBP1-11
D10 2 4 AATGSFNKL 8.2 2.1 2.1 ASGGGQGRAEQ H2-A
K
-conalbumin
TCR! TCR"
Table 1.8: V"8.2 TCRs with unique TCR! or "D-J-CDR3 usage maintain germline contacts
TCR pMHC
Adapted from Feng et al, 2007
172.10 over I-Au–MBP1-11 and D10 over I-Ak–conalbumin16. The
1934.4 and cl19 CDR1b and CDR2b loops had very similar positions
and conformations (Fig. 4a–c) and formed a network of bonds with
the I-Au a-chain (Fig. 4a,b), suggesting a conserved recognition
strategy for Vb8.2-encoded TCRs binding I-A MHC haplotypes
(Supplementary Table 1). The convergence of the Vb8.2 footprints
on I-Au contrasts with the wide variation in docking modes seen in
other human MHC class II–restricted TCR complexes (Fig. 4d).
CDR1b Asn31 and CDR2b Tyr48, Tyr50 and Glu56 mediated inter-
actions with the I-Au a-helix in each of the structures (Fig. 4a,b).
These four TCR residues interacted through both hydrogen bonds and
van der Waals contacts with three a-chain residues conserved
throughout all I-A MHC alleles (Lys39, Gln57 and Gln61)16
(Fig. 4b). CDR2b Tyr50 is notable in that
in all four complexes it formed a ‘knob-in-
hole’ interaction with the I-A a-helix whereby
the aromatic side chain lay flat and parallel to
the helical axis, inserting between the Gln57
and Gln61 side chains (Fig. 4a).
The constellation of contacts between the
Vb8.2 and I-A helix we found here was
indeed mediated by amino acid side chains
rather than being directed mainly by the
MHC helix backbone. However, compared
with other receptor-ligand interfaces, the
TCR-MHC interfaces noted here were some-
what structurally unique and did encompass
some features presciently suggested in pub-
lished studies9,10,23. Side-chain interactions
did not occur between the extended tips of
residues on the a-helices and residues on the
CDR loops. Instead, the CDR loops seemed
to penetrate, or interdigitate, between side
chains of the helix. The ‘landing pads’ on the
MHC helices for both Va and Vb CDR loops
are devoid of large side chains, and steric
inhibitions that would obstruct the close
approach of a TCR. Such gaps in the
a-helices may enable the CDR1 and CDR2 loops to bind in such
a way as to allow maximum contact of the CDR3 loop with the
MHC-bound peptide.
Peptide recognition mediated by main-chain contacts
As with the 172.10 TCR16, interactions of the 1934.4 and cl19 TCRs
with peptide were mediated entirely by the CDR3 loops, with no
involvement of germline-encoded Va and Vb residues. Also as with the
172.10 complex, most peptide contacts were not specific for 1934.4
and cl19 CDR3-loop side chains; in contrast, main-chain atoms of
CDR3 loops engaged in interactions with peptide side chains (Fig. 5).
That observation may be due at least in part to the presence of glycine
residues at the tips of the CDR3a and CDR3b loops. The 1934.4
a b
c d
CDR2β
α1 helix
E56
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Q57
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Q61
CDR1β
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31 50 56
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GDAGGG Y– – –
Figure 5 Main-chain interactions dominate contacts between TCR CDR3 loops and MBP1-11. Yellow,
peptide; red dashed lines, hydrogen bonds; black dashed lines, van der Waals interactions. TCR amino
acids are designated by one-letter amino acid code followed by position number; peptide amino
acids are designated by position (P) number, followed by the one-letter amino acid code. Below,
two-dimensional projections of the CDR3-peptide contacts. (a) The 1934.4 complex. (b) The cl19
complex. (c) The 172.10 complex.
Figure 4 Recognition ‘codon’ between Vb8.2 and I-A. (a) Similar hydrogen-
bonding network for four superimposed Vb8.2-containing TCR complexes
with I-A (I-Ak from the D10 complex and I-Au from the 1934.4, cl19 and
172.10 complexes): magenta, 1934.4; blue, cl19; cyan, 172.10; yellow,
D10; red dashed lines, conserved hydrogen bonds between TCR CDR1b
and CDR2b loops and the I-A a1-helix. (b) Shared interactions between
the Vb8.2 CDR1 and CDR2 loops in a and the I-A a1-helix. Highlighting
indicates all TCR and MHC residues involved in interactions; residues not
highlighted are designated as contacts. I-A residues in green are conserved
across various I-A allotypes (I-Au, I-Ak, I-Ad, I-Ab, I-Aq, I-Ar and I-Af).
Red dashed lines, hydrogen bonds; black dashed lines, van der Waals
interactions. For several TCR and MHC residues (such as D10 CDRb
Asn30), the assignment of hydrogen bond or van der Waals interaction is
ambiguous because of the resolution differences of the structures; in such
cases, the interaction is designated here as van der Waals. (c) Top view of
the TCR CDR1b and CDR2b loop footprints (dashed red circle) on the pMHC
composite surface. (d) Divergent footprints of other MHC class II–restricted
TCRs aligned on I-Au: the HA1.7 TCR footprint (orange) from the crystal
structure of HA1.7 bound to HLA-DR1–HA (Protein Data Bank accession
code, 1FYT); the 3A6 TCR footprint (red) from the crystal structure of 3A6
bound to HLA-DR2a–MBP87-99 (Protein Data Bank accession code, 1ZGL);
the Ob.1A12 TCR footprint (slate) from the crystal structure of Ob.1A12
bound to HLA-DR2–MBP85-99 (Protein Data Bank accession code, 1YMM);
and the E8 TCR footprint (gray) from the crystal structure of E8 bound to
HLA-DR1–TPI (Protein Data Bank accession code, 2INA).
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Marrack et al (Marrack et al, 2008) with this new structural knowledge re‐addressed the then  current  TCR‐pMHC  library  analysing  all  germline  contacts  between  the  TCR  and pMHC, with new criteria, including the caveat that due to the nature of positive selection enriching for peptide specificity (as demonstrated by Dai et al), not all germline contacts will be preserved in “post‐selected” TCRs representing the majority of solved structure. This analysis highlighted key positions that are often highly conserved with one or two amino acids and often make contacts to conserved MHC residues. These summaries are listed in Table 1.9.  It was further suggested that when the preferred residues were not present  at  the  specified position,  they  often did  not  contact  the MHC molecule  and  in these  instances  other  as  yet  unidentified  interaction  combinations  were  dominant. While  it was proposed key  germline positions drive  recognition,  it would not prevent other  interactions  from  taking place  as  a  result  of  hypervariable CDR3  structures  and influences  from  the  pMHC  complex  during  positive  selection.  Thus  a  combination  of germline code with the influential process of thymic selection was proposed to explain the  lack  of  truly  conserved  binding  footprints  in  hitherto  analysed  TCR‐pMHC structures.   
 
Table 1. 9: Summary of key germline TCR CDR positions and corresponding MHC interactions highlighted by 
Marrack et al, 2008  
Class I Class II
TCR Chain CDR Position Residues Residue (chain) Residue (Chain)
31 Y or F Q/H/R 155 (!2) R70 ("1)
Found in 40% of human TCR!, 10/13 
structures analysed with this residue contacted 
the MHC. No other residue at this position 
found to interact with MHC.
29 Y - H81/T77 ("1)
Interaction only occurs when proline present at 
position 30. Suggested special germline rule for 
V-segments with prolines here.
51 S A158/G151 (!2)  T77 ("1)
Most conserved amino acid in all published 
structures. Only in two structures analysed did 
not use this residue for MHC interaction.
50 Y A158* (!2) A73* ("1)
Not abundant throughout V! segments, but 
when present, often interacts with MHC.
CDR1 29 N or Y - Q61 (!1)
These two residues are relatively conserved 
throughout all V-segments.
46 Y or F R/Q65 (!1) Q57 (!1)
In 16/22 structures analysed, Y or F at this 
position contacts the MHC class I or class II. 
However only in 5/10 class I structures.
48 Y/Q/V/R X69* (!1) -
The most conserved position that shows 
consistent MHC binding in the "-chain. Always 
contacts MHC in depression at top of helix, thus 
acts as potential pivot point for docking angle. 
Tyrosine is the most studied residue.
54 D or E R65 (!1) Q57 (!1)
4/14 class I crsytals show contact with the 
MHC only. 6/8 class II structures show 
interaction with same MHC conserved MHC 
residues.
TCR Common MHC Contacts
MHC positions are not complete lists, but dominant positions often contacted. * refers to residues at centre of various interactions. X denotes a position 
that is contacted often but contains various residues.
Table 1.9: Summary of key germline TCR CDR positions and corresponding MHC interactions highlighted by Marrack et al, 2008
TCR!
TCR"
CDR1
CDR2
CDR2
Notes
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Garcia et al distilled these new data into a model termed the “codon” hypothesis (Garcia 
et  al,  2009).  In  principle,  it  was  proposed  that  TCR  V‐segments  have  evolved  very specific  triads  of  residues  termed  interaction  codons  that  upon  interacting  with  a specific pMHC environment will find a combination that represents the lowest energetic minima (i.e. optimal binding). Each V‐segment could contain several combinations with the nature of the MHC and the TCR’s own CDR3 region determining which residues will participate. Effectively the work of Dai et al and Feng et al had recognised examples of codons  used  in  Vβ8  containing  TCR  chains  with  evidence  of  other  residual  codons highlighted by Marrack et al.  More recent work has focussed on functionally testing the role of these codon positions 
in vivo and their evolutionary conservation (Scott‐Browne et al, 2009 and Scott‐Browne 
et  al,  2011).  In  the  first  study  the key βCDR2  residues were  individually mutated and used in a retrogenic system resulting in T cells developing with a fixed WT or mutated TCRβ chain (from the DO‐11.10 TCR specific for the OVA323‐339 peptide presented on H2‐Ab and H2‐Ad) that can pair with a full endogenous repertoire of TCRα chains.  Mutations to  these  codon  residues  were  shown  to  reduce  the  efficiency  of  T  cell  selection  and endogenous  TCRα  repertoire  diversity,  inferring  a  general  requirement  for  these residues in optimal MHC recognition both in T cell selection and immune response. The second  study  highlighted  examples  of  the  conservation  of  one,  some  or  all  of  the  key germline  residues defined  in murine Vβ8.2  (or  related human Vβ11)  containing CDR2 regions (YXYXXXXXE) across evolutionarily divergent vertebrate species including fish, frogs and opossums. Grafting of these whole CDR2 sequences to the aforementioned DO‐11.10 TCRβ chain demonstrated that elements of this conserved motif were sufficient to rescue the inefficient response to the original DO‐11.10‐H2‐Ad‐OVA323‐339, regardless of the surrounding CDR2 sequence. Use of the frog (Xenopus laevis) TRBV2 CDR2 region in place of the canonical DO‐11.10 sequence also facilitated efficient T cell development in the similar retrogenic system just described. These data were taken to  infer that some TCR  germline  regions  that  have  co‐evolved  to  recognise  MHC,  evolved  before  the divergence  of  the  vertebrate  line  and  have  been  maintained  –  also  explaining  why germline encoded recognition could also underlie xenoreactivity as well as alloreactivity (see next section). Evidence  for  co‐evolution  between  TCR  and  MHC  is  also  evident  at  the  genome  and sequence levels, in particular in comparing TCRs with the related, but MHC unrestricted, 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Ig  molecules.  This  data  is  presented  in  the  next  chapter  as  a  preface  to  a  relevant analysis completed as part of this work. Other work has also directly or indirectly been used  to  support  a  germline  code  in  TCR  restriction  to  MHC.  This  evidence  and alternative theories are summarised in Table 1.10. 
 A  final  point  to  note  is  that  as  well  as  controlling MHC  recognition,  it  has  also  been suggested that the germline recognition of MHC by TCRs as surmised by Marrack et al (Marrack et al, 2008) can also explain the conserved diagonal docking mode adopted by TCRs. While  this docking angle  is  varied,  there  is no  clear molecular mechanism as  to why structures have not been found where TCRα and β chains are orientated towards the  carboxyl‐  and  amino‐termini  of  the  peptide  and  opposite  sides  of  the  MHC.  Any mechanism would however have to account for the variability in docking angle and pitch that is seen (Section 1.4.2). Marrack proposes that each MHC allele contains a conserved dish  like  depression  that  is  not  sequence,  but  structurally  conserved,  where  key germline  TCR  residues  are  known  to  interact.  Support  for  a  germline  encoded  TCR docking angle is  inferred by TCRs mutated in a cell free system maintaining conserved docking  angles  (Table  1.10)  and  the  fact  apparent  “pre‐selection”  TCRs  such  as  the YAe62  depict  docking  angles  comparable  to  post‐selection  structures  (Dai  et  al,  2007 and Yin et al, 2011b). Thus  if germline TCR residues have evolved to  interact within a depressed  surface  as  opposed  to  specific  residues,  this  would  perhaps  explain  how binding angles can be germline mediated, but still variable and also why more extreme binding  angles  and  a  switched  orientation  are  not  seen.  This  generally  conserved docking geometry was proposed  to be mediated  through  signalling  requirements  (see next section) but Garcia suggests the variability that exists in the structural database is too broad for a model where extrinsic factors mediate docking geometries (Garcia et al, 2009).  The  42F3  TCR  is  specific  for  the  H2‐Ld‐QL9  pMHC  but  was  shown  to  retain specificity to altered peptides randomly generated from the original QL9 peptide, to the H2‐Ld class I MHC (Adams et al, 2011). Interestingly, the altered peptides (which could be divergent  from  the original  in  all  nine  residues)  resulted  in  altered docking  angles and the one peptide studied (3A1) that lost agonist function altogether had the sharpest docking angle, repositioning recognition to a near orthogonal angle. This suggests that peptide  specificity  (in  the  context  of  germline  recognition) may  influence  the  docking angle, which is vital for subsequent signalling steps. 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Table 1. 10: Summary of further evidence supporting a form of germline­encoded restriction of TCR to MHC  
 
 
 
 
 
Evidence Description References
Conserved MHC interacting residues
Three class I MHC residues are invariably contacted upon 
TCR engagement. These are residues 65, 69 and 155 in the 
!2 class I domain. Proposed to form part of pairwise co-
evolved residues and are the minimal docking framework 
required for TCR recognition, even in extreme cases such as 
peptide bulging.
Marrack et al, 2008, 
Tynan et al, 2005b and 
Burrows et al, 2010
Interaction codon from human V"11 (comparable to murine 
V"8.2) containing NK-T cell TCRs, which recognise glycolipds 
presented on MHC-like molecule CD1d, were found to have 
significant affects on NK TCR-CD1d affinity.
Wun et al, 2008
The murine V"8.2 codon motif present in other vertebrate's 
"CDR2 that contained no other sequence  homology could 
still mediate recognition of the CD1d MHC like ligand when 
transferred onto the murine NK TCR framework.
Scott-Browne et al, 
2011
TCRs with abnormal topology still 
maintain "CDR2 interactions
Structure of an autoimmune Hy.1B11 TCR bound to HLA-DQ-
MBP ligand showed highly altered toplogy yes the "CDR2 
retained contacts. Although these contacts were distinct 
relative to "accepted" interaction codon interactions.
Sethi et al, 2011
Maintaining MHC tertiary shape is 
not sufficient forTCR recognition
Forced expression of the MHC class II related molecule HLA-
DM which shares teritary structure and some homology with 
MHC class II could not select T cells in vivo on an otherwise 
MHC deficient background. Concluded molecules removed 
from co-evolutionary pressure lost the capability to 
intirinsically recognise TCRs.
Kim et al, 2005
TCRs selected in a cell free 
environment retain MHC docking 
mode
A structure of the 2C TCR bound to H2-L
d
-QL9 was subjected 
to yeast hybrid pull downs for higher affinity mutants with 
alterations in the CDR3. Despite the cell free system to 
select mutants, all alternative versions bound with near 
identical interactions as the original structure.
Colf et al, 2007
Tritope Model
Theoretetical model defining an even more stringent 
germline model than the interaction codon theory. Proposed 
that TCRs recognise three distinct elements upon pMHC 
binding. The first is a general MHC specific interaction, the 
second a scanning of MHC haplotype to distinguish allotypes 
and finally scanning of the bound peptide.
Cohn, 2003
Alternative saddle-shape theory
Proposed TCRs could have co-evolved to recognise the 
general "saddle" shape of pMHC peptide-binding domains, 
accounting for the variability seen in the context of 
restriction. 
Mazza and Malissen, 
2007
Table 1.10 Summary of further evidence supporting a form of germline encoded resriction of TCR to MHC
Interaction codons recognise CD1d
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1.5.2 Evidence against germline restriction of TCR to MHC and alternative theories As  with  early  theories  surrounding  germline  encoded  MHC  restriction,  alternative hypotheses were  also  proposed  that  infer MHC  restriction  is  imparted  in  the  thymus during  the  process  of  T  cell  development.  This was  demonstrated  through mixed  BM chimera  experiments  from  mice  of  different  haplotypes  with  MHC  restriction determined by the thymus MHC background regardless of the BM source (Zinkernagel, 1978). While few studies have sought to establish a lack of requirement of TCR germline components in MHC restriction, several lines of evidence support such a notion directly or indirectly.  Perhaps  the  strongest  premise  is  the  clear  lack  of  overall  conservation  in  TCR‐pMHC interactions. As dissected in detail in Section 1.4, the binding of TCR to its ligand pMHC is highly  diverse  in  terms  of  docking  angles,  conformational  changes,  residues  used  and the  relative  importance  of  the  TCR  germline  CDRs,  hypervariable  CDRs,  MHC  and presented  peptides.  In  particular  are  the  examples  of  germline  CDRs  that  contact  the peptide  (Stewart‐Jones  et  al,  2003  and  Cole  et  al,  2009)  and  that MHC mutations  can affect  CDR3  binding  without  altering  the  peptide‐binding  groove  (Miller  et  al,  2007). Such variability, coupled to other features of T cell development, such as the ~95% of T cells that fail to proceed through thymic selection supports such an idea that restriction is  imparted  to  any TCR  that meets  the  requirements based on affinity or  avidity only, which  explains  both  the  seemingly  random  nature  of  TCR  binding  within  structural limits  that  could  be  enforced  through  the  requirements  of  signalling  (Minguet  and Schamel,  2008)  but  also  the  consideration  that  few  developing  T  cells  are  positively selected on self‐pMHC despite having multiple attempts at TCR audition. As discussed, Huseby et al’s original hypothesis proposed that TCR germline affinity for MHC may be directed to conserved backbone residues, but although the model predicted that  the  process  of  thymic  selection  would  result  in  some  remodelling  of  germline contacts  in  the  context  of  hypervariable  CDR3s,  one  would  still  expect  to  see considerable peptide backbone interactions in post‐selection TCR‐pMHC crystals, which is not  the case  (Ely et al, 2008). Key examples  from the structural database clearly do not  support  the  germline  code.  For  example,  as  shown  in Table  1.9,  the  review  from Marrack et al (Marrack et al, 2008) stated that three of the key residues proposed to be dominant  in MHC recognition  included Y/F at P31 (αCDR1), an S at P50 (αCDR2) and D/E  at  P54  (βCDR2;  Numbering  based  on  Kabat  database).  The  SB27  TCR,  which 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recognises  the  EBV  derived  LPEP  peptide  presented  on  HLA‐B*3508  has  an  altered docking  topology  due  to  the  13mer  peptide  bulging  from  the  peptide‐binding  groove (see  Section  1.4.2).  Despite  containing  all  three  aforementioned  key  residues,  none contacted  the  class  I molecule  (Tynan  et  al,  2005b).  Interestingly  however,  this  same study  highlighted  a  so‐called  restriction  triad  of  MHC  residues  that  are  invariably contacted  in  some  form  by  germline  TCR  residues  (Table  1.10),  which  were  also proposed  as  a  contender  for  the  underpinning  of  TCR  restriction  to  MHC.  However, point  mutational  analysis  of  these  three  class  I  residues  (at  P65,  69  and  155) individually  or  together  did  not  affect  the  SB27  TCR’s  ability  to  form  compensatory interactions  as  demonstrated  by  the  crystal  structure  of  the  SB27  bound  to  the  same LPEP  presenting MHC with  all  three  residues modified  to  alanine  (HLA‐B*3508‐AAA; Burrows  et  al,  2010).  Thus  data  from  the  SB27‐HLA‐B*3508‐LPEP  system  does  not support hypotheses proposing crucial restriction elements are contributed by the MHC and the TCR side of the interaction.  A second system that also demonstrates a lack of germline determinants in both the TCR and MHC is the HLA‐A2‐Tax class I complex. Two human TCRs, A6 and B7, recognise the HLA‐A2‐Tax class I complex (Ding et al, 1999) and both share identical TCRβ chains with different partner chains, thus reflect a similar situation as that presented by Feng et al which described the first evidence of a conserved interaction codon in Vβ8.2 containing TCRs. While Feng et al found tremendous conservation of the βCDR2 interactions, Ding 
et al, showed that the identical TCRβ chains shared no conserved germline interactions whatsoever,  despite  similar  overall  binding  modes.  The  HLA‐A2‐Tax  system  also highlighted  important  MHC  residues  that  were  required  by  numerous  HLA‐A2‐Tax specific  T  cell  lines  for  successful  recognition;  R65,  K66  and  A69,  thus  sharing  two positions  (65  and  69)  with  those  defined  in  the  SB27‐HLA‐B*3508‐LPEP  system described  above  (Baker  et  al,  2001).  Mutation  of  the  novel  K66  residue  abrogates recognition  of  HLA‐A2‐Tax  specific  clones,  but  rather  than  being  a  germline determinant, it was subsequently shown to instead be maintaining a stable electrostatic environment,  in  which  mutation  of  the  positively  charged  lysine  increased  the  net negative charge, prohibiting TCR binding. Indeed, mutation of a neighbouring negatively charged  glutamic  acid,  in  conjunction with  the  positively  charge  lysine,  re‐established pMHC recognition (Gagnon et al, 2005). 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While Vβ8.2 containing TCRs displayed remarkable conservation of interactions across three  H2‐A  haplotypes  in  the  context  of  different  partner  chains  and  ligands  (see previous  section;  Feng  et  al,  2007  and  Dai  et  al,  2007),  other  TCRs  under  similar circumstances  have  not  reproduced  this  conservation.  For  example,  as  described  in 
Section 1.4.4, the 2C TCR showed remarkable divergence in its germline footprint when bound  to  its  cognate H2‐Kb‐dEV8  complex  compared  to  its  allo‐ligand  the H2‐Ld‐QL9. While the two complexes use different class I genes, the fact the Vβ8.2 interaction codon recognises both classical and non‐classical MHC class I, which are more divergent than the  K  and  D  genes  would  suggest  a  similar  germline  footprint  could  be  expected, however this was not the case as demonstrated by the 2C TCR’s shift in binding angle of 20° (Colf et al, 2007).   Finally, sequence analysis of bovine TCR loci has discovered the presence of apparent TCR V‐segments  that  lack any CDR2 sequences, which  indirectly suggests a lack of requirement for these germline structures (Reinink and Rhijn, 2009). Perhaps the clearest structural evidence against a germline code for TCR mediated MHC recognition, was published this year by Stadinski et al (Stadinski et al, 2011). Using an endogenous TCRα repertoire paired with the “pre‐selection” YAe62 TCRβ chain, one of the original receptors to contain an anticipated interaction codon (see previous section), repertoires  of  MHC  specific  and  MHC  cross‐reactive  TCRs  were  selected  using  mice deficient  in  specific MHC gene combinations. Cross‐reactive  (CD4 T cells  selected on a class I MHC competent, class II deficient background) and specific (CD4 T cells selected on class I and class II competent background) TCRs were stimulated with the H2‐Ab‐3K ligand to generate receptors that are specific to the same pMHC complex as the original YAe62  TCR,  but  only  contain  the  β  chain  of  the  original  receptor.  Mutational  studies between specific and cross‐reactive clones indicated that the partner TCRα chain could alter  TCRβ  contacts  in  order  to modify  specificity  to  the MHC,  also  supported  by  the segregation  of  different  endogenous  TCRα  V‐segments  into  the  specific  and  cross‐reactive groups. This suggested that despite the original YAe62 TCR’s original ability to recognise both a class  I and II MHC using a defined  interaction codon (Yin et al, 2011; see previous section), when paired with different TCRα chains, such conserved contacts are  not  maintained.  This  was  confirmed  by  solving  the  structure  of  the  J809.B5  TCR (YAe62β/Vα2) bound to H2‐Ab‐3K with comparison to the original YAe62 bound to the same  complex,  revealing divergent TCRβ  footprints  in  the  context  of  a different TCRα 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chain,  despite  previous  use  of  the  proposed  interaction  codon  in  previous  structures (Dai et al, 2007 and Yin et al, 2011).  The foundations of germline encoded restriction theories lay with the original systems that perpetrated to  lower the level of negative selection and thus identify the inherent MHC reactivity of a pre‐selection TCR repertoire (Ignatowicz et al, 1996 and Zerrahn et 
al, 1997; see previous section). The system used by Zerrahn et al, while blocking T cell development at the DP stage, thus enriching for a pre‐selection repertoire, subsequently relied on ex vivo selection in the FTOC system used to mature DP to SP cells. Hence it is possible  that  this  selection  step  could  have  affected  the  final  population  and  its reactivity.  The  system  adopted  by  Ignatowicz  et  al,  facilitated  selection  in  vivo  but reduced negative selection through limiting positive selecting pMHC to a single class II complex. However a near identical approach, only this time selecting T cells on a single class  I  MHC,  demonstrated  that  resultant  CD8  T  cells  were  highly  MHC  and  peptide specific  in  their responses (Wang et al, 2009).  It could be argued that  this approach  is also more physiological as it used primary cells derived from the mice and not the added process  of  hybridoma  creation.  In models where  expression  of  a  single  pMHC  species directs selection, the artificially high peptide density may effect the resulting repertoire. Finally, both the Ignatowicz et al and Zerrahn et al methods relied in some form on MHC deficient  backgrounds.  In  their  review,  Collins  and  Riddle  also  question  the completeness  of  the MHC KO  strains  used  and  their  affect  on  the  resultant  outcomes (Collins and Riddle, 2008) as the KO strains used (H2‐Ab ‐/‐β2m ‐/‐) still select residual T cell populations. If  MHC  restriction  of  TCRs  is  not  germline  encoded,  then  it  also  suggests  that  the relatively  conserved diagonal docking mode of TCRs  to pMHC must also be controlled independently. Mechanisms that are not dependent on pair wise co‐evolution between the TCR and pMHC could be related to more generic features of the TCR‐pMHC interface or regulated extrinsically. The permissive geometry model (Minguet and Schamel, 2007) of signalling (Table 1.6) is based on work demonstrating that TCRs can be activated by soluble multimers but not monomers of pMHC (Boniface et al, 1998; Cochran et al, 2000; Cebecauer et  al,  2005 and Stone et  al,  2006)  inferring  that  signalling  is  dependent on TCR  clustering.  The  model  proposes  that  when  unbound/monovalent  the  TCR‐CD3 signalling  complex  exists  in  an  inert  state.  Upon  binding  between  clustered TCRs  and pMHC complexes, rotation of adjacent TCRs relative to each other leads to  ‘opening’ of 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the signalling complex and consequent signalling. A sufficient opening upon rotation of the TCRs is dependent on a starting diagonal docking mode, thus only T cells with such a docking mode will be able  to  signal. However,  the ability of  such a mechanistic model being  able  to  function  within  such  a  variety  of  recorded  docking  angles  is  disputed (Garcia et al, 2009). Just as the ability of a Fab Ig to bind pMHC with a similar diagonal docking goes against a germline encoded theory, it also argues against a TCR model that relies  heavily  on  external  molecules  and  clustering  that  are  unrelated  to  Ig  function, including  co‐receptors whose  adjacent  binding  to MHC has  also  been  implemented  in influencing  TCR  docking  angles  (Buslepp  et  al,  2003).  A  role  for  mean  surface electrostatic potential (MSEP) of TCRs has been proposed to define TCR docking angles, binding affinities and ligand specificity (see below; Kahn and Ranganathan, 2011).  The above data questions both the structural conclusions and experimental approaches used to support a germline encoded, co‐evolved form of TCR restriction to MHC. Recent theories  have  proposed  a  more  dominant  role  for  the  co‐receptors  in  biasing  T  cell signalling to MHC. Mice with the most comprehensive MHC deletions maintain negligible T cell  selection – potential evidence  for a germline requirement of MHC  for successful TCR selection and T  cell development. As discussed  in detail  in Section 1.4.3,  CD4 and CD8  co‐receptors  mediate  highly  conserved  binding  to  class  II  and  class  I  MHC respectively  and  contain  intracellular  motifs  that  bind  the  downstream  Lck  kinase required  for  TCR  signalling.  Studies  have  shown  that  co‐receptors  only  interact  with MHC  after TCR  engagement  (Krogsgaard et  al,  2005)  and  that when  the TCR  remains unbound, the co‐receptors sequester the cytoplasmic pools of Lck by remaining bound to  the kinase (Haughn et al, 1992 and Wiest et al, 1996). Van Laetham and colleagues proposed  that  the  lack  of  T  cell  selection  on  MHC  KO  mice  could  in  fact  be  related therefore  to  a  by‐proxy  requirement  of  TCRs  to  bind  MHC  in  order  to  access  the otherwise  sequestered  Lck  with  engagement  with  non‐MHC  ligands  failing  to  attract MHC‐specific co‐receptors and thus downstream signalling molecules (Van Laetham et 
al, 2007). In order to test this hypothesis, mice lacking MHC class I and class II and the CD4  and  CD8  co‐receptors  (quad‐KO)  were  generated.  Remarkably,  T  cells  still developed  in  vivo with  a  similarly  diverse Vβ  repertoire  as WT  controls.  Lower T  cell output was explained through an increase in spontaneous signalling, expected due to the now uncontrolled nature of Lck‐TCR proximity. This was proven by demonstrating that the  level  of  Ig‐induced  (co‐receptor  independent)  TCR  activation  was  directly proportional  to  the  severity  of  a  series  of mutations  inserted  to  the  CD4  Lck  binding 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domain in CD4 competent cells. T cell clones made from quad‐KO mice were shown to clearly  respond  to  MHC  deficient  stimulators  from  donor  spleen  cells  through  a mechanism that was shown not to be self‐activation. These results clearly suggest that the TCRs inability to respond to non‐MHC ligands is dependent on “fixing” the signalling pathways to the requirement of binding MHC (Figure 1.12). The idea of co‐receptor mediated restriction was expanded further by Collins and Riddle (Collins and Riddle, 2008) who drew on the work of Van Laetham et al and also work showing  that  co‐receptors  (particularly  CD8)  can  influence  the  magnitude  of  TCR response  to  pMHC  (see  Section  1.4.3)  and  may  control  the  docking  angle  of  TCRs  to facilitate signalling. Indeed, as discussed, some signalling models (see Section 1.4.3 and 
Table 1.6) also propose  that a diagonal docking mode  is  required  in order  to organise the TCR/CD3/Co‐receptor/Lck  into positions  that  facilitate  signalling  in  the context of receptor clustering (Minguet and Schammel, 2008).  
 
Figure 1. 12: Sequestering of signalling molecules by co-receptors may enforce TCR restriction to MHC.  
Schematic overview of the model proposed by van Laetham et al (van Laetham et al, 2007) to describe the 
phenomenon of MHC restriction. In a normal situation (left), the co-receptor (CD4 in this case) binds to highly 
conserved residues on the MHC class II molecule. If a TCR engages in this scenario it will receive downstream 
signalling molecules such as Lck that are otherwise sequestered by the co-receptor through intracellular binding. 
Thus in a scenario where the CD4 was not involved in the interaction (right), even if the TCR bound specifically 
to the pMHC, there would be no Lck available to induce downstream signalling. Thus while TCRs could 
potentially respond to other ligands, they are required to bind to MHC to access Lck, which is held there through 
the co-receptor’s highly conserved specificity to the MHC. 
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While Van Laetham et al, demonstrated clearly the ability of T cells to develop on ligands other than MHC, they did not define any specific non‐MHC ligands. However, examples do  exist  of  apparent  non‐MHC  TCR  ligands  generated  both  in  vitro  and  in  vivo.  Ig molecules,  like  TCRs,  have  the  inherent  capability  to  be  cross‐reactive.  The  normally HLA‐A2  restricted,  AHIII  TCR  was  “removed”  from  the  restrictions  of  MHC  and  co‐receptors and measured for its ability to recognise a proteome array from yeast in a cell free,  unbiased  manner,  using  the  H57‐97  (anti‐TCR)  Ig  as  a  control  (Bangham  et  al, 2005). While both proteins recognised a different array of Ag  from the proteome,  this TCR recognised a comparable number as the Ig, inferring it can be as broadly reactive as the  MHC  unrestricted  Ig  molecule.  Several  other  non‐MHC αβTCR  ligands  have  been proposed  using  various  systems  and  with  different  degrees  of  specificity  and  are summarised in Table 1.11. These data indicate there is a potential for recognition of non‐MHC  ligands  by  the  TCR,  with  their  rare  occurrence  perhaps  attributed  to  the sequestering  role  of  the  co‐receptors.  Reconciliation  between  the  two  divergent concepts  of  germline  or  co‐receptor  mediated  MHC  restriction  has  been  proposed, where  an  inherent  germline  preference  to MHC  is  kept  “in  check”  by  co‐receptors  to prevent chance reactions with non‐MHC ligands due to the still considerable diversity in the TCR repertoire (Kranz, 2009). 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Table 1. 11: Summary of proposed non­MHC αβTCR ligands A final  independent model for TCR recognition of pMHC in terms of specificity, affinity and docking angle is based on generic chemical features of the germline CDRs. Kahn and Ranganathan  revaluated  61  TCR‐pMHC  co‐crystal  structures measuring  the MSEP  for both  receptor  and  ligand.  They  reported  a  strong  correlation  between  the  MSEP  of germline CDRs with their docking footprint on the pMHC, which could also account for the variable binding angles seen throughout the structural database for both class I and class II MHC. The strength of such electrostatic forces was also directly proportional to the  free binding energy calculated  for each structure studied. Electrostatic  forces have shown to be important in TCR‐pMHC specificity, as described earlier in this section for the HLA‐A2‐Tax system when loss of recognition through mutation of a key MHC lysine residue was shown to be caused by a change in the electrostatic interaction between the TCRs and MHC as opposed to a germline encoded one (Gagnon et al, 2005). Such a model could  also  explain  apparent  scanning  models  where  TCRs  could  be  ‘steered’  by  the electrostatic compatibility of a pMHC ligand. 
Ligand Discovery Reference
DR4-sTRAIL
T cell clone found to respond to kidney carcinoma cell line 
in an MHC independent manner. Discovered to be the DR4 
receptor for the immune ligand TRAIL. T cell clone was 
specific only for TRAIL bound to the DR4. Interaction also 
required CD2 co-receptor bound to CD58.
Hanada et al, 2011
MUC1
MUC1 is a protein expressed on epithelial cells, 
contributing to the mucosal layer through heavy 
glycosylation. T cell clone shown to interact with tandem 
repeat peptides from MUC1 resulting in a similar response 
as when activated by pMHC in terms of signalling and co-
receptor molecules required.
Magarian-Blander et al, 1998 
Barnd et al, 1989 
HFE
HFE is an MHC class I like molecule, but bears no immune 
function, being involved instead in iron uptake. Despite 
having a peptide groove, it is too narrow to present Ag. 
Specific CD8 T cells were shown to signal in response to 
HFE in vitro, with signalling shown to be mediated through 
TCRs predomnantly using V!6.1 or V!6.6.
Rohrlich et al, 2005
Avidin and MBP
In vitro studies using T helper cell lines showed response 
to soluble avidin and MBP and also demonstrated response 
was not due to the T cells themselves "presenting" to each 
other.
Altmann et al, 1987
Haem
In vitro work using T cells from whole spleen showed the 
ability to respond to the haem component of 
haemoglobulin. Response shown to be specific, but did not 
rule out potential superantigen style binding to MHC 
molecules.
Sherman and Lara, 1989
Arsonate
T cell clones responded to arsonate in an MHC 
independent and Ag specific manner. Competition studies 
with APC suggested affect was mediated by the TCR.
Rao et al, 1984
Table 1.11: Summary of proposed non-MHC !"TCR ligands
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1.6 Aim of project Alternative  theories  that have demonstrated the ability of TCRs to recognise non‐MHC ligands,  while  convincing,  have  failed  to  address  a  question  raised  by  Garcia  and colleagues  (Garcia  et  al,  2009).  Both  the  T  cells  from  the  quad‐KO  system  of  Van Laetham  et  al  and  the AHIII  TCR used  in  the  yeast  proteome  study  of  Bangham et  al, while  able  to  respond  to  non‐MHC  ligands  out  of  context,  did  not  prove  that  the receptors from these systems do not still retain the ability to intrinsically recognise MHC and that it is the sheer diversity of the TCR repertoire that facilitates recognition of non‐MHC  ligands when an MHC  ligand  is not present. Also,  identification of  apparent non‐MHC TCR ligands currently provides very little in the way of molecular characterisation and have generally been identified in artificial settings. Indeed, presently, no study has addressed  the  role  of  germline  CDR  regions  in  relation  to  MHC  recognition  and restriction  in  a  broad,  direct  and  unbiased  manner,  with  most  functional  studies addressing a specific residue or defined interaction. The work presented in thesis aims to address this key unanswered question in understanding the molecular nature of MHC restriction through remodelling of germline CDR loops in the context of physiological T cell development.  Specific questions addressed are: 1. Is there evidence in germline repertoires of TCR molecules that indicates cryptic codes associated with MHC restriction? 2. If given the opportunity, will TCRs select functional non‐germline CDR1 and 2 in place of canonical structures? 3. Will replacement of all germline CDR positions,  including those  implemented in germline recognition of MHC, on the TCRα or TCRβ chains inhibit development of thymically derived T cell lineages? 4. Can TCRs lacking germline CDRs still mediate immune pMHC‐mediated immune responses? 5. Can gross alteration of germline CDR composition alter their ability to distinguish self from non‐self MHC? 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Chapter 2: Germline TCR CDR analysis and overview of experimental approach 
2.1 Comparison of TCR and Ig germline CDR1 and 2 repertoires 
2.1.1 Overview 
The number of TCR V-segments that are encoded within a mammalian and other vertebrate 
genomes, coupled to their polymorphic and polygenic ligand MHC molecules (Table 1.2 and 
1.4) means the relatively rich database of co-crystal structures that exist still only represent a 
minutiae of potential TCR-pMHC interactions. An in-depth structural review in support of a 
germline code of TCR-pMHC recognition (Marrack et al, 2008) attempted to reconcile this 
disparity by highlighting two studies (Tanaka et al, 1989; Jaeger et al, 1994) that taken 
together, were proposed to demonstrate that the CDRs of TCRs, in comparison to that of Igs, 
are more conserved in length and sequence, suggesting an evolutionary pressure favouring a 
“narrowing” of the germline TCR repertoire – namely restriction to MHC.  
The first highlighted study measured the relative rate of synonymous versus non-synonymous 
nucleotide mutations in the framework regions and CDRs of Ig molecules in mice and 
humans (Tanaka et al, 1989). The second study applied the same analysis, this time 
comparing the framework regions and CDRs of TCR molecules between primates and 
humans (Jaeger et al, 1994).  The former indicated that in both mice and humans, non-
synonymous mutations were more prevalent in the Ig CDRs – i.e. evolution is selecting for 
diversity, a beneficial trait for Ig mediated Ag recognition. The latter study demonstrated that 
between primates and humans, synonymous mutations were favoured in TCR CDR regions, 
indicating a preference for maintaining CDR sequence through evolution. However a study 
published this year (Matsutani et al, 2011) demonstrated that the ratio of synonymous versus 
non-synonymous mutations in the TCR CDR of different primate species and humans are not 
universal and differ between related species and their TCRα and β chains. Also, a review of 
TCR sequences in all ectothermic species proposed a broad and evolutionary maintained TCR 
diversity (Charlemagne et al, 1998).  
A thorough statistical comparison (Stewart et al, 1997) of 646 TCRα and 783 TCRβ V-
segments with 2,674 Igκ V-segment sequences submitted to the now defunct Kabat database 
(Johnson and Wu, 2000) indicated that TCR CDR1 and 2 were in fact more diverse than their 
Ig counterparts. However the same authors upon comparison of nucleotide differences of the 
TCRα and TCRβ chain inferred conservation within each chain based on the rate of 
synonymous/non-synonymous nucleotide changes, suggesting it may be linked to MHC 
restriction (Johnson and Wu, 1997). An overall analysis of deposited sequences by Jores et al 
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(Jores et al, 1990) showed when comparing total sequence diversity (framework and CDRs), 
that TCRαβ generally demonstrated less than 50% amino acid identity, whereas IgH, Igκ and 
Igλ retained on average >50% amino acid sequence identity. 
Recent functional studies have also sought to link TCR evolution with MHC restriction 
(Scott-Browne et al, 2011). The murine Vβ8.2 residues Y46, Y48 and E54 have been 
proposed to form an interaction codon (Feng et al, 2007; Dai et al, 2008, Marrack et al, 2008; 
Garcia et al, 2009; Scott-Browne et al, 2009) as discussed in detail in Chapter 1.5.1, Scott-
Browne et al demonstrated that this motif has been subsequently found to be relatively 
conserved across several vertebrate genomes. When these conserved sequences were grafted 
in place of the corresponding Vβ8.2 sequence in the DO-11.10 TCRβ chain, the resulting 
TCRs maintained specific recognition of IAd-OVA pMHC complex, whereas point mutations 
of the motif residues negated this recognition.  
Overall, the links between sequence conservation, genomic TCR diversity and the functional 
roles of the CDRs is ambiguous. Since the sequencing of the mouse and human TCR and Ig 
loci and the deposition of a full array of germline TCR and Ig CDR sequences to the IMGT 
database (Lefranc et al, 2003), a full analysis of the overall germline diversity for both TCR 
and Ig from mice and humans is now feasible and was conducted to see if any differences in 
diversity were apparent at the genome level.  
2.1.2 Comparison of CDR1 and 2 lengths in TCR and Ig molecules 
As mentioned above, it was proposed that the TCR CDRs are more conserved in length as 
well as sequence diversity and this was thus examined using all deposited sequences in the 
IMGT database. Further, analysis of the diversity of a single (most common) length CDR, 
would allow a more direct position-by-position comparison of the germline repertoire (see 
Section 2.1.3). 
As shown in Figure 2.1, the length of both murine and human CDR1 and 2 between the 
comparable Ig heavy chain (IgH) and TCRα chain and similarly comparable Ig light chains 
(Igκ and Igλ) and TCRβ chain is not conserved.  For CDR1, in both mice and humans, the 
TCRα chain has a range of 5-8 amino acids, whereas for IgH the range differs but overall the 
length is in fact more conserved, between 8-10 amino acids. This effect is further emphasised 
in CDR2, where in mice the TCRα ranges from 4-7 amino acids in length and 7-10 for IgH 
(with no recorded lengths of 9 amino acids). Similarly in human CDR2, the TCRα chains 
have a relatively even distribution of length, from 3-7 amino acids, whereas germline 
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sequences of IgH can potentially encode CDR2 lengths ranging from 6-11 amino acids. 
However this latter range has an unequal distribution.  
Evaluation of the TCRβ CDR1 and 2 versus the corresponding Igκ and Igλ regions was more 
ambiguous. For CDR1 in mice and humans, TCRβ length was restricted to 5 or 6 amino 
acids, whereas Igκ had a remarkable range of between 5-12 (mouse) or 6-12 (human) amino 
acids. Igλ however was more restricted with CDR1 lengths of 7-9 (mouse) and 6-9 (human) 
amino acids – again more variable than the TCRβ CDR1. Analysis of the CDR2 for these 
chains demonstrated a remarkably restrained CDR2 length for the Igκ and λ chains, with 
between 74.6 and 100% of all sequences analysed for mice and humans encoding for a length 
of 3 amino acids. The TCRβ CDR2 sequences were more similar to the CDR1, showing a 
small range of 6-7 (mouse) and 5-7 (human). 
Overall, the analysis from this work of all available CDR1 and 2 sequences from two 
divergent mammalian species yielded no clear data to support the concept of germline CDR 
length being more conserved in TCRs relative to Igs as has been inferred (Marrack et al, 
2008), especially in relation to TCRα and IgH CDR1 and 2. An interesting aside from these 
data is the remarkable overall conservation of length of all TCR and Ig CDR1 and 2 between 
mice and humans (compare charts vertically opposing each other in Figure 2.1). All dominant 
CDR lengths are conserved between mice and humans, with the exception of the Igλ CDR1 
where 8 amino acids long is dominant in the murine genome compared to 9 amino acids in 
humans. This suggests that for TCR and Ig mediated responses, CDR length is an important 
feature, albeit in different ways due to the largely non-overlapping ranges of germline CDR 
length. This agrees with previous work showing that Ig (and TCRγδ) CDR3 are generally 
longer than their αβTCR counterparts, most likely due to the restrictions associated with 
recognising peptide in context with MHC (Rock et al, 1994). 
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Figure 2. 1: Analysis of TCR and Ig germline CDR1 and 2 from mice and humans. 
Peptide sequences from the IMGT database (Lefranc et al, 2003) corresponding to TCR and Ig germline CDR1 
and 2 regions were analysed and varying length in amino acids presented as a percentage of the total sequences 
analysed for the CDR. Analyses were carried out on sequences from mice and humans. 
 
2.1.3 Analysis of germline CDR1 and 2 diversity in TCR and Ig molecules 
While analysis of CDR length provides some insight into conservation of CDR structure, 
detailed analysis of germline sequences from sequenced genomes could reveal any potential 
relationship between sequence diversity and positional conservation to functional 
requirement. The most common length for each of the CDRs analysed in Figure 2.1 (between 
45 and 100% of the total sequences for each CDR) were studied for chemical diversity at each 
CDR residue position, comparing corresponding Ig and TCR chains from mice and human 
genome sequences (Figure 2.2).  
A global overview of these data shows a general bias within all TCR and Ig germline CDR1 
towards hydrophobic and polar amino acid usage. In CDR2 however there is a greater 
prevalence of charged amino acid use across both TCR and Ig chains. As with CDR length, 
an interesting aside is the high level of conservation in the overall pattern of amino acid usage 
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between the corresponding CDR sequences in mice and humans (vertical comparison of 
charts in Figure 2.2).  It should be noted however that the lack of diversity in position 1 (P1) 
of the IgH CDRs (with 90-100% of P1 using the same amino acid) is most likely related to 
the important roles in CDR1 structure as demonstrated by the conservation across diverse 
species (Hsu, 1996).  
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Figure 2. 2: Amino acid use within germline CDRs of mouse and human TCR and Ig variable gene segments.  
The percentage use of each amino acid at each position is represented by colour intensity. Amino acids are 
grouped according to their chemical properties as indicated on the Y-axis. Numbers in brackets correspond to the 
number of V segments that encode CDRs of that length out of the total number present in the genome. 
 
A crude comparison of overall CDR diversity of the data presented in Figure 2.2 was to 
compare the average number of amino acids (out of 20) used per CDR position (Figure 2.3). 
Analysis of this comparison clearly demonstrates that TCR CDR1 and 2 germline diversity is 
comparable or greater than their Ig counterparts. A second more sensitive measurement 
utilised the Shannon entropy index (Shannon, 1948) in conjunction with the “Protein 
Variability Server” (Garcia-Boronat et al, 2008). Using multiple protein alignments a 
diversity value (H) is calculated for each CDR position based on the following equation: 
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Where Pi is the fraction of amino acid type i and M is the number of amino acid types (out of 
20). Using these parameters H has a minimum value of 0, where only one residue is present at 
that given position and a maximum of 4.322, where all 20 residues are equally represented at 
that given position). Generally, values ≤ 1 are considered highly conserved, ≤ 2 conserved 
and ≥ 2 variable (Litwin and Jores, 1992). Values generated for all CDR positions are 
presented in Table 2.1 and the average value per position for each CDR is shown in Figure 
2.4. 
 
Figure 2. 3: Summary of average number of amino acids used per CDR position in TCR and Ig molecules. 
The average number of amino acids (out of 20 possible) for each CDR position was calculated from Figure 2.2, 
based on the most common length CDRs found for each molecule. 
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Genome CDR Molecule Position H Value Av. H/CDR position
Mouse CDR1 TCR 1 2.294
2 2.413
3 2.641
4 2.426
5 2.866
6 1.946 2.43
IgH 1 0.241
2 1.047
3 1.453
4 0.875
5 1.479
6 2.331
7 0.979
8 3.079 1.44
TCR 1 2.407
2 1.708
3 0.267
4 2.829
5 2.733 1.99
1 1.474
2 2.336
3 1.006
4 2.689
5 2.797
6 2.539 2.14
Ig 1 0
2 0
3 0.722
4 0
5 0
6 0.722
7 1.522
8 0.722 0.46
CDR2 TCR 1 1.943
2 2.688
3 1.993
4 2.354
5 2.618
6 2.409 2.33
IgH 1 0.618
2 2.632
3 1.935
4 2.792
5 2.526
6 1.249
7 3.174
8 1.128 2.01
TCR 1 2.021
2 2.328
3 2.731
4 2.664
5 3.243
6 3.011 2.67
Ig 1 3.518
2 1.953
3 0.96 2.14
Ig 1 1.842
2 0.863
Table 2.1: Calculated diversity of most common length CDR in Ig and TCR chains from mice and humans
Ig
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Table 2. 1: Calculated diversity of most common length CDR in Ig and TCR chains in mice and humans 
 
 
3 1.379 1.36
Human CDR1 TCR 1 2.784
2 1.475
3 2.902
4 2.767
5 3.122
6 2.439 2.58
IgH 1 0
2 1.172
3 0.663
4 0.851
5 1.362
6 1.847
7 1.523
8 2.672 1.26
TCR 1 2.052
2 1.645
3 0.274
4 3.212
5 2.868 2.01
Ig 1 0.371
2 1.255
3 0.491
4 1.062
5 1.068
6 2.135 1.06
Ig 1 0.523
2 1.402
3 2.469
4 1.703
5 1.875
6 1.821
7 2.095
8 1.993
9 2.587 1.83
CDR2 TCR 1 1.962
2 2.954
3 2.025
4 2.295
5 2.461
6 2.868 2.43
IgH 1 1.082
2 2.329
3 2.788
4 2.646
5 1.983
6 1.161
7 2.584
8 1.681 2.03
TCR 1 1.68
2 2.878
3 3.129
4 2.669
5 3.127
6 3.504 2.83
Ig 1 3.024
2 1.138
3 0.301 1.49
Ig 1 2.918
2 2.304
3 1.091 2.10
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As with Figure 2.3, the more sensitive analysis presented in Figure 2.4 clearly demonstrates 
both Ig and TCR CDR1 and 2 maintain similar overall diversity and some instances TCR 
encode germline loops of greater diversity, for e.g. between TCRα and IgH CDR1.  
 
 
Figure 2. 4: Summary of average amino acid diversity per CDR position in TCR and Ig molecules.  
Diversity (H) values were calculated using Shannon entropy analysis for each CDR position based on data from 
Figure 2.2. Average H values were generated based on scores generated for each CDR position (Table 2.1) and 
are plotted above for mouse and human genome CDR1 and 2 sequences. Error bars = S.E.M 
 
Overall, this data implies that, contrary to previous deductions, the level of diversity of the 
germline TCR CDR1 and 2 is not lower than that of evolutionary related Ig molecules. While 
this is not surprising for the TCRβ versus Ig light chains (the IgH chains have been shown to 
contain the majority of Ig diversity; Jores et al, 1990), it is also true when comparing TCRα 
with IgH. This is true of divergent murine and human genomes and regardless of previously 
calculated rates of mutation in CDR regions, which have also been shown to differ starkly in 
the TCR of closely related species (Matsutani et al, 2011). Indeed, this phenomenon may not 
relate to TCR restriction to MHC and is perhaps linked to more discrete pressures.  
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2.1.4 Conservation of CDR position is not directly related to MHC recognition 
In spite of these results, a relevant hypothesis would still be to assume that if evolutionary 
pressures have been exerted by MHC restriction on the TCR, then the most globally 
conserved TCR CDR residues within the genome would be predicted to be important in MHC 
interaction. Indeed this assumption could account for the proposed narrowing of the germline 
TCR repertoire based on mutation rate. From the current analysis, this appears to be not the 
case, exemplified by the only globally conserved residue from the murine and human TCRβ 
chain, the P3 histidine from the 5 amino acid long CDR1 (Figure 2.2). This histidine is the 
only residue used in all 5 amino acid long TCRβ CDR1 regions, with this length constituting 
nearly 100% of total TCRβ CDR1 sequences (Figure 2.1). The TCR structures presented by 
Marrack et al (2008) were all proposed to contain elements of a germline encoded interaction 
codon (Garcia et al, 2009) that drives recognition of specific MHC alleles. Despite being 
present in all but two of the TCRs from these 22 structures, the P3 histidine from Figure 2.2 
(position 27 in Marrack et al, position 29 based on IMGT numbering) only contacts the 
pMHC once, in the 2C TCR co-crystallised with H2Kb presenting the dEV8 peptide (Garcia 
et al, 1996).  
From the analysis carried out here, the TCRα CDRs contain fewer highly conserved residues 
than TCRβ. One of the more relatively conserved residues is the P3 serine, which was found 
in 43.2% and 52.2% of 6 amino acid long TCRα CDR2 loops in mice and humans 
respectively (Figure 2.2). Further, this length of TCRα CDR2 only corresponds to 
approximately half of all TCRα CDR2 regions. However this serine is also found in TCRα of 
different lengths (Lefranc et al, 2003) but unlike the more highly conserved TCRβ CDR1 P3 
histidine, this relatively less conserved TCRα residue has been implicated as an interaction 
codon constituent by Marrack et al (2008; Position 51 in Marrack et al, IMGT 58). Out of the 
22 structures proposed to contain this “version” of an interaction codon, 15 contained a serine 
at this position, of which 12 made pMHC contacts (just over half of all the structures 
presented). These examples seem to suggest that there is no direct link between genomic 
conservation of CDR positions and MHC recognition and add further weight to the 
requirement to carry out in depth functional analysis of TCR CDRs. 
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2.2 Design and overview of retrogenic approach used to study TCR CDR1 and 2 
2.2.1 Overview 
The initial molecular theory surrounding CDR mediated MHC recognition arose from 
functional studies analysing mice expressing a single peptide on a class II MHC molecule 
(Ignatowicz et al, 1996; Zerrahn et al, 1997 and Huseby et al, 2005), while subsequent details 
and theories have been generated through mainly structural studies (Dai et al, 2008; Marrack 
et al, 2008 and Feng et al, 2007). Only a few studies have formally contributed to the 
question of the TCR CDR role in MHC recognition (Scott-Browne et al, 2009; Scott-Browne 
et al, 2011 and Burrows et al, 2010). These studies focussed on single amino changes using 
systems with defined TCR-pMHC interactions (see Section 1.5.1). The aim of this thesis was 
to approach the question of the functional role of the TCR CDR requirement in MHC 
recognition using broader and unbiased systems as the diversity of the TCR and MHC makes 
single residue changes an underpowered approach. Due to the number of modified TCR 
constructs used in this study, a retrogenic approach was chosen for in vivo expression of the 
proteins of interest as this allows relatively quick, if temporary, generation of a broad array of 
mice. 
2.2.2 Overview of retrogenic system 
The basic premise of the retrogenic approach used in this study was to generate mice 
expressing a single, fixed retrogenic TCRα or TCRβ chain which had the capacity to 
contribute to T cell development and pair with an endogenous repertoire of corresponding 
partner chains. For example, analysis of a modified fixed TCRβ chain would require a TCRβ 
deficient background but a fully functional endogenous TCRα locus, thus generating a TCR 
repertoire with a clonal TCRβ chain paired to a WT endogenous TCRα repertoire. The 
opposite would thus be required when studying retrogenic TCRα chains. The concept of 
fixing a single TCR chain to pair with an endogenous partner repertoire has been shown to 
work successfully in both retrogenic (Scott-Browne et al, 2009) and transgenic (Bounead et 
al, 2000; He et al, 2002 and Ferreira et al, 2006) murine systems. FVB/N (H2q) TCRβδ-/- 
(Mombaerts et al, 2002) and CBA (H2k) TCRα-/- (Philpott et al, 1992) mice were used for the 
relevant TCR deficient backgrounds.  
This retrogenic approach was used in experiments based on conventional mutagenesis of the 
TCR CDR regions and in a novel approach designed in this study that generates random 
mutations in vivo in targeted regions of the TCR through the inclusion of “recombination 
cassettes”. For this study, the TCRβ CDRs were mutated but the approach can be used to 
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mutate any target protein. The exact details of the constructs and systems will be discussed in 
subsequent relevant results chapters, however a brief summary of all constructs used 
throughout is listed in Table 2.2, to allow further understanding of the retrogenic approach. 
Modified TCR chains of interest were cloned into the 6231bp pMigR1 retroviral vector (Pear 
et al, 1998; Figure 2.5). This vector contains an internal ribosomal entry site (IRES) in 
between the cloning site and the green fluorescent protein (GFP) gene ensuring GFP 
expression as a marker of expression of the cloned gene of interest. The 5’ and 3’ long 
terminal repeats (LTR) contain the viral promoter that initiates transcription upstream of the 
cloning site. The LTRs also facilitate random genome integration upon transduction (see 
below). 
 
 
Table 2. 2: Brief overview of TCR genes clones into pMigR1 vector 
 
 
 
 
 
noitpircseDRCT
WT C6  TCR gene with wild type CDR1 and 2
CDR1 C6  TCR gene with modified CDR1
CDR2 C6  TCR gene with modified CDR2
CDR1 2 C6  TCR gene with modified CDR1 and 2
CDR3 C6  TCR gene with WT CDR1 and 2 and modified CDR3
CDR1 2 3 C6  TCR gene with modified CDR1, 2 and 3
CDR1 2 3
C6
CDR3
 TCR gene with TCR V1 CDR1 and 2
CDR1WT-Rec
C6
CDR3
 TCR gene with a recombination cassette in CDR1
CDR2WT-Rec
C6
CDR3
 TCR gene with a recombination cassette in CDR2
CDR1 -Rec
C6
CDR1 2 3
 TCR gene with a recombination cassette in CDR1
Table 2.2: Brief overview of TCR genes cloned into pMigR1 vector
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Figure 2. 5: Schematic of pMigR1 retroviral vector used for cloning of WT and modified TCRα and β chains.  
Ori = Origin of replication, 5’ LTR = 5’ Long terminal repeat, IRES = Internal ribosome entry site, GFP = Green 
fluorescent protein, 3’ LTR = 3’ Long terminal repeat and AMP = Ampicillin antibiotic resistance gene. Figure 
adapted from Pear et al, 1998 and http://www.addgene.org/27490/ (accessed: 05/10/2011). 
 
The retrogenic process is outlined in Figure 2.6 and discussed in detail in Chapter 6. In 
general, the gene of interest is cloned into the pMigR1 vector as described. Constructs were 
sequenced and prepared in sufficient quantities. Constructs were transfected into the Phoenix 
Eco packaging cell line to produce construct-containing virions that were then used to infect, 
via transduction, cultured haematopoietic stem cells (HSC) from the bone marrow (BM) of 
donor mice lacking the relevant TCR loci. Transfection and transduction efficiency were 
followed using the construct encoded GFP expression. Between 1x105 – 1.0x106 GFP+ HSC 
were adoptively transferred to irradiated 4-week-old recipient mice, also deficient in the TCR 
loci of interest. In the recipient mice, HSC expressing the TCR gene of interest enter the 
thymus and undergo normal T cell development in vivo, using the retrogenic TCR chain, 
pairing with the reciprocal endogenous chain’s repertoire. HSCs that have not received the 
vector cannot give rise to T cells and all T cells that develop will therefore be using the 
retrogenic TCR gene of interest. 
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Figure 2. 6: Overview of the retrogenic system used to analysis TCR CDR function in vivo. 
The retrogenic process is divided into three stages: Transfection, transduction and adoptive transfer. Constructs 
containing a gene of interest are transfected into plated packaging phoenix-ecotropic cells. Viral supernatant is 
harvested after 48 hours with transfection efficiency measured via flow cytometry. For transduction, donor mice 
are injected with 5-fluorouracil 72 hours before bone marrow harvest. Bone marrow cells are cultured in the 
presence of cytokines to generate HSC cells, which are then infected via transduction with viral supernatant 
containing the gene of interest. Transduced cells are cultured for a further 72 hours before being adoptively 
transferred into irradiated recipient mice, also deficient in the relevant TCR loci. 
 
Although an indirect measurement, transfection efficiency of constructs into the packaging 
cell line was a reliable indicator for subsequent viral supernatant titres. Transfection 
efficiency of the constructs listed on Table 2.2 was variable, but generally transfections above 
30% yielded viral supernatant with a suitable titre for acceptable HSC transduction (Figure 
2.7).  
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Figure 2. 7: Summary of transfection efficiency into a packaging cell line of TCRα or β chain genes cloned into 
the pMigR1 retroviral vector. 
Transfection efficiency of constructs listed in Table 2.1 as determined by percentage of GFP+ phoenix ecotropic 
cells, 48 hours post-transfection as measured by flow cytometry. A no DNA negative control and the pMigR1 
vector on its own as a positive control are included in the first two lanes. Lines represent the mean and error bars 
the standard error of the mean (S.E.M). 
 
2.2.3 Generation of modified TCRα and β chains 
As a single residue modification approach was deemed insufficient to allow an in-depth 
analysis of TCR CDR1 and 2, conventional mutagenesis was used to generate 7 constructs 
that contained severe multi-residue changes to the CDRs of the C6TCRα and β chains (see 
the top 7 constructs listed in Table 2.2). An overlap PCR method was used to generate all 
constructs modified from the original WT sequences and is summarised in Figure 2.8 and 
discussed in more detail for each construct in later chapters. To modify a series of residues in 
a CDR loop, 4 primers are designed. Two are external primers that anneal to the 5’ and 3’ 
ends of the gene of interest. These are tagged with restriction sites (EcoRI and BglII) that 
facilitate subsequent cloning into the pMigR1 vector. The second set of primers anneal on 
complementary strands upstream and downstream of the target site in the gene respectively. 
The internal primers are tagged with complementary sequences that encode for the desired 
modification to the gene. Two separate reactions (R1 and R2) are set up using an external 
primer with its complementary internal primer, generating two products that encode upstream 
or downstream of the site of interest and overlap with each other via the desired inserted 
sequence. A subsequent extension and amplification step (R3) using only the external primers 
generates a final product complete with the inserted sequence, which can then be cloned to the 
pMigR1 vector. These constructs can subsequently be used as templates for making multiple 
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changes to different CDRs in the same gene. This process was extremely effective – for 
example, allowing a creation of a 10 amino acid long CDR1 from a 6 amino acid long 
template in the βCDR1γ2γ3Δ construct (see Chapter 4.4).  
 
Figure 2. 8: Schematic overview of overlap PCR used to modify TCR CDR regions. 
The three CDRs of TCR chain are depicted by red rectangles within the TCR gene (blue rectangle). The yellow 
rectangles represent the desired sequence to be inserted in place of the WT CDR. Horizontal arrows show 
forward (above) and reverse (below) primers. The DNA sequences shown tagged to terminal primers contain the 
restriction sites for BglII (left) and EcoR1 (right). The text on the right hand side describes an overview of the 
process. 
 
The second approach utilising the retrogenic system to study the role of TCR CDRs was a 
novel system using newly termed “recombination cassettes”. Similar approaches have been 
used in the past, to create transgenic “mini TCR loci” in mice. Here, cassettes containing 
several J-segments flanked by their endogenous RSS were linked to an otherwise defined 
TCR framework, allowing a TCR repertoire to be formed in the CDR3 region in an otherwise 
fixed TCRα chain (Correia-Nevis et al, 2001 and Kouskoff et al, 1995). 
This concept was modified in this study and used in three constructs to look at the functional 
role of CDR1 and 2 (bottom three of Table 2.1 and described in detail in Chapter 3). The 
premise of this approach was to redirect V(D)J recombination from where it normally occurs 
to generate a hypervariable CDR3 to the normally fixed, germline CDR1 or CDR2 region of 
an exogenous retrogenic TCRβ chain (Figure 2.9). This was achieved by taking versions of 
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the C6 TCRβ chain and inserting two RSS sequences, separated by a 500bp linker region into 
the preferred CDR region. The RSS from murine Vβ8.1 (7/23/9) and Dβ1 (9/12/27) were 
used as they have been shown to mediate highly efficient recombination with each other 
(Wilson et al, 2001). The 500bp endogenous Dβ1 upstream sequence was taken as the linker 
between the two RSS (Appendix 1). Constructs were generated using custom gene synthesis. 
Using the cloning and retrogenic system described in Section 2.2.2, adoptive transfer of 
TCRβδ-/- HSC transduced with such a construct, would, in theory, result in the endogenous 
recombination machinery recognising the exogenous RSS and recombining the germline 
CDR1 or 2. The enzyme TdT, through the same actions that normally produce hypervariable 
CDR3 regions, would thus generate a non-germline repertoire of mutants. Due to the distinct 
expression patterns of the components of the recombination machinery, recombination of the 
exogenous TCRβ chain would take place at the same time as the endogenous TCRβ locus 
would normally rearrange, thus not interfering with the process of T cell development. Any 
TCRβ mutants generated by redirected V(D)J recombination will be subject to the normal T-
cell developmental checkpoints– namely being able to pair and signal with the pTα chain to 
ensure in-frame rearrangement, and being subject to audition for positive selection on self-
pMHC to determine MHC recognition capacity. Thus this novel system can potentially 
generate, regulate and select a functional library of non-germline TCRβ CDR1 or 2 mutants 
entirely in vivo. 
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Figure 2. 9: Schematic overview of novel recombination cassette TCR CDR modification system. 
An exogenous TCRβ chain cloned into the retroviral vector is modified by insertion of a recombination cassette 
(demonstrated in this instance in the CDR2). Relative TCR components are as indicated (Top, in vitro). Upon 
adoptive transfer of HSC transduced with this construct, endogenous recombination enzymes such as Rag1/2 
will remove the recombination cassette with random nucleotides inserted and deleted by endogenous TdT, 
generating a library of non-germline βCDR2 regions (depicted by the blue rectangle). TCR with successfully 
rearranged TCRβ chains will subsequently be able to mediate T cell development and thymic selection. 
 
Overall, these conventional overlap PCR and novel recombination cassette approaches 
provide powerful tools with which to greatly modify and assess the roles of germline TCR 
CDR regions in vivo. 
 
2.2.4 General comments on using a retrogenic approach 
The retrogenic approach applied for in vivo analysis of TCR CDRs provides several benefits 
in comparison with the conventional transgenic approach. First, the retrogenic method is 
inevitably quicker than generation of transgenic mouse strains. Typically, design, production 
and analysis of retrogenic mice expressing a new TCR mutant can be achieved within 4-5 
months. While stocks of retrogenic mice cannot be bred, requiring new mice to be produced 
for further experiments, it opens the possibility to test and modify a greater number of 
constructs to optimise and broaden the study if an initial cohort of mice proves to be sub-
optimal.  However this approach does have some technical and experimental limitations. 
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Generating each recipient mouse requires between 2-3 BM donors, making the set-up process 
relatively inefficient. For example to generate a recipient cohort of just 6 mice (3 control mice 
and 3 sample mice) requires BM extraction from up to 18 donor mice. Reconstitution of the T 
cell compartment of retrogenic mice typically takes between 4-8 weeks. If anything in the 
experimental process and subsequent analysis fails, one has to start from the beginning to 
replicate the experiment taking a further 8-12 weeks. By contrast, once established, transgenic 
strains provide a constant source of material. 
Other technical limitations could also impact biological interpretations. Variable transfection 
rates and thus viral supernatant production ultimately leads to further variations in 
transduction efficiency of cultured HSCs from BM. Random genome integration may also 
result in detrimental effects on retrogenic mouse development. Further, the number of BM 
cells initially harvested from donors was wide-ranging ultimately varying the number of GFP+ 
HSCs available for adoptive transfer to irradiated recipients (Figure 2.10). This variation can 
result in differences in the time taken for reconstitution of the T cell compartment and on 
occasion, also limited the number of cells that could be harvested for flow cytometric 
analysis, cell purification and in vitro assays. The variables can also affect thymic 
reconstitution as has been reported elsewhere (Scott-Browne et al, 2009). 
 
 
 
 
 
 
  104 
 
Figure 2. 10: The inherent variation in the retrogenic system results in adoptive transfer of varying numbers of 
GFP+ HSC.  
The plots represent the summary of GFP measurement on HSC using flow cytometry for all constructs used for 
in vivo work in this study. Data is presented both in terms of the total number of GFP+ HSC given per recipient 
per experiment (A) and the transduction efficiency of cultured HSC as measured by percentage GFP (B). For 
part A, each dot represents an experiment that may have contained several mice receiving the same number of 
HSC transduced with the same construct. The line equals the mean and error bars the S.E.M. 
 
2.3 Chapter Summary 
The concept of germline-encoded recognition of pMHC complexes by TCR has been 
supported predominantly by structural observations. But analysis of the relative rates of 
mutation over evolutionary time of TCR versus Ig CDR regions (Tanaka et al, 1989; Jaeger et 
al, 1994) has been proposed to support the notion that TCR CDR are subject to a narrowing 
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or conservation of CDR diversity as a result of pressures being induced by MHC restriction 
(Marrack et al, 2008). 
The data presented in this section, demonstrates that genomic sequence diversity of V 
segment encoded TCR CDR loops is comparable to that of the MHC “unrestricted” Igs, both 
in terms of length and amino acid composition. This argues against the interpretation that the 
lower rate of non-synonymous mutation in TCR CDR1 and 2 relative to Ig proves MHC 
restriction induced narrowing of the TCR germline repertoire. These data are further 
supported by the observation that there is no apparent direct correlation between amino acid 
conservation in the TCR CDR and importance in MHC interaction (Section 2.1.4).  
One would expect that if such evolutionary pressures exist then they would exert clearer 
influence in murine and human genomes, based on the time since evolution of the TCR-
pMHC relationship and the period of divergence of all jawed vertebrates that utilise this 
mechanism. Recent work demonstrates conservation of TCRβ CDR2 motifs between 
evolutionary distinct vertebrates that retain the ability to specifically recognise a defined 
pMHC complex (Scott-Browne et al, 2011). However, this may be more simply explained on 
the basis that similar motifs would be expected to retain reactivity to a defined pMHC 
complex for which specific residues have been deemed responsible for recognition. Indeed, it 
may merely emphasise the potential limitations of functional data comparing closely related 
structures that supports germline encoded MHC recognition (Chapter 1.5.1). 
Thus the data presented here, coupled to the limited functional data hitherto published 
provides the impetus for the deeper analysis of variable TCR CDR loops (Kranz, 2009). The 
work that forms this thesis aims to utilise conventional and novel approaches to modify and 
analyse these germline regions in an unbiased and broad-ranging approach in the context of a 
retrogenic approach. Despite some limitations associated with this system, the work reported 
in subsequent chapters makes an original contribution to our understanding of MHC 
restriction.  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Chapter 3: Design and use of a novel in vivo mediated recombination system to mutate 
TCR CDR1 and 2 
3.1 Redirection of V(D)J recombination to WT TCRβ  CDR1 and 2 generates functional 
TCRs in vivo that can mediate MHC recognition 
3.1.1 Overview of constructs 
As discussed in Chapter 2.2.2 the redirection of V(D)J recombination to a germline TCR 
CDR using the retrogenic system should facilitate generation of  libraries of mutants in vivo 
that are subject to normal T cell development. The Vβ11 containing C6 TCRβ chain was used 
as a template (See Chapter 6.7.4). While the C6 TCRβ chain pairs efficiently with its cognate 
TCRα partner, the abnormally long CDR3 interferes with pairing to other α chains from an 
endogenous repertoire (Bartok et al, 2010). To avoid this problem, the template chain used a 
shortened CDR3 made of a triple glycine linker (βCDR3Δ: see Table 2.2 and Figure 4.1). 
Sequences were designed to contain recombination cassettes inserted either into the centre of 
the WT CDR1 or CDR2 of the βCDR3Δ chain and subsequently synthesised and cloned into 
pMigR1 (βCDR1WT-Rec and βCDR2WT-Rec; See Appendix 2).  The point of recombination would 
thus occur at the centre of the CDR loop apex in each construct, (Figure 3.1).  
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Figure 3. 1: Insertion of recombination cassettes into the WT CDR1 and 2 of βCDR3Δ.  
Schematics showing the general positioning of cassettes relative to the rest of the TCRβ chain (left) and where 
the point of recombination occurs within the WT CDR sequences (right) for the βCDR1WT-Rec (A) and βCDR2WT-Rec 
(B). The arrows in the right hand side schematics indicate the point of recombination. Thus one would predict 
alteration of these structures to radiate from the centre of the loop apex. 
 
3.1.2 Adoptive transfer of transduced HSC and detection of T cell selection 
TCRβδ-/- HSC successfully transduced with βCDR1WT-Rec or βCDR2WT-Rec were adoptively 
transferred to irradiated TCRβδ-/- recipient mice (Figure 3.2A and Figure 2.9). GFP+ T cells 
were detected in the blood of recipient mice after 8 weeks and at sizeable levels around 10-12 
weeks post-HSC transfer (Figure 3.2B). As T cell selection in these mice is dependent on the 
use of a functional exogenous TCRβ chain, these data imply that successful rearrangement of 
the recombination cassettes has generated in-frame chains that can pair with the endogenous 
TCRα chain repertoire and undergo MHC mediated T cell selection. Flow cytometric analysis 
of whole spleen from these mice revealed substantial GFP+Vβ11+ T cell populations. As with 
the blood 10 weeks post-transfer, there was however a clear skewing to the CD4 T cell 
compartment in mice using both constructs (Figure 3.3).  
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Figure 3. 2: Generation of GFP+ T cells from βCDR1WT-Rec and βCDR2WT-Rec mice.  
 (A) Representative flow cytometric plots of HSC from TCRβδ-/- mice transduced with βCDR1WT-Rec or βCDR2WT-Rec 
constructs cloned into pMigR1.  (B) Flow cytometric analysis of blood from βCDR1WT-Rec and βCDR2WT-Rec mice 
taken at 5, 8 and 10 weeks post-transfer of HSC. Plots were gated on GFP+ lymphocytes and are representative 
of n = 3 mice. 
 
The unexpected MHC class II bias is further analysed in Chapter 4. Overall however, this 
preliminary data indirectly confirmed the functionality of the cassette system. Further analysis 
was required to determine whether the predicted non-germline repertoire of CDR1 and 2 
mutants had been generated and whether they were tolerant of change at the amino-acid level.  
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Figure 3. 3: Detection of splenic GFP+Vβ11+ T cells in TCRβδ-/- mice using βCDR1WT-Rec and βCDR2WT-Rec 
constructs.  
Flow cytometric analysis of whole spleen from mice 12 weeks post-HSC transfer. Left panel shows CD4 versus 
CD8 compartments, gated on GFP+ lymphocytes. Right panel shows staining for Vβ11 specific antibody on 
GFP+ CD4 T cells (solid line) relative to GFP+CD4-CD8- lymphocytes as a control (filled peak). 
 
3.2 Mature T cells generated from recombination cassettes inserted into WT TCRβ  CDR1 
and 2 have a diverse non-germline repertoire 
3.2.1 Sorting of peripheral T cells and detection of recombined TCRβ chains 
Modifications to the germline CDR1 or CDR2 were analysed through cell sorting of 
GFP+CD4+ lymphocytes from whole spleen and lymph node (LN; Figure 3.4A). cDNA was 
made from extracted RNA and subjected to PCR using primers specific for the TCRβ 
constant region and upstream of the Vβ11 CDR1, either side of the point of recombination. 
This would facilitate subsequent analysis of any regions of diversity generated between these 
conserved regions. Evidence that recombination had occurred was shown by the loss of the 
500bp linker on PCR products from cDNA relative to the genes with cassettes cloned into 
pMigR1 (Figure 3.4B). To analyse sequence diversity PCR products generated from cDNA 
were cloned into a bacterial vector and used to transform competent bacterial cells. Due to the 
clonal nature of the transformed bacteria, subsequent sequencing of colony PCR products 
facilitated analysis of any repertoire generated at the single sequence level. 
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Figure 3. 4: Analysis of cDNA from mice using βCDR1WT-Rec and βCDR2WT-Rec constructs confirms cassette 
recombination.  
(A) Representative flow cytometric plots from fluorescence activated cell sorting of GFP+CD4+ lymphocytes 
from whole spleen and LN. (B) PCR of βCDR1WT-Rec and βCDR2WT-Rec in unrecombined state in pMigR1 vector (V) 
and from cDNA of mature CD4 T cells (D) using primers specific for the β constant region and upstream of the 
Vβ11 CDR1, demonstrating loss of the 500bp linker. M = marker. Sizes as indicated in base pairs (bp).  
 
3.2.2 Analysis of in vivo generated non-germline CDR1 and 2 repertoires 
A total of 128 and 292 CDR sequences were analysed from βCDR1WT-Rec and βCDR2WT-Rec mice 
respectively, yielding 51 and 101 unique events (Table 3.1 and Table 3.2). Further, the 
original WT sequences were only remade in a small minority of sequences (highlighted 
sequences in Table 3.1 and Table 3.2). These data demonstrate clearly that both germline 
CDR1 and CDR2 of the TCRβ chain are dispensable for successful interaction with pMHC in 
the thymus with >150 unique non-germline TCRβ chains generated and selected in vivo in an 
entirely unbiased manner through redirected V(D)J recombination. 
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Table 3. 1: Full repertoire of sequences generated from βCDR1WT­Rec mice 
 
 
 
CDR1 Peptide  Length CDR1 Nucleotide (No. of Sequences)
SGHHV 5 TCAGGACACCACGTT (5)
SGHKV 5 TCAGGACATAAGGTT (2)
SGHNV 5 TCAGGACATAATGTT (2)
SGHRV 5 TCAGGACATAGAGTT (3)
TCAGGACATAGGGTT (6)
SGHSR 5 TCAGGACATAGTCGG  (1)
SGHSV 5 TCAGGACATAGTGTT (5)
SGHTV 5 TCAGGACATACCGTT (1)
SGLHV 5 TCAGGACTCCACGTT (1)
SGQAV 5 TCAGGACAAGCTGTT  (2)
TCAGGACAGGCTGTT (1)
SGQNV 5 TCAGGACAAAATGTT (2)
SGRHA 5 TCAGGACGCCATGCT (1)
SRRAV 5 TCACGTCGAGCTGTT (1)
CIIVAV 6 TGTATCATTGTGGCTGTT (1)
CNIVAV 6 TGTAACATTGTGGCTGTT (1)
SGHFAV 6 AGTGGACATTTTGCTGTT (1)
SGHHAV 6 TCAGGACACCACGCTGTT (3)
SGHNGV 6 TCAGGACATAACGGTGTT (2)
SGHNHV 6 TCAGGACATAACCATGTT (1)
SGHPAV 6 TCAGGACATCCCGCTGTT (1)
SGHRAV 6 TCAGGACATAGAGCTGTT (1)
TCAGGACATAGAGCTGTT (22)
TCAGGACATAGGGCTGTT (6)
SGHRDV 6 TCAGGACATAGAGATGTT (1)
TCAGGACATAGGGATGTT (1)
SGHRGV 6 TCAGGACATAGAGGTGTT (2)
SGHRSV 6 TCAGGACATAGAAGTGTT (2)
TCAGGACATAGATCTGTT (5)
TCAGGACATAGGTCTGTT (1)
SGHRTV 6 TCAGGACATAGAACTGTT (1)
SGHRWV 6 TCAGGACATAGATGGGTT (1)
SGHSAV 6 TCAGGACATAGCGCTGTT (2)
TCAGGACATTCCGCTGTT (1)
SGHSGV 6 TCAGGACATAGTGGGGTT (4)
SGHSHV 6 TCAGGACATTCCCATGTT (1)
SGHSKV 6 TCAGGACATAGTAAAGTT (1)
SGHSNV 6 TCAGGACATAGTAATGTT (1)
SGHSRV 6 TCAGGACATAGCCGGGTT (1)
TCAGGACATAGTAGGGTT (4)
TCAGGACATAGTCGCGTT (4)
SGHSSV 6 TCAGGACATAGTAGTGTT (1)
SGHSTV 6 TCAGGACATAGTACCGTT (4)
TCAGGACATAGTACTGTT (6)
SGHTAV 6 TCAGGACATACCGCTGTT (2)
SGLCVF 6 TCAGGACTTTGTGTTTTC (1)
SGQIRV 6 TCAGGACAAATCCGTGTT (2)
SGQNEV 6 TCAGGACAGAACGAGGTT (1)
SGQTSV 6 TCAGGACAAACCTCTGTT (2)
SGSPDV 6 TCAGGATCCCCTGACGTT (3)
Table 3.1: Full repertoire of sequences generated from !CDR1WT-Rec 
SGSRAV 6 TCAGGATCTCGCGCTGTT (1)
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CDR2 Peptide Length CDR2 Nucleotide (No. of Sequences)
TCCTGCCCT3PRS  (1)
WTP 3 TGGACTCCT (1)
AWAP 4 GCGTGGGCTCCT (4)
FPAP 4 TTTCCCGCTCCT (1)
FRAP 4 TTTCGTGCTCCT(1)
VLPP 4 GTACTTCCTCCT (1)
FRKAP 5 TTTCGGAAAGCTCCT (1)
LKQAP 5 TTAAAGCAAGCTCCT (9)
LSLAP 5 TTATCTCTAGCTCCT (2)
LSQAP 5 TTATCTCAAGCTCCT (1)
SRQAP 5 TCCCGTCAAGCTCCT (2)
FLTGAP 6 TTCCTGACCGGGGCTCCT (1)
FRAQAP 6 TTTCGTGCCCAAGCTCCT (6)
FRDQAP 6 TTTCGAGACCAAGCTCCT (3)
FRFQAP 6 TTTCGTTTTCAAGCTCCT (12)
TTTCGTTTTCAGGCTCCT (1)
FRGQAP 6 TTTCGGGGGCAAGCTCCT (1)
6 TTTCGTGGTCAAGCTCCT (1)
FRHQAP 6 TTTCGGCATCAAGCTCCT (3)
FRIQAP 6 TTTCGAATTCAAGCTCCT (1)
FRIRAP 6 TTTCGAATTCGAGCTCCT (1)
FRKGAP 6 TTTCGAAAGGGAGCTCCT (3)
TTTCGAAAGGGGGCTCCT (6)
FRKKAP 6 TTTCGAAAGAAAGCTCCT (8)
FRKQAP 6 TTTCGAAAACAAGCTCCT (3)
FRKRAP 6 TTTCGAAAGAGGGCTCCT (1)
TTTCGAAAGCGAGCTCCT (1)
FRKWGP 6 TTTCGAAAGTGGGGTCCT (1)
FRLQAP 6 TTTCGACTCCAAGCTCCT (4)
TTTCGACTTCAAGCTCCT (3)
TTTCGGCTGCAAGCTCCT (1)
FRMAAP 6 TTTCGAATGGCGGCTCCT (1)
FRMLAP 6 TTTCGAATGCTGGCTCCT (5)
FRMQAP 6 TTTCGAATGCAAGCTCCT (3)
FRNEAP 6 TTTCGAAATGAAGCTCCT (3)
TTTCGAAATGAGGCTCCT (1)
FRNGAP 6 TTTCGAAACGGGGCTCCT (2)
TTTCGAAATGGAGCTCCT (11)
TTTCGAAATGGCGCTCCT (1)
TTTCGAAATGGGGCTCCT (36)
FRNKAP 6 TTTCGAAATAAAGCTCCT (7)
FRNKGP 6 TTTCGAAATAAAGGCCCT (1)
FRNLAP 6 TTTCGAAATCTGGCTCCT (1)
TTTCGAAATTTGGCTCCT (3)
FRNMAP 6 TTTCGAAATATGGCTCCT (1)
FRNQAP 6 TTTCGAAATCAAGCTCCT (11)
FRNRAP 6 TTTCGAAACCGGGCTCCT (4)
TTTCGAAATAGAGCTCCT (2)
TTTCGAAATAGGGCTCCT (6)
TTTCGAAATCGAGCTCCT (5)
Table 3.2:  Full repertoire of sequences generated from !CDR2WT-Rec 
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Table 3. 2: Full repertoire of sequences generated from βCDR2WT­Rec mice 
The Shannon entropy index, as described in Chapter 2 facilitates statistical comparison of the 
diversity of a sample based on the number of unique events within that sample. While it was 
employed in Figure 2.4 to measure the diversity at each position of aligned germline Ig and 
TCR CDRs, as has been done previously (Stewart et al, 1997), it can also measure the global 
diversity of whole TCR sequences – for example analysis of hypervariable TCR CDR3 
repertoires (Singh et al, 2010). Here, diversity (D) values are calculated from the ratio of the 
TTTCGAAATCGCGCTCCT (4)
TTTCGAAATCGGGCTCCT (4)
FRNRTP 6 TTTCGAAATCGGACTCCT (1)
FRNSAP 6 TTTCGAAATAGCGCTCCT (2)
TTTCGAAATTCGGCTCCT (2)
FRNTAP 6 TTTCGAAATACGGCTCCT (2)
FRNWAP 6 TTTCGAAATTGGGCTCCT (7)
FRQQAP 6 TTTCGACAGCAAGCTCCT (1)
TTTCGGCAACAAGCTCCT (1)
FRRGAP 6 TTTCGAAGGGGAGCTCCT (2)
FRRQAP 6 TTTCGAAGACAAGCTCCT (4)
TTTCGAAGGCAAGCTCCT (1)
TTTCGGCGGCAAGCTCCT (1)
FRRRAP 6 TTTCGAAGACGGGCTCCT (1)
FRSAAP 6 TTTCGGAGCGCAGCTCCT (1)
FRSGAP 6 TTTCGATCGGGAGCTCCT (1)
FRSQAP 6 TTTCGAAGCCAAGCTCCT (1)
TTTCGAAGTCAAGCTCCT (3)
TTTCGATCACAAGCTCCT (1)
TTTCGATCTCAAGCTCCT (1)
TTTCGTAGTCAAGCTCCT (1)
FRTGAP 6 TTTCGAACGGGGGCTCCT (1)
FRVQAP 6 TTTCGGGTGCAAGCTCCT (13)
FRVRAP 6 TTTCGGGTCCGGGCTCCT (1)
FRYQAP 6 TTTCGGTATCAAGCTCCT (3)
FTWQAP 6 TTTACGTGGCAAGCTCCT (1)
HLRGAP 6 CACCTCAGGGGCGCTCCT (1)
LRNRAP 6 CTTCGAAATCGGGCTCCT (1)
STLQAP 6 TCGACCTTGCAAGCTCCT (1)
FQTQAP 7 TTCCAAACGCAAGCTCCT (1)
FRGMQAP 7 TTTCGAGGGATGCAAGCTCCT (1)
FRKGQAP 7 TTTCGAAAGGGGCAAGCTCCT (1)
FRKKKAP 7 TTTCGAAAAAAAAAAGCTCCT (1)
FRNIGAP 7 TTTCGAAATATAGGGGCTCCT (1)
FRNSQAP 7 TTTCGTAACTCTCAAGCTCCT (2)
FRNSRTP 7 TTTCGAAATAGTAGGACTCCT (1)
FRNTGAP 7 TTTCGAAATACGGGAGCTCCT (3)
FRRGKAP 7 TTTCGAAGGGGGAAAGCTCCT (3)
FRTDGAP 7 TTTCGAACAGACGGAGCTCCT (2)
FRIHPQAP 8 TTTCGAATCCACCCTCAAGCTCCT (1)
FRIPGGAP 8 TTTCGAATCCCGGGGGGGGCTCCT (1)
FRNGLQAP 8 TTTCGAAATGGGTTGCAAGCTCCT (1)
FRNIPGAP 8 TTTCGAAATATCCCAGGGGCTCCT (1)
FRNIRGAP 8 TTTCGAAATATAAGGGGAGCTCCT (2)
FRNISKAP 8 TTTCGAAATATTTCCAAAGCTCCT (2)
FRNIVGAP 8 TTTCGAAATATCGTAGGGGCTCCT (3)
FRNPLRAP 8 TTTCGAAATCCCTTGCGAGCTCCT (1)
FRTPLQAP 8 TTTCGAACCCCTTTGCAAGCTCCT (2)
FRTSLQAP 8 TTTCGAACCTCCCTCCAAGCTCCT (2)
FLTSTLQAP 9 TTCCTGACTTCGACCTTGCAAGCTCCT (1)
FRKRPLQQAP 10 TTTCGAAAGAGACCCCTCCAACAAGCTCCT (6)
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Shannon entropy index (H) expressed as a percentage of the maximum diversity (H’) in 
which every sequence analysed is presumed to be unique. H is calculated by: 
H = -Σi-n[ln(frequency of unique sequence/total number of sequences)] 
 
This method was used to calculate the overall diversity of both the peptide and nucleotide 
sequences analysed from the non-germline repertoire of CDR1 and 2 that were generated. 
This approach also facilitates a direct comparison between different D values, which 
normalises for the varying number of sequences analysed (Figure 3.5). The D values 
calculated for both CDR1 and 2 were less than that previously measured for CDR3 sequences 
associated with a single-family member V-segment (Singh et al, 2010; Chapter 4.3). This 
indicates that the overall repertoires generated in germline regions are not as diverse as 
conventionally generated CDR3 regions. This may relate to potential structural constraints of 
the CDR1 and 2, or a by-product of this artificial recombination system. Both recombined 
CDR1 and 2 mutants had comparable diversity, indicating that neither CDR1 nor 2 from 
TCRβ chains are more constrained by germline sequence and are equally adaptable at the 
sequence level. 
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Figure 3. 5: Overall diversity of non-germline CDR1 and CDR2 mutants generated in vivo from βCDR1WT-Rec and 
βCDR2WT-Rec mice. 
Each segment represents a unique nucleotide (top) or peptide (bottom) sequence derived from colony PCR. The 
total diversity is presented as the D value, which are calculated from Shannon entropy indices (see main text) as 
a function of total potential diversity. 
 
During conventional CDR3 generation, addition and subtraction of nucleotides at the point of 
recombination results in variable length ranging typically from 5-10 amino acids long. 
Interestingly, despite similar overall diversity, the repertoire generated across WT CDR1 was 
of limited length with over 70% of sequences maintaining the germline length of 6 amino 
acids. The remainder of sequences analysed encoded loops of only 5 amino acids (Figure 
3.6). However, while a similar proportion of non-germline CDR2 mutants also maintained 
germline CDR length, a significant fraction encoded for CDR2 regions varying from 3 to 10 
amino acids in length (Figure 3.6). These data suggest that while overall sequence diversity 
potential is not different between CDR1 and CDR2, structural constraints may limit variation 
in CDR1 length.  
!CDR1WT-Rec !CDR2WT-Rec 
Nucleotide 
Peptide D = 25.8  D = 23.3  
D = 35.1  D = 30.71  
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Figure 3. 6: Redirected V(D)J recombination to germline CDRs generates a restricted CDR1 but not CDR2 loop 
length.  
CDR length in amino acids was calculated from sequences presented in Table 3.1 and 3.2 for βCDR1WT-Rec and 
βCDR2WT-Rec mice. Data is presented as the percentage of unique peptide sequences (top) and total sequences 
analysed (bottom). 
 
A summary of the mutations analysed from the CDR1 and 2 that encoded for the most 
common length (6 amino acids) is presented in Figure 3.7. As one would expect, the majority 
of diversification of the germline sequences is concentrated at the point of recombination, 
namely P3 and P4 of the CDR regions. However both sets of mice contained CDRs modified 
at the terminal P1 (βCDR2WT-Rec) or P1 and P6 (βCDR1WT-Rec), implying that all positions of WT 
CDR1 and 2 are amenable to change without inhibiting pMHC-mediated thymic selection. 
Only the P6 proline from the CDR2 sequence set was found not to have been altered. 
Interestingly, while the P3 and P4 in altered CDR2 regions were equally diverse, the P3 
histidine from the CDR1 mutants was maintained in nearly two-thirds of all sequences 
analysed, whereas the P5, which is not proximal to the point of recombination, was greatly 
altered. As stated in Chapter 2.1.2, this P3 H is found in the majority of germline sequences, 
yet has only been implemented in one known TCR-pMHC interaction (Garcia et al, 1996). 
These data would suggest that there is a preference for having a histidine at this position, 
however its role appears not to involve direct contribution within the interface. A similarly 
conserved residue, K66 from the class I HLA-A2 MHC was found not to be important for 
interaction, but instead provided an optimal chemical environment for surrounding residues 
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(Miller et al, 2007). However P3 was modified in some instances, suggesting it too is not 
indispensible. This residue is also modified in later constructs without affecting the TCR’s 
ability to interact with pMHC (see Section 3.4 and Chapter 4). 
 
Figure 3. 7:  Amino acid and nucleotide modifications generated from WT TCRβ CDR1 and 2.  
Stack summaries of amino acid (left) and nucleotide (right) usage within CDRs of WT length. Single letter 
amino acid and nucleotide codes are used. The height of each letter corresponds to frequency of occurrence. 
Each stack equals 100%. Original WT reference sequences are written in below the stack charts. Arrows 
represent the point of recombination. Colours correspond to chemical property/grouping. For amino acids: Blue 
= large hydrophobic, green = polar, purple = small hydrophobic, orange = positively charged, black = negatively 
charged and red = other. For nucleotides: T (red) = thymidine, C (blue) = cytidine, G (yellow) = guanosine and 
A (green) = adenosine. 
 
3.2.3 Increase in net positive charge detected in modified CDR1 and CDR2  
The unbiased approach to the modification and selection of CDR1 and 2 mutants could 
highlight any features or residues beneficial for pMHC recognition. Indeed, the in vivo 
generated modifications presented here bear no immediate resemblance to any particular 
germline CDR sequence (Lefranc et al, 2003). However, while analysis of unique sequences 
revealed chemically diverse mutations, summation of the properties of the total sequences 
examined, revealed an overall increase in net positive charge (Figure 3.8). This is clear from 
the CDR2 modifications, where >30% of sequences had an increase in net positive charge (+1 
from the P2 arginine). Indeed one sequence encoded for a loop with a net charge of +4 
(FRKKKAP). Less than 10% of CDR2 sequences had a net charge less positive than the 
S G H  S  A  V
 CDR1WT Recombination
 CDR2WT Recombination
F  R N  Q A P
 CDR2WT Recombination
T T T CG A A A T C A A GC T CC T 
 CDR1WT Recombination
T C A G G A C A  T A G T G C T G T  T
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original +1 WT sequence. Where this did occur, it was both through a loss of the P2 arginine 
or through the inclusion of a negatively charged glutamic acid at P3 in conjunction with the 
P2 arginine. The WT CDR1 sequence also has a net charge of +1 due to the aforementioned 
P3 histidine. Nearly 60% of all CDR1 sequences analysed also displayed an increase in net 
positive charge. However no net charge above +2 was measured. A similar level of 
approximately 10% of CDR1 sequences analysed had a neutral charge, with only a single 
sequence encoding for CDR1, with a net negative charge (SGSPDV). 
This prevalence of increased net positive charge is an intriguing phenomenon. One could 
conclude that presence of positively charged amino acids may benefit the resultant αβ TCRs 
during thymic selection. Recent analysis of the TCR-pMHC structural database has indicated 
the mean surface electrostatic potential (MSEP) of a TCR can correlate to both the published 
affinities of all solved TCR-pMHC crystal structures and also the varying binding angles 
(Yoshida et al, 2010; Kahn and Ranganathan, 2011).  As shown in Figure 3.3, there was a 
clear bias to the CD4 compartment of GFP+ T cells, which were the source material for RNA 
extraction in the above sequencing analysis. Thus the preference for positively charged amino 
acids may also be limited to class II restricted T cells. Further, it is also plausible that CDR 
loops with an increased net positive charge were generated at a higher frequency in the 
thymus and this bias is manifested after thymic selection. However as demonstrated in Table 
3.1 and Table 3.2, introduction of positive charge, particularly to CDR2, is present across 
varying lengths of CDR, at several codon positions, generated from both template codons and 
from newly generated TdT mediated sequences. Further, all three positively charged amino 
acid residues (arginine, lysine and histidine) were utilised in several positions.  Finally, many 
of the CDR peptide sequences that encode for an increase in net positive charge often use 
more than one codon to encode for the positively charged residue. This perhaps indicates a 
selectable preference of positively charged residues as opposed to their generation being an 
inherent bias of recombination (Table 3.1 and Table 3.2). Taken together then, the chances of 
recombination bias generating such a diverse array – both chemically and positional - of 
positively charged features appear unlikely. 
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Figure 3. 8: In vivo generation of random non-germline CDR1 and 2 mutations result in an increase in net 
positive charge. 
Data is based on total sequences presented in Table 3.1 and Table 3.2. Data from all lengths of CDRs recorded is 
included. The original net charge of the WT CDR1 and 2 is indicated by a *.  
 
To address the potential prevalence of positively charged CDR generation in the thymus, one 
would require a sequence analysis of the pre-selection repertoire after recombination of the 
cassettes had occurred. However, this presented several technical difficulties. Cell sorting of a 
GFP+CD4+CD8+ DP population from the thymus would include cells that have already been 
positively selected. Markers such as CD5 and CD69 expression levels are proportional to 
pMHC interaction (Yamashita et al, 1993; Tarakhovsky et al, 1995; Azzam et al, 2001 and Azzam et al, 1998) and are good markers to distinguish positive and negative selection at the 
DP phase of thymic development. Thus, a GFP+CD4+CD8+CD5LOCD69LO sort could be used. 
However, coupled to the previously described inefficiencies of the retrogenic system that can 
limit thymi size and reconstitution, the yield of such a sorting would not generate enough 
material for meaningful analysis. Similarly, as TCRβ recombination occurs at the DN3 stage 
of development, cell sorting of CD4-CD8- DN thymocytes was also not feasible due to the 
presence of unrecombined recombination cassettes and the ability of untransduced GFP- HSC 
to reach the DN phase of the thymic development. While separation of GFP+CD25-CD44- 
DN4 thymocytes that should only contain rearranged TCRβ chains (Chapter 1.2.2) would 
also struggle to generate a suitable yield for analysis. 
An attempt to extract RNA from a whole thymus from a βCDR2WT-Rec mouse yielded only 10 
in-frame recombined sequences, of which 7 were unique (Table 3.3) and one corresponded to 
the remade WT CDR sequence (highlighted in the table). While this sample size is too small 
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to draw any meaningful comparison, it is interesting to speculate that an increase in positive 
charge may be not be present before selection of T cells. Further discussion is provided in 
Chapter 5. 
 
 
Table 3. 3: Sample sequences from the whole thymus of a βCDR2WT­Rec mouse 
 
3.3 Redirection of V(D)J recombination to the CDR1 of a TCRβ  chain lacking both 
germline CDRs produces a non-germline repertoire independent of WT sequence  
3.3.1 Overview of construct 
The above data clearly demonstrates the flexibility of both germline CDR1 and 2 of the TCRβ 
chain in terms of pMHC recognition during thymic selection. However in both cases the 
exogenous TCRβ chains would still maintain one WT germline CDR loop and thus 
autonomous roles for WT CDR1 and 2 in MHC engagement could not be ruled out. To 
address this, the WT βCDR1 and 2 loops from the βCDR3Δ template were replaced with 
glycine-alanine linkers that bear no resemblance to any germline CDR structures (Lefranc et 
al, 2003; Figure 4.1). This modified chain was synthesised with a recombination cassette 
inserted into the CDR1 region (Appendix 2; Figure 3.9) generating the βCDR1Δ-Rec construct. 
 
 
CDR2 Peptide Length CDR2 Nucleotide (No. of Sequences)
FLLQAP 6 TTCCTCCTCCAAGCTCCT (1)
FRDQAP 6 TTTCGGGATCAAGCTCCT (1)
FRNGAP 6 TTTCGAAACGGTGCTCCT (1)
FRNGAP 6 TTTCGAAATGGAGCTCCT (1)
FRNGAP 6 TTTCGAAATGGGGCTCCT (1)
FRNLAP 6 TTTCGAAATTTAGCTCCT (1)
FRNQAP 6 TTTCGAAATCAAGCTCCT (1)
FRNQVP 6 TTTCGAAATCAAGTTCCC (1)
FSGGAP 6 TTCTCTGGGGGGGCTCCT (1)
FRKPPLQAP 10 TTTCGAAAGCCCCCTCTGCAAGCTCCT (1)
Table 3.3:  Sample sequences from whole thymus of a !CDR2-WT mouse
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Figure 3. 9: Insertion of recombination cassettes into the CDR1 of a TCR βCDR3Δ lacking germline CDR1 and 2. 
Schematics showing the general positioning of cassettes relative to the rest of the TCRβ chain (left) and where 
the point of recombination occurs within the modified CDR sequences (right) .The arrow in the right hand side 
schematic indicates the point of recombination. Thus one would predict alteration of these structures to radiate 
from the centre of the loop apex. 
 
3.3.2 Adoptive transfer of transduced HSC and detection of T cell selection 
The βCDR1Δ-Rec chain was cloned into the pMigR1 vector and used to transduce cultured HSC 
from FVB TCRβδ-/- donor mice (Figure 3.10A), which were adoptively transferred into 
irradiated FVB TCRβδ-/- recipients. GFP+ T cells were detected in the blood after 9 weeks 
post-HSC transfer, with clear populations by 13 weeks – within a similar range as mice using 
cassettes inserted to the WT βCDR1 and 2 regions. This both indicated that recombination 
was successful and that loss of germline TCRβ CDR loops does not impede the process of T 
cell development. Flow cytometric analysis of spleen from βCDR1Δ-Rec mice also revealed 
GFP+Vβ11+ T cells, further indicating that recombination had produced viable exogenous 
TCRβ chains used in thymic selection (Figure 3.11). Interestingly as with the βCDR1WT-Rec and 
βCDR2WT-Rec mice, a clear skew to the CD4 T cell compartment was observed in the spleen and 
blood. 
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Figure 3. 10: Generation of GFP+ T cells from βCDR1Δ-Rec mice.  
(A) Representative flow cytometric plot of HSC from TCRβδ-/- mice transduced with βCDR1Δ-Rec construct cloned 
into pMigR1.  (B) Flow cytometric analysis of blood from βCDR1Δ-Rec mice taken at 6, 9 and 13 weeks post-
transfer of HSC. Plots were gated on GFP+ lymphocytes and are representative of n = 3 mice. 
 
 
Figure 3. 11: Detection of splenic GFP+Vβ11+ T cells in TCRβδ-/- mice using βCDR1Δ-Rec construct.  
Flow cytometric analysis of whole spleen from mice 13 weeks post-HSC transfer. Left panel shows CD4 versus 
CD8 compartments, gated on GFP+ lymphocytes. Right panel shows staining for Vβ11 specific antibody on 
GFP+ CD4 T cells (solid line) relative to GFP+CD4-CD8- lymphocytes as a control (filled peak). 
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3.4 Mature T cells generated from recombination cassettes inserted into a TCRβ  CDR1 
generate diverse CDR1 regions independent of any germline structure  
3.4.1 Sorting of peripheral T cells and detection of recombined TCRβ chains 
To examine any CDR1 modifications generated from CDR1 recombination in the context of 
no WT CDRs, GFP+CD4+ lymphocytes from whole spleen and LN were subjected to FACS 
(Figure 3.12A) and cDNA synthesised from extracted RNA. As with the other recombination 
cassette constructs, PCR using the same primers that bind to conserved regions upstream and 
downstream of the CDR1 and 2 revealed loss of the 500bp cassette from the cDNA 
confirming recombination at the DNA level. Colony PCR and sequencing was used as before 
to analyse CDR1 repertoire (Figure 3.12B). 
 
 
Figure 3. 12: Analysis of cDNA from mice using the βCDR1Δ-Rec construct confirms cassette recombination.  
(A) Representative flow cytometric plots from flow activated cell sorting of GFP+CD4+ lymphocytes from 
whole spleen and LN. (B) PCR of βCDR1Δ-Rec in an unrecombined state in pMigR1 vector (V) and from cDNA of 
mature CD4 T cells (D) using primers specific for the β constant region and upstream of the Vβ11 CDR1, 
demonstrating loss of the 500bp linker. M = marker. Sizes as indicated in base pairs (bp).  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3.4.2 Analysis of in vivo generated WT CDR independent CDR1 repertoire 
A total of 40 unique CDR1 sequences were observed from 113 analysed (Table 3.4). Again, 
the original glycine-alanine linker was remade minimally, being generated on 3 occasions 
(highlighted in Table 3.4). As with the data presented in Section 3.3, these sequences confirm 
that diverse non-germline CDR regions can be encoded for without loss of pMHC 
recognition. Further, in the case of this βCDR1Δ-Rec construct, a repertoire of successful 
sequences can be generated from a non-germline CDR1 template, in the absence of a second 
WT germline βCDR2. This implies that ability to generate diversity within CDRs is 
independent of the influence of any germline sequence encoded within the same chain. 
Additionally, it reveals that pMHC recognition does not appear to be more dependent on one 
germline βCDR over another. 
Sequences from βCDR1Δ-Rec were subjected to diversity analysis through Shannon entropy 
measurement as described in Section 3.3.2 (Figure 3.13). Interestingly, at both nucleotide and 
peptide level, the diversity of the CDR1 generated in the context of no germline CDRs is 
somewhat lower than that of CDR1 and CDR2 WT counterparts from the βCDR1WT-Rec and 
βCDR2WT-Rec mice (Figure 3.5). However diversity that is generated in the absence of any WT 
CDR sequences is significant and underpins the true flexibility that exists at the interface 
between TCR and pMHC. 
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Table 3. 4: Full repertoire of sequences generated from βCDR1Δ­Rec mice 
 
 
CDR1 Peptide Length CDR1 Nucleotide (No. of Sequences)
SADGV 5 TCGGCAGACGGAGTT (1)
SAFGV 5 TCAGCATTTGGAGTT (1)
SAGRV 5 TCGGCAGGTCGAGTT (1)
LAEGGV 6 TTGGCAGAGGGAGGAGTT (1)
LAGSVV 6 TTGGCAGGATCAGTAGTT (1)
SAEGGV 6 TCGGCAGAGGGAGGAGTT(12)
SAESGV 6 TCGGCAGAATCAGGAGTT (2)
SAEVGV 6 TCGGCAGAGGTAGGAGTT (1)
SAFFRF 6 TCGGCATTTTTCAGATTT (1)
SAFLGV 6 TCGGCATTTTTGGGAGTT (1)
SAFSGF 6 TCTGCATTTTCAGGATTT (1)
SAFSVF 6 TCGGCATTTTCAGTATTT (1)
SAGAGV 6 TCGGCAGGGGCAGGAGTT (3)
SAGFGV 6 TCGGCAGGATTTGGGGTT (2)
SAGLKF 6 TCGGCAGGTTTAAAATTT (1)
SAGLKV 6 TCGGCAGGTTTGAAAGTT (1)
SAGLRV 6 TCGGCAGGATTGAGAGTT (1)
SAGRGV 6 TCGGCAGGAAGGGGAGTT (3)
SAGSGV 6 TCGGCAGGATCAGGAGTT (7)
TCGGCAGGATCCGGAGTT (3)
TCGGCAGGATCGGGAGTT (7)
TCGGCAGGATCTGGAGTT (5)
TCGGCAGGATCTGGGGTT (2)
TCTGCAGGATCAGGAGTT (1)
TCTGCAGGATCTGGAGTT (1)
SAGSKL 6 TCGGCAGGATCAAAACTT (1)
SAGSKV 6 TCGGCAGGATCAAAAGTT (8)
TCGGCAGGATCGAAAGTT (3)
SAGSRV 6 TCGGCAGGATCAAGAGTT (7)
TCGGCAGGATCCAGAGTT (4)
TCGGCAGGATCCCGGGTT (3)
TCGGCAGGATCGAGAGTT (2)
TCGGCAGGATCGAGGGTT (1)
TCGGCAGGATCTCGAGTT (1)
SAGSSV 6 TCGGCAGGATCAAGTGTT (2)
SAGSVV 6 TCGGCAGGATCAGTAGTT (16)
SALFRV 6 TCGGCATTATTCAGAGTT (1)
SAVGGV 6 TCGGCAGTTGGAGGAGTT (1)
SGSPGV 6 TCGGGGAGTCCGGGAGTT (1)
VADVGV 6 GTCGCAGATGTAGGAGTT (1)
Table 3.4: Full repertoire of sequences generated from !CDR1"-Rec 
  126 
 
Figure 3. 13: Overall diversity of non-germline CDR1 mutants generated in vivo from βCDR1Δ-Rec mice.   
Each segment represents a unique nucleotide (top) or peptide (bottom) sequence derived from colony PCR. The 
total diversity is presented as the D value, which are calculated from Shannon entropy indices (see main text) as 
a function of total potential diversity. 
 
Analysis of CDR1 length variation from sequences studied in βCDR1Δ-Rec mice revealed a 
similar restricted pattern as those observed from βCDR1WT-Rec mice. Once again, the majority of 
sequences encoded for CDR1 loops of 6 amino acids, with a minority encoding loops of 5 
amino acids, despite no similarity between the CDR1 sequences generated from WT or 
glycine-alanine linker templates (Figure 3.14 and Figure 3.6). Thus this data confirms that, 
regardless of CDR1 chemical composition, structural constraints appear to limit CDR1 length, 
relative to the CDR2 that can facilitate loop lengths between 3 and 10 amino acids long. In 
addition, it demonstrates that loss of the germline WT CDR2 sequences does not influence 
CDR1 diversity in terms of CDR length. 
A summary of the mutations analysed from the CDR1 that encoded for the most common 
length (6 amino acids) is presented in Figure 3.15. Again, the majority of diversification of 
the glycine-alanine template is concentrated at the point of recombination, namely P3 and P4 
of the CDR1.  
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Figure 3. 14: Redirected V(D)J recombination to non-germline CDR1 generates a restricted CDR1 length.  
CDR length in amino acids was calculated from sequences presented in Table 3.4 for βCDR1Δ-Rec and mice. Data is 
presented as the percentage of unique peptide sequences (top) and total sequences analysed (bottom). 
 
 
Figure 3. 15:  Amino acid and nucleotide modifications generated from non-germline TCRβ CDR1.  
Stack summaries of amino acid (left) and nucleotide (right) usage within CDRs of germline length. Single letter 
amino acid and nucleotide codes are used. The height of each letter corresponds to frequency of occurrence. 
Each stack equals 100%. Original template reference sequences are written in below the stack charts. Arrows 
represent the point of recombination. Colours correspond to chemical property/grouping. For amino acids: Blue 
= large hydrophobic, green = polar, purple = small hydrophobic, orange = positively charged, black = negatively 
charged and red = other. For nucleotides: T (red) = thymidine, C (blue) = cytidine, G (yellow) = guanosine and 
A (green) = adenosine. 
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Modifications were recorded however for all positions apart from the P2 alanine, although 
this position was previously shown to be amenable to change in βCDR1WT-Rec mice (Figure 
3.7). This data further demonstrates that all germline CDR positions are not important for 
pMHC recognition, in the presence or absence of other WT CDRs. Interestingly, despite the 
unbiased potential of sequence generation, histidines were not observed at the CDR1 P3, 
despite the high level of conservation of this residue in the germline repertoire encoded in the 
murine genome (Figure 2.2) and the relatively high level of retention of this residue in 
sequences generated from the WT CDR1 template in βCDR1WT-Rec mice (Figure 3.7). Indeed, 
no positively charged amino acids were encoded at P3 when using the glycine-alanine linker 
template, but negatively charged aspartic and glutamic acids were both used successfully in 
this position. Further, while similarly bulky residues to histidine in the form of phenylalanine 
were observed, so too were small hydrophobic amino acids such as the original glycine from 
the template and newly generated valine. Thus while it appears that histidine at this position 
in TCRβ CDR1 plays a preferential role that is most likely not related to actual pMHC 
engagement, this residue is, like all germline TCRβ residues, dispensable in T cell selection. 
The most popular unique residue generated from the glycine-alanine linker template at P4 was 
serine, which is the original P4 residue in the WT CDR1 (Figure 4.1). A preference for this 
residue is indicated by all 4 serine codons being present. However this result is most likely 
coincidental as P4 position from βCDR1WT-Rec mice was greatly diversified and this position is 
not highly conserved in the murine genome (Figure 2.2). Despite a lower overall diversity in 
the βCDR1Δ-Rec relative to βCDR1WT-Rec (Figure 3.5 and Figure 3.13), diversification was more 
evenly spread out across all CDR positions (Figure 3.7 and Figure 3.15). This was perhaps 
due to having less chemical diversity in the initial template that may encourage broader 
diversification, while the overall limit of diversification is due to the presence of a glycine-
alanine linker in the CDR2. 
A final analysis of total sequences was conducted to see if an overall preference for an 
increase in net positive CDR charge was maintained in the absence of any WT CDR (Figure 
3.16). While both the WT CDR1 and CDR2 templates used in earlier recombination cassette 
constructs encoded an initial net positive charge +2 (with each CDR being +1; Figure 3.7), 
the βCDR1Δ-Rec construct maintained a neutral net CDR charge, due to both CDR1 and 2 being 
replaced by glycine-alanine linkers. However, nearly 35% of all sequences analysed encoded 
for an increase in net positive charge. Although ~15% also encoded net negative CDR, 
entirely through the inclusion of the aforementioned aspartic and glutamic acids at P3 of the 
CDR1. Further, no increase in net positive charge above +1 was recorded. However, the 
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significant increase in net positive CDR1 charge from βCDR1Δ-Rec mice was not dependent on 
one recombination event that was represented at a high proportion in the total population, but 
through several unique sequences found through the repertoire (Table 3.4). This data, coupled 
to the earlier analysis on net charge indicates that an increase in net positive charge is 
beneficial to pMHC interaction in this system. Although this has yet to be resolutely 
confirmed to be a function of thymic selection instead of an inherent bias of recombination 
(see Section 3.2.4).    
 
 
Figure 3. 16: In vivo generation of random non-germline CDR1 mutations in the absence of any WT CDR 
sequence also results in an increase in net positive charge.  
Data is based on total sequences presented in Table 3.4. Data from all lengths of CDRs recorded is included. The 
original net charge of the CDR1 template is indicated by the *.  
 
3.5 Chapter Summary 
The data presented in this chapter demonstrate successful application of the novel 
“recombination cassette” system described in Chapter 2.2.3. The diversity observed was less 
than that seen for endogenous CDR3 rearrangements (Singh et al, 2010; see Chapter 4.3.5). 
However, almost 200 novel, functional TCR mutants were defined in the TCRβ CDR1 or 2 
produced via an unbiased and in vivo method of mutagenesis. Thus, rather than CDR 
sequence being defined by specific positions deemed likely to be vital in pMHC recognition 
(Garcia et al, 2009 and Marrack et al, 2008), diversification of the CDR regions was only 
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modifications at the terminal CDR residues. The only example of conservation between 
cassette generated and genome encoded amino acid usage was the highly conserved P3 
histidine in the βCDR1. However this residue was not essential or reproduced when replaced 
as part of a glycine-alanine linker in the βCDR1Δ-Rec construct. 
Autonomous roles for individual germline CDRs were ruled out by synthesising constructs 
where germline CDR1 and 2 were replaced by glycine-alanine linkers that bear no 
resemblance to any germline structure (Lefranc et al, 2003) before inserting a recombination 
cassette into βCDR1. As a result over 40 unique TCRβ chains were sequenced that contained 
no germline CDR structure yet could undertake pMHC mediated positive selection. Indeed 
the selection of mutant TCR repertoire generated by these cassettes can be assumed to 
undergo pMHC dependent selection due to the presence of co-receptors that ensure ligand 
engagement between the TCR and pMHC (Van Laetham et al, 2007). In addition, the fact 
diversification is still promoted in the absence of other germline CDR structures in the βCDR1Δ-
Rec construct, further implies that the in vivo generated CDR1 are engaging with pMHC. This 
is most likely true for all the non-germline CDR1 and 2 mutants produced, due to the 
consistency with which βCDR1 and 2 interact with pMHC in some capacity (Rudolph et al, 
2006) while being limited in their own intrinsic movements, limiting the capacity for the 
loops to be entirely excluded from pMHC engagement (Armstrong et al, 2008). 
The random generation of CDR variants implies that general features of CDR chemistry may 
be more important than specific residues in recognition of pMHC. In support of this, there 
was a general trend across all CDR1 and 2 variants to encode loops with an increase in net 
positive charge. It has not been possible to fully determine whether this phenomenon is 
favourably selected from a more diverse pre-selection repertoire, however the variable nature 
with which positive charges were inserted into the loops imply a general bias of the 
recombination process is not responsible. While this net charge characteristic was not 
universal, a significant proportion (between 30-40%) of all variants demonstrated increased 
net charge, in the presence and absence of WT CDR1 and 2 structures. There was however no 
direct correlation between a construct’s basal net charge and the overall increase in the net 
charge of the TCRβ chain. 
A final unexpected result was a disparity in CDR length conservation between βCDR1 and 
βCDR2 regions. Genome analysis reveals that both βCDR1 and CDR2 are limited to a range 
of 2 lengths of CDR (5 and 6 residues for CDR1 and 6 and 7 residues for CDR2; Figure 2.1). 
CDR1 and 2 diversification using the WT sequences as templates resulted in a similar level of 
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overall diversity (Figure 3.6), however CDR1 sequences were restricted to germline lengths 
only, whereas CDR2 lengths varied from 3 to 10 amino acids, more akin to range expected of 
CDR3 loops (Rock et al, 1994). This restriction in CDR1 length was also prevalent in TCRβ 
chains using glycine-alanine linkers as CDR1 and 2 templates, indicating it is not sequence 
dependent. Thus this work also reveals a hitherto unknown structural constraint difference 
between CDR1 and 2. The functional implications of this are discussed in Chapter 5. 
The germline CDR sequence analysis carried out in Chapter 2 revealed MHC restriction has 
not reduced overall TCR germline diversity. The results presented here, demonstrate that this 
lack of reduction in germline diversity is likely to be related to the flexibility of germline 
CDR sequence in pMHC recognition as shown through the generation of diverse repertoires. 
Further, it suggests that diversity may in fact be a positive attribute, which is relevant to 
reported importance of cross-reactivity in effective immune responses (Mason, 1999). In 
order to study the functional nature of germline residues in more detail a conventional 
mutagenesis approach was opted for to fix single TCRβ or TCRα chains with modified CDR1 
and 2 regions which were then analysed in the context of thymic selection and peripheral 
MHC mediated responses as presented in Chapter 4.  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Chapter 4: Functional analysis of TCRα  and TCRβ  CDR1 and 2 
4.1 Design, generation and testing of TCR mutants 
4.1.1 Design of TCRα and TCRβ CDR1 and 2 mutants 
In order to examine the role of CDR1 and 2 thoroughly this study aimed to modify entire 
CDR loops instead of adopting a single amino acid approach. The resultant mutants were 
designed so as to remove all WT positions that have been proposed to encode amino acids 
deemed important in controlling MHC recognition (Table 1.9). While the C6 TCR, used here 
as a template, has not been co-crystallised with its cognate pMHC ligand (H2-Kk-Smyc; 
Chapter 6.3), Marrack et al (2008) and others (Garcia et al, 2009) have concluded that CDR 
position is most likely to be the underlying factor in MHC recognition by TCR. Thus 
modifications to the C6 template were designed to remove all WT CDR structure, including 
key amino acids based on proposed “interaction codon” positions (Marrack et al, 2008). 
Summaries of modifications made to TCRα and TCRβ templates are summarised in Figure 
4.1A. As described earlier, all TCRβ constructs contained a shortened triple glycine linker in 
place of the WT CDR3 (see Chapter 3.1.1; Bartok et al, 2010). Such a βCDR3 would be 
considered functional due to the similarity of the modified CDR3 here and that of the well 
characterised 2C TCR βCDR3, which contains only one glycine more (Garcia et al, 1996). 
All but one position per chain found to commonly recognise different MHC molecules 
published by Marrack et al have been altered in the designs. Examples of residues shared 
between the template CDRs and of those presented by Marrack et al at these positions clearly 
exist. For example, although the Vα8.3 CDR1 and 2 of the C6 TCR template has not been 
crystallised, the murine AHIII TCR, bound to the xenoreactive A2 MHC contains the closely 
related Vα8.5 in its TCRα (Miller et al, 2003). As shown in Figure 4.1B, they both share an 
adjacent tyrosine and serine residue in their CDR1 (Y28 and S29 in Marrack et al and IMGT) 
which form key interacting residues in the AHIII co-crystal.  Similarly they share a CDR2 
threonine (T50 in Marrack et al, IMGT T59) also implicated as important for AHIII 
recognition of A2. Further, other common positions involved in pMHC recognition (positions 
51 and 52 in Marrack; IMGT 60 and 61) and positions that occasionally contact pMHC 
complexes (αCDR1 positions 26 and 27 and αCDR2 48, 49, 51, 52 in Marrack; IMGT 57, 58, 
60, 61) were also altered. 
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Figure 4. 1: Overview of CDR modification design to the C6 TCRα and β chain templates.  
(A) Schematics show WT (αWT/βCDR3Δ) and modified (αCDR1Δ2Δ/βCDR1Δ2Δ3Δ) CDR1 and 2 amino acid sequences. 
Open boxes indicate WT CDR positions instigated in pMHC recognition by Marrack et al, 2008. Filled boxes 
indicate the total number of changes made to the WT sequence. CDR residue numbering from Marrack et al, 
2008 and IMGT are as indicated. Relevant framework residues are indicated between CDR sequences. (B) 
Comparison of the template Vα8.3 CDR1 and the Vα8.5 CDR1 that has been crystallised as part of the AHIII 
TCR. Open boxed residues indicate residues from the AHIII Va8.5 CDR1 that contacted the MHC in the co-
crystal structure (Miller et al, 2007).  
Similarly, for the TCRβ template CDR1, positions 26-29 (Marrack et al; IMGT 28-31) which 
includes the two CDR1 positions shown to make common pMHC contacts as well as the 
highly conserved histidine (see Chapter 2.1.3) which has also been shown to make pMHC 
contacts (Garcia et al, 1996) were modified. The key positions encoded within the TCRβ 
CDR2 are 46, 48 and 54 (Marrack et al, 2008; IMGT 54, 56 and 67), which often contain a 
tyrosine, tyrosine and glutamic/aspartic acid respectively and are the most studied with 
respect to germline-encoded recognition of MHC (Marrack et al, 2008; Garcia et al, 2009; 
Dai et al, 2008; Feng et al, 2007; Scott-Browne et al, 2009; Scott-Browne et al, 2011; Yin et 
al, 2011 and Huseby et al, 2005). The C6 TCRβ template used in this study contained a 
tyrosine, arginine and aspartic acid at those positions. The first tyrosine (which arguably is a 
framework and not CDR residue) was deleted in mutant constructs and the arginine, which 
when at this position has also been implemented in pMHC recognition (Reiser et al, 2000; 
Reiser et al, 2002 and Mazza et al, 2007), was replaced as part of the glycine-alanine linker. 
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The other CDR2 positions modified with the glycine-alanine linkers (49-51 in Marrack et al, 
2008; IMGT 57-59) have also been found to consistently form contacts with pMHC 
complexes in mice and human structures (Marrack et al, 2008).   
The only “interaction codon” positions not altered in this study were the terminal αCDR1 
proline and a glutamic acid encoded near the βCDR2 (Figure 4.1A). In terms of the TCRα 
residue is was thought the proline at that position may have an important structural role in 
terms of loop positioning and thus was not modified. Similarly the β chain template glutamic 
acid was deemed to form part of the framework downstream of the CDR2. However this 
residue position has been reported to be less important than other key βCDR2 positions 
(Scott-Browne et al, 2009 and 2011). Importantly the resultant mutants bear no resemblance 
to any naturally occurring CDR1 and 2 pair encoded within the murine genome. This ensures 
any interaction between the mutant TCR and any pMHC is novel and unrelated to any 
interaction that has been subject to co-evolutionary pressures exerted on CDR1 and 2 by 
MHC molecules.  
In summary, key germline CDR positions have been proposed to be conserved in recognising 
different classes and alleles of MHC, coupled to other positions that play a less dominant role 
(Marrack et al, 2008). The modifications to germline CDR1 and 2 of the TCRα and β chain 
templates presented here, correspond to the majority of these dominant and secondary 
positions. Critically, these mutants will be tested during thymic selection against several 
MHC alleles from the CBA TCRα-/- or FVB/N TCRβδ-/- recipient mice (Table 4.1) some of 
which have been co-crystallised interacting with TCRs using these proposed conserved 
positions. Interestingly, the H2-A class II gene on both haplotypes used in this study (H2k and 
H2q) contains conserved α-helical residues contacted consistently by the proposed interaction 
codons from previously described TCR-pMHC structures (see Chapter 1.4.5 and Feng et al, 
2007). Thus regardless of the MHC background, all key potential germline interacting 
positions will have been modified despite the presence of commonly contacted ligand 
residues. 
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Table 4. 1: Summary of common mouse strain haplotype and MHC allele use 
 
4.1.2 Generation of TCRα and TCRβ CDR1 and 2 mutants 
Several modified genes were already available at the time of starting this project including the 
βWT, βCDR1Δ2Δ (already cloned into pMigR1; kind gifts from Istvan Bartok and Matthew 
White) and the αWT, αCDR1Δ, αCDR2Δ and αCDR1Δ2Δ (maintained in a standard bacterial vector; 
kind gifts from Istvan Bartok and Edward Wang). The βWT and βCDR1Δ2Δ genes were used as 
templates to replace the WT βCDR3 with the short triple glycine linker using the overlap 
PCR method described in Chapter 2.2.3 and Figure 2.8 generating the final βCDR3Δ and 
βCDR1Δ2Δ3Δ mutants (Figure 4.2A). These, plus the assorted TCRα constructs were sub-cloned 
into the pMigR1 vector and mutations then confirmed by sequencing (Figure 4.2B). All 
constructs were shown to successfully transfect the viral packaging cell line (Figure 2.7). 
 
 
 
 
 
 
Strain Haplotype K D L A E
FVB/N H2q + + - + -
Balb/c H2d + + + + +
C57BL/6 H2b + + - + -
CBA H2k + + - + +
II ssalCI ssalC
MHC Allele
Table 4.1: Summary of common mouse strain haplotype and MHC allele use
Mouse
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Figure 4. 2: Generation of TCRα and TCRβ CDR mutants and sub-cloning to the pMigR1 vector.  
 (A) Gel electrophoresis demonstrating generation of the βCDR3Δ and βCDR1Δ2Δ3Δ chains from the βWT and βCDR1Δ2Δ 
templates respectively. R1, R2 and R3 refer to stages described in Figure 2.8. R3 represents the full-length 
chains of 997 base pairs (bp). M = the marker lane with relevant sizes indicated. (B) Partial protein alignments of 
TCRα and TCRβ chain CDR mutants. Sequences generated from chains sub-cloned to the pMigR1 vector. 
Sequences are compared to original C6 TCRα and TCRβ sequences. Relevant CDR sequences are highlighted, 
along with the key framework tyrosine (Y) removed upstream of CDR2 in the βCDR1Δ2Δ3Δ mutant. Sequences 
aligned with eBioX using a ClustalW (accurate) algorithm. 
 
4.1.3 TCRs with modified CDR1 and 2 can form surface expressed TCRs with an endogenous 
partner chain repertoire 
To ensure the exogenous WT and mutant TCRα and β chains could form stable TCRs with an 
endogenous repertoire of partner chains, concanavalin A (ConA) activated splenocytes from 
WT C57BL/6 or CBA mice were transduced with viral supernatant containing the most 
drastically altered CDRs and their controls. Splenocytes were subjected to flow cytometric 
analysis using C6 TCR Vα8.3 or Vβ11 specific antibodies to confirm TCR expression 
(Figure 4.3). Studies have shown that in normal TCR, structural stability was not affected by 
changes to the surface exposed variable regions, but was more drastically affected by changes 
in the invariant, constant domain interface regions of V-segments (Richman et al, 2009). 
Analysis of GFP+ T cells from WT CBA splenocytes (that contain no endogenous Vβ11 due 
to superantigen deletion; Tomonari et al, 1993) transduced with the βCDR1Δ2Δ3Δ and βCDR3Δ 
chains, universally expressed Vβ11, demonstrating alteration of the C6 TCRβ chain CDR1-3 
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does not affect the chain’s capacity to form stable TCRs (Figure 4.3A). While GFP+ αWT 
transduced T cells from WT C57BL/6 transduced splenocytes, universally expressed Vα8.3, 
comparable populations of GFP+ αCDR1Δ2Δ transduced T cells mice only contained a small 
positive peak. This peak can be attributed to the endogenous C57BL/6 Vα8.3 population and 
is also present in the vector only negative control.  The anti-Vα8.3 antibody clone used for 
staining was the B21.14. The epitope recognised by this antibody has been mapped to the 
unique CDR1 sequence, thus lack of staining for the αCDR1Δ2Δ could have been related to lack 
of binding as opposed to lack of expression (Brodnicki et al, 1996). This was further implied 
by the fact that T cells expressing the αCDR2Δ but not the αCDR1Δ mutant were stained with this 
antibody (Figure 4.3B). A general point to note is that the lack of uniformity of the peaks for 
all constructs can be explained due to the competition between the exogenous and 
endogenous chains for dimer formation. 
 
Figure 4. 3: TCRα and β germline CDR mutants can form surface expressed TCR with an endogenous partner 
chain repertoire.  
(A) Flow cytometric analysis of cultured splenocytes transduced with viral supernatant containing the βCDR3Δ, 
βCDR1Δ2Δ3Δ, αWT, αCDR1Δ2Δ or pMigR1 vector only controls. Plots were gated on GFP+ T cells and 
stained for exogenous TCR chain specific antibodies (blue line). Expression was measured relative to GFP+ 
non-T cells (CD4-CD8- lymphocytes; filled grey peak). (B) The same flow cytometric analysis as for (A) carried 
out on splenocytes transduced with viral supernatant containing the αCDR1Δ or αCDR2Δ retrogenes. 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As the alteration of all 3 TCRβ CDRs did not inhibit αβTCR formation, it was assumed the 
lack of αCDR1Δ2Δ detection was most likely due to loss of staining as opposed to lack TCR 
formation. As the retrogenic approach could be conducted on a TCRα deficient background, 
it was decided to use the αCDR1Δ2Δ construct for in vivo work, as T cell development would 
indicate definitive surface expression of TCRs using the exogenous chain. Thus the most 
extreme TCRα and TCRβ mutants were selected for in vivo analysis. As these chains can 
form stable TCRs, any resultant difference between mutant and WT chains could be attributed 
to their altered CDRs. 
4.2 Analysis of thymic development of T cells in mice lacking TCRα  and TCRβ  CDR1 and 
2 
4.2.1 Mice expressing exogenous TCRα chains have delayed T cell development and lower 
numbers of peripheral T cells than mice expressing exogenous TCRβ chains  
Cultured HSCs from the relevant TCR deficient donors were successfully transduced with 
viral supernatants containing the αWT, αCDR1Δ2Δ, βCDR3Δ or βCDR1Δ2Δ3Δ constructs (Figure 2.10; 
Figure 4.4A). Flow cytometric analysis of blood over time revealed that both the WT and 
mutant TCRα retrogenic mice developed T cells at a slower rate than their TCRβ counterparts 
(Figure 4.4B). Detection of GFP+ T cells in the blood of TCRα WT or mutant retrogenic mice 
occurred around 8 weeks post-HSC transfer, and clearer populations taking as long as 12-15 
weeks to fully appear (Figure 4.4B). Both sets of TCRβ retrogenic mice however generally 
displayed clear GFP+ T cell populations by 6 weeks. TCRβ retrogenic T cells stained 
uniformly for Vβ11, while the αWT retrogenic T cells stained similarly for Vα8.3. The 
presence of T cells and positive staining for pan-TCR antibody on GFP+ CD4 and CD8 
lymphocytes confirms expression and formation of TCRs using the αCDR1Δ2Δ (see previous 
section). The difference in T cell development time is thus related to differences in exogenous 
TCR chain expression and is not a result of CDR modification.  
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Figure 4. 4: Generation of mice expressing WT and CDR modified TCRα and TCRβ chains.  
(A) Flow cytometric analysis of cultured HSC transduced with viral supernatant containing TCR constructs as 
labelled. (B) Flow cytometric analysis of CD4 and CD8 T cells from the blood of mice expressing TCRα and 
TCRβ retrogenic chains, taken from 6, 8 and 15 weeks. Plots were gated on GFP+ lymphocytes. The inset panel 
shows staining of Vα8.3, Vβ11 or pan-TCR antibodies on GFP+ CD4 (blue line) and CD8 (red line) T cells 
relative to GFP+ non-T cells (filled grey plot). 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Total GFP+ T cell numbers were determined from whole spleen (Figure 4.5A). While the 
numbers were variable for each mouse group – attributed to variations in the retrogenic 
approach, there were no significant overall differences between mice expressing the αCDR1Δ2Δ 
or βCDR1Δ2Δ3Δ and their WT controls. However, the differences between the TCRα and TCRβ 
retrogenic mice was again highlighted by the average GFP+ T cell number in TCRα 
retrogenics being an order of magnitude less than their TCRβ counterparts (x106 versus x107). 
Finally, further evidence for relatively poor T cell development in TCRα WT and mutant 
retrogenics is demonstrated by the presence of the lower proportions of GFP+ T cell 
lymphocytes relative to GFP+ non-T cells, which was evident from blood (Figure 4.4) and 
spleen (Figure 4.5B).  
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Figure 4. 5: Retrogenic mice expressing exogenous WT or mutant TCRα chains develop few GFP+ T cells.  
(A) Summary of GFP+ T cell counts from whole spleen of retrogenic TCRα and TCRβ mice. Counts were 
determined by comparing total splenocyte number calculated by light microscopy with proportions GFP+ T cells 
determined by flow cytometry. WT chains were compared to CDR1 and 2 mutant chains using a two-tailed 
unpaired student’s t-test. NS = not significant.  (B) Comparison of proportions of GFP+ lymphocytes from whole 
spleen of retrogenic mice that are deemed T cells (CD4+ or CD8+) or non-T cells (CD4-CD8-). Proportions were 
determined by flow cytometry of whole spleen. n = αWT = 5, αCDR1Δ2Δ = 5, βCDR3Δ = 7 and βCDR1Δ2Δ3Δ = 8. Error 
bars represent S.E.M. TCRβ and TCRα mice were analysed 6-8 weeks and 12-15 weeks post-HSC transfer 
respectively. 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TCR retrogenic or transgenic mice often exhibit lymphopenia due to clonal competition in the 
thymus (Hataye et al, 2006). Subsequent homeostatic mechanisms in such mice include 
expansion due the sense of “space” in the periphery (Takada and Jameson, 2009). CD44 is a 
marker for homeostatic expansion in naïve mice (Kieper and Jameson, 1999) and can be 
detected at low, medium and high expression levels. CD44 levels were measured via flow 
cytometry on T cells from TCRβ retrogenic mice to determine if any differences in T cell 
development are being compensated for via homeostatic expansion as has been shown in 
previous studies using retrogenic TCRs with CDR2 modifications (Scott-Browne et al, 2009). 
Both retrogenic TCRβ mice displayed significantly higher proportions of CD44hi T cells 
relative to fully WT FVB/N mouse. This is unsurprising given that WT FVB/N utilise two 
fully WT TCR loci to generate their TCR repertoires (Figure 4.6). Interestingly however, 
despite similar overall GFP+ T cell numbers, there was also a significant difference between 
the βCDR1Δ2Δ3Δ and its βCDR3Δ control in terms of CD44HI expression levels on GFP+ CD4 and 
CD8 T cells. 
 
 
Figure 4. 6: Loss of TCRβ CDR1 and 2 results in increased homeostatic expansion of CD4 and CD8 T cells.  
Flow cytometric analysis was performed on whole spleen of FVB/N, βCDR3Δ and βCDR1Δ2Δ3Δ mice. Cells were 
gated on GFP+ lymphocytes and CD44HI expression measured on CD4 and CD8 T cells. The figure shows 
representative plots of the TCRβ retrogenic mice relative to the FVB/N WT control (left) and summary charts of 
the TCRβ retrogenics (right). Groups were compared by an unpaired, two-tailed student’s t-test. *** = p 
<0.0001. 
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Overall these data clearly show that extensive modification of TCRα and TCRβ CDR1 and 2 
does not prevent MHC dependent in vivo selection of T cells. This implies that a full 
complement of germline contacts is not required for successful pMHC recognition. Loss of 
WT CDR sequence from the TCRα or TCRβ chain does not affect the kinetics of T cell 
development or overall T cell numbers. However clear differences between TCRα and TCRβ 
retrogenics were observed indicating timing of expression of the different chains could 
influence the efficiency T cell development irrespective of CDR sequence. This is further 
studied in Section 4.3.3. In the TCRβ retrogenics, the comparable GFP+ T cell number 
between the βCDR3Δ and βCDR1Δ2Δ3Δ mice was shown to be a product of increased homeostatic 
expansion in the latter, suggesting that loss of germline βCDR1 and 2 may influence T cell 
development in thymus, without prohibiting MHC recognition. This was further investigated 
in Section 4.2.2. 
4.2.2 Analysis of thymi from mice expressing TCRβ chains lacking WT CDR1 and 2 have 
reduced selection efficiency and MHC class bias 
Any deficiency in T cell selection in βCDR1Δ2Δ3Δ mice should most likely be manifested at the 
DP stage of thymic development as consistent expression of the exogenous TCRβ would 
ensure all GFP+ cells could successfully pair with the pTα ensuring progression to the DN4 
and DP phases of development. 
Successfully reconstituted thymi from retrogenic TCRβ mice were subjected to flow 
cytometric analysis. CD5 is a negative regulator of TCR signalling acting to contain excessive 
responses (Tarakhovsky et al, 1995; Azzam et al, 1998 and Azzam et al, 2000). It is up 
regulated upon successful engagement of pMHC in the thymus by DP thymocytes and 
expression levels have been shown to be directly proportional to the efficiency of MHC 
engagement by the TCR. GFP+ DP thymocytes from βCDR1Δ2Δ3Δ mice showed a significantly 
decreased CD5 expression level relative to the βCDR3Δ control (Figure 4.7). Thus while 
removal of TCRβ germline CDR1 and 2 does not prevent pMHC recognition, replacement 
with glycine-alanine linkers does result in a decrease in selection efficiency. To test whether 
such an effect is haplotype specific, HSC from TCRβδ-/- mice were transduced with βCDR3Δ or 
βCDR1Δ2Δ3Δ as above and transferred to irradiated H2k CBA TCRα-/- recipient mice. In the 
resulting chimeras, thymocytes are generated from H2q HSC but selected on an H2k haplotype 
MHC (Table 4.1). 
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Similar analysis of successfully reconstituted thymi from H2k recipients also displayed a 
similar reduction in CD5 expression levels (Figure 4.8), proving this effect is a general result 
of loss of the germline CDR1 and 2 structures.  
 
 
Figure 4. 7: Replacement of germline CDR1 and 2 structures with glycine-alanine linkers results in decreased 
selection efficiency.  
Flow cytometric analysis of GFP+CD4+CD8+ thymocytes from βCDR3Δ and βCDR1Δ2Δ3Δ mice on H2k (top) and H2q 
(bottom) backgrounds. Representative plots (right) of CD5 expression for the βCDR3Δ (dark line) relative to 
βCDR1Δ2Δ3Δ (filled peak) and plot summaries (left) measuring the percentage of CD5HI cells. Groups were 
compared by an unpaired, two-tailed student’s t-test. H2k: n =4, p<0.0202 and H2q: n = 3, p<0.0058. 
 
Further analysis of GFP+ thymocytes revealed a skew towards CD4 SP in βCDR1Δ2Δ3Δ mice in 
comparison to βCDR3Δ mice, which had a relatively normal selection ratio of SP T cells (~1:2 
CD8:CD4 ratio; Figure 4.8). This phenomenon was also haplotype independent; presenting 
on both H2q and H2k backgrounds, showing the apparent preference for class II is not limited 
to H2-A (the only class II gene on the H2q haplotype). The CD4 skewing also manifested in 
the periphery for both GFP+ T cells in spleen and LN on H2q and H2k haplotypes. On H2q, 
βCDR3Δ mice displayed a roughly 1:2 CD8:CD4 ratio, comparable to a normal spleen, whereas 
βCDR1Δ2Δ3Δ mice often had CD4 bias up to 1:6. This effect was more pronounced in the 
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periphery on the H2k background, particularly in the LN. Here, the βCDR3Δ mice exhibited a 
clear CD8 preference (indeed, the original C6 TCR is H2Kk specific, although the C6 TCRα 
chain has been proposed to drive this preference; Furmanski et al, 2010), whereas as with 
H2q, selection of βCDR1Δ2Δ3Δ containing T cells on H2k resulted in a significant skew to CD4, 
with the LN demonstrating a complete mirror image of T cell compartment preference 
(Figure 4.9).  Further, replacement of just one of the βCDR1 or 2 loops is sufficient to induce 
a CD4 skew in the periphery (Bartok, unpublished; Figure 4.9B). 
Overall these data further establish that while replacement of germline βCDR1 and 2 with 
glycine-alanine linkers does not prevent T cell selection, there is a significant haplotype 
independent drop in selection efficiency at the DP phase. This most likely explains the 
resultant increase in homeostatic expansion reported in the previous section. Interestingly, 
there is also a clear skew towards the CD4 T cell compartment that originates during thymic 
selection and is maintained in the periphery in βCDR1Δ2Δ3Δ mice. It cannot be conclusively 
demonstrated that the drop in selection efficiency is entirely due to a lack of selection on class 
I MHC, however the fact that both CD4 and CD8 βCDR1Δ2Δ3Δ T cells demonstrate significant 
up-regulation of CD44 in the periphery infers that selection on both class I and II are 
relatively inefficient and that the class bias is an inherent event. 
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Figure 4. 8: Removal of germline βCDR1 and 2 results in a CD4 bias selected in the thymus.  
(A) Flow cytometric analysis of βCDR3Δ and βCDR1Δ2Δ3Δ thymi on H2q (top) and H2k (bottom) haplotypes. Figure 
shows summary plots (right) gated on GFP+ thymocytes and CD4 skew summary (left) presented as the total 
percentage of all SP thymocytes that are CD4 SP. Groups were compared using an unpaired two-tailed student’s 
t-test. *** = p<0.0058, * = p<0.0202. (B) Comparable analysis of mice expressing the exogenous TCRβ chain 
with only the CDR2 modified (construct provided and generated by Istvan Bartok).  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Figure 4. 9: The thymically selected CD4 bias in βCDR1Δ2Δ3Δ mice is maintained in peripheral lymphoid organs.  
Flow cytometric analysis of whole spleen (left) and inguinal LN (right) from βCDR3Δ and βCDR1Δ2Δ3Δ mice on 
H2q and H2k haplotypes. Representative plots (bottom) are gated on GFP+ lymphocytes and skew summary (top) 
is presented as the total proportion of T cells that are CD4+. Groups were compared using an unpaired two-tailed 
student’s t-test. For H2q: *** = p<0.0001, * = p<0.0180. For H2k: *** = p<0.0001. 
 
4.2.3 Competition between GFP+ and GFP- cells results in poor T cell selection in retrogenic 
TCRα mice 
As shown in Section 4.3.1, TCRα retrogenic mice exhibited delayed appearance of peripheral 
T cells and greater proportions of transferred GFP+ HSC were likely to develop into non-T 
cell lymphocytes. This indicated that early expression of the TCRα chain, regardless of its 
CDR complement, could be affecting T cell development. Previous studies have shown the 
timing of TCRα expression can influence T cell development (Baldwin et al, 2005). However 
this work also demonstrated that while early expression of the TCRα can increase DN 
cellularity at the expense of DP cellularity, early expression of the TCRα chain did not affect 
positive selection at the DP stage. Indeed C6 TCRα transgenic mice from work in this 
laboratory were shown to develop and select T cells efficiently in the thymus (Furmanski et 
al, 2010). Flow cytometric analysis of GFP+ thymocytes of retrogenic TCRα mice however, 
confirmed that selection of T cells in both αWT and αCDR1Δ2Δ was poor with negligible SP 
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populations and expression of CD5 on DPs lower than fully WT mice (Figure 4.10). This was 
confirmed using both H2k and H2q recipient mice.  
 
 
Figure 4. 10: T cell selection in WT and mutant TCRα retrogenic mice is poor, regardless of the selecting 
haplotype.  
(A) Flow cytometric analysis of GFP+ thymocytes in TCRα retrogenic mice. Plots shown are representative and 
show expression of CD4 versus CD8. (B) Flow cytometric analysis of GFP+ DP thymocytes from TCRα 
retrogenic mice. In the main plot, CD5 expression is measured in αWT on H2k (Orange) and H2q (Red) and 
similarly for αCDR1Δ2Δ on H2k (Green) and H2q (Blue) mice. Expression levels from all these mice are 
consistently lower than that of a fully WT FVB/N mouse (Grey). If compared with Figure 4.8, a general shift to 
the right of CD5 expression is seen. This is due to the use of different flow cytometers and antibody 
conjugations in TCRα and TCRβ retrogenic mice. To control for this, GFP+DP thymocytes from βCDR3Δ mice on 
H2k (deemed CD5HI in Figure 4.8; Inset, dashed line) were compared to the same FVB/N WT population (Inset, 
filled peak), to show the decrease in WT and mutant TCRα mice is genuine relative to FVB/N mice. Plots are 
representative.  
The blockage at the DP stage, if not related to early TCRα expression, may be explained by 
competition with GFP- HSC that have been adoptively transferred with the GFP+ HSC that 
express the retrogenic TCRα chains (Figure 2.10). As successful progression from DN4 to 
DP requires a functional TCRβ chain, GFP- HSC from the TCRβ retrogenics (i.e. from 
TCRβδ-/- donors) cannot progress to the DP, meaning only thymocytes containing the 
exogenous TCRβ chains can audition for T cell selection. However, in the TCRα retrogenics 
where HSC contain a WT TCRβ locus, GFP- thymocytes should be able to progress through 
DN1-4 and to the DP stage. Only at this stage will the lack of a functional TCRα chain 
prevent selection of mature T cells.  Figure 4.11A summarises flow cytometric analysis of 
GFP- DN thymocytes from αWT and αCDR1Δ2Δ mice, which contain comparable DN1-4 
proportions as a fully WT mouse (Baldwin et al, 2005). While the TCRβ retrogenic mice also 
contained GFP- DN4 thymocytes (data not shown), these cells should not readily progress to 
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the DP stage unlike GFP- TCRα retrogenic DN4 thymocytes. This was proven by the fact that 
TCRα retrogenic mice contained significantly higher proportions of GFP- DP thymocytes 
relative to TCRβ retrogenics (Figure 4.11B). Although a surprisingly high number of GFP- 
DP thymocytes were found in both sets of TCRβ retrogenic mice, these cells could not 
undergo positive selection (see next section). Finally, another factor that would diminish T 
cell selection in the TCRα retrogenics is that during normal TCR rearrangement, a rearranged 
TCRβ chain can audition with different TCRα partner chains for positive selection (Chapter 
1.2.2), which is also true of the TCRβ retrogenic system. However in the TCRα retrogenics, 
the endogenous TCRβ repertoire can only audition with the single exogenous TCRα chain, 
which may also impede development of T cells at the DN4-DP transition. 
 
 
Figure 4. 11: GFP- cells from TCRα retrogenic mice progress through T cell development and populate the DP 
compartment.   
(A) Flow cytometric data of GFP- DN thymocytes reveal comparable proportions of CD25-CD44- DN4 cells in 
αWT and αCDR1Δ2Δ mice. Representative plots (left) are shown for the αWT (top) and αCDR1Δ2Δ (bottom) mice. The 
key to DN stages based on CD25 and CD44 expression is shown top right. Summary of n = 3 for both sets of 
mice is shown on the right. Error bars = S.E.M. (B) Comparison of proportion of CD4+CD8+ DP GFP- 
thymocytes present in TCRα and TCRβ retrogenics. Data is based on flow cytometric analysis of GFP- 
thymocytes gated on CD4 and CD8 expression. Data taken from TCRα retrogenics and TCRβ retrogenics 
selected on H2k and H2q haplotypes respectively. Groups were compared via a one-way ANOVA with Tukey’s 
multiple comparison post-test. n = αWT = 7, αCDR1Δ2Δ, βCDR3Δ and βCDR1Δ2Δ3Δ = 8. NS = not significant, * and ** = 
p < 0.05. Error bars show standard deviation (SD) to highlight the variability of retrogenic approach. 
 
 
0
20
40
60
80
100
DN1
DN2
DN3
DN4
!
W
T
!
C
D
R
1
"
2
"
11.3 2.33
5.52
80.8
5.09 1.54
3.97
89,4
DN1
DN2DN3
DN4
P
ro
p
o
rt
io
n
 G
F
P
- 
D
N
 t
h
y
m
o
c
y
te
s
 (
%
)
CD44
C
D
2
5 0
20
40
60
80
100 NS * NS
**
*
**
!
W
T
!
C
D
R
1
"
2
"
#
C
D
R
3
"
#
C
D
R
1
"
2
"
3
"
P
ro
p
o
rt
io
n
 G
F
P
- 
D
P
 t
h
y
m
o
c
y
te
s
 (
%
)
A B
  150 
While these technical difficulties precluded any in depth analysis of retrogenic TCRα thymi, 
and despite inefficient T cell selection, both αWT and αCDR1Δ2Δ mice produced mature T cell 
populations, albeit with lower peripheral numbers as discussed in Section 4.3.1. Analysis of 
peripheral populations of GFP+ lymphocytes from whole spleen and LN of αWT and αCDR1Δ2Δ 
mice on H2k and H2q selecting backgrounds was thus performed. While removal of the 
βCDR1 and 2 resulted in a class II bias, reciprocal modifications to the αCDR1 and 2 
produced an apparent opposing skew to MHC class I (Figure 4.12). Although this skew was 
only statistically significant for splenocytic T cells selected on H2q, the general trend is clear 
and in stark contrast to the effect seen upon modifying the βCDR1 and 2. While it is possible 
the alpha mutations impart a less severe effect than their TCRβ counter parts, the skewing 
from αCDR1Δ2Δ containing TCRs may be being masked by the poor selection in the thymus, 
where the βCDR1Δ2Δ3Δ skew originates. 
 
 
Figure 4. 12: Removal of TCRα germline CDR1 and 2 results in a slight CD8 bias in peripheral lymphoid 
organs.  
Flow cytometric analysis of whole spleen (left) and inguinal LN (right) from αWT and αCDR1Δ2Δ mice on H2q and 
H2k haplotypes. Representative plots (bottom) are gated on GFP+ lymphocytes and skew summary (top) is 
presented as the total proportion of T cells that are CD4+. Groups were compared using an unpaired two-tailed 
student’s t-test. NS = not significant, * = p < 0.05. 
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4.2.4 Removal of TCRβ but not TCRα CDR1 and 2 may inhibit Treg development 
As discussed in Chapter 1.2.2, the role of the TCR in nTreg development is contentious 
(Josefowicz and Rudensky, 2009). As the modified TCRs used in this study can clearly 
interact with MHC during thymic selection, the work presented here cannot contribute 
directly to requirement of TCR instruction for nTreg development in the thymus. However 
the changes made to the TCRα and TCRβ CDR1 and 2 do have the ability to influence the 
quality of any interaction with MHC. Indeed, it has been shown that the largely non-
overlapping repertoire of nTregs generally encode for a TCR of slightly higher affinity 
(Jordan et al, 2001). To measure the affinity of TCR-pMHC requires the generation of a 
clonal TCR via immunisation with Ag and subsequent screening which was out of the scope 
of this study. Nonetheless replacement of WT structured CDR1 and 2 with flexible glycine-
alanine linkers would generate TCRs with a somewhat flattened interacting surface, (Figure 
4.13) that could alter the diversity of endogenous TCR partner chains (see next section) and 
thus nTreg development could be affected. 
 
Figure 4. 13: Replacement of germline CDR1 and 2 flattens the interaction surface of TCR.  
Homology model of C6 TCRβ chain based on 2C TCR sequence. WT (grey net) and mutated (blue net) CDR1 
and 2 are highlighted to show the topology of the interacting surface of the TCRβ chain. Model produced by 
Istvan Bartok and Matthew White. 
 
CD4+CD25+FoxP3+ nTregs can be detected in the SP CD4 thymic compartment of normal 
mice. Analysis of thymocytes in βCDR3Δ and βCDR1Δ2Δ3Δ mice revealed a slight reduction of 
CD4 T cells bearing these markers in the latter (Figure 4.14A). Although the permeabilisation 
process required to detect FoxP3 would remove any GFP+ signal, analysis of GFP- peripheral 
cells were shown to contain negligible CD4+ populations, thus one can assume any CD4 cells 
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detected after fixation and permeablisation were previously expressing the exogenous TCR 
chain (Figure 4.14B). Unfortunately, as the TCRα retrogenic mice displayed negligible SP 
populations a similar analysis could not be conducted.  
 
Figure 4. 14: Removal of germline TCRβ CDR1 and 2 does not prevent thymic generation of nTregs.  
(A) Flow cytometric analysis of CD4 SP thymocytes in βCDR3Δ and βCDR1Δ2Δ3Δ mice looking at CD25 and FoxP3 
expression. Representative plots are shown on the left and a summary of the average proportion of 
CD4+CD25+FoxP3+ thymocytes on the right. Groups were compared using an unpaired student’s t-test. NS = not 
significant. n = βCDR3Δ = 3, βCDR1Δ2Δ3Δ = 4. Error bars = S.D. (B) Representative flow cytometric plots from 
βCDR3Δ and βCDR1Δ2Δ3Δ lymphocytes from whole spleen. Plots show CD4 and CD8 expression on GFP+ (left) and 
GFP- (right) populations. 
Both TCRα and TCRβ CDR1 and 2 WT and mutant mice exhibited similar proportions of 
CD4+CD25+FoxP3+ lymphocytes in the spleen, implying Tregs can also develop in TCRα 
mice also (Figure 4.15A). There was, however, a slightly lower proportion in the TCRβ 
retrogenics, relative to the TCRα mice. Further, the CD4+CD25+FoxP3+ phenotype does not 
distinguish between iTregs and nTregs in TCRα retrogenics, thus it is plausible that all 
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αCDR1Δ2Δ mice could only generate Tregs through induction in the periphery. Recently, the 
Ikaros transcription family member Helios, whose expression appears limited to the T cell 
haematopoietic compartment (Kelley et al, 1998 and Hahm et al, 1998), has been proposed to 
be a peripheral marker that distinguishes between iTregs (Helios-) and nTregs (Helios+) 
(Thornton et al, 2011).  It was shown that approximately 70% of CD4+CD25+FoxP3+ Tregs 
co-expressed Helios, which was also found to be expressed at the DN1 stage of T cell 
development and present in 100% of all thymocytes from DN2, with nearly all CD4 SP 
FoxP3+ cells in the thymus expressing the novel marker. While it has yet to be universally 
accepted, Helios provided the best opportunity for detection of nTregs in the TCRα 
retrogenics. As shown in Figure 4.15B, αWT and αCDR1Δ2Δ mice express comparable 
proportions of CD4+CD25+FoxP3+Helios+ T cells, both to each other and to the original study 
by Thornton et al. The same analysis was carried out in TCRβ retrogenic mice, with these 
mice also demonstrating equivalent proportions of CD4+CD25+FoxP3+Helios+ T cells to each 
other. Interestingly, both the βCDR3Δ and βCDR1Δ2Δ3Δ mice contained a lower proportion than the 
TCRα retrogenic mice. However, the lack of absolute nTreg numbers, coupled to selection 
efficiency variation and relatively small samples sizes makes it difficult to draw any 
meaningful conclusion on genuine differences between fixing a TCRα versus a TCRβ chain. 
As with direct detection of thymic nTregs in the TCRβ retrogenic mice, use of Helios to 
define nTregs in the periphery also highlighted a slight reduction in the βCDR1Δ2Δ3Δ mice 
relative to the βCDR3Δ control. 
Ultimately, these data imply nTreg development is not influenced by germline CDR structure 
and its interaction with MHC and that T cells with modified TCRα and TCRβ CDR1 and 2 
produce TCRs with suitable affinities and endogenous TCR partner diversity to select nTregs. 
While no functional analysis was carried out on these populations to confirm suppressive 
activity, complete loss of Treg function can result in systemic autoimmunity, which was not 
detected in our primary retrogenic mice. 
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Figure 4. 15: TCRα and TCRβ retrogenic mice contain both induced and natural Tregs based on FoxP3 and 
Helios expression.  
(A) Flow cytometric analysis of whole spleen gated on CD4+ lymphocytes looking at Foxp3 and CD25 
expression. Representative plots are displayed on the right with summary charts plotting the proportion of 
CD4+CD25+FoxP3+ lymphocytes from whole spleen. Groups were compared using an unpaired student’s t-test. 
NS = not significant. (B) Flow cytometric analysis of whole spleen from TCRα and TCRβ retrogenic mice. 
Samples were gated on CD4+CD25+ lymphocytes (representative plots; top) and analysed for expression of the 
transcription factors Helios and FoxP3 (representative plots; middle and summary charts; bottom). Summary 
plots were compared using an unpaired student’s t-test. NS = not significant. 
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4.2.5 Removal of TCRα or TCRβ CDR1 and 2 results in a decrease in endogenous partner 
chain CDR3, but not V-segment, diversity 
DN4 thymocytes entering the DP phase of thymic development express a rearranged TCRβ 
chain that has successfully signalled in conjunction with the pTα (Chapter 1.2.2). While 
successful TCRβ rearrangement results in allelic exclusion, to avoid further rearrangements, 
more than one TCRα chain can audition with the fixed TCRβ. This is because not all 
combinations can successfully pair with each other, for example due to incompatibility of the 
hypervariable CDR3s (Bartok et al, 2010) and functions to maximise repertoire diversity. 
This section aimed to analyse whether altering the CDR1 and 2 can also influence the 
repertoire of partner chain diversity. Previous work using mice expressing a B6.2.16 TCRβ 
transgene demonstrated that the selecting MHC haplotype could alter the partner TCRα 
repertoire (Ferreira et al, 2006). The B6.2.16 TCRβ chain’s cognate TCRα partner chain 
contains a Vα9 segment and the resultant TCR is specific for the HY Smcy peptide presented 
on H2-Db class I MHC (Millrain et al, 2001). Analysis of TCRα partner chain diversity on 
different selecting haplotypes revealed a loss of Vα9 preference on haplotypes other than 
H2b. Subsequent examination of Vα9 associated J-segment and CDR3 repertoires were 
similarly reduced in diversity. This suggests that the B6.2.16 TCRβ chain interacts optimally 
with the H2b haplotype when paired with Vα9 where optimal CDR1 and 2 interactions 
facilitate selection of a diverse partner chain repertoire. Replacement of WT CDR1 and 2 with 
flexible glycine-alanine linkers, while not preventing MHC recognition, may be akin in 
causing sub-optimal MHC interactions which could have ramifications for partner chain 
repertoires during thymic selection.  
Flow cytometric analysis on GFP+ T cells from the spleen of αWT and αCDR1Δ2Δ mice on an 
H2q background for endogenous TCRβ V-segment expression revealed largely comparable V-
segment repertoires. As one would expect, the multi-family member Vβ8 represented the 
greatest proportion in both WT and mutant groups (Figure 4.16). While the B6.2.16 TCRβ 
mice displayed a preference to partner chains containing the same Vα9 segment as its original 
cognate partner chain when selected on the original haplotype, the CD8+ T cells from αWT 
mice did not show the same bias to Vβ11 TCRs when selected on H2k (Furmanski et al, 2010) 
relative to the data presented here on an H2q haplotype. This could be due to the abnormally 
long βCDR3 associated with the cognate C6 TCRβ chain as discussed (Bartok et al, 2010; 
See below).  
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Figure 4. 16: Removal of TCRα CDR1 and 2 does not alter endogenous TCRβ V-segment diversity.  
Summary of flow cytometric analysis on lymphocytes gated on GFP+CD4+ (top) and GFP+CD8+ (bottom) T 
cells stained with anti-mouse TCRβ V-segments. Data is presented as the percentage of the total for the GFP+ T 
cell population. n = 3 for all samples. P values represent the results from a two-way ANOVA analysis comparing 
columns within each V-segment across the whole sample. p > 0.05 is deemed not significant. Error bars 
represent SD. 
 
Similar flow cytometric analysis on TCRβ retrogenic mice was less useful due to the lack of 
specific anti-Vα antibodies of which only 4 exist: anti-Vα2, Vα3.2, Vα8.3 and Vα12. 
Further, the anti-Vα12 clone (B20.1) is specific for TCRs selected on H2b and H2d 
backgrounds only, reducing the available panel to three Vα segments (Figure 4.17A). Both 
sets of mice had comparable expression on CD4 T cells, regardless of selecting haplotype.  
Due to nature of the skewing to CD8, one may predict an associated drop in V-segment 
repertoire in the mutant mice, however both βCDR3Δ and βCDR1Δ2Δ3Δ GFP+CD8+ T cells showed 
a reduction in use of the three Vα segments analysed.  To facilitate a more in-depth analysis 
of Vα segment partner chain preference, a novel qRT-PCR approach that measured 
expression mRNA levels for all known Vα-segments was utilised (Figure 4.17B). While this 
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approach may include rearranged receptors that are not expressed on the cell surface or have 
not participated in thymic selection it will reveal significant changes in the functional 
repertoire. Analysis of mRNA expression levels from purified CD4 cells of whole spleen also 
demonstrated comparable Vα-segment usage between βCDR3Δ and βCDR1Δ2Δ3Δ in which both 
showed broad partner chain diversity, comparable to an FVB/N WT mouse, regardless of the 
selecting haplotype (Appendix 3). The only outlier existed for Vα8 in the βCDR1Δ2Δ3Δ CD4 T 
cells and is related to a single mouse within the group tested that demonstrated extremely high 
levels of Vα8 expression. This single occurrence is believed to be an artefact.  
 
Figure 4. 17: Removal of TCRβ CDR1 and 2 does not alter endogenous TCRα V-segment diversity.  
(A) Summary of flow cytometric analysis on lymphocytes gated on GFP+CD4+ and GFP+CD8+ T cells selected 
on H2q or H2k and stained with anti-mouse TCRα V-segments. Data is presented as the percentage of the total 
for the GFP+ T cell population. (B) qRT-PCR of cDNA made from isolated CD4 cells from spleen of βCDR3Δ and 
βCDR1Δ2Δ3Δ of TCR Vα segments. Further nomenclature used to distinguish distinct Vα4 and Vα13 segments is 
discussed in Chapter 6.1.  P value represents the results of a two-way ANOVA analysis comparing columns 
within each V-segment across the whole sample. p > 0.05 is deemed not significant. n = 4 for all samples. Error 
bars represent SD. 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To analyse endogenous J-segment and CDR3 diversity, RNA was extracted from CD8 or 
CD4 bead-purified splenocytes from TCRα and TCRβ retrogenic mice respectively. 
Repertoire diversity analysis was carried out via the colony PCR method as described in 
Chapter 3.2.2 for recombination cassette mice and elsewhere for CDR3 diversity (Ferreira et 
al, 2006 and Singh et al, 2010). Single V-segment containing families that expressed 
comparable levels between WT and mutant mice (Vβ7 in the TCRα retrogenics and Vα9 in 
the TCRβ retrogenics; See Figures 4.16 and 4.17) were selected. The designation of CDR3 
boundaries and numbering, differs between studies and databases (Garcia et al, 1996; Johnson 
and Wu, 2000; Lefranc et al, 2003 and Al-lazikani et al, 2000). The designation used here for 
Vα9 and Vβ7 containing TCRs is depicted in Figure 4.18 as used by (Ferreira et al, 2006 and 
Singh et al, 2010: c.f. to Garcia et al, 1996, who place the CDR3 boundary one amino acid 
further up from the J-segment motif). 
 
 
Figure 4. 18: Schematic depicting the definition of TCRα and TCRβ CDR3 boundaries as used in this study.  
The schematic represents the CDR3 regions in the context of Vα9 and Vβ7 – the endogenous rearrangements 
analysed in Figures 4.21 and 4.22. The beginning of the CDR3 occurs immediately after the germline 
framework region (GL3; red), which is proximal to the end of the framework 3 region (FR3; green). The GL3 
region is liable to modification through the action of TdT. The end of the CDR3 is deemed to terminate two 
residues upstream of the conserved J-segment FGXG motif (blue and dashed line) and is inclusive of any P/N 
nucleotide insertion made through V(D)J recombination (orange). Residue numbering from IMGT (α104 and 
β104: Lefranc et al, 2003) and the Kabat databases (α90 and β92; Johnson and Wu, 2000) are shown. 
 
 
 
 
FR 3 
CDR3 
P/N J-segment (+D ) 
V 9 
V 7 
S A K Y F C A L E X X X X X X X F G X G X X  
GL 3 
V-Segment 
S A K Y F C A L E X X X X X X X F G X G X X  
104 
92 
104 
90 
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PCR of cDNA with primers specific for Vα9 and Vβ7 with their respective constant regions, 
produced positive PCR signals that were cloned and subjected to colony PCR. Subsequent 
sequence analysis was carried out on 58, 84, 83 and 77 sequences for αWT, αCDR1Δ2Δ, βCDR3Δ 
and βCDR1Δ2Δ3Δ mice respectively (see Tables 4.2 and 4.3 for list of unique sequences). 
Endogenous J-segment analysis revealed a decrease in diversity in both TCRα and TCRβ 
mutant retrogenic mice, relative to the their WT counterparts (Figure 4.19). Interestingly, this 
reduction was not random, and was instead manifested through maintenance of the most 
common rearrangements, but loss of less common J-segments. Both αWT and αCDR1Δ2Δ mice 
showed preference for endogenous Jβ2.7 and 1.1 with the TCRβ retrogenic mice both biased 
towards Jα42 and 53. As discussed in Chapter 1.3.2, J-segment choice is not random, and the 
results presented here show loss of germline CDR1 and 2 does not prevent the preferable 
rearrangements from maintaining dominance but preclude more exotic options from forming 
suitable partner chains.   
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Mouse V!9 GL-3 CDR3 J-segment CDR3 Length
!
CDR3"
SAKYF CAPT SFSKL VFGQGTSLSVV 5
SAKYF CAR GSNYKL TFGKGTLLTVT 6
SAKYF CALY SNTDKV VFGTGTRLQVS 6
SAKYF CAL WFASAL TFGSGTKVIVV 6
SAKYF CALE GRNNNAP RFGAGTKLTVK 7
SAKYF CALG RSNTDKV VFGTGTRLQVS 7
SAKYF CAL ANSGYQNF YFGKGTSLTVI 8
SAKYF CAL GHPGYQNF YFGKGTSLTGI 8
SAKYF CALE GMDYANKM IFGLGTILRVR 8
SAKYF SAPE GPGGNEKI TFGAGTKPLIK 8
SAKYF CALE GPGGNNKL TFGQGAVLSVI 8
SAKYF CALG GPNNNNAP RFGAGTKLTVK 8
SAKYF CALE GRENANKV IFGKGTLFRVL 8
SAKYF CALE GRENAYKV IFGKGTHLHVL 8
SAKYF CALG ITGNTRKL IFGLGTTLQVQ 8
SAKYF CALE MTGGADRL TFGKGTQLIIQ 8
SAKYF CAL QSSNTDKV VFGTGTRLQVS 8
SAKYF SVHW RASSFSKL VFGQGTSLPVV 8
SAKYF SVHW RVGSGGKL TLGTGTRLQVN 8
SAKYF CALE AEAGNTRKL IFGLGTTLQVQ 9
SAKYF CAL AYSGGGNAK LTFGKGTKLSVK 9
SAKYF CSLE DSGESKTKR TLGKGTKLSGK 9
SAKYF CALE DSGGSNAKL TFGKSTKLSVK 9
SAKYF CALE DSGGSNYKL TFGKGTLLTVT 9
SAKYF CALE DTGANTGKL TFGHGTILRVH 9
SAKYF SALE EGGGTNNKL TFGKGTTLPVK 9
SAKYF SAVA EGSCSNNKL IFGKGTKLSVK 9
SAKYF FAVE ESGGSNNKL TFGKGTILSVK 9
SAKYF FAQA ESRGSTNKL TFGKGTKLTVK 9
SAKYF FSLV GGAGTYNKL TFGKGTTLTVK 9
SAKYF CALE GPDTGYQNF YFGKGTSLTVI 9
SAKYF CALE GSGGSNAKL TFGKGTKLSVK 9
SAKYF CALE GSGGSNYKL TFGKGTLLTVT 9
SAKYF LCTA IASSPFPQL VFGQGTSLSVV 9
SAKYF LCSD IASSSFSKL VFGQGTSLSVV 9
SAKYF CALE NTGGGSAKL IFGEGTRLTVS 9
SAKYF CALE VLQEVQIDS PLGKGLS 9
SAKYF CAL ANSGGSNYRLT SGKGTLLTMT 10
SAKYF CAL AYSGGTNAKL TFGKGTKLSVK 10
SAKYF CALE DLNTGGADRL TFGKGTKLSVK 10
SAKYF SAL GERGGTNNK LTFGKGTKLTVK 10
SAKYF SAQ GESSGSNSKL IFGKGTKLPVK 10
SAKYF CALE GGASSSFSKL VFGQGTSLSVV 10
SAKYF CAV GHSGGSKANL TFGKGTELSGK 10
SAKYF CAL GPSNYGNEKI TFGAGTKLTIK 10
SAKYF CALE GRETGNTRKL IFGLGTTLQVQ 10
SAKYF CALE GRLGANTGKL TFGHGAILRVH 10
SAKYF CSAE KNYGGSSNKL IFGTGTLLSVK 10
SAKYF CALE KTFGGSGNKL IFGAGGLLSGK 10
SAKYF CALE DLEGSSSFSKL VFGRGTSLSVV 11
Table 4.2: Summary of unique CDR3 sequence associated with V!9 in TCR" retrogenic mice
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Table 4. 2: Summary of unique CDR3 sequences associated with Vα9 in TCRβ  retrogenic mice 
 
 
 
 
 
 
 
 
SAKYF CALE DLEGSSSSSKL VFGQGTSLSVV 11
SAKYF CAL GGPWDGGNNKP TFGQGTVPSVI 11
SAKYF CALE GRRTGNTRKLI SGLGTTLQVQ 11
SAKYF CALE GTGSGGTNYKW TFRKGALLTGA 11
SAKYF CALE GWNSGGSNYKL TFGKGTLLTVT 11
SAKYF CAL RGASSSFSKL VFGQGTSLSVV 11
SAKYF CALE VMNYGGSGNKL IFGTGTLLSVK 11
SAKYF CALE DLDVGDNSKLIW GLGTSLVVN 12
!
CDR1"2"3"
SAKYF CAL WFAGAL TFGSGTKAIVL 6
SAKYF CAL WFASAL TSGSGTRVIVL 6
SAKYF CAL WLSSAW TSGSGGKVIGA 6
SAKYF CAL WTANAL TFGSGTKVIVA 6
SAKYF CALE GCNKNAP RFGAGTKLTVK 7
SAKYF CALE GRNNNAP RFGAGTKLTVK 7
SAKYF SALE AWGTANKM TFGSGAKLPVT 8
SAKYF CALE GPGGNEKI TFGAGTKLTIK 8
SAKYF CALE GRENAYKV TFGKGTHLHVL 8
SAKYF CALE DSGGTNAKL TFGKGTKLSVK 9
SAKYF SAVE ERCGTTNKL TFGKGTKLPVK 9
SAKYF SAEE ERGGTTNKL TFGKGTKLTVK 9
SAKYF SAEE ESRGSNSKL TFGKGTKLTVK 9
SAKYF CAL GASSSLSKL VFGQGTSLSVV 9
SAKYF CALE GWGYSNNRL TLGKGTQVVVL 9
SAKYF CALE ISGGSNYKL TFGKGTLLTVT 9
SAKYF SALA KRCGTKNKL IFGKGTKLTVA 9
SAKYF CALE VSGGSNYKL TFGKGTLLTVT 9
SAKYF CAL ANGGGSNYKL TFGKGTLLTVT 10
SAKYF CAL ASSGGSNYRL TFGKGTLLTVT 10
SAKYF CAL AYSGGSNAKL TFGKGTKLSVK 10
SAKYF SAE GERGGSTNKL TFGKGTKLTVK 10
SAKYF CALE GRRTGDTRKL IFGLGTTLQVQ 10
SAKYF CALE GRRTGNTRKL IFGLGTTLQVQ 10
SAKYF SAV GVSGGSTYKL TFGKGTLLPVT 10
SAKYF CALE DLEGSSSFSKL VFGQGTSLSVV 11
SAKYF CSSA DLEGSSTFNKL AFGQGTPLPVA 11
SAKYF CALE GWNSGGSNYKR TFGKGTLLTGA 11
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Mouse V!7 GL-3 CDR3 J-segment CDR3 Length
!
WT
QTSVYF CASS FQ YFGPGTRLTVL 2
QTSVYF CASS GEQ YFGPGTRLTVL 3
QTSVYF CASS SQF PGTGTLYFAAGTRLTVT 3
QTSVYF CASS LQGP YFCPGTRLTVL 4
QTSVYF CASS SQFQ YFGPGTRLTVL 4
QTSVYF CASS LIGQQ YFGPGTRLTVL 5
QTSVYF CASS LGGHEQ YFGPGTRLTVL 6
QTSVYF CASS LSDERL FFGHGTKLSVL 6
QTSVYF CASS NSAETL YFGSGTRLTVL 6
QTSVYF CASS QGVYEQ YFGPGTRLTVL 6
QTSVYF CASSL RGHTEV FFGKGTRLTV 6
QTSVYF CASS FSGDREV FFGKGTRLTV 7
QTSVYF CAA GRNTGQL YFGEGSKLTVL 7
QTSVYF CSSS GRSNKEQ YFGPGTRLTVL 7
QTSVYF CASS LGSQNTL YFGAGTRLLVL 7
QTSVYF CASS LRGTHEQ YFGPGTRLTVLEDL 7
QTSVYF CASS PRSAETL YFGSGTRLTVL 7
QTSVYF CASS PTDKDTQ YFGPGTRLLVL 7
QTSVYF CASSS SQGVYEQ YFGPGTRLTVL 7
QTSVYF CA AGRNTGQL YFGEGSKLTVL 8
QTSVYF CSSC CARSNKEL YFGPGTRLTVL 8
QTSVYF CSSC CGGGNKEL YFGPGTRLTVL 8
QTSVYF CSSS CGRSNKEL YFGPGTRLTVL 8
QTSVYF CASS FPGTANTEV FFGKGTRLTVV 8
QTSVYF CASS FPTGAATEV FFGKGTRLTVV 8
QTSVYF CASS LDSNYAEQ FFGPGTRLTVL 8
QTSVYF CASS LGQANTEV FFGKGTRLTVV 8
QTSVYF CASS LNRENTEV FFGKGTRLTVV 8
QTSVYF CASSL PGTGQRKI IFGHGTKLSS 8
QTSVYF CA RGTEHYEQ YFGPGTRLTVL 8
QTSVYF CASS SSQGVYEQ YFGPGTRLTVL 8
QTSVYF CASS YRGPGQAP LFGEGTRLSVL 8
QTSVYF CAS GGQGAAETL YFGSGTRLTVL 9
QTSVYF CASS PRQISNERL FFGHGTKLSVL 9
QTSVYF CASS LPGQDSAETL YFGSGTRLTVL 10
QTSVYF CASS LSAGRSGNTL YFGEGSRLI 10
QTSVYF CASS LSCGAGNQAP LFGEGTRLSVL 10
QTSVYF CASS LYRRGSYAEQ FFGPGTRLTVL 10
QTSVYF CASS LYSGQGGNTL YFGEGSRLIVV 10
QTSVYF CSSSL PTVTGSSYEQ YFGPGPRLTVL 10
QTSVYF CASS LPTVTGSSYEQ YFGPGTRLTVL 11
!
CDR1"2"
QTS LGTP RFGPGTRLTVL 4
QTSVYF CAS NGQGEQ YFGPGTRLTVL 6
QTSVYF CASSL RGHTEV FFGKGTRLTV 6
QTSVYF CASS LRGHTEV FFGKGTRLTVV 7
QTSVYF SGGQGEV LFGTGTRLTVL 7
QTSVYF CASS SRGHTEV FFGKGTRLTVV 7
QTSVYF CASS YRGHTEV FNGKGTRLHSVE 7
QTSV LADWGYEQ YFGPGTRLTVL 8
QTSVYF CASS LNWGPYEQ YFGPGTRLTVL 8
Table 4.3: Summary of unique CDR3 sequence associated with V!7 in TCR" retrogenic mice
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Table 4. 3: Summary of unique CDR3 sequences associated with Vβ7 in TCRα  retrogenic mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QTSVYF CAS RGRGYAEQ FFGPGTRLTVL 8
QTSVYF CASS RQGKAETL YFGSGTRLTVL 8
QTSVYF CASS YGTGSSYEQ YFGPGTRLTVL 9
QTSVYF CASS LSLTGGFQNT LYFGAGTRLSVL 11
QTSVYF SY LTNHSSGWQTEV LFGPGTRLTVL 12
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Figure 4. 19: Removal of germline TCRα or TCRβ CDR1 and 2 results in a decrease in endogenous J-segment 
usage. 
Endogenous J-segment usage associated with Vα9 and Vβ7 was conducted on the total sequences made up of 
the unique sequences presented in Table 4.2 and 4.3. Sequences were compared to those listed on IMGT 
(Lefranc et al, 2003) and columns represent the order of functional segments as listed by IMGT. Data is 
presented as the percentage J-segment usage from total sequences analysed. 
 
Overall diversity analysis of endogenous CDR3 repertoires across all J-segments from Vα9 or 
Vβ7 containing TCRs demonstrated a clear drop in αCDR1Δ2Δ and βCDR1Δ2Δ3Δ mice relative to 
their WT controls (Figure 4.20A). Shannon entropy diversity values (D; as explained in 
Chapter 3.2.2) for the αWT (D = 60.3) and βCDR3Δ (D= 66.8) controls were slightly lower than 
those reported for the B6.2.16 TCRβ transgenic mouse, also looking at Vα9 CDR3 diversity 
(Singh et al, 2010). However they were considerably greater than the diversities of the 
αCDR1Δ2Δ and βCDR1Δ2Δ3Δ mutants, whose overall diversity was greatly reduced (D = 14.4 and 
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20.9 respectively). Indeed, the endogenous partner chain CDR3 repertoires of the TCRα and 
TCRβ mutants displayed lower diversity than that generated artificially in TCRβ CDR1 and 2 
via the recombination cassettes system (Figure 3.5). The variation in CDR3 length (typically 
5-12 amino acids) was greatly reduced in the αCDR1Δ2Δ and βCDR1Δ2Δ3Δ mutants relative to their 
WT controls (Figure 4.20B). This effect was less pronounced in the βCDR1Δ2Δ3Δ mice however. 
The restriction in length was manifest both in the breadth of range and average length, 
showing a skew towards shorter, and thus less flexible CDR3 (Ferreira et al, 2006). The 
dominant length for the αWT and βCDR3Δ partner CDR3s were 10 and 9 amino acids long 
respectively, with ranges from 3-12 and 5-11 amino acids. This is in comparison to the 
αCDR1Δ2Δ (dominant length 4 and 7 amino acids, range between 4-11 amino acids) and βCDR3Δ 
(dominant length 8 and 9 amino acids, range between 5-11 amino acids).  
 
Figure 4. 20: Removal of germline TCRα or TCRβ CDR1 and 2 results in a decrease in endogenous CDR3 
diversity.  
(A) Overall endogenous CDR3 diversity associated with Vβ7 (top) or Vα9 (bottom) is depicted with each 
segment representing a unique sequence and the segment size corresponding to the frequency of the sequences. 
Overall diversity (D) values were calculated as described in Chapter 3.2.2. (B) Summary of endogenous CDR3 
lengths associated with Vβ7 (left) and Vα9 (right). Data is presented as a proportion of the total sequences 
analysed. CDR3 lengths were defined as represented in Figure 4.20. 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4.2.6 Section summary 
Overall, the data presented in this section clearly demonstrate that removal of the germline 
CDR1 and 2 does not prevent recognition of MHC during thymic selection. These 
modifications incorporate the majority of positions implicated as playing major or minor roles 
in pMHC recognition (Marrack et al, 2008) despite template CDRs containing examples of 
specific residues that contact MHC in co-crystal structures (Miller et al, 2007). WT and 
mutant TCRα and TCRβ retrogenic mice generate peripheral populations of CD4 and CD8 T 
cells as well as evidence supporting the development of nTregs in the thymus.  
The significant increase in homeostatic expansion markers on T cells in βCDR1Δ2Δ3Δ mice 
relative to βCDR3Δ indicated potential differences in thymic selection. Indeed the replacement 
of germline βCDR1 and 2 structures with glycine-alanine linkers resulted in decreased 
selection efficiency (as measured by CD5 expression on DP thymocytes), which could 
account for any increased expansion. Further a clear class II bias was observed in βCDR1Δ2Δ3Δ 
mice, which was further manifest in peripheral lymphoid organs, regardless of the selecting 
MHC haplotype. Interestingly, the replacement of the corresponding TCRα CDR1 and 2 with 
glycine-alanine linkers resulted in a reciprocal peripheral skew to CD8 T cells. This data 
clearly implies an inherent MHC class bias in the two chains of the TCR heterodimer, which 
has hitherto never been clearly stated. 
Both αCDR1Δ2Δ and βCDR1Δ2Δ3Δ mutants maintained similar endogenous V-segment diversities as 
their WT controls, but showed clear reduction of J-segment and CDR3 diversity, including 
CDR3 length. The shortening of the endogenous CDR3 lengths in the αCDR1Δ2Δ and βCDR1Δ2Δ3Δ 
mutants, may also imply less optimal MHC interaction. The loss of selection efficiency 
demonstrated by lower CD5 expression and reduced partner chain diversity, coupled to MHC 
class bias could be attributed to two mechanisms. The first could be a generic loss of CDR 
structure caused by using the flexible, flattened glycine-alanine linkers reducing MHC 
interaction. More specifically, it could be due to the loss of the specific germline sequences 
that although not controlling MHC recognition may be involved in optimisation of the 
process. This subject was further studied in the following section. 
4.3 Expression of TCRβ  chains grafted with TCRγ  CDR1 and 2 restores WT phenotype 
4.3.1 Overview 
Due to the limited movements of germline CDR loops (Armstrong et al, 2008 and 
Borbulevych et al, 2011), any structured TCR CDR1 and 2 would unlikely be excluded from 
the interacting environment with pMHC. However the use of artificial glycine-alanine linkers 
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as used in the previous section, would increase flexibility and perhaps minimise the ability of 
germline CDRs to interact with MHC and account for the differences between the WT and 
mutant TCRα and TCRβ chains. To test this, one could replace the CDR1 and 2 with non-
germline, but chemically structured loops and subject them to a similar retrogenic analysis. 
Indeed, the chemical diversity generated via the cassette system described in Chapter 3 
implies such structured loops are most likely to interact with MHC during thymic selection. 
Unfortunately, the thymi in cassette mice were poorly reconstituted, as evidenced by the 
relatively long time for T cells to repopulate the periphery relative to normal TCRβ retrogenic 
chains (Figure 3.2 and 4.4) making it difficult to draw comparison to the βCDR3Δ construct. 
Further, in a review by Mazza and Malissen (2007), the authors predicted that replacement of 
TCR V-regions with Ig regions would prevent DP thymic selection of αβ T cells due to loss 
of this MHC preference. Thus using TCRγ (or Ig; Attaf et al, unpublished) CDR1 and 2 in 
lieu of germline β sequence would directly address this notion. 
As design of novel mutants could be deemed biased, naturally occurring but non-MHC 
restricted WT CDR loops from Vγ1 were chosen to replace the CDR1 and 2 of the βCDR3Δ 
construct. γδ T cells make up around 5% of the T cell pool (Davis et al, 1998) and although 
evolutionarily related to αβ TCRs have distinct functional roles in the immune response, 
despite often being labelled as a relatively archaic subset (Chapter 1.1.1). Little is still known 
about the exact form of antigen recognition by γδ TCRs, although some have demonstrated 
recognition of non-classical MHC-like molecules such as T22, although these are dominated 
by CDR3 of the TCR (Adams et al, 2005). This mode of recognition if genuine, is not 
canonical and γδ T cells are not considered MHC restricted. Also, γδTCR CDR3 regions are 
more like those found in IgH chains as opposed to the shorter αβTCR equivalents (Rock et al, 
1994). Finally, if αβ loci (and thus MHC restriction), evolved from original γδ progenitors, 
MHC restriction could only evolve via convergent means (Chapter 1.1.1). The TCRγ chain is 
analogous to the TCRβ, and contains chemically diverse CDR1 and 2 regions (Lefranc et al, 
2003). However, as shown earlier, while there appears to be a structural constraint on TCRβ 
CDR1 length of 6 amino acids, TCRγ CDR1 loops are generally 8 amino acids long, with one 
encoding for a loop of 10 amino acids.  Thus, replacing the βCDR3Δ with WT CDR1 and 2 
encoded naturally by Vγ1.1 would facilitate testing the hypothesis of requirement of germline 
sequence versus generic chemical properties, and also the capability of CDR1 to 
accommodate an enforced increase in length.  
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4.3.2 Design, generation and testing of the βCDR1γCDR2γCDR3Δ mutant 
The design of the βCDR3Δ gene modified with Vγ1.1 CDR1 and 2 is depicted in Figure 4.21A. 
To modify the length of the CDR1 further, the terminal serine and valine of the template were 
maintained with the 8 amino acids long Vγ1.1 inserted between. As the template and Vγ1.1 
CDR2 were both 6 amino acids long, the full WT sequence was replaced entirely. These 
designed changes would alter the structural landscape, relative to the original glycine-alanine 
linkers, while remaining entirely unique of any naturally occurring βCDR1 and 2 regions and 
removing the majority of the aforementioned key MHC recognition residues (Section 4.2.1). 
The construct was generated through 2 rounds of overlap PCR, using the βCDR3Δ as the initial 
template, creating a βCDR1γ3Δ intermediate and βCDR1γ2γ3Δ final construct. Sequencing was 
confirmed before use in transfection to produce viral SN (Figure 4.21B and Figure 2.7). Test 
expression and the chain’s ability to pair with an endogenous repertoire was carried out as 
described in Section 4.2.3, by infecting ConA stimulated splenocytes from C57BL/6 mice 
with viral SN containing the βCDR1γ2γ3Δ construct (work carried out by Ashkenaz Richard, as 
part of a supervised MSc laboratory project). Subsequent flow cytometric analysis however 
revealed no apparent Vβ11 expression above that of the expected endogenous level. The lack 
of surface expression detection could have been attributed to pressures induced from 
increasing the CDR1 length, or the change in steric environment may have prevented binding 
of the anti-Vβ11 antibody. As with the αCDR1Δ2Δ construct, putting the βCDR1γ2γ3Δ construct into 
the retrogenic system using TCRβδ-/- BM donors and recipients would ensure T cell 
development could only occur upon successful expression of the exogenous TCRβ chain. 
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Figure 4. 21: Design and creation of the βCDR1γ2γ3Δ construct.  
(A) Schematic (left) shows WT (βCDR3Δ) and modified (βCDR1γ2γ3Δ) CDR1 and 2 amino acid sequences. Open 
boxes indicate WT CDR positions implicated in pMHC recognition by Marrack et al, 2008. Filled boxes indicate 
the residue changes made to the WT sequence. CDR residue numbering from Marrack et al, 2008 and IMGT are 
as indicated in Figure 4.1. Relevant framework residues are indicated between CDR sequences. Gel 
electrophoresis (right) demonstrating generation of the βCDR1γ3Δ intermediate and βCDR1γ2γ3Δ chains from the 
βCDR3Δ and βCDR1γ3Δ templates respectively. R1 (~800 bp), R2 (~200 bp) and R3 refer to stages described in 
Figure 2.8. R3 represents the full-length chains of 997 base pairs (bp). M = the marker lane with relevant sizes 
indicated. The faint band represented at around 7000 bp is from the template vector construct. (B) Partial protein 
alignment of the βCDR1γ2γ3Δ mutant. Sequences generated from chains sub-cloned to the pMigR1 vector. 
Sequences are compared to original C6 TCRβ sequence. Relevant CDR sequences are highlighted. Sequences 
aligned with eBioX using a ClustalW (accurate) algorithm.  
The βCDR1γ2γ3Δ construct was successfully transduced into cultured HSC from TCRβδ-/- donor 
mice as for the constructs described above (Ashkenaz Richard, MSc student and Figure 2.2). 
As with the other TCRβ retrogenic mice, GFP+ T cells were detected in blood from 6 weeks 
post-HSC adoptive transfer to irradiated TCRβδ-/- recipient mice (Figure 4.22). Interestingly, 
despite also lacking the germline CDR1 and 2, the class II MHC bias present in the βCDR1Δ2Δ3Δ 
mice using the same analysis (Figure 4.4) was absent from the repertoires selected by this 
hybrid chain, which displayed a WT like CD4/CD8 ratio. Both the CD4 and CD8 T cells in 
the blood stained positively for TCRβ, confirming that the exogenous TCR was being 
expressed and used to direct T cell development in the otherwise TCRβ deficient 
environment. To further prove this, PCR was carried out on cDNA extracted from whole 
lymphocytes using Vβ11 specific primers and yielded only a single sequence corresponding 
to the exogenous TCRβ chain (Figure 4.22). 
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Figure 4. 22: T cells using the βCDR1γ2γ3Δ chain can be selected in vivo.  
Flow cytometric analysis of GFP+ lymphocytes from whole blood, 6 weeks post-HSC transfer (top). 
Representative plots showing CD4 and CD8 T cells (left) and TCRβ expression (right) on GFP+CD4+ (blue line) 
and GFP+CD8+ T cells (red line) relative to GFP+CD4-CD8- lymphocytes (filled peak). PCR of cDNA made 
from CD4 T cells from two mice using a generic constant TCRβ primer with a general Vβ11 internal primer on 
returned one clonal sequence that corresponds to the βCDR1γ2γ3Δ CDR1 and 2, confirming the successful and 
unique use of the chain (bottom). Sequences were aligned using eBioX and a ClustalW algorithm. 
 
4.3.3 Mice expressing TCRβ with TCRγ CDR1 and 2 display thymic selection comparable to 
mice with WT TCRβ CDR1 and 2 
The initial blood analysis thus inferred that replacement of germline βCDR1 and 2 with 
structured, non-germline loops from a related, non-MHC restricted chain, could direct T cell 
development in a manner similar to fully WT TCRβ chains in terms of MHC class preference. 
To further analyse whether a similar effect could be observed in relation to thymic selection 
efficiency (which was also reduced in βCDR1Δ2Δ3Δ mice) flow cytometric analysis was carried 
out on GFP+CD4+CD8+ thymocytes to measure CD5 expression, as described earlier. All 
mice expressing the βCDR1γ2γ3Δ chain displayed comparable levels of CD5 expression to fully 
WT FVB/N and βCDR3Δ mice (Figure 4.23 and Figure 4.10) suggesting use of the structured 
γCDRs on a TCRβ framework function as well as the canonical βCDRs in terms of MHC 
recognition. This notion was further supported through analysis of peripheral T cell 
populations in βCDR1γ2γ3Δ mice. Unlike the strong CD4 skew recorded in βCDR1Δ2Δ3Δ mice 
relative to the βCDR3Δ mice, GFP+ T cells from both the spleen and LN of βCDR1γ2γ3Δ mice 
retained a normal CD4/CD8 ratio, comparable to the βCDR3Δ T cells (Figure 4.24A). Further, 
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comparable CD5 levels in the thymus was coupled to a reduced proportion of CD44HI T cells 
in βCDR1γ2γ3Δ mice, analogous to the βCDR3Δ mice and thus significantly lower than the 
βCDR1Δ2Δ3Δ mice (Figure 4.24B). Finally, flow cytometric analysis of endogenous Vα-segment 
usage demonstrated a similar array to both the βCDR3Δ and βCDR1Δ2Δ3Δ mice (Figure 4.24C). 
Overall, these data clearly demonstrate that the differences relating to MHC recognition 
efficiency in βCDR1Δ2Δ3Δ are most likely due to lack of structural competency than loss of any 
inherent code in the germline sequence per se. Interestingly however, the use of such flexible 
linkers may have highlighted the requirement of structurally complex loops to maintain MHC 
class selection balance and suggest that each TCR chain may indeed have an inherent class 
preference.  
 
Figure 4. 23: Replacement of germline TCRβ CDR1 and 2 with TCRγ CDR1 and 2 maintains WT selection 
efficiency.  
Flow cytometric analysis measuring CD5 expression of GFP+CD4+CD8+ thymocytes from βCDR1γ2γ3Δ mice on 
H2q (top) and CD4+CD8+ thymocytes from FVB/N WT mice. Overlaid peaks correspond to four independent 
βCDR1γ2γ3Δ retrogenic mice. Dashed lines represent the equivalent CD4-CD8- DN thymocytes from each set of 
mice as a negative control. 
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Figure 4. 24: Replacement of germline βCDR1 and 2 with non-germline, structured CDR1 and 2 regions retains 
a WT like T cell development phenotype.  
(A) Flow cytometric analysis of GFP+ lymphocytes from whole spleen (top) and LN (bottom) of βCDR1γ2γ3Δ mice. 
Representative plots displaying CD4 versus CD8 T cells (left) with the data summarised and presented as 
proportion of CD4 T cells of total T cells (right). The data from the βCDR1γ2γ3Δ mice is compared to that presented 
in Figure 4.14 for βCDR3Δ and βCDR1Δ2Δ3Δ mice. Statistical analysis was conducted using a one-way ANOVA test 
with a Tukey’s post-test analysis. * = p < 0.05, *** = p < 0.0005 and NS = not significant. (B) Flow cytometric 
analysis of GFP+ lymphocytes from whole spleen (top) and LN (bottom) of βCDR1γ2γ3Δ mice. Representative plots  
(left) displaying CD44 versus expression on CD4 (top) and CD8 (bottom) T cells with the data summarised 
(right) and presented as proportion of CD44HI cells. The data from the βCDR1γ2γ3Δ mice is compared to that 
presented in Figure 4.15 for βCDR3Δ and βCDR1Δ2Δ3Δ mice. Statistical analysis was conducted using a one-way 
ANOVA test with a Tukey’s post-test analysis. * = p < 0.05, *** = p < 0.0005 and NS = not significant. (C) 
Summary of endogenous Vα segment partner chain usage via flow cytometric analysis. Data is summarised 
from GFP+CD4+ T cells of 4 βCDR1γ2γ3Δ mice. Data is compared to the similar analysis carried out in Figure 4.19 
on βCDR3Δ and βCDR1Δ2Δ3Δ mice. Error bars represent the SD.  
4.4 Functional analysis of T cells lacking TCRα  and TCRβ  CDR1 and 2 
4.4.1 Overview 
As discussed in Chapter 1.2.3, thymic selection predominantly functions to impart tolerance 
to self-peptides in the context of self-MHC (Zinkernagel et al, 1978). Such tolerance is 
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manifest in differing TCR affinities with pMHC (Alam et al, 1996). Further, a diverse and 
cross-reactive repertoire is clearly required to facilitate robust and broad-ranging immune 
responses (Chapter 1.3.3). The lack of germline CDRs has resolutely been demonstrated to 
not prevent MHC recognition in the thymus. However the decrease in selection efficiency and 
reduction in endogenous partner chain diversity in the presence of minimal linkers (βCDR1Δ2Δ3Δ) 
but not in TCRs containing non-germline structured CDRs (βCDR1γ2γ3Δ), implies that germline 
loops play a more generic role that may facilitate greater adaptability and thus, one assumes, 
cross reactivity. This is further emphasised by the active selection of non-germline repertoires 
using the recombination cassette system described in Chapter 3. If T cells using the βCDR1Δ2Δ3Δ 
chain can retain the capacity to elicit immune responses, including maintaining the ability to 
distinguish self versus non-self MHC, it would further highlight to an extreme degree, the 
nature of TCR adaptability.  
4.4.2 T cells lacking TCRα or TCRβ CDR1 and 2 can still mediate Th2 responses 
The classic CD4 T helper Th1 and Th2 immune responses that have been well characterised 
are central to the dogma of the adaptive immune response (Zhou et al, 2009). Briefly, the Th2 
response is triggered upon MHC class II binding resulting in IL-4 mediated expansion, 
defined through the actions of the lineage specific transcription factor GATA3. Through the 
action of cytokines including IL-4 and IL-5, committed Th2 CD4 T cells activate B cells, 
triggering the humoral branch of the adaptive immune response. Activation of B cells 
includes the induction of Ig class switching. Here, the isotypes of Ig molecules on naïve B 
cells (IgD or IgM) are switched through an activation-induced (cytidine) deaminase (AID) 
mediated gene conversion mechanism, that replaces the constant region encoding exons with 
those that encode for other Ig isotypes (Durandy, 2003). This process results in specialisation 
of antibody function while maintaining antigen specificity of the Ig. 
Class switching is measureable in the blood serum through ELISA based detection of Ig 
isotypes and can thus be used as an indirect approach of detecting successful TCR-pMHC 
interaction. An enzyme-linked immunosorbent assay (ELISA) was carried out on sera from 
TCRα and TCRβ WT and mutant retrogenic mice measuring pre-switch IgM and post-switch 
IgG1 using serum from WT C57BL/6 mouse and TCRβδ-/- and TCRα-/- mice as positive and 
negative controls respectively (Figure 4.25). As expected, all mice contained comparable 
levels of pre-switch IgM, which is the dominant isotype in naïve mice. However, IgG1 
detection would be dependent on successful engagement of TCR-pMHC. As shown, the two 
TCR KO mice contained negligible levels of IgG1, whereas both WT and mutant retrogenic 
mice showed IgG1 levels comparable to the C57BL/6 control mouse. This indirectly confirms 
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that TCRs that have been selected lacking canonical TCRα or TCRβ CDR1 and 2 loops 
maintain the ability to induce pMHC dependent responses. An ultimate test of functionality 
however would be to measure the alloreactive capabilities of TCRs where one partner chain 
contains non-canonical, unstructured CDRs. 
 
 
Figure 4. 25: TCRs lacking germline α or βCDR1 and 2 can still adapt to induce Th2 responses.  
ELISA on serum of TCRα and TCRβ WT and mutant retrogenic mice relative to positive (C57BL/6) and 
negative (TCRβδ-/- and TCRα-/-) control mice. Sera levels were tested for IgM and IgG1, which represent pre 
and post-class switching isotypes respectively. Error bars represent S.E.M. 
 
4.4.3 Loss of TCRα or TCRβ CDR1 and 2 does not prevent allo-responses 
As discussed in Chapter 1.4.4, structural evidence has revealed both peptide and MHC centric 
models of allo-recognition. The concept of allo-recognition is also embedded deep in the 
germline code modes of TCR restriction to MHC (Chapter 1.5.1) with the process due to 
syngeneic TCRs having higher reactivity with allogeneic MHC due to the germline contacts 
not being re-modelled during thymic selection to facilitate tolerance (Huseby et al, 2005). 
Thus testing the ability of TCRs lacking germline CDR1 and 2 to mediate allo-recognition is 
an even more acute test of the germline-encoded theories. 
Allo-responses were first tested using a traditional mixed lymphocyte responses (MLR) assay 
(Figure 4.26). CD4 T cells were bead-purified from whole spleen and LN of TCRα and 
TCRβ retrogenic mice and cultured with LPS-activated bone marrow derived dendritic cells 
(BMDC) from syngeneic (H2k for TCRα retrogenics, H2q for TCRβ retrogenics) and 
allogeneic (H2b) backgrounds using proliferation as a marker of response. For the TCRα 
retrogenic mice, both the αWT and αCDR1Δ2Δ proliferated poorly in the presence of allogeneic 
H2b BMDC. However both were still higher than the proliferation measured in the presence 
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of syngeneic H2k BMDC. The result for the TCRβ retrogenics was clearer. Here, cells from 
both the βCDR3Δ and βCDR1Δ2Δ3Δ mice proliferated strongly in the presence of allogeneic H2b 
BMDC, with negligible proliferation in the presence of syngeneic H2q BMDC. These data, 
especially for the TCRβ retrogenics, demonstrate that replacement of germline CDR1 and 2 
with non-germline flexible linkers does not prevent allo-recognition.  
 
Figure 4. 26: TCRs lacking germline α or βCDR1 and 2 maintain the ability to distinguish self and non-self 
MHC in vitro.  
CD4 T cells were purified from TCRα and TCRβ retrogenic mice and cultured with titrated numbers of 
syngeneic (dashed line) or allogeneic (solid line) BMDC activated with LPS. Cultures were incubated for 72 
hours before pulsing with tritiated thymidne and left for a further 24 hours. Cells were harvested and the level of 
proliferation defined by the counts per minute (CPM). Error bars represent S.E.M. n = 3 for all mice. 
 
As the saturating nature of such ex vivo assays prevents the analysis of the quality of 
response, an in vivo approach was also used for the TCRβ retrogenic mice to measure allo-
recognition. TCRβδ-/- mice were injected (i.v.) with whole splenocytes from primary βCDR3Δ 
or βCDR1Δ2Δ3Δ mice. After four weeks to allow the cells to expand, the mice received adjacent 
syngeneic H2q (FVB/N) and allogeneic H2b (C57BL/6) skin grafts. As shown in Figure 
4.27A, both sets of mice accepted 100% of the syngeneic grafts, indicating tolerance and 
demonstrated clear rejection of the allogeneic graft. Interestingly, while the βCDR3Δ and 
βCDR1Δ2Δ3Δ mice displayed comparable allo-responses during the MLR, the βCDR1Δ2Δ3Δ 
exhibited slower allogeneic graft rejection (median survival time, MST = 22 days relative to 
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12.5 days for the βCDR3Δ mice). Further, 1/6 mice in the βCDR1Δ2Δ3Δ cohort failed to completely 
reject the allogeneic graft. 
 Th2 responses contribute to T cell mediated skin graft rejection (Illigens et al, 2009), 
resulting in isotype switching and antibody production. Incubation of sera taken from grafted 
and ungrafted mice with allogeneic spleen cells from the same background as the graft, results 
in the binding of the allo-antibodies produced during graft rejection to the splenocytes in 
vitro. Subsequent indirect flow cytometric analysis, staining for the bound allo-antibodies 
using anti-mouse IgG has been shown to quantify the intensity of the rejection response 
(Leenaerts et al, 1990). Such an analysis was performed using serum from the grafted mice 
containing T cells using the two exogenous TCRβ chains (Figure 4.27B). H2b splenocytes 
incubated with serum from the skin-grafted mice demonstrated higher levels of anti-mouse 
IgG binding relative sera taken from ungrafted controls. Interestingly however, sera from 
grafted mice containing βCDR1Δ2Δ3Δ TCR displayed lower levels of anti-mouse IgG binding 
compared to the βCDR3Δ WT control. Taken with the graft data itself, this again suggests that 
the ability of the βCDR1Δ2Δ3Δ mice to reject the skin grafts was somewhat impaired. 
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Figure 4. 27: TCRβ chains lacking germline CDR1 and 2 maintain the ability to reject allogeneic skin in vivo.  
(A) TCRβδ-/- mice were adoptively transferred with whole splenocytes from βCDR3Δ (filled symbols) or βCDR1Δ2Δ3Δ 
(open symbols) mice and doubly grafted with syngeneic (H2q; circles) and allogeneic (H2b; triangles) skin. Graft 
rejection was measured from the day of the procedure. Graft rejection was deemed complete when only minimal 
scabbing remained in the graft bed. (B) Flow cytometric analysis of allogeneic (H2b) splenocytes incubated with 
serum from skin-grafted mice. The presence of bound anti-mouse IgG to the splenocytes was detected via 
secondary staining and was used as a read out of graft rejection response. Representative plots measuring anti-
mouse IgG levels from two serum dilutions are shown for βCDR3Δ (blue peak), βCDR1Δ2Δ3Δ (red peak) and control 
ungrafted mice (grey peak) and summarised in the chart underneath which displays the mean fluorescent 
intensity (MFI) of IgG on whole lymphocytes from the spleen cells. n = 6 for all mice. Error bars represent 
S.E.M. The apparent increase in staining at the 1 in 10,000 relative to 1 in 1,000 serum dilution is most likely 
explained by the removal of further inhibitory factors from the serum that could affect staining. Indeed, more 
concentrated dilutions resulted in negative staining across all groups (data not shown).  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This reduction in functional capability of the mice repopulated with βCDR1Δ2Δ3Δ T cells to 
respond to allogeneic stimuli could be related to the sub-optimal interaction with pMHC 
during the allogeneic response, or more generally to their inability to repopulate the host 
effectively relative to the βCDR3Δ T cell containing mice. 4x106 splenocytes, pooled from 
donor retrogenic mice were transferred to empty recipient mice and cells were allowed to 
expand for 4 weeks before the skin grafting. The splenocytes used as donors from βCDR3Δ and 
βCDR1Δ2Δ3Δ mice contained comparable proportions and total numbers of GFP+ T cells (Figure 
4.28A), ensuring the founder populations in recipient mice were comparable. Analysis of 
blood from donor mice after the allotted expansion time revealed a significantly lower 
proportion of GFP+ lymphocytes in the βCDR1Δ2Δ3Δ mice, indicating expansion was less 
efficient. Interestingly, in both sets of mice, only the CD4 T cells expanded (Figure 4.28B). 
Evidence for the βCDR1Δ2Δ3Δ T cells impairment was also suggested by the significant decrease 
in the surface expression levels of the TCR. Taken together, these data suggest that the 
inferior skin rejection by βCDR1Δ2Δ3Δ mice may be related to an inability to repopulate the host 
which points to a more general impairment of TCR-pMHC interactions during homeostasis 
rather than a diminished capability of distinguishing between self and non-self MHC. Indeed 
in the blood of the single mouse that failed to reject the allogeneic skin graft, no GFP+ T cells 
were detected via flow cytometry (Figure 4.28B, bottom right panel). Despite this 
disadvantage, the level of rejection in βCDR1Δ2Δ3Δ mice was significant.  
Ultimately, and rather startlingly, in vivo and in vitro data presented here indicates that TCR 
lacking 50% of canonical germline CDRs can still develop to differentiate between self and 
non-self MHC molecules, further underpinning the immense adaptability of the TCR and 
refutes germline-encoded theories on the molecular nature of alloreactivity (Huseby et al, 
2005 and Marrack et al, 2008). 
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Figure 4. 28: Less efficient allo-recognition in βCDR1Δ2Δ3Δ is related to sub-optimal repopulation of the grafted 
mice.  
(A) Lymphocytes from whole spleen of donor βCDR3Δ and βCDR1Δ2Δ3Δ contained comparable proportions of GFP+ 
cells as depicted by GFP+ proportion (top left) and total GFP+ splenocytes number (top right). n = 3 for both 
groups. Groups were compared by an unpaired student’s t-test. NS = not significant. Flow cytometric analysis of 
blood after adoptive transfer of donor splenocytes to empty syngeneic hosts resulted in poorer expansion of the 
βCDR1Δ2Δ3Δ GFP+ lymphocytes relative to comparable βCDR3Δ populations (bottom) as shown by the representative 
FACS plot of GFP+ lymphocytes (left) and a summary of the proportion of GFP+ lymphocytes in whole blood in 
recipient mice (right). Samples were compared using an unpaired student’s t-test. *** = p < 0.0001. (B) Both 
groups of mice showed dominant expansion of CD4 T cells (representative plots gated on GFP+ lymphocytes; 
top) but analysis of the MFI of Vβ11 expression on this population revealed a decrease in the βCDR1Δ2Δ3Δ mice. 
Representative plot are shown on the left (βCDR3Δ, filled grey peak and βCDR1Δ2Δ3Δ, red line) and summary of MFI 
levels on the right. Groups were compared using an unpaired student’s t-test. *** = p < 0.0001.   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 4.5 Isolated case of lupus like autoimmunity in mice lacking TCRβ  CDR1 and 2 
4.5.1 Mice repopulated with βCDR1Δ2Δ3Δ expressing T cells displayed significant weight loss 
and skin pathogenesis 
The molecular nature of autoreactive TCRs is one of the most fascinating in TCR biology. 
The relatively recent publications of autoreactive TCRs have shown the tremendous structural 
variability in TCR-pMHC interaction and how this can ultimately lead to disease (Chapter 
1.4.5). Changes in TCR signalling can also result in an autoreactive phenotype due to 
normally higher affinity TCRs escaping negative selection due to decreased signalling 
strength as demonstrated by induced or natural mutation of CD3 ITAMs (Holst et al, 2008 
and Lundholm et al, 2010). Removal of two of the four germline CDRs from all TCRs could 
have the capability to influence subsequent TCR binding, especially when one considers the 
effect on binding orientation single residue changes can make (Wucherpfennig et al, 2009). 
Despite this, both βCDR1Δ2Δ3Δ and αCDR1Δ2Δ mice displayed no signs of pathogenesis. However, 
in one instance, transfer of splenocytes from primary βCDR3Δ and βCDR1Δ2Δ3Δ retrogenic mice, 
as performed prior to skin grafting, led to some of the βCDR1Δ2Δ3Δ recipient mice developing a 
clear pathogenesis that was not present in any of the βCDR3Δ recipients. Initial observations 
were manifest in the form of hair loss and significant weight loss (Figure 4.29). 
Immunohistochemistry of skin sections revealed IgG antibody deposition at the hair follicles 
(Figure 4.29B).  
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Figure 4. 29: Indication of autoimmunity in mice adoptively transferred with βCDR1Δ2Δ3Δ T cells.  
(A) Summary of the weight of mice adoptively transferred with splenocytes containing βCDR3Δ or βCDR1Δ2Δ3Δ T 
cells. Weight was recorded from the day of adoptive transfer. n = 4. Error bars represent S.E.M. (B) Photographs 
of two representative mice from the groups weighed in part (A) show clear hair loss in the βCDR1Δ2Δ3Δ group (top). 
Immunohistochemical staining for IgG1 showed clear antibody deposition at the hair follicles in the 
representative βCDR1Δ2Δ3Δ mice (bottom). 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4.5.2 Autoimmune phenotype was not induced by loss of Tregs but may have been related to 
increased anti-dsDNA antibody titres 
Systemic autoimmune diseases such as systemic lupus erythematosus (SLE) are often 
characterised by increased titres of autoreactive antibodies specific to nuclear components of 
cells (Eliat and Anderson, 1994). Previous TCRβ retrogenic approaches have resulted in 
autoimmunity as a result of the loss of Tregs, which inevitably leads to systemic disease 
(Bosco et al, 2010). Flow cytometric analysis of the blood from the diseased and control mice 
revealed a lower proportion of CD4+FoxP3+ Treg cells in the former (Figure 4.30A). 
However the overall number of Tregs may have still been comparable due to the increased 
proportion of total CD4 T cells in the βCDR1Δ2Δ3Δ mice relative to the βCDR3Δ control mice. 
However without absolute numbers, which were impossible to calculate from blood, and 
without functional analysis of the cells bearing Treg markers with inhibition assays, it appears 
the loss of Tregs was not inducing the autoimmune phenotype, although this could not be 
definitely confirmed. ELISAs measuring auto-antibodies including anti-dsDNA, -ssDNA and 
-histone antibodies were conducted on serum from the diseased mice and compared to 
relevant controls. Unfortunately, a high level of background signal was recorded in the 
majority of cases (data not shown). This was most likely due to the blocking steps of the 
ELISA using a BSA containing solution and BSA perhaps being present in the buffer used to 
inject the splenocytes into the recipient mice originally. Unfortunately there was not enough 
serum to repeat the ELISA using a different blocking agent such as gelatin. Nonetheless, there 
was a significant difference in anti-dsDNA antibody levels between the βCDR1Δ2Δ3Δ and βCDR3Δ 
mice (Figure 4.30B), which supports the notion of an SLE like disease phenotype when 
coupled to the skin and weight loss.  
The widespread hair loss, weight loss and antibody deposition are consistent with an 
autoreactive pathology perhaps mediated by βCDR1Δ2Δ3Δ T cells but not βCDR3Δ T cells. This 
pathology was however not observed in comparable repeat experiments excluding further 
investigation. 
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Figure 4. 30: βCDR1Δ2Δ3Δ mice displaying autoimmune phenotype had increased titres of auto-antibodies.  
(A) Representative (top) and summary (bottom) flow cytometric data from the blood of mice studied in Figure 
4.31. βCDR1Δ2Δ3Δ mice contained lower proportions of FoxP3+ CD4 T cells (left), but greater overall proportions 
of CD4 T cells (right). (B) ELISA on serum of mice studied in Figure 4.29 measuring levels of anti-dsDNA IgG 
antibodies. Samples were compared to a C57BL/6 and TCRβδ-/- mice as negative controls. Samples were 
compared using an unpaired student’s t-test. * = p < 0.05. n = 5 for βCDR3Δ and 6 for βCDR1Δ2Δ3Δ mice. Error bars 
represent SD. 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Chapter 5: Discussion 
5.1 Overview 
The complex and diverse nature of the adaptive immune system has been maintained 
throughout the evolution of jawed vertebrates. This complexity is further confounded in the T 
cell compartment through MHC restriction. The unique dichotomy that requires a TCR to be 
restricted yet tolerant to self-MHC while responding sensitively but robustly to foreign Ag 
generates arguably the most obscure/intangible relationship in immunology, if not protein 
biology. This is further exacerbated by the sheer variability of the receptor, MHC and Ag as 
well as the requirements for TCRs to be cross-reactive to multitudes of Ag to the order 1x106 
(Mason, 1998). As such, despite more than 60 co-crystal structures of TCRs bound to pMHC 
the only constant rule is one of diversity – in docking angles, CDR contributions and 
flexibility of the TCR and presented Ag. The molecular nature of what restricts TCRs to 
MHC is intensely contested, with theories varying from highly conserved germline CDR 
contacts in the TCR (Garcia et al, 2009 and Marrack et al, 2008) to the TCR playing no active 
role in restriction, which is instead enforced through extrinsic forces such as the CD4 and 
CD8 co-receptors (Van Laetham et al, 2007 and Collins and Riddle, 2008). The phenomenon 
of alloreactivity, coupled to examples where tolerance fails such as in auto-reactive TCRs and 
recognition of atypical ligands like TCR-Be-MHC further demonstrate the diverse modes of 
this complex recognition. The work undertaken in this study represents the most 
comprehensive modification of TCR germline CDR1 and 2 thus far and is coupled to an 
entirely unbiased approach to MHC recognition. In total, nearly 200 unique non-germline 
TCR variants were shown to recognise MHC in vivo. These mutants varied in terms of their 
chemical nature and length as generated via the recombination cassette system with glycine-
alanine linker based modifications designed to replace the majority of key germline residues 
implicated in germline-encoded recognition of MHC (Table 1.9).  
5.2 Limitations of the retrogenic approach 
The pros and cons of the retrogenic approach utilised were outlined in Chapter 2.2.4. Such 
limitations have impeded strong conclusions from being drawn for certain aspects of the data 
presented here. In the TCRβ retrogenic system, one would expect no GFP- thymocytes from 
the TCRβδ-/- HSC donors to progress past DN3 to the DN4 and DP phases – yet these were 
recorded in both βCDR3Δ and βCDR1Δ2Δ3Δ mice. Loss of GFP expression has been noted in TCR 
transgenic and other systems using bi-cistronic GFP reporters under control of an IRES 
(Baldwin et al, 2005 and Zhang et al, 2002). Why this would occur is unclear, although 
complex chromatin remodelling during T cell development coupled to random genome 
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integration of the retroviral vector could contribute. Support for a temporary turning off of the 
GFP gene is supported by the fact no GFP- mature T cells were found in the periphery (Figure 
4.14). Nonetheless, all data presented here relied on GFP+ thymocyte gating. As described in 
Chapter 4.3.3, the use of a retrogenic system on a TCRα deficient background which allows 
genuine GFP- DP thymocytes to develop using the endogenous TCRβ locus most likely 
explains the lack of efficient selection in both WT and mutant TCRα retrogenic chains. 
Further, the TCRα locus normally does not rearrange until the DN4-DP phase, with 
progression dependent on the TCRβ-pTα autonomous signalling at the DN3 stage (Chapter 
1.2.2). Retrogenic TCRα chains will be expressed earlier in thymocyte development and have 
been shown to pair with newly rearranged TCRβ chains at the DN3 stage (Lacorazza et al, 
2001 and Borowski et al, 2004). Such interactions are less efficient in positive signalling for 
progression to the DN4-DP phase, and may also explain the poor positive selection in all 
TCRα retrogenic mice. These limitations prevent a full comparison with the TCRβ retrogenic 
WT and mutant chains in terms of selection efficiency, selection of nTregs and also prevented 
a clear manifestation of any clear MHC bias as a result of mutating the αCDR1 and 2, a key 
finding of this work for the βCDR1 and 2 modifed genes. 
5.3 Analysis of germline and cassette generated CDR1 and 2 support a requirement for 
diversity of MHC engagement 
The analysis of amino acid usage per germline CDR position in Chapter 2 supports the notion 
that the evolutionary strategy of TCR restriction to MHC has not diminished the germline 
diversity of the TCR, relative to the unrestricted Igs. The studies that support the idea for a 
restriction induced repertoire reduction often arise from comparison of mutational rates 
between the molecules rather than a comparison of the sequences themselves (Tanaka et al, 
1989 and Jaeger et al, 1994). The fact that mutational rates differ between species for the 
same molecule (the TCR; Matsutani et al, 2011) emphasises the difficulty in forming any 
broad conclusions when comparing distinct molecules such as the TCR and Ig.  While the 
analysis carried out here only analysed the most common length of all germline CDRs, this 
grouping constituted over 75% of all genome sequences in mice and humans. Interestingly, 
despite divergent evolutionary paths with distinct pathogen relationships and disparate MHC 
sequences – where even the highly conserved co-receptor interactions are unique (Engelhard 
et al, 1988), the overall repertoire of the murine and human TCR CDR1 and 2 regions show 
remarkably similar patterns of amino acid usage. This “set” of residues has perhaps been 
maintained as it represents a diverse stock with which to form suitable Ag receptors 
regardless of the molecular nature of the ligand – which in this case includes diverse MHC 
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molecules. This notion goes against the idea of a honing of a code designed to preferentially 
recognise MHC, where one would therefore expect different genomic repertoires in divergent 
species with dissimilar MHC. This is further supported by the fact a similar pattern of 
conservation is seen between unrestricted murine and human Ig germline repertoires  (Figure 
2.2). Studies that have highlighted instances of conservation of germline motifs infer that the 
code for germline restriction may have been laid down in earlier ancestors, which could also 
explain the similar germline profiles of murine and human TCR CDR1 and 2. However an 
ancestral code appears to be self-contradicting when the highlighted CDR residues interact 
with MHC side chains that themselves have continued to diversify upon species divergence 
(Scott-Browne et al, 2011). The fact some motifs are shared between different species could 
be due to chance or could in fact be due to a shared ancestral V-segment. While one cannot 
deny the importance of the Vβ8.2 Y48 and Y50 βCDR2 residues from the DO-11.10 TCR in 
recognition of the H2-Ad-OVA pMHC (Scott-Browne et al, 2009), grafting of CDRs bearing 
the same motif onto an otherwise identical TCR molecule, regardless of their evolutionary 
source, could be expected to also be important in recognition of an already defined ligand. 
Once again, the isolated and narrow focus of key germline contacts makes broader 
conclusions less convincing.   
Germline analysis therefore points towards the maintenance of diversity to maximise ligand 
recognition. It is unsurprising therefore that the features that underpin αβTCR heterodimer 
stability are found within the constant domain at the inter-chain interfaces (Richman et al, 
2009) and not in the variable CDR loops. Further, the fact non-germline TCR CDR mutants in 
this study could compete with endogenous WT chains in in vitro expression tests, further 
underpins the flexibility of the ligand recognition portions of the TCR in terms of receptor 
viability (Figure 4.3). However, while the germline diversity may not be affected by MHC 
restriction, other more general features such as length appear to be. Relative to γδTCR and Ig 
CDR3 loops, αβTCR CDR3 show a more conserved profile of lengths (Rock et al, 1994) 
suggesting that recognition of Ag in the context of MHC enforces structural constraints on 
CDR3 length, despite the non-germline nature of their generation. The germline lengths of the 
CDR1 and 2 of the αβTCR are more conserved (and also generally shorter) than the IgH 
counterparts (Figure 2.1), which further imply a structural constraint that must be 
evolutionary maintained by restriction to the MHC for germline encoded TCR regions, 
whereas the minimal lengths of three amino acids associated with the IgL chains is most-
likely related to their subservient role on Ig Ag recognition (Hamers-Casterman et al, 1993). 
The unbiased approach of the cassette system revealed that in the βCDR1, despite generation 
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of a diverse repertoire in terms of sequence selection, resulted in a maintenance in CDR 
length, whether starting from the original WT or non-germline gly-ala linker template (Figure 
3.6 and 3.14). This is most likely not because of an inherent restriction in the artificial system, 
due to the variability of lengths seen in the corresponding βCDR2WT-Rec mice. Both the CDR1 
and CDR3 loops are more likely to engage with the presented peptide Ag (Rudolph et al, 
2006), thus perhaps the stringent length associated with CDR1 presented here and the 
aforementioned CDR3 rather than CDR2 facilitates optimal binding generally to MHC in 
more viable docking modes and places the emphasis of Ag recognition on the presented 
peptide, rather than the presenting MHC. The relative range in terms of CDR2 length – which 
generally engages with the MHC, may further highlight the diversity of this interaction, 
assuming the minimal movements associated with germline CDR loops (Armstrong et al, 
2008).  Despite different restrictions in terms of CDR length, distinct roles of CDR1, 2 or 3 in 
recognition of the Ag or MHC should by no means be considered fixed (Chapter 1.4.2; Borg 
et al, 2005 and Manning et al, 1998) and this is further highlighted in the βCDR1γ2γ3Δ mice 
where the Vγ1.1 CDR1 modification produced a CDR1 length of 10 amino acids long that 
could mediate normal MHC-dependent T cell selection as efficiently as WT FVB/N mice 
(Figure 4.22 and 4.23). Whether such receptors could respond to complex Ag as efficiently as 
a receptor composing CDRs of a normal length would be an interesting test of these apparent, 
but not essential, structural constraints. 
The concept of variability being important in MHC binding was tested directly through the 
novel recombination cassette approach outlined in Chapter 2.2.3. The generation and 
selection of novel mutants in vivo represents a direct and unbiased method of testing for key 
germline determinants in MHC recognition. The many novel CDR1 and 2 loops that were 
present at frequencies higher than the germline templates demonstrated no germline set of 
residues appeared to be preferentially used. While each individual sequence may still contain 
elements of the germline code, taken as a population, all positions were shown to be amenable 
to changes in some form or another. In the original cassette design, the highly conserved 
tyrosine (position 46 Kabat; 54 IMGT) that exists upstream of the βCDR2 was conserved, 
five residues upstream of the point of recombination and thus was conserved in all cassette 
generated TCRβ chains. However all other shared residues with which this tyrosine has been 
implicated in recognising MHC were modified by the system, and the idea of this single 
residue overruling the full diversity of those CDRs generated seems highly unlikely. Further, 
the sheer chemical diversity of non-germline amino acids utilised extended the range of 
amino acids most likely utilised in MHC binding (Figure 2.2 and Figure 3.7). The most 
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extreme example of this was a modified CDR2 that contained a string of 4 adjacent lysine 
residues (Table 3.2). These further advocate a relaxed relationship between germline CDRs 
and pMHC complexes that is reflected in the maintained diversity of the natural germline 
TCR repertoire as described above. Interestingly, while the CDR1 loops generated on the 
βCDR1Δ-Rec background were less diverse than those generated on the WT background (Figures 
3.5 and 3.15), the range of positions modified was more spread out from the point of 
recombination. This could be related to the relative inefficiency of small flexible gly-ala 
linkers to interact well with MHC (as shown for the βCDR1Δ2Δ3Δ mice), meaning more extreme 
modifications to terminal CDR positions were sought to facilitate successful selection when 
on a chemically unexciting background. Arguably the most unexpected finding of this study 
is the clear class II bias in TCRβ mutants modified via the recombination cassette or 
conventional mutagenesis (discussed later). However, as the H2q recipient mice in the cassette 
system encode only for a single H2-A class II molecule, it demonstrates a remarkable ability 
for hundreds of unique non-germline CDR1 and 2 mutants to interact successfully with the 
same MHC molecule, which despite varying selecting peptides, further proves that there must 
be many, potentially hundreds, of solutions to bind to the same framework MHC, which could 
contribute to requirement of cross-reactivity (Mason, 1998). While the diversity generated 
with cassette system is less than that recorded for non-germline CDR3 regions (Figure 4.22; 
Singh et al, 2010; Ferreira et al, 2009 and Ferreira et al, 2006) this can be attributed to the 
fact the measurements of CDR3 diversity, while restricted to a single V-segment, included the 
recombination to a full array of J-segments, thus providing much broader scope of source 
material with which to create diverse sequences. Thus, when taken in context, one could 
strongly argue that germline CDR1 and 2 have a comparable potential for hypervariability as 
canonically generated CDR3 loops, further supporting the notion of a requirement of diversity 
to recognise the vast array of MHC molecules. Perhaps if feasible from an evolutionary 
perspective, a hypervariable mechanism to generate all CDR regions could have proven just 
as effective as maintaining a concurrent hypervariable and combinatorial strategy.  
5.4 Further uses of the recombination cassettes in MHC restriction and immunotherapy 
The novel recombination cassette system described in this study has proved invaluable in 
answering a fundamental question about TCR immunobiology, however it could also have 
wider applications in immunotherapy. An interesting experiment to further address the 
adaptability of conserved residues of defined TCR-pMHC interactions (Burrows et al, 2010), 
would be to insert a recombination cassette into a CDR with proposed key germline contacts 
with resultant mutants screened against the original cognate ligand (Huseby et al, 2005). 
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Keeping all other aspects of the TCR-pMHC constant, assuming germline bias, one would 
predict those mutants that retain specificity for the original ligand would most likely remake 
or retain the same key germline residues. Indeed, work has shown that minimal conservation 
of key germline motifs is sufficient to retain pMHC specificity in TCRs where the rest of the 
sequence remains constant (Scott-Browne et al, 2011). While the mutants generated in this 
study were selected on a fully WT array of self-pMHC complexes, the sheer diversity and 
variability generated makes it unlikely that other combinations of non-germline residues 
within a CDR1 or CDR2 would not find successful solutions to a shared pMHC ligand even 
where the remaining TCR sequences was conserved. While the potential therapeutic 
properties of Ig and Fab fragments have long been investigated, only relatively recently has 
focus turned to modification of TCRs for therapeutic purposes (Till et al, 2008). The use of 
TCRs is more complicated as while increasing the affinity of TCRs to induce more potent 
responses to cognate ligand, one must consider the possibility of increased cross-reactivity or 
introducing a TCR that would otherwise have been deleted in the thymus. Humanised murine 
systems that contain a full complex of human MHC and TCR loci, effectively allows the 
study of human T cell responses in a controlled experimental setting (Li et al, 2010). Using 
such an MHC background, a recombination cassette system would generate mutant libraries 
in vivo that will undergo thymic education, creating a self-limiting step screening step, 
meaning only TCRs that function at acceptable physiological levels would be prevalent in the 
periphery, which could thus be subjected to immune challenge. 
5.5 Germline TCR CDRs have an optimising but non-essential role in MHC engagement While  the  cassette  approach  concluded  CDR  structures  other  than  germline  regions, even  in  the  context  of  complete  absence of WT CDR  sequence,  could mediate positive selection on class I and II MHC (albeit with a clear bias), analysis of the thymi in these mice was difficult due to the general inefficiencies of the retrogenic system being further compounded by  the artificial nature of  cassette  recombination.   The single  fixed TCRβ chain on a TCRβδ‐/‐ background would ensure progression through to the DP phase of T cell development, and quite possible divergence from the γδ lineage, whereas successful T cell selection  in cassette mice required recombination to occur at a random point of genome  integration.  Further  as  the  TCRβ  chains  produced would  be  variable  it made analysis of exact CDR roles more difficult.  Replacement of the WT structures with short glycine‐alanine  linkers  facilitated  a  more  detailed  analysis  of  the  requirement  of germline  CDRs while  not  prohibiting  thymic  reconstitution.    Previous  studies making single  residue  changes  to  proposed  evolutionary  conserved  interaction  codon 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constituents  reported  a  reduction  in  selection  efficiency  upon MHC  recognition  in  the thymus (Scott‐Browne, et al, 2009). This result was interesting as it demonstrated that these  positions  affect  the  efficiency  of  MHC  engagement  on  a  broad  array  of  MHC regardless of MHC class or  the presented bound peptide,  as opposed  to a defined and crystallised pMHC ligand (Dai et al, 2008 and Feng et al, 2007). This result is somewhat hard to reconcile with certain aspects of an interaction codon based theory (Garcia et al, 2009),  which  predicts  that  a  single  V‐segment  would  contain multiple  codons  whose usage would change depending on its interaction environment (i.e. pMHC ligand). Thus one  could  expect  that  removal  of  a  single  residue  within  such  a  diverse  interacting environment  would  not  have  such  a  significant  effect.  Using  the  same  retrogenic approach,  the TCRβ mutants used here  that  removed seven germline positions  from a template  that  included  tyrosines  at  both  of  the  key βCDR2 positions  (Figure  4.1),  one might  expect  a  more  pronounced  or  even  catastrophic  effect  on  T  cell  selection. However  while  efficiency  of  MHC  engagement  was  hindered,  as  evidenced  by  CD5 expression upon positive selection in the thymus and the inability to of T cells to expand efficiently  in  empty  hosts,  presumably  due  to  loss  of  homeostatic  cues  that  control expansion in lymphopenic mice (Figures 4.7 and 4.28; Takada and Jameson, 2009), loss of MHC  recognition was  no  less  extreme  than  in  the  single  point mutations made  by Scott‐Browne  et  al,  suggesting  it  may  be  related  to  a  more  general  CDR  rather  than residue  specific  affect.  Also,  the  reduction  of  CD5  expression  in  DP  thymocytes  in 
βCDR1Δ2Δ3Δ  mice  cannot  solely  be  attributed  to  a  lack  of  selection  on  class  I  MHC  as suggested by  the CD4  skew as  both CD4  and CD8 peripheral  T  cells  demonstrated  an increased homeostatic expansion (Figure 4.6). An interesting control by Scott‐Browne et 
al would have been to generate double or triple mutant variants to see if a proportional effect could be measured.  While the removal of the full germline CDR complement of the TCRα or β chain hindered the  efficiency  of  pMHC  recognition,  it  did  not  negate  this  ability  altogether,  which  a germline encoded theory may have predicted. The ability to carry out pMHC‐dependent immune functions such as class switching was not impaired and response to allogeneic stimuli was also clear (discussed in more detail later). Further, nTregs, which select with distinct  TCR  repertoires  at  higher  affinities  (Jordan  et  al,  2001),  were  present  in  the TCRβ  and  most  likely  the  TCRα  mutant  mice  based  on  the  presence  of CD4+CD25+FoxP3+Helios+  peripheral  T  cells.  Importantly  therefore,  germline  mutant TCRs maintained a  sensitivity  that  allowed  them  to mediate MHC mediated  responses 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that  require  distinct  types  of  interactions,  for  example  in  terms  of  different  affinities. The  inefficiency of T  cell  selection was most  likely also  related  to  the  inability of CDR mutants to find suitable partner chains with which to audition for selection, exemplified by the reduction  in endogenous partner chain CDR3 repertoire diversity (Figure 4.20), which had shortened  lengths,  characteristic of  sub‐optimal MHC  interactions  (Ferreira 
et al, 2006). The reduction in partner chain CDR3 diversity may reflect a reduction in the variety of contacts germline CDRs are able to make with MHC, thus limiting the range of pMHC  complexes  that  can  be  recognised  during  selection,  indirectly  reducing  the diversity of the peptide recognising CDR3s. Alternatively, recent examples of TCR‐pMHC structures have demonstrated the ability of hypervariable CDR3 to directly compensate for  a  partner  chain whose  germline  CDRs  are  excluded  from  the  TCR‐pMHC  interface (Sethi et al, 2011). This data supports the requirement for a diverse germline repertoire of CDR1 and 2, which could allow selection of a broader array of CDR3 regions, and thus Ag recognition through provision of a greater potential to engage MHC. This concept of diverse germline contacts providing a more diverse engagement strategy as opposed to driving recognition is supported by recent work demonstrating that distinct CDR1 and 2 contacts  from the TCRα  chain  facilitated  the same TCRβ  chain  to diversify  its range of contacts against the same pMHC,  furthering the scope for cross‐reactivity (Stadinski et 
al, 2011).  The  regained  WT  selection  phenotype  in  mice  using  TCRβ  chains  with  CDR1  and  2 modified to contain the comparable loops from a TCRγ chain demonstrated clearly that any  loss  of  in MHC  recognition  in mice using  flexible  glycine‐alanine  linkers was  thus related to the loss of germline structure rather than sequence. While some γδ TCRs have been shown to interact with MHC like molecules such as T22 (Adams et al, 2005), these interactions  are  atypical  and  there  is  no  definitive  evidence  to  suggest  γδ  T  cells  are restricted  to MHC, particularly  if  one  considers  them  to be  the  common ancestor  that evolved prior to MHC restriction (Richards and Nelson, 2000). This conclusion is further backed up by preliminary data generated in the lab that shows TCRβ chains with CDR1 and  2  regions  derived  from  IgH  and  IgL  chains  can  also  mediate  WT  like  T  cell development  (Meriem  Attaf,  unpublished).  A  key  argument  against  the  conclusions reached so far, could be that the endogenous partner chains, which still maintain a full germline  complement  of  CDRs  could  be  utilising  evolutionary  conserved  interactions with  MHC  to  maintain  restriction  and  recognition.  However,  any  conserved  germline contacts that co‐evolved in the context of self‐MHC must have evolved in the context of 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their  partner  chains  and  their  relationship  with  the  MHC  also;  thus  the  extreme modifications  applied  to  the  germline  CDRs  on  an  exogenous  chain would  inexorably influence  the  ability  of  the  endogenous  germline  CDRs  to  function  normally  (Kranz, 2005). This  is supported by the reduction in partner chain CDR3/J‐segment but not V‐segment  usage  (Figure  4.16‐4.20).  If  endogenous  germline  residues would  drive MHC recognition in the absence of exogenous germline CDRs, one would expect a narrowing or  skewing  of  the  endogenous  V‐segment  repertoire,  which  was  in  fact  broadly comparable  in both WT and mutant  retrogenic TCR chains. The βCDR1Δ2Δ3Δ  and αCDR1Δ2Δ chains  could  be  co‐expressed  in  vivo  on  a  RAG‐/‐  background  to  directly  test  this hypothesis,  however  this makes  the  large  assumption  that  the modified  chains would form  a  viable  heterodimer  and  that  if  it  did  it  would  engage  with  self‐pMHC  in  the thymus at an affinity that mediates positive selection. This seems unlikely given the fact that  only  3%  of  TCRs  generated  from  endogenous  α  and  β  loci  meet  these  criteria (Miller, 1961). Previous systems (Kouskoff et al, 1995) have designed exogenous mini‐TCRα  loci  where  a  fixed  Vα‐segment  can  recombine  with  a  minimal  array  of  Jα‐segments, allowing the generation of a TCRα chain with fixed CDR1 and 2 but variable CDR3α regions. Such a mini‐locus using the fixed mutated αCDR1 and 2 coupled to the fixed βCDR1Δ2Δ3Δ  chain would perhaps generate a  repertoire of TCR  lacking all  germline CDRs, but with diverse CDR3 regions facilitating a greater likelihood of viable receptors to be made, thus placing the emphasis of selection on the lack of germline CDRs.   
5.6 Implications for alloreactivity and tolerance to self-MHC Perhaps  the most  damning  evidence  for  the  dispensability  of  germline  CDRs  in  MHC reactivity  is  the  clear  ability  of  TCRβ  chains  lacking  7  germline  CDR  residues  with  a minimal triple glycine CDR3 to distinguish between self and non‐self MHC in vitro and in 
vivo  (Figure  4.26  and  4.27).    As  discussed  in  Chapter  4.4.3,  the  molecular  nature  of alloreactivity has been demonstrated to be peptide or MHC centric. Theories promoting an  inherent  germline  affinity  of  TCR  CDRs  to  MHC  are  more  easily  reconciled  with alloreactivity, consistent with the idea that positive selection on self‐MHC selects TCRs where  the  inherent  MHC  reactivity  of  the  TCR  is  subdued  through  the  influence  of hypervariable CDR3 loops (Huseby et al, 2005 and Marrack et al, 2008) leaving the naïve TCR repertoire tolerant to self but inherently reactive to non‐self MHC. In other words, allo‐reactivity is merely an extension of co‐evolved MHC restriction. The data from this study suggests that the two phenomena may be distinct. As discussed later in, the work here  presents  a  robust  counter‐argument  against  germline  encoded  MHC  restriction, 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which must  otherwise be  enforced  through extrinsic  forces  such  as  co‐receptors  (Van Laetham  et  al,  2007).  As  the  co‐receptor’s  interactions  with  MHC  occur  at  highly conserved  interfaces  across  the  otherwise  highly  diverse  MHC  population  (Chapter 
1.4.3),  the  ability  of  the  TCR  to  distinguish  between  MHC  haplotypes  must  be  TCR dependent but not intrinsic. It has been noted as a terribly inefficient strategy if thymic selection  itself  selects  TCRs  that  are  MHC  restricted  by  chance  from  a  pre‐selection repertoire that contains no inherent preference and that germline predisposition makes more  sense  (Kranz,  2009).  However  the  tremendous  inefficiency  of  positive  selection when taken into consideration relative to the proportion of thymocytes that successfully engages and auditions with MHC (i.e. not just die by neglect; Merkenschlager et al, 1997) makes such a notion less nonsensical. The small proportion of cells that exit the thymus as  mature  naïve  T  cells  that  have  undergone  such  stringent  selection  criteria,  could likely be highly focussed to the selecting haplotype in the context of extrinsic restriction mechanisms, with TCRs only positively selected on a relatively weak affinity (Alam et al, 1996). The  fact  that outside molecules would  impart restriction, places  less constraint on the types of interactions that could meet the criteria for positive selection, supporting the observed variability and malleability of TCR CDR1 and 2 diversity described earlier. Indeed, such variability may be essential in ensuring that enough cells are able to pass through the intense censorship process.   In an allogeneic setting therefore, recognition of the allo‐MHC would be initiated by the extrinsic processes that mediate restriction to all MHC molecules but with the stringent criteria of self‐MHC tolerance imparted during positive  selection  not  being  met  –  which  could  also  be  a  result  different  types  of interactions.  Put  simply,  it  suggests  that  germline CDR1 and 2 during  allo‐recognition function  in a manner akin to CDR3 loops upon recognition of pathogenic Ag that were not  negatively  selected  against  due  to  their  absence  in  the  thymus  or  more appropriately,  in  a  similar  way  to MHC  unrestricted  Ig molecules.  Such  a mechanism implies that the pMHC is seen as a single surface rather than two distinct entities. 
5.7 TCR docking angle and TCR binding and triggering While  no  structural  or  kinetic work was  carried  out  in  this  study,  certain  theories  on TCR binding and docking angles can also be questioned circumstantially  in  light of  the malleability of TCR CDR1 and 2.  If  the pMHC  is  seen as  a  single  interaction  surface,  it makes  it  unlikely  that  distinct  interactions  occur  between  the  peptide  and MHC  –  for example  as  proposed  by  the  two‐step  binding model  (Wu  et  al,  2002;  Chapter  1.4.4). Such  a mechanism  is  also  dependent  on  a  germline  affinity  for  MHC  in  the  TCR  that 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would mediate docking prior to peptide scanning. The mutant TCR’s ability to recognise MHC in vivo as demonstrated here and the ability to signal in terms of thymic selection and  peripheral  responses  negates  this  idea,  supporting  work  that  demonstrates elements of  the whole pMHC complex and not distinct  components  can  influence TCR binding.  TCR  docking  angles  can  be  considered  partially  conserved  in  that  the  actual angle  is  highly  variable  but  the  overall  docking  mode  consistently  diagonal  with  the TCRα  or  β  V‐domains  always  positioned  relative  to  the  same  corresponding  MHC domains  (Rudolph  et  al,  2006).  Like  TCR  binding  mechanisms  to  MHC,  key  germline residues implemented in MHC recognition were also proposed to dominate the mode of docking, with variations in angle related to the fact these conserved CDR positions were focussed on depressions on top of the α‐helices of the MHC which could then act as a a pivot,  allowing  the  TCR  to  swivel within  a  confined  axis  (Marrack  et  al,  2008).  These CDR  positions,  Vα29,  31,  50  and  51  (Kabat  and  IMGT)  and  Vβ28,  29,  46,  48  and  54 (Kabat; 30, 31, 54, 56 and 67 IMGT) were altered in this study apart  from two (Figure 
4.1). One assumes that the library of TCR mutants generated in this study also utilise this conventional docking approach despite lacking these key residues, based on their ability to mediate MHC‐dependent functions in vivo, with no examples of alternative modes of docking reported. As discussed  in Chapter 1.5.2,  a narrow spectrum of docking angles, like MHC restriction  in general, may be enforced by extrinsic molecules –  for example the  requirement  of  diagonal  binding  to  facilitate  correct  down  stream  positioning  of signalling molecules or to allow appropriate access of co‐receptors in the IS (Collins and Riddle,  2008).  However,  Fab  Ig  molecules  raised  against  pMHC  complexes  have  also demonstrated a binding mode akin  to TCR, suggesting  that docking angles may not be controlled by co‐evolved interactions, but overall shape complementarity that facilitates suitable access of the CDRs (from Ig or TCR) to the pMHC complex (Stewart‐Jones et al, 2009; see next section). 
5.8 General features of CDR biology may be important in optimal MHC engagement The discussion so far, implies that germline sequences are not vital in MHC recognition, consistent  with  the  diverse  variants  selected  artificially  in  vivo  via  recombination cassettes and the efficient TCR‐pMHC interactions mediated by structured CDR1 and 2 derived  from TCRγ. Yet,  germline CDR structures are maintained  in evolution. General CDR features may therefore promote optimal or efficient binding to MHC. It is possible that shape complementarity plays a role, with structured CDRs positioned in a diagonal orientation  facilitating  optimal  access  to  the  pMHC  complexes.  Replacement  of  WT 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structures  with  flexible  glycine‐alanine  linkers  could  disrupt  such  shape complementarity  resulting  in  less optimal MHC  interactions, whereas  those  from non‐germline mutants  that contain structures comparable  to canonical αβTCR CDR1 and 2 regions, for example the βCDR1γ2γ3Δ chain, could facilitate WT like engagement with MHC (Figures 4.22 and 4.23). The aforementioned anti‐pMHC Fab Ig molecules that interacted in  a  manner  comparable  to  TCRs  using  their  own  CDRs,  despite  the  lack  of  any  co‐evolutionary predisposition, also supports the notion that having the “shape” associated with  germline  CDRs  is  sufficient  to  facilitate  pMHC binding.  If  shape  is  not  consistent with efficient MHC recognition more general chemical properties that can be attributed to  both  Ig  and  TCR  CDRs  may  optimise  the  binding  process.  Analysis  of  Ig  CDRs proposed that tyrosines and asparagines were critically important in recognition of Ag (Ofran  et  al,  2008).  Interestingly  the  same  amino  acids  are  often  highlighted  as important  in  TCR‐pMHC  interactions,  and  form  many  of  the  so‐called  “evolutionary conserved” TCR CDR positions (Marrack et al, 2008). This view is further supported by the  comparable panel  of  amino  acids  found  in  the  germline  codes  of  both  Ig  and TCR CDR1 and 2 regions (Figure 2.2), with both showing preferences for polar and aliphatic (small hydrophobic) amino acids,  along with a  lesser preference  for  charged  residues. Further,  these key residues are also  found  in  the modified CDRs of  the βCDR1γ2γ3Δ  chain and may  contribute  to  the  observed WT  like  selection  phenotype.  The  fact  that  such features may  be  beneficial  as  opposed  to  required  is  highlighted  by  the  fact  that  the random CDR mutants generated with the recombination cassette system did not show any evidence of bias towards tyrosine or asparagine (Tables 3.1, 3.2 and 3.4).  Another general feature of CDRs that has recently been retrospectively attributed to the docking angles and binding affinities of solved TCR‐pMHC structures is that of MSEP, as described in Chapter 1.5.2 (Kahn and Ranganathan, 2011). As described in Chapter 2.1.4, conservation of CDR position is not proportional to MHC interactions as exemplified by the  P3  histidine  of  the βCDR1  in  both murine  and  human  genomes  (Figure  2.2).  It  is possible therefore that this residue creates an important electrostatic environment that is  vital  in  guiding  engagement  with  the  reciprocal  environment  of  MHC  alleles. Interestingly, the equivalent P3 histidine was relatively highly conserved in the βCDR1 recombination  cassette mice  despite  being  next  to  the  point  of  recombination  where most  diversity  was  otherwise  observed  (Figure  3.7).  The  study  described  in  Chapter 
1.5.2  that  demonstrated  loss  of  pMHC  recognition  upon  deletion  of  a  key MHC  lysine from  the HLA‐A2‐Tax pMHC was not  related  to  a  loss of  interaction with  the TCR but 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rather a disruption in electrostatic compatibility that could be reverted with the mutual deletion  of  a  neighbouring  glutamic  acid  (Gagnon  et  al,  2005).  Such  a  requirement  of MSEP  forces  could  explain  the  lack  of  efficiency  in  MHC  engagement  of  the  mutant glycine‐alanine  linker  containing  TCRs  used  in  this  study,  while  other  non‐germline mutants such as the βCDR1γ2γ3Δ were successful. The  increase  in net positive charge that was  preferentially  associated  with  the  βCDR2  containing  recombination  cassettes (Figure 3.8), could be due to the positively charged CDR2 preferentially interacting with selecting  MHC  resulting  in  the  enrichment  of  charged  sequences  detected  in  the periphery,  that were most  likely not  enriched  in  the pre‐selection  repertoire  (Chapter 
3.2.3).  The  class  II  bias  associated  with  all  three  TCRβ  chains  modified  with recombination  cassettes  (Table  2.2)  indicates  the majority  of  T  cells  in  these  cassette mice  were  selected  on  the  sole  class  II  H2‐A  molecule,  which  is  relatively  highly conserved across different haplotypes (Feng et al, 2007). Interestingly, the region of α1 domain  of  H2‐A  that  the  βCDR2  has  been  shown  to  interact  with  does  contain  some pockets of negative MSEP, which supports the notion of a positive charge in the TCR at the βCDR2 being beneficial (Kahn and Ranganathan, 2011 Maynard et al, 2005) although pockets  of  positive  MSEP  also  exist.  Unfortunately  it  is  difficult  to  fully  substantiate these  conclusions  without  analysing  the  pre‐selection  or  mature  CD8  cassette repertoires, which was attempted but was unsuccessful. Thus  there  is  a potential  role for  general  chemical  features  of  CDRs  to  optimise  and  guide  MHC  engagement  as highlighted  tentatively  in  this  study.  Key  studies  would  be  to  replace  full  CDRs  with chemically extreme CDRs and measuring preferences to MHC of defined MSEP in vivo.  
5.9 Comment on the isolated case of autoimmunity in βCDR1Δ2Δ3Δ mice and MHC class bias 
Two unexpected phenomena that arose from this unbiased approach to analyse the role of 
germline CDRs was that of the MHC class bias, present in some of the TCR CDR mutants 
and the isolated case of systemic autoimmunity observed in mice that received adoptively 
transferred splenocytes from βCDR1Δ2Δ3Δ mice. The isolated case of systemic autoimmunity 
occurred in an experimental group size of n = 6 with significant differences between mice that 
received splenocytes from βCDR3Δ or βCDR1Δ2Δ3Δ mice in terms of weight and anti-dsDNA 
antibodies suggesting this was a genuine event with the latter readout dependent on TCR 
mediated responses. Thus the point of contention is why it was only observed on one occasion 
despite a total of three similar experiments being set up using comparable group sizes (data 
not shown). As discussed in Chapter 4.5, the two groups of mice contained different 
proportions of CD4 T cells, although both contained cells with a regulatory phenotype. It is 
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possible that the less efficient colonisation of empty recipients could have resulted in loss of a 
functional Treg population – functionality tests from the WT and mutant mice could confirm 
whether any difference in peripheral tolerance existed between the groups. Similarly, the 
reduction in TCR diversity in mutant mice may have resulted in an impaired regulatory 
repertoire, which can be associated with autoimmunity (Ferreira et al, 2009). Autoimmune 
TCRs are nearly always associated with low affinity interactions with self-pMHC and 
reduced signalling capacity has also been demonstrated to lead to an autoimmune TCR 
response as evidenced by naturally occurring variants and directed mutagenesis of the CD3 
ITAMs (Holst et al, 2008 and Lundholm et al, 2010). It is possible that a fraction of TCRs 
from the mutant mice had impaired MHC recognition, which is clear in thymic selection in 
the primary mice, that may result in decreased signalling strengths resulting in autoimmunity. 
While atypical docking angles representative of some human autoimmune TCRs 
(Wucherpfennig et al, 2009) have not been characterised for murine counterparts, one could 
speculate that a diminished contribution at the pMHC interface mediated by a flexible 
glycine-alanine linker may encourage altered binding modes that could result in 
autoimmunity. Alternatively, if the flexible linkers of mutant TCRs are actively engaging 
pMHC, recognition may be less stringent due to the same flexibility leading to pathogenic 
cross-reactivity. Unfortunately, the lack of reproducibility of this phenotype allows only 
conjecture in attempting to ascribe the underlying cause – with the biggest caveat relating to 
the fact that other data presented here showed clear tolerance to self-MHC in an in vivo 
transplant setting and in vitro proliferation assay (Figure 4.26 and 4.27).  
The nature of class bias in the germline CDR mutants is arguably the most perplexing, 
intriguing and unexpected result obtained in this study. While the CD8 skewing in αCDR1Δ2Δ 
mice cannot be confirmed due to generally poor T cell development in all TCRα retrogenic 
mice (Chapter 4.2.3), the clear skewing to the CD4 SP compartment in thymi of the 
corresponding TCRβ CDR mutants markd a clear divergence in lineage choice. Generation of 
transgenic αCDR1Δ2Δ expressing mice would facilitate clearer analysis of any CD4/8 skew. 
Although some studies have proposed specific TCR V-segments contain slight inherent 
preferences for MHC class (DerSimonian et al, 1991 and Jameson et al, 1990), all V-
segments contain the potential to contribute to class I or class II restricted receptors 
(Valkenburg et al, 2010 and Jorgensen et al, 1992).  The fact that βCDR1γ2γ3Δ containing TCRs 
can mediate selection on class I and class II MHC comparable to TCRβ chains with WT 
CDR1 and 2 argues against a concept where germline residues within each chain maintain 
opposing inherent preferences. Further, mutagenesis studies on the YAe62 
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been crystallised with both class I and II pMHC ligands, showed that the same germline CDR 
residues were important in recognition of both classes of MHC (Yin et al, 2011). Comparison 
of class I specific TCRs made from distinct V-segments that were deemed to be CD8 
dependent (2C, A6, B7 and KB5-C20; Buslepp et al, 2003b; Guimezanes et al, 2001 and 
Daniels and Jameson, 2000) or independent (AHIII, BM3.3, LC13 and JM22; Guimezanes et 
al, 2001; Sewell et al, 1999; Lawson et al, 2001 and Buslepp et al, 2003) were shown to form 
two distinct groupings of Vα docking modes atop the MHC molecule (Buslepp et al, 2003b). 
It was concluded the CD8 independent TCRs most likely sterically inhibit CD8 mediated 
signalling through distinct docking modes (Collins and Riddle, 2008). If at a sufficient 
affinity, these docking modes may facilitate co-receptor independent TCR signalling.  Such 
affinities would result in negative selection in the thymus, which is consistent with the 
absolute requirement of CD8 in class I mediated selection (Crooks and Littman, 1994). 
Endogenous TCRα chains pairing with retrogenic TCRβ chains using minimal glycine-
alanine linkers as CDRs, may be limited in their docking options with MHC during T cell 
selection resorting in docking modes that also sterically block CD8 mediated signalling. As 
CD8 help is required for successful signalling in selection of class I restricted T cells, it could 
explain the observed CD4 skew in TCRβ mutant retrogenic mice using glycine-alanine 
linkers but not structured non-germline replacements such as the βCDR1γ2γ3Δ chain. Such a 
process is consistent with the notion of reduced selection efficiency as measured by CD5 
expression (Figure 4.7) without a drop in endogenous partner chain Vα-segment usage 
(Figure 4.19).  
The skewing to MHC class II in the recombination cassette mice adds a further layer of 
complexity. The fact the recombination system only modified one CDR at a time is consistent 
with data showing modification of the βCDR2 to a gly-ala linker while maintaining the 
germline CDR1 sequence is sufficient to induce a thymically selected class II skew (Figure 
4.9). Conversely however, the non-germline modifications created through redirected V(D)J 
recombination generated structured loops with the majority of modifications focussed at loop 
apices, which makes the non-germline products of recombination more akin in structure to the 
non-germline CDR loops in the βCDR1γ2γ3Δ mice, which produced no lineage skewing (Figure 
4.24). This suggests that distinct mechanisms could account for the skewing noted between 
the cassette modified and glycine-alanine linker containing non-germline TCRβ mutants. As 
discussed in the previous section, the preference in class II skewing in cassette mice could be 
attributed to the increase in net positive charge generating favourable MSEP with the 
selecting H2-A class II molecule. Conversely, replacement of the WT βCDR1 and 2 with 
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glycine-alanine linkers would have the opposing effect on the TCRβ MSEP through loss of 
the two canonical positively charged residues (Figure 4.1). Intriguingly, the opposite is true 
with regards to the modification of the C6 TCRα CDR1 and 2 with the glycine-alanine 
linkers, which would result in an increase in positive MSEP through loss of the canonical 
aspartic acid in the CDR2 (Figure 5.1). It is possible these opposing characteristics could play 
an active role in MHC class preference, although it is hard to reconcile how an increase and 
decrease in net positive charge in the cassette generated and glycine-alanine linker modified 
TCRβ chains respectively, could both mediate a strong skew to the CD4 lineage. Repertoire 
analysis of the inferior CD8 T cells populations from cassette mice could shed further light on 
this discrepancy. 
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Figure 5. 1: Replacement of C6 TCRα and TCRβ CDR1 and 2 with glycine-alanine linkers polarises the net 
charge of each chain.  
Homology model representations of the variable domains comparing the αWT and βCDR3Δ chains (top) with their 
relevant mutant chains (bottom). The α and β chains are depicted as paired TCRs for simplicity with the dashed 
line defining each chain. The MSEP is displayed with red equating negative charge and blue, positive charge as 
described by Kahn and Ranganathan, 2011. The charged residues removed upon modification with glycine-
alanine linkers are highlighted in the top picture. Relative positions of the CDRs are highlighted indicated with 
dotted circles. The models were built using the PDB 1NFD, which was selected based on a BLAST search of the 
template sequences. The models were generated and kindly supplied by Shoba Ranganathan. 
 
5.11 Summary 
Overall, the work presented here has demonstrated the dispensability of germline TCR CDR 
sequence in mediating a broad array of MHC mediated events, including T cell selection, 
immune response, development of nTregs and alloreactivity as a well as the capacity of 
hundreds of non-germline variants to mediate MHC recognition in vivo. Such data is 
inconsistent with the notion that conserved pair wise interactions have developed and been 
maintained between the TCR and MHC over evolutionary time and has ramifications in other 
aspects of TCR-pMHC biology including the role of docking angles and binding mechanisms. 
The tremendous capacity for modification within the intrinsic features of the TCR without 
affecting the ability to mediate MHC restricted responses refocuses the attention on extrinsic 
factors to underpin the fundamental nature of MHC restriction. Other data supports a more 
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general role for germline CDRs that may function to optimise the nature of the TCR-pMHC 
interaction. By allowing such flexibility in the germline CDRs, one subsequently lessens the 
limitations on the hypervariable CDR3 regions, ultimately making the presented Ag the 
driving force of the interaction and not the MHC. Only an approach such as this would 
facilitate the level of cross-reactivity required to efficiently respond to the vast plethora of 
peptide Ag that comes into contact with the adaptive immune system. 
Such an extrinsically regulated system is perhaps the only approach that could lead to the 
extreme level of diversity observed for TCR-pMHC interactions described in Chapter 1.4.2 
and also why a clear, conserved mode of interaction has not emerged. The malleability of 
germline CDR1 and 2 in terms of chemical composition neatly highlighted by the 
recombination cassette system suggests that within a TCR-pMHC interface mediated by 
extrinsic features such as co-receptors, it is the chemical and not biological nature of the 
relationship that determines ligand suitability. In such an environment it would not be 
surprising to find variable angles (albeit restricted by further extrinsic requirements) and 
relationships where the “canonical” roles of the germline or hypervariable CDRs are switched 
to recognise the Ag and MHC respectively (Stewart-Jones et al, 2003; Cole et al, 2009 and 
Kjier-Nielson et al, 2003). Indeed, in the thymus any combination that could bind with 
suitable affinity could be selected regardless of whether the peptide or CDRs were required to 
change conformation upon engagement. While this approach may appear to compromise the 
requirement of specificity, one could envisage a successful chemical interface between a 
particular TCR and pMHC would, like any other favourable interaction, be the favoured 
solution.  Self-reactivity within any repertoire would be minimised through stringent positive 
and negative selection (Merkenschlager et al, 1997) as described. The downside of relying on 
extrinsic factors to determine TCR binding angles could be the allowance of abnormal and 
pathogenic docking modes that a germline code could otherwise prevent (Wucherpfennig et 
al, 2009 and Marrack et al, 2008). Similarly, the imperfect nature of co-receptor mediated 
MHC restriction (van Laetham et al, 2007) that facilitates higher affinity interactions in the 
periphery with alternate binding angles that exclude the co-receptor from the intracellular 
interface   (Buslepp et al, 2003b), could explain the apparent recognition of non-pMHC 
ligands even in the presence of co-receptors (Table 1.11). 
 
In conclusion, the presence of a germline TCR code to mediate MHC restriction and 
recognition may allow greater control over the consistency and perhaps specificity of the 
interactions. However, while reliance on extrinsic control may facilitate pathogenic and 
atypical ligand recognition, coupled to a highly stringent selection mechanism it eases the 
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restrictions on the role of the germline CDRs, leading to generation of a diverse but largely 
tolerant repertoire that has a more realistic chance in achieving the required levels of cross-
reactivity that are vital for a functional and effective adaptive immune response and 
ultimately the survival of the organism.  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Chapter 6: Methods and Materials 
6.1 TCR nomenclature The  TCR  nomenclature  of  Arden  et  al  (Arden  et  al,  1995)  was  used  predominantly throughout  due  to  ease  of  comparison  with  other  studies.  The  more  recent nomenclature derived from the IMGT database (Bosc et al, 2003) was used in the qRT‐PCR  analysis  (Section  6.7.2.2)  in  conjunction  with  that  of  Arden  et  al,  as  it  further distinguishes  between  Vα‐segments  Vα4  and  Vα13  (TRAV6  and  5  from  IMGT numbering  respectively)  into  TRAV6.1/6.2  and  TRAV5.1/5.2.  Specific  primers  in  the qRT‐PCR  analysis  of  repertoire  amplified  the  distinct  segments  and  are  marked  on 
Figure 4.19B. 
6.2 TCR residue numbering TCR residue numbering from both the unique number system from IMGT (Le Franc et al, 2003) and from the original numbering derived from the Kabat database (Johnson and Wu, 2000) is used. Comparisons between the two are made where required in the text and  figures.  All  standard  single  letter  amino  acid  codes  are  used  throughout  when describing position numbers. 
6.3 C6 TCR 
The original C6 TCR is HY-specific and was isolated from a CBA (H2k) female mouse 
immunised with CBA male splenocytes. The peptide epitope is TENSGKDI, derived from the 
Smyc gene product that is recognised on the MHC class I H2-Kk molecule. The TCR itself is 
Vβ11 and Vα8.3. Like most Vβ11 TCR, C6 TCRs interact with endogenous superantigens 
encoded by mouse mammary viruses, normally leading to negative selection. The C6 TCR, 
for not completely known reasons, is exceedingly well selected in the presence of 
superantigens. Reflecting the selection on MHC class I molecules, the C6 transgenic mouse 
shows a slight skew to CD8+ selected cells (Scott et al, 1995 and Chai et al, 1999). 
6.4 Cell Counts 
Cell counts were made using a haemocytometer (Neubauer 0.0025mm2, Germany) with 4 
fields of view counted under a x10 objective on a standard light microscope (Wild Heerbrugg, 
Germany) and averages taken. 
6.5 Mice WT  C57BL/6  (H2b),  CBA  (H2k)  and  FVB/N  (H2q)  mice  were  obtained  from  Harlan (Blackthorn, UK). CBA TCRα‐/‐ mice (H2k) contained a complete deletion of the TCRα loci 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encompassing  the  constant  region  gene  segments,  thus  preventing  any  viable  TCRα chain from being made (Phillpot et al, 1992). FVB/N TCRβδ‐/‐ (H2q) mice (Mombaerts et 
al, 1992) contain a deletion from the Dβ1.3 segment to the Cβ2 gene segment, thus also lack the ability to generate any TCRβ chain due to loss of both constant region segments. Both TCR deficient mice were kind gifts from Adrian Hayday. All mice were maintained in  specific‐pathogen  free  (SPF)  conditions  at  the  Hammersmith  Campus  of  Imperial College  London.  All  experiments were  carried  out with  Home  Office  and  local  ethical committee approval. 
6.6 Analysis of germline TCR and Ig repertoire TCR  and  Ig  segment  sequences were  downloaded  from  IMGT.  All  gene  segments  that were  deemed  to  be  able  to  be  expressed were  included  in  the  analysis;  orphan  gene segments and pseudo‐genes were omitted. CDR lengths were calculated based on IMGT boundaries  (Le Franc et al,  2003). The most  common  length of CDR  for each  receptor chains were analysed to facilitate a position‐by‐position comparison, as using all lengths could  have  skewed  the  data,  as  not  every  V‐segment  would  be  represented  at  each position. Data  is presented as  the percentage each amino acid  is used at  that position relative to the total number of V‐segments. Heat maps were generated using J‐color grid software  (Joachimiak et al,  2006).  Shannon’s  entropy analysis  as described  in Chapter 
2.1, was calculated using the protein variability server, which calculates diversity based on sequence alignments of a common length (Garcia‐Boronat et al, 2008). 
6.7 Molecular Biology 
6.7.1 RNA extraction and generation of cDNA RNA  was  extracted  from  purified  cells  (see  Section  6.10)  using  an  RNAqueous®  RNA extraction  kit  following  the  manufacturer’s  protocol  (Applied  Biosciences,  USA).  RNA was eluted in 50µl of double‐distilled (dd)H20 containing 1U of RNA guard (Amersham Pharmacia, UK) and stored at ‐80°C. Complementary (c)DNA was synthesised using the Superscript  III®  system  (Invitrogen,  USA)  according  to  manufacturer’s  instructions. Successful cDNA synthesis was confirmed through polymerase chain reaction (PCR; see next  section),  amplifying  for  the  housekeeping  gene  HPRT1,  which  encodes  for  the hypoxanthine‐guanine  phosphorbiosyltransferase  (HPRT)  protein  that  is  ubiquitously expressed throughout all cells (data not shown). cDNA was stored at ‐80°C. 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6.7.2 TCR repertoire analysis  
6.7.2.1 Sequencing approach 
Primers specific for the diverse region of interest (Table 6.1) were used in PCR under 
standard cycling conditions. For each reaction, 2.5µl x10 reaction buffer (Invitrogen, USA), 
0.75µl 50mM MgCl2 (Invitrogen, USA), 0.5µl 10mM mix of each dNTP (Bioline, USA), 
0.5µl of 1U/µl BIOTAQTM (Bioline, USA), 1.25µl of 1% W1 (Bioline, USA), 1µl of 10µM 
forward primer and 1µl of 10µM reverse primer was made up to 25µl with ddH2O. Cycling 
conditions were as follows: 1x[95ºC 5 minutes], 25-35x[(95ºC 45 seconds)(XºC 45 
seconds)(72ºC 45 seconds)], 1x[72ºC 10 minutes] with reactions maintained at 4ºC until 
analysis. See Table 6.1 for exact annealing temperatures (X) and cycling number for each 
primer pair. To analyse sequences, fresh PCR products were cloned using the TOPO® TA 
cloning kit into the pCR®2.1-TOPO® vector using the manufacturer’s instructions and 
transformed to chemically competent DH5α using one-shot TOP10® (Invitrogen, USA). 5, 50 
and 100µl of bacteria were plated out on to LB-Agar plates containing a final concentration of 
100µg/ml of ampicillin (Invitrogen, USA) and incubated at 37°C overnight.  Colony PCR that 
gave positive results (checked by running on a 1% agarose gel; data not shown) using the 
original primer pair were analysed by sequencing using primers specific for the constant 
region of the chain (Section 6.7.6). Repertoires of endogenous sequences were determined 
through comparison of sequences to the IMGT database (Lefranc et al, 1999). The stacking 
charts used in Figure 3.7 to summarise the repertoire diversity created by the recombination 
cassette approach were generated using Web Logo (http://weblogo.berkeley.edu/logo.cgi; accessed 07/12/11). 
 
 
Table 6. 1: Forward (F) and reverse (R) primers used to analyse TCR repertoires via sequencing 
PCR Target Sequence (5'-3') Name Annealing Temp. (°C)
Endogenous V!7-CDR3 F TACAGGGTCTCACGGAAGAAGC V!7
R CACTGATGTTCTGTGTGACAG C!(C) 
Endogenous V"9-CDR3 F ACACCGTTGTTAAAGGCACC V"9
R CTTTCAGCAGGAGGATTCG C"L
Cassette V!11 CDR1/2 F CAAGAAGCAACTCTGTGGTGTGAG CDR1-RecF
R CACTGATGTTCTGTGTGACAG C!(C) 
HPRT F CCTGCTGGATTACATTAAAGCACTG HPRTF
R GTCAAGGGCATATCCAACAACAAAC HPRTR
54
59
54
Table 6.1:  Forward (F) and Reverse (R) primers used to analyse TCR repertoires via sequencing
58
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6.7.2.2 Quantitative Real-time PCR approach 
Quantitative Real-time (qRT) PCR was performed by Dr Raphael Genolet using LightCycler 
FastStart DNA Master SYBR Green I® (Roche Diagnostics, Switzerland). 1 µl of cDNA 
template from bead purified CD4+ splenocytes (Section 6.10) was mixed with 500nM of the 
appropriate primers, 2mM MgCl2 and 2 µl of LightCycler® FastStart DNA Master SYBR 
Green (Roche Applied Science, USA) in a total volume of 20µl. Amplification was performed 
after an initial denaturation step at 1x[95°C 10 minutes] using the following protocol: 40x [(5 
seconds 95°C) (5 seconds at the annealing temperature determined for each primer pair) (20 
seconds 72°C)]. After the final amplification, dissociation curves were assessed in the range 
of 60 to 95°C. Ct values were determined with the Fitpoint algorithm of the LightCycler 
software (v3.5). The slope efficiency for every amplification reaction was calculated by linear 
regression of four different Ct values taken in the linear phase of the amplification (0.2, 0.4, 
0.8, 1.6 units of fluorescence). Data was presented for each Vβ segment relative to the 
expression of the Cβ signal (i.e. 100%). 
6.7.3 Mutant TCR generation by overlap PCR mutagenesis 
The R1 and R2 reactions (see Figure 2.7) were carried out as separate 50µl reactions using 
5µl x10 reaction buffer (Invitrogen, USA), 1.5µl 50mM MgCl2 (Invitrogen, USA), 1µl 10mM 
mix of each dNTP (Bioline, USA), 0.5µl of 5U/µl high fidelity Taq polymerase (Invitrogen, 
USA) and 1.25µl of 1% W1. The R1 reaction primers (10µM) contained a forward primer 
tagged with a BglII restriction site and a reverse primer tagged with the desired modification. 
The R2 reaction primers (10µM) contained a forward primer tagged with a sequence 
complementary to that of the R1 reverse primer and a reverse primer tagged with an EcoRI 
restriction site (See Table 6.2 for primer sequences). Cycling conditions for these reactions 
were 1x[95ºC 5 minutes], 30x[(95ºC 30 seconds)(60ºC 30 seconds)(72ºC 30 seconds)], 
1x[72ºC 10 minutes] with reactions left at 4ºC. The samples were treated with Dpn1 
(Invitrogen, USA) for 1 hour at 37ºC to remove methylated template DNA and cleaned using 
a PCR purification kit (Qiagen, USA) following the manufacturer’s instructions and eluted in 
30µl ddH2O. For the extension reaction, equimolar amounts of R1 and R2 were mixed at a 
final amount between 500-1000ng.  This DNA mix was used in a 50µl PCR reaction set up as 
for the original R1/R2 PCR, but excluding any primers. Cycling conditions were 1x[95ºC 5 
minutes], 25x[(95ºC 30 seconds)(65ºC 30 seconds)(72ºC 30 seconds)], 1x[72ºC 10 minutes]. 
The R3 amplification step contained 1µl of 10 µM R1 forward primer and R2 reverse primer 
added to the reaction mixture and cycled as described for the R1 and R2 reactions.  
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Table 6. 2: Forward (F) and reverse (R) primer sequences for overlap mutagenesis 
 
6.7.4 Recombination cassette design and synthesis 
Using the βCDR3Δ or βCDR1Δ2Δ3Δ chain as template (see Figure 2.9), the 7/23/9 RSS from murine 
Vβ8.1 and the 9/12/7 RSS from Dβ1 joined by the endogenous 500bp sequence upstream on 
Dβ1 were designed to insert into the centre of the relevant CDR (Appendices 1 and 2). The 
constructs were synthesised de novo (Mr Gene®, Germany) with EcoRI and BglII restriction 
sites tagged to the 3’ and 5’ ends respectively to facilitate cloning into the pMigR1 vector (see 
Figure 2.5 and the next section).  
6.7.5 Cloning of modified TCRs into pMigR1 vector 
Modified TCRs generated by overlap mutagenesis or gene synthesis were cloned into the 
pMigR1 retroviral vector by digesting both plasmid and sample with EcoRI and BglII (New 
England Biolabs, USA; 4U/µg DNA) in a 100µl reaction containing 10µl EcoRI x10 reaction 
buffer (New England Biolabs, USA), made up to 100µl with ddH2O and incubating overnight 
at 37ºC. Digested products and vector were mixed at 3:1 ratio (90:30fmol) with 1µl 5U/µl T4 
ligase and 4µl of the associated 5X buffer (Invitrogen, USA), made up to 20µl with ddH20 
and left for 2 hours at room temperature (RT). 1µl of the ligation reaction was used to 
transform chemically competent DH5α as described in Section 6.7.3 and plated overnight as 
also described. Single colonies were grown in 5ml of LB medium (MRC Clinical Sciences 
Centre, London) containing 100µg/ml of ampicillin (Invitrogen, USA) at 37°C overnight at 
220 revolutions per minute (rpm) and plasmids purified using a quick-lyse Mini-Prep plasmid 
purification kit (Qiagen, USA) following the manufacturer’s instructions and eluted in 30µl 
ddH20.  Presence of the insert was checked by re-digestion as described above with samples 
run on 1% agarose gels, with positive clones then sequenced (see next section).  
Targeted mutation Reaction  Sequence (5'-3') Name
R1 Reaction F GGAGATCTACCACCATGGCCCCCAGGCTC C6bBglF
R ACCTCCTCCGCTGCTTGCACAAAGATACAC C6bCDR3R
R2 Reaction F GTGCAAGGCAGCGGAGGAGGTACCTTGTACT C6bCDR3F
R CCGAATTCGCTCAGGAATTTTTTTTCTTGACCATGG C6bRIR
R1 Reaction F GGAGATCTACCACCATGGCCCCCAGGCTC C6bBglF
R GAAAACAGCTGTGTTGGAGAAATATGGAAGTGAAATTGGCTCACACCACA !CDR1-TGV1R
R2 Reaction F ATTTCACTTCCATATTTCTCCAACACAGCTGTTTTCTGGTACAGACAGAC !CDR1-TGV1F
R CCGAATTCGCTCAGGAATTTTTTTTCTTGACCATGG C6bRIR
R1 Reaction F GGAGATCTACCACCATGGCCCCCAGGCTC C6bBglF
R AATCATCTATATTGTAGTTTGTTGAGACGTAAGTCAGGAACTCCAGGCCC !CDR1-TGV2R
R2 Reaction F CCTGACTTACGTCTCAACAAACTACAATATAGATGATTCAGGGATGCCCA !CDR1-TGV2F
R CCGAATTCGCTCAGGAATTTTTTTTCTTGACCATGG C6bRIR
Table 6.2: Forward (F) and Reverse (R)  primer sequences for overlap mutagenesis
CDR3!
CDR1"
CDR2"
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6.7.6 DNA sequencing All sequencing was carried out by the MRC genomics facility at Hammersmith Hospital, London. Sequencing of colony PCR products analysing TCR repertoire diversity used one way reverse sequencing primers specific  for  the TCRα or TCRβ  constant region (Table 
6.3).  Modified  TCRs  cloned  into  pMigR1  for  in  vivo  work  were  sequenced  in  both directions using primers  specific  for  edge of  the multiple  cloning  site  in pMigR1  itself (Table  6.3 and  Figure  2.5).  Positive  clones were  further  concentrated  by  transforming and  plating  DH5α  chemically  competent  bacteria  as  described  in  Section  6.7.5.  Single colonies  were  grown  in  2ml  of  LB  medium  with  100µg/ml  final  concentration  of ampicillin  for  8  hours  at  37°C  and  220rpm  and  then  transferred  to  100ml  of  similar medium  and  left  shaking  overnight.  Plasmids  were  purified  using  an  endo‐toxin  free maxi‐prep plasmid purification kit  (Qiagen, USA) with  constructs  eluted  in ddH20 and stored at ‐20°C. Sequences were analysed using 4peaks software (v1.7.2) and sequence alignments  generated  using  BioX  (v1.6b1)  with  ClustalW  alignment  algorithm (Thompson et al, 1994).   
 
Table 6. 3: List of sequencing primers 
6.8 Transfection of Phoenix Ecotropic cell line 
2x105/well of the Phoenix Ecotropic lenti-virus packaging cell line (PEco) were plated in a 6 
well plate (Falcon, USA) with 2ml Iscove’s Modified Dubeccos Medium (IMDM; Gibco, 
USA) supplemented with 10% foetal calf serum (FCS; Autogen Bioclear, UK) and 2mM L-
glutamine (Sigma, USA). After 24 hours at 37°C (5% CO2), the media was replaced and cells 
were prepared for transfection. For each well, 3µg of pMigR1 containing the desired insert in 
conjunction with 1µg of pCL-Ecotropic helper vector (Naviaux et al, 1996) was added to 
250µl in Opti-MEM® media (Invitrogen, USA). In separate tubes, 10µl lipofectamine-2000 
(Invitrogen, USA) was added to 250µl Opti-MEM® media and incubated for 20 minutes at 
RT. The tubes containing the DNA and lipofectamine were mixed and incubated for a further 
20 minutes before being added to the cells. Viral supernatant (SN) was harvested after further 
72 hour incubation at 37°C and either used directly for transductions (see next section) or 
Name Sequence (5'-3') Direction Target
C!Seq CATAGCTTTCATGTCCAGC Reverse TCR! constant region
TRBCs GATGGCTCAAACAAGGAG Reverse TCR" constant region
MigR1Fs CTAGGCGCCGGAATTAG Forward 5' end of pMigR1 multiple cloning site
MigR1Rs CTTATTCCAAGCGGCTTC Reverse 3' end of pMigR1 multiple cloning site
Table 6.3: List of sequencing primers
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frozen in liquid nitrogen for later use. Transfection efficiency was measured via flow 
cytometry of PEco cells using GFP from pMigR1 as a marker (see Section 6.13).  
6.9 Transduction of primary cells with viral supernatant 
6.9.1 HSC 
BM donor mice were injected intra-peritoneally (i.p.) with 150mg/kg 5’-Fluorouracil (5’FU; 
Invivogen, USA) 72 hours prior harvesting. Cells were flushed from tibia, fibula and humeri 
of desired donor mice with phosphate buffer solution (PBS; Sigma, USA) through a 70µm 
cell strainer using a 30-gauge needle. Red blood cells were lysed for ten minutes on ice using 
2ml of red cell lysis buffer (0.8% Ammonium Chloride, 0.1mM ethylinediaminetatreacetic 
acid (EDTA) with KHCO3 as a buffer; StemCell technologies, France). Cells were then 
washed with PBS by spinning at 1500rpm. 2x106 cells were plated in a 12-well plate (Nunc, 
Denmark) in 2ml IMDM (10% FCS and 2mM L-Glutamine) in conjunction with 20ng/ml 
recombinant mouse IL-3  (Invitrogen, USA), 10ng/ml IL-6 (Invitrogen, USA), 10ng/ml SCF 
(Invitrogen, USA) and 10ng/ml recombinant human FLT-3 ligand (Invitrogen, USA). Media 
and cytokines were topped up by 1ml after 24 hours incubation at 37°C (5% CO2) and after 
48hrs conditioned media was retained and cells were harvested by scraping with a pipette tip. 
Up to 4x106 cells were re-suspended in 2ml viral SN containing desired constructs with 1µl of 
4mg/ml polybrene (Sigma, USA) and plated in a 12-well plate (Nunc, Denmark). Spin 
infection of the cells was induced by centrifugation at 2000rpm for 90 minutes. After 
centrifugation, 0.5ml of fresh media and 1ml of conditioned media was added to each well in 
conjunction with fresh cytokines at final concentrations described above. Cells were further 
incubated at 37ºC (5% CO2). After 48 hours cells were harvested by scraping once more and 
~1x105 cells analysed by flow cytometry for expression of the retrogene. Recipient TCRα-/- or 
TCRβ-/- mice were irradiated at 400 or 600rads respectively. The remaining cells were 
washed with PBS and prepared to allow transfer of 0.1-1.0x106 GFP+ HSC per recipient 
mouse in 200µl PBS via intravenous (i.v.) injection into the lateral tail vein. 
6.9.2 ConA blasts 
Single cell suspensions of splenocytes from C57BL/6 or CBAWT mice were made by teasing 
cells through a 70µm cell strainer (BD Falcon, USA) and washed at 1500rpm with PBS 
(Sigma, USA). 6x106 cells were plated in a 12-well plate (Nunc, Denmark) with 2ml of 
Roswell Park Memorial Institute (RPMI; Gibco, USA) supplemented with 2mM L-Glutamine 
(Sigma, USA) and 10% FCS in conjunction with 2ng/ml recombinant mouse IL-7 (Santa-
Cruz, USA) and stimulated with 4ng/ml of Con A (Sigma, USA). The protocol continued as 
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described for HSC in the previous section, but using reagents noted here. All cells were 
harvested and subjected to flow cytometric analysis to analyse surface expression of the 
transduced retrogene (Section 6.13). 
6.10 Cell purification T  cells  isolated  for  endogenous  TCR  repertoire  analysis  (Section  6.7.2)  and  in  vitro proliferation assays (Section 6.12) were purified using MACS® bead purification system using self‐made MACS buffer (PBS, 2mM EDTA and 0.5% bovine serum albumin (BSA)). Cells  were  purified  using  anti‐CD4  (L3T4)  or  anti‐CD8  microbeads  (Milentyi  Biotec, Germany)  following  the  manufacturer’s  instructions  using  MS‐manual  separation columns. 
6.11 Generation of BMDC 
BMDC were generated based on the method of Inaba et al. (Inaba et al, 1992).  BM was 
flushed from the long bones of donor mice (TCR βδ-/-, TCRα-/- or C57BL/6) as described in 
Section 6.9.1. Cells were re-suspended in IMDM (Gibco, USA) supplemented with 10% FCS 
(Autogen Bioclear, UK), 2mM L-glutamine (Sigma, USA), 100IU/ml penicillin (Invitrogen, 
USA) and 100µg/ml streptomycin (Invitrogen, USA) at a concentration of 1x106/ml and 10ml 
plated in 20cm2 flasks (BD Falcon, USA) with 10% (v/v) GM-CSF containing supernatant at 
37°C (5% CO2). On day 3, half of the media was replaced and fresh GM-CSF containing 
supernatant added to 10% (v/v) and re-incubated. On day 6, the cells were harvested by 
scraping and re-plated in similarly supplemented medium at the original density. On day 7, 
the BMDC were activated with LPS (Sigma-Aldrich, St. Louis, MO, USA) at 100 ng/ml and 
harvested on day 8 for use in in vitro cell proliferation assays (see next section). GM-CSF was 
produced from the murine encoded gene cloned into the mammalian expression vector 
(BCMGSNeo) and transfected into the X63-Ag8 plasmacytoma cell line. Cells were selected 
with G418 (Sigma, USA) added at a concentration of 1mg/ml. To harvest SN, cells were 
washed twice at 1500rpm in PBS (Sigma, USA), aliquoted and stored at -20°C. 
6.12 In vitro proliferation assay 
An in vitro mixed lymphocyte response (MLR) proliferation assay was carried out as 
previously described (Chai et al, 1998). 1x105 CD4 T cells purified as described in Section 
6.10 were co-cultured with 0, 1x104, 2x104 or 4x104 allogeneic or syngeneic irradiated 
BMDC in a total volume 200µl of RPMI (Gibco, USA), supplemented with 10% FCS 
(Autogen Bioclear, UK), 2mM L-glutamine (Sigma, USA), 100IU/ml penicillin (Invitrogen, 
USA) and 100µg/ml streptomycin (Invitrogen, USA) in round-bottomed 96-well plates 
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(Nunc, Denmark).  BMDC were generated as described in the previous section and irradiated 
at 1000 Rads prior to incubation. After 72 hours incubation at 37°C (5% CO2), wells were 
pulsed with 1µCi [3H] thymidine in 1µl ddH20 (New England Nuclear, USA) and left for a 
further 18 hours. Thymidine uptake was measured using a Wallac 1205 Betaplate liquid 
scintillation counter (PerkinElmer, USA). All samples were measured as duplicates from at 
least n=3 mice. 
6.13 Flow cytometry 
6.13.1 Antibodies and hardware used 
Flow cytometric analyses were performed on a FACSCalibur (BD Bioscience, USA) or Cyan-
ADP (Dako, Denmark) instrument acquired with BD CellQuest and Summit® software 
respectively. Data was analysed using FlowJo software (Treestar, v8.8.6). Antibodies were 
obtained from eBiosciences (USA); CD4-FITC (RM4-5), CD8-APC (53-6.7), FoxP3-APC 
(FJK-16s), FoxP3-FITC (FJK-16s), CD5-PE (53-7.3) and TCR-PE (H57-597), BD 
Biosciences PharMingen (San Jose, CA, USA); CD25-PE (PC61), CD44-PE (IM7), CD44-
APC (IM7), CD4-PerCP (RM4-5), Vα2-PE (B20.1), Vα3.2-PE (8-8.96), Vα8.3-PE (B21.14), 
Vα12-PE (B20.1), Vβ2-PE (B20.6), Vβ3-PE (KJ25), Vβ4-PE (KT4), Vβ5.1-PE (MR9-4), 
Vβ6-PE (RR4-7), Vβ7-PE (TR310), Vβ8-PE (F23.1), Vβ8.1/8.2-PE (MR5-2) and Vβ11-PE 
(RR3.15) and eBiosciences (USA); Helios-APC (22F6). 
6.13.2 Preparation of tissues Thymocytes  and  lymphocytes  from  spleen  and  LN  were  made  into  single  cell suspensions as described in Section 6.9.1. Inguinal, brachial and axillary LN were taken as  standard.  Cells  in  culture were  scraped  from wells  using  a  pipette  tip.  Splenocytes were lysed on ice for 10 minutes in 2ml of red cell lysis buffer (0.8% Ammonium Chloride, 
0.1mM EDTA with KHCO3 as a buffer; StemCell technologies, France). All cells were 
washed twice in 50ml PBS (Sigma, USA) at 1500rpm and re-suspended in a final volume of 
100µl for staining. 
6.13.3 Surface staining 0.5‐1µl of required antibody was added to each sample for approximately every 1x106 cells and gently tapped. Samples were incubated in the dark at RT for 20 minutes before washing  twice with 2ml of PBS  (Sigma, USA)  at  1500rpm. Cells were  re‐suspended  in 300µl of PBS (Sigma, USA) and kept at 4°C until analysis. 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6.13.4 Internal staining For internal staining of FoxP3 and Helios expression, at least 2x106 cells were prepared and  surface  stained  as  described  in  Section  6.13.2  and  6.13.3.  Cells  were  fixed  and permeablised  in  0.3ml  FixPermTM  solution  diluted with  the  designated  dilutant  (both from eBiosciences, USA) at a 1:4 ratio. Samples were incubated in the dark at 4°C for a minimum  of  1  hour  or maximum  for  overnight.  Cells  were  washed  in  0.8ml  of  Perm BufferTM  (eBiosciences,  USA)  diluted  1:10  in  PBS  (Sigma,  USA).  0.5µl  of  the  desired internal staining antibody was added in 10µl of Perm BufferTM (eBiosciences, USA) and incubated in the dark at 4°C for 20 minutes. The samples were washed again in 0.8ml of Perm BufferTM (eBiosciences, USA) at 1500rpm and re‐suspended in 300µl PBS (Sigma, USA). Samples were run immediately after the final wash step. 
6.13.5 Secondary staining after serum incubation The protocol for measuring anti‐allo Ig was based on that of Leenaerts et al (Leenaerts 
et al, 1990). Whole splenocytes were made into a single cell suspension as described in 
Section 6.9.1 but were left without lysing red blood cells. Fc receptors were blocked with 0.5ml of 2.4G2 SN (a kind gift from Jian‐Guo Chai) incubated with the cell pellet for 15 minutes at RT.  Cells were re‐suspended in RPMI (Gibco, USA) at a final concentration of 
1x106/ml. 100µl of suspension was used in each well of a round-bottomed 96-well plate 
(Nunc, Denmark).  Blood was collected from the tail vein of mice using a 21-gauge needle. 
The blood was left to clot on the bench for around 10 minutes and was then spun down using 
a bench top centrifuge for 1 minute at 5000rpm. Serum was collected from the upper phase of 
the samples and transferred to new tubes and stored at -80°C. When ready to use, the serum 
was thawed on ice and then a serial dilution made from 1 in 10 to 1 in 10,000. 100µl of the 
desired dilution was transferred to plated cells and left at RT for 20 minutes. Cells were 
harvested from the plate and washed twice at 1500rpm in ice cold PBS (Sigma, USA). Cells 
were re-suspended in 100µl PBS (Sigma, USA) 0.5µl of anti-mouse IgG conjugated antibody 
added to each sample and incubated at RT in the dark for 20 minutes. Cells were washed in 
2ml of PBS (Sigma, USA) at 1500rpm and then re-suspended in 300µl PBS (Sigma, USA) 
and kept at 4°C until analysed. 
6.13.6 Fluorescence activated cell sorting (FACS) To  purify  CD4  T  cells  from  recombination  cassette mice, whole  spleens  and  LN were prepared  as  described  in Section  6.13.2.  The  cells were  combined  and  surface  stained with anti‐CD4 conjugated antibody as described in Section 6.13.3. Samples were filtered 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through  muslin  and  maintained  in  PBS  (Sigma,  USA)  containing  10%  FCS  (Autogen 
Bioclear, UK). Samples were sorted using a FACS Aria III (Beckton-Dickinson, USA) gating 
on CD4+GFP+ cells. The MRC Clinical Sciences Flow Cytometry Facility based at 
Hammersmith Hospital carried out all cell sorting. Samples were pelleted by centrifugation at 
1500rpm and SN removed and pellets stored at -80°C until ready for RNA extraction (Section 
6.7.1). 
6.14 Histology  
Immunohistochemical staining was kindly carried out by Dr Fang-Ping Huang at Imperial 
College. Briefly, Snap-frozen kidneys were cut and fixed in cold acetone for 5 minutes and 
air-dried. Sections were incubated with 20% normal goat serum to block non-specific 
binding. 
FITC-conjugated goat antibody specific for IgG1 (Serotec, STAR81F) (1/100 dilution), or 
IgG2b (Serotec, STAR83F) was applied for 1 hour at RT. Slides were washed 5 minutes in 
PBS (Sigma, USA) for three times and mounted with PermaFluor. The tissue slides were 
analyzed using an Olympus BX4 fluorescence microscope and images were acquired with a 
Photonic Science Color Coolview digital camera. 
6.15 Enzyme-linked immunosorbent assay (ELISA) 
6.15.1 Class switching ELISA  
The ELISA was carried out using the BD PharmigenTM Mouse Immunoglobulin Isotyping 
ELISA kit, following the manufacturer’s instructions. The kit contained an internal positive 
control that required samples to be diluted such that absorbance readings fell into the 
exponential phase of the internal positive control serial dilution. As such, sera from the TCRβ 
retrogenic mice were diluted 1:200 into PBS (Sigma, USA) (along with C57BL/6 and TCRβ-/- 
negative control) and the TCRα retrogenics were diluted 1:400 (including the TCRα-/- 
negative control). Plates were read at 570nm-450nm as specified in the protocol 
(SpectramaxM2, Molecular Devices, USA). 
6.15.2 Autoimmune ELISA 
96-well plates (Nunc, Denmark) were coated in 50µl of 1µg/ml streptavidin (Roche Applied 
Science, USA) diluted in Boric Acid buffer (100mM boric acid, 25mM Na tetraborate and 
75mM NaCl at pH 8.3-8.5) and incubated at 37ºC (5% CO2) for 3 hours. Wells were then 
saturated with 100µl PBS (containing 0.5% BSA-NaN3; Sigma, USA) at RT for 1 hour. 
Biotinylated dsDNA was added in 50µl at 200ng/ml in PBS (Sigma, USA) or 50µl PBS for 
negative controls and incubated at 4ºC for 5 hours. Wells were saturated as before. Wells 
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were washed 5 times with PBS (Sigma, USA) and diluted serum samples (1:100) added in 
50µl PBS (plus 2% BSA) and incubated at 4ºC for 5 hours before being washed 5 times with 
PBS as before. An alkaline phosphatase conjugated antibody (BD Pharmigen, USA) diluted 
in 50µl PBS with 2% BSA (Sigma, USA) was added to each well and incubated for 5 hours at 
4ºC, again being washed 5 times with PBS. Alkaline phosphatase substrate (Sigma, USA; 
FAST p-Nitrophenyl phosphate tablet sets) was made up as directed and added in 50µl/well. 
The reaction was allowed to proceed at RT being measured every hour for 5 hours at 405nm 
(SpectramaxM2, Molecular Devices, USA).  
6.16 Skin grafting I am greatly  indebted to Dr David Coe  for carrying out skin grafting operations on my behalf.  Recipient  mice  were  injected  with  3x106  whole  splenocytes  i.v.  from  pooled donors and allowed to expand for 4 weeks. Skin‐grafting procedure was based on that of Billingham et al (Billingham et al, 1951). Skin sections approximately 1cm2 were taken from syngeneic  and allogeneic donor  tail  skin and kept  in PBS  (Sigma, USA) until use. Recipient mice were  anaethesetised with  isoflurane  (Halocarbon  Products  Corp,  USA) and  then  injected  subcutaneously  (s.c.) with 260ng of Metcam  (Boehringer  Ingelheim, Germany). The mice were immobilised and the surgical site shaven and sterilised with 70%  ethanol  and  Opsite  spray®  dressing  applied.  A  corresponding  2cm2  skin  section was  removed  from  the  recipients  above  the  right  flank  to  create  a  graft  bed.  The syngeneic and allogeneic donor skin was placed into the graft bed adjacent to each other and  then  covered  in  Vaseline‐soaked  muslin.  A  plaster  was  then  applied  around  the graft, extending to the thorax and mice were placed in a 32°C chamber to recover with wet  food.  The  plasters  were  removed  after  8  days  post‐operation  and  skin  graft rejection  scoring was determined using a +/- system of graft rejection where ++ = full 
acceptance, defined by no aggravation and growth of hair on grafted skin, + = No sign of hair 
growth but no visible shrinking or aggravation of the graft, +/- = No hair growth with signs of 
aggravation or scabbing but with no shrinking of graft, +/-- = as for +/- but with shrinkage of 
graft and - = complete rejection no sign of original graft on graft area due to shrinking and 
aggravation. Scoring was measured from the day of grafting. 
6.17 Statistical Analysis 
6.17.1 Shannon’s entropy analysis A  full  description  of  Shannon’s  entropy  analyses  used  in  this  study  is  provided  in  the relevant chapters. Please refer to Chapter 2.1.3 and 3.2.2. 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6.17.2 Unpaired student’s t-test and One-way ANOVA All statistical analyses used excluding that in Section 6.17.1, was analysed with GraphPad 
Prism (v5.0c for Mac OSX, USA). Tests for significance are described in relevant figure 
legends throughout the study. The one way ANOVA analysis used a Tukey’s multiple 
comparison post-test to compare columns within groups, where P<0.05 is counted as 
significant.  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Appendices  
 
I. Nucleotide sequence of Vβ8.2­Dβ1 recombination cassette 
               
CACAGTGATGTGGGGTTTCCTCCCCTCTGCACAGAAAGGTTACATCACGTCATTTCACACTCGTTGTTAGAAATGTGGTGCATTC
TTCACCACCGTTCTAAGAAGTCCAGAGCCTAAGTTAGCCCCTTGAAAAGGCTCAAATTTGTCACACACAGAGTCTTGATTGTGGG
ACAAGGTATAACCTCTGAGTGACGCACAGCCTTAGGGCAAGGGCAAAGCTAGGCTAGATTGGGGGCTGTTACTTCTTCATAGG
GTGGTTCCCTTATATGACAAAAATTTGAGAAGGGCGGATACAAGAGGGAATCCAGCCCCTTCAGCAAAGATCATTTCAATGACA
CCCAGCGCCAAGAAAAAAGAACATTCAAAAGAAGAACAGGGGGTAAAGAGGAAACCCCTGCATTAGCTCGCATCTTACCACCAC
CTTGCACAATGGGGGTCGGGGGGGGATGTCACCTTCCTTATCTTCAACTCCCCCCCAGAGGAGCAGCTTATCTGGTGGTTTCTT
CCAGCCCTCAAGGGGTAGACCTATGGGAGGGTCCTTTTTTGTATAAAGCTGTAACATTGTG 
7 9 23 
mV 8.2 RSS 
9 7 12 
mD
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II. Sequences synthesised for βCDR1WT­Rec, βCDR2WT­Rec and βCDR1Δ­Rec recombination 
cassettes   
 
GGAGATCTACCACCATGGCCCCCAGGCTCCTTTTCTGTCTGGTTCTTTGCTTCTTGAGAGCAGAACCAACAAATGC
TGGTGTCATCCAAACACCTAGGCACAAGGTGACAGGGAAGGGACAAGAAGCAACTCTGTGGTGTGAGCCAATTTC
AGGACATAGTGCTGTTTTCTGGTACAGACAGACCATTGTGCAGGGCCTGGAGTTCCTGACTTACTTTCGAAATCAC
AGTGATGTGGGGTTTCCTCCCCTCTGCACAGAAAGGTTACATCACGTCATTTCACACTCGTTGTTAGAAATGTGGT
GCATTCTTCACCACCGTTCTAAGAAGTCCAGAGCCTAAGTTAGCCCCTTGAAAAGGCTCAAATTTGTCACACACAG
AGTCTTGATTGTGGGACAAGGTATAACCTCTGAGTGACGCACAGCCTTAGGGCAAGGGCAAAGCTAGGCTAGATT
GGGGGCTGTTACTTCTTCATAGGGTGGTTCCCTTATATGACAAAAATTTGAGAAGGGCGGATACAAGAGGGAATCC
AGCCCCTTCAGCAAAGATCATTTCAATGACACCCAGCGCCAAGAAAAAAGAACATTCAAAAGAAGAACAGGGGGTA
AAGAGGAAACCCCTGCATTAGCTCGCATCTTACCACCACCTTGCACAATGGGGGTCGGGGGGGGATGTCACCTTC
CTTATCTTCAACTCCCCCCCAGAGGAGCAGCTTATCTGGTGGTTTCTTCCAGCCCTCAAGGGGTAGACCTATGGGA
GGGTCCTTTTTTGTATAAAGCTGTAACATTGTGCAAGCTCCTATAGATGATTCAGGGATGCCCAAGGAACGATTCT
CAGCTCAGATGCCCAATCAGTCGCACTCAACTCTGAAGATCCAGAGCACGCAACCCCAGGACTCAGCGGTGTATC
TTTGTGCAAGCAGCGGAGGAGGTCAGGGGGCTCGGAGTCAAAACACCTTGTACTTTGGTGCGGGCACCCGACT
ATCGGTGCTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCA
AACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGT
GAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCC
TGAGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCC
ATGGGCTTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCC
TGGGGCCGAGCAGACTGTGGAATCACTTCAGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAG
ATCCTACTGGGGAAGGCCACCCTATATGCTGTGCTGGTCAGTGGCCTGGTGCTGATGGCCA 
TGGTCAAGAAAAAAAATTCCTGAGCGAATTCGG 
BglII START  
STOP EcoRI
CDR2WT-Rec 
CDR1 -Rec 
GGAGATCTACCACCATGGCCCCCAGGCTCCTTTTCTGTCTGGTTCTTTGCTTCTTGAGAGCAGAACCAACAAATGC
TGGTGTCATCCAAACACCTAGGCACAAGGTGACAGGGAAGGGACAAGAAGCAACTCTGTGGTGTGAGCCAATTTC
GGCAGGACACAGTGATGTGGGGTTTCCTCCCCTCTGCACAGAAAGGTTACATCACGTCATTTCACACTCGTTGTTA
GAAATGTGGTGCATTCTTCACCACCGTTCTAAGAAGTCCAGAGCCTAAGTTAGCCCCTTGAAAAGGCTCAAATTTG
TCACACACAGAGTCTTGATTGTGGGACAAGGTATAACCTCTGAGTGACGCACAGCCTTAGGGCAAGGGCAAAGCT
AGGCTAGATTGGGGGCTGTTACTTCTTCATAGGGTGGTTCCCTTATATGACAAAAATTTGAGAAGGGCGGATACAA
GAGGGAATCCAGCCCCTTCAGCAAAGATCATTTCAATGACACCCAGCGCCAAGAAAAAAGAACATTCAAAAGAAGA
ACAGGGGGTAAAGAGGAAACCCCTGCATTAGCTCGCATCTTACCACCACCTTGCACAATGGGGGTCGGGGGGGG
ATGTCACCTTCCTTATCTTCAACTCCCCCCCAGAGGAGCAGCTTATCTGGTGGTTTCTTCCAGCCCTCAAGGGGTA
GACCTATGGGAGGGTCCTTTTTTGTATAAAGCTGTAACATTGTGGCAGGAGTTTTCTGGTACAGACAGACCATTGT
GCAGGGCCTGGAGTTCCTGACTTACTTTGGAGCTGGTGCTCCTATAGATGATTCAGGGATGCCCAAGGAACGATT
CTCAGCTCAGATGCCCAATCAGTCGCACTCAACTCTGAAGATCCAGAGCACGCAACCCCAGGACTCAGCGGTGTA
TCTTTGTGCAAGCAGCGGAGGAGGTCAGGGGGCTCGGAGTCAAAACACCTTGTACTTTGGTGCGGGCACCCGA
CTATCGGTGCTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTG
CAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGG
GTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTG
CCTGAGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTT
CCATGGGCTTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGG
CCTGGGGCCGAGCAGACTGTGGAATCACTTCAGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATG
AGATCCTACTGGGGAAGGCCACCCTATATGCTGTGCTGGTCAGTGGCCTGGTGCTGATGGCCATGGTCAAGAAAA
AAAATTCCTGAGCGAATTCGG 
BglII
 
START 
STOP EcoRI  
GGAGATCTACCACCATGGCCCCCAGGCTCCTTTTCTGTCTGGTTCTTTGCTTCTTGAGAGCAGAACCAACAAATGC
TGGTGTCATCCAAACACCTAGGCACAAGGTGACAGGGAAGGGACAAGAAGCAACTCTGTGGTGTGAGCCAATTTC
AGGACATCACAGTGATGTGGGGTTTCCTCCCCTCTGCACAGAAAGGTTACATCACGTCATTTCACACTCGTTGTTA
GAAATGTGGTGCATTCTTCACCACCGTTCTAAGAAGTCCAGAGCCTAAGTTAGCCCCTTGAAAAGGCTCAAATTTG
TCACACACAGAGTCTTGATTGTGGGACAAGGTATAACCTCTGAGTGACGCACAGCCTTAGGGCAAGGGCAAAGCT
AGGCTAGATTGGGGGCTGTTACTTCTTCATAGGGTGGTTCCCTTATATGACAAAAATTTGAGAAGGGCGGATACAA
GAGGGAATCCAGCCCCTTCAGCAAAGATCATTTCAATGACACCCAGCGCCAAGAAAAAAGAACATTCAAAAGAAGA
ACAGGGGGTAAAGAGGAAACCCCTGCATTAGCTCGCATCTTACCACCACCTTGCACAATGGGGGTCGGGGGGGG
ATGTCACCTTCCTTATCTTCAACTCCCCCCCAGAGGAGCAGCTTATCTGGTGGTTTCTTCCAGCCCTCAAGGGGTA
GACCTATGGGAGGGTCCTTTTTTGTATAAAGCTGTAACATTGTGAGTGCTGTTTTCTGGTACAGACAGACCATTGT
GCAGGGCCTGGAGTTCCTGACTTACTTTCGAAATCAAGCTCCTATAGATGATTCAGGGATGCCCAAGGAACGATT
CTCAGCTCAGATGCCCAATCAGTCGCACTCAACTCTGAAGATCCAGAGCACGCAACCCCAGGACTCAGCGGTGTA
TCTTTGTGCAAGCAGCGGAGGAGGTCAGGGGGCTCGGAGTCAAAACACCTTGTACTTTGGTGCGGGCACCCGA
CTATCGGTGCTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTG
CAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGG
GTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTG
CCTGAGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTT
CCATGGGCTTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGG
CCTGGGGCCGAGCAGACTGTGGAATCACTTCAGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATG
AGATCCTACTGGGGAAGGCCACCCTATATGCTGTGCTGGTCAGTGGCCTGGTGCTGATGGCCA 
TGGTCAAGAAAAAAAATTCCTGAGCGAATTCGG 
BglII
 
START
STOP EcoRI
 
CDR1WT-Rec 
CDR1
CDR2
CDR3
Cassette
KEY
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III. qRT­PCR of cDNA from CD4+ T cells from FVB/N WT and TCRβ retrogenic mice 
from an H2k background measuring endogenous Vα segment repertoire 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